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 The emergence of field of nanomedicine for addressing the biomedical challenges created 
a toolkit which has been evolving dynamically with the advances in the medicine itself. At the 
heart of nanomedicine, nanoparticles exist which are envisioned to shift the paradigm of 
conventional therapy by furnishing the field with their unprecedented properties. On top of the 
promising features, nanoparticles can also simultaneously be endowed with imageability to track 
the success of therapy and hence a subfield in nanomedicine called “theranostic” advened in recent 
years. However, the obstacles in the translation of the nanoparticles such as batch to batch variation 
during scale-up, the lack of control over cargo release and particle instability slowed their 
application in real life. An approach is proposed here where these challenges can be overcome by 
designing nanoparticles which are inherently therapeutic without the encapsulation of the 
secondary drug while they can also be imaged by various imaging modalities. These nanoparticles 
are based on carbon dots and hafnium oxide which can be imaged with fluorescent imaging and 
CT imaging as two major imaging modalities in the clinic. The surface-modified nanoparticles 
were utilized in this thesis to work out the localized diseases (dental biofilm, bone microdamage) 
and systemic diseases problems. 
At first, I applied strategies from materials science to modify the chemical properties of the 
carbon dots and worked towards the improvement of their interaction with the cells/ cellular 
components. I next demonstrated that the chemical properties of these nanoparticles can be tuned 
iii 
 
easily depending on the desired outcome for multiscale, multicolor imaging. Then, I geared 
towards the specific biomedical issues which can benefit from these nanoparticles. I presented the 
work on using nanoparticles of hafnium for the detection of the dental plaque by typical dental X-
ray device based on a molecularly targeted approach toward carious bacteria. The therapeutic 
antibiofilm properties of these nanoparticles were established as well by comprehensive in vitro 
and in vivo studies. The inherently therapeutic nanoparticles of carbon which target the pH of the 
biofilm were investigated in the follow-up study without changing the diversity of the oral 
microbiota. 
The nanoparticles developed in the previous chapters were aptly surface functionalized and 
were used to target the bone microdamage in the following chapter. The distinct X-ray 
characteristic of the hafnium oxide nanoparticles made the detection of the damage viable in vivo 
using advanced CT technologies. Moreover, we showed that the nanobeacons of carbon dot can 
be used in the fluorescent microscopic evaluation of the bone damages ex vivo.         
Finally, the nanoparticle of inherently therapeutic carbon dots derived from certain algae 
was suggested to be used as activatable agents for the UV therapy of the cancerous skin cells.  
Together, these studies present the promise of the ‘inherently theranostic’ nanoparticles for 
the health-related issues. Therefore, the conveyed message which is built throughout this thesis is 
the unlimited opportunities for these agents which can be extended to the realm of the medicine 
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CHAPTER 1: INTRODUCTION 
1.1.Background 
1.1.1. What is nanomedicine? 
Nanotechnology is the manipulation of the materials on the nanoscale (1- 100 nm) to 
achieve the unprecedented properties that are not typically observed on the macroscale [1, 2]. One 
of the branches of the nanotechnology is nanomedicine which brings together scientists from 
various fields namely chemistry, biology, physics, and engineering to address the human’s health 
problems [3, 4]. The application of the materials on the nanoscale has increasingly garnered 
attention and has led to the miniaturization of the methods of diagnosis, therapy, imaging, 
vaccination, and medical devices in the recent years [5-7]. There is a surge of interest in 
nanomedicine products which are estimated to amount to more than 200 cases which are either 
under clinical trials or clinically approved [8-10].          
Nanoparticles can be tailored in various sizes, shapes, composition, surface properties and 
morphology [11]. One major classification for nanoparticles is based on their composition which 
can be either organic or inorganic. Organic nanoparticles include liposomes, polymeric NPs, 
carbon-based nanomaterials, and inorganic nanoparticles encompass metallic based NPs and 
quantum dots [12, 13]. 
The interest in the nanoparticles for the treatment in healthcare originates from the unique 
properties offered by them. They have a large surface to volume ratio which facilities the 
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absorption and carrying of multiple agents on their surface [14]. They have great potential to be 
applied as drug carriers so as to protect the drug and enhance their water solubility while adjusting 
the rate of delivery and release of their cargo [15-17]. Moreover, they have unique 
pharmacokinetics (PK) and pharmacodynamics and can overcome the hurdles posed by the tissues 
and cells [18, 19]. They can be designed to be stimuli-responsive and represent targeting moieties 
on their surface for attaching to the intended biomarkers [20, 21]. 
One approach in nanomedicine is to curb the imaging and therapeutic capabilities of the 
NPs simultaneously in a strategy coined as “Theranostics” which would enable the tracking of the 
therapy outcome in real-time [22-24]. This topic has been of great importance to a point to be 
included in the National Institute of Health (NIH) Challenge Grants in Health and Science 
Research part of the American Recovery and Reinvestment Act of 2009 [25].  
Considering all these exciting properties that NPs possess, it is easy to imagine that the 
gamut of the nanomedicine can be as extensive as the breadth of the clinical issues. Figure 1.1 
demonstrates the evolution of the translated NPs which are currently in use in the clinic [11]. Most 
of the approved NP carriers are based on lipids and polymers subsequent to the commercial success 
of Doxil in 1995 which is the PEGylated NP platform for doxorubicin [26]. 
1.1.2. Limitations of Nanomedicine 
Despite all the promises that the NPs hold, unfortunately, their translation to the clinic has 
been slow. This has been attributed to the several factors such as heterogeneity of the investigated 
disease (e.g. cancer), the lack of proper control and bias in most of the preclinical studies, lack of 
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proper theoretical models to describe the pharmacokinetics, and issues with the large-scale 
synthesis and not having reproducible results when tested in biological entities in the repeated 
trials [27-29].  
On the other hand, the human body is a complicated system and although the preclinical 
success of the NPs in the animal models might be promising, incidences such as protein absorption, 
particle instability, premature release and drug leaking might happen [30, 31]. More to it, the 
animal models which is all inclusive of the human conditions have not been reported to date [32, 
33].  
One strategy to overcome this issue could be to design the NPs which are therapeutic by 
themselves and can potentially act as contrast agents.    
1.1.3. Computed tomography and use of nanoparticles as contrast agents 
Computed tomography is one of the most widely used imaging methods in the clinic which 
utilizes the X-ray to image inside the body [34]. It is a favorable imaging modality due to its high 
depth of penetration, fast acquisition, and its capability for revealing the whole-body anatomical 
features [35].  
When the X-ray hits the material, it can interact in various routes (Figure 1.2): one of them 
being the lowering of the energy compared to the entering X-ray due to the energy absorption [36]. 
This attenuation is representative of the electron density of the material it interacts with: the high 
Z materials tend to attenuate X-ray more than low Z- materials [37]. The attenuation is proportional 
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to the attenuation coefficient which itself is described with 𝜇 =
𝜌𝑍4
𝐴𝐸3
 where Z is the atomic number, 
A is the atomic mass and E is the X-ray energy [38]. The attenuation is defined in a unit called 
Hounsfield unit which is formulated as 𝐻𝑈 =  
𝜇𝑜𝑏𝑗𝑒𝑐𝑡−𝜇𝑎𝑖𝑟
𝜇𝑤𝑎𝑡𝑒𝑟−𝜇𝑎𝑖𝑟
× 1000 [39]. Once the material absorbs 
more of X-ray it is shown as whiter on the X-ray film (radiopacity). CT employs the same concept 
in the imaging acquisition as 2D X-ray; however, the scanner rotates to generate X-ray images 
from various slices which are subsequently 3D reconstructed [37]. 
 
 
Figure 1.1. The timeline of the evolution of the nanoparticles applied in modern medicine. 




Although CT in its conventional form would provide general anatomical information, the 
HU might appear the same for various materials at different concentrations or thicknesses and 
thereby making their distinguishing difficult [40]. This is particularly important if one tries to find 
a mass of heavy anomaly (such as tumor calcification) against hard tissue. Therefore, the 
instruments have been emerging recently to compensate for this issue as elaborated in the 
following.  
1.1.4. Spectral computed tomography 
Another interaction of the X-ray with the matter is when the X-ray energy is so high that it 
can expel an electron from the innermost shell (K shell) of the matter. When this happens, the 
electron emitted is called the photoelectron while an electron from outer shell will fill in its 
vacancy. The energy being relaxed is characteristic of each of the material and is denoted as ‘K-
edge’ which is the binding energy of the K-shell [36]. At the K-edge the attenuation coefficient 
(described above) will undergo a drastic increase due to the photoelectric absorption of the 
photons. This sharp increase (Figure 1.2 B) has been utilized in the CT imaging of various 




Figure 1.2. The interaction of X-ray with the matter. (A) Of note is the generation of the 
photoelectrons whose energy is characteristic of matter and can be applied in K-edge CT imaging; 
(B) mass attenuation coefficient of various materials including Hf which is used in this thesis vs. 
photon energy.     Produced with permission from references [36, 42]. 
In the K-edge imaging double X-ray energy source is used to distinguish between the 
materials while in ‘photon counting CT’ or ‘spectral CT’ only one X-ray source is used and based 
on the K-edge of the material and the detection bins the sensor can segregate multiple materials 
simultaneously (Figure 1.3). 
The first dual-energy commercial CT scanner was introduced by` Siemens in 2006 [43] 
which was able to discriminate between calcium and iodine, detect bone, do kidney stone analysis, 
etc. [44-46]. However, there were problems associated with it such as increased radiation dose and 
false positive in the materials detection when they have close attenuation curves [47-49]. 
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Therefore, spectral CT has been developed to address some of the shortcomings in the dual beam 
X-ray where here only one X-ray beam is used for the generation of multicolor images.      
 
 
Figure 1.3. Single energy conventional CT vs. dual energy vs spectral CT. Reproduced with 
permission from reference [50]. 
In general, one method to enhance the diagnosis is the use of contrast agents. Although the 
use of high Z elements as contrast agent materials is now being practically pursued in the clinic 
(e.g. iohexol, iodixanol, ioxaglate, iothalamate [35]), for the utility of contrast agents for spectral 
CT, materials with certain Z number is more favorable. Most of the CT scanners have a tube 
voltage between 80-140 kV and it has been calculated that the most prominent response is 
generated for atomic numbers between 64-73. The lower atomic number materials simply do not 
yield enough contrast while the higher atomic numbers would lead to ‘photon starvation’ and 
‘beam hardening’ effects meaning that the photons are not sufficient for generating the images [51, 
52].    
8 
 
1.1.5. Hafnium nanoparticles 
Hafnium NPs are emerging inorganic nanoparticles which have been recently investigated 
for the cancer radiotherapy. The atomic number of Hf is 72 which allows the high X-ray beam 
blocking due to its high atomic number and electron density leading to the localized energy build 
up and the destruction of the tumor by the high energy dose deposition. The high energy deposition 
leads to the high electron production and reactive oxygen species generation which is one of the 
known methods to damage the tumor [53, 54]. Therefore, HfO2 NPs can be regarded as 
radiosensitizers to enhance the effect of radiation therapy.  
The most prominent radioenhancer in this family is NBTXR3 which is 50 nm crystalline 
HfO2 NPs functionalized negatively and being intratumorally injected in the solid tumor [54]. In 
radiation therapy, the most active mode for cancer cell apoptosis is through double-stranded DNA 
break which gets augmented in the presence of NBTXR3 [55, 56]. So far, these NPs have been 
employed in seven clinical trials namely: soft tissue sarcoma of the extremity and trunk wall (phase 
II/III) [#NCT02379845], head and neck cancer in elderly patients not eligible for chemotherapy 
[#NCT01946867], head and neck cancer in combination with chemotherapy [#NCT02901483], 
Hepatocellular carcinoma and liver metastasis [#NCT02721056], unfavorable intermediate risk or 
high risk prostate adenocarcinoma [#NCT02805894], locally advanced or unresectable rectal 
cancer [#NCT02465593], advanced head and neck squamous cell carcinoma or non-small cell lung 
cancer with PD-1 inhibitors [57-60].       
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Very recently (Oct 2018), phase II and III clinical trials for soft tissue sarcoma of the 
extremity and the truck wall was concluded effectively [58]. In this randomized clinical trial (180 
recruited patients), which included radiotherapy and then tumor resection, the response to the 
treatment was evaluated with a parameter called pathological complete response rate (pCRR). 
Accordingly, pCRR is the percentage of the patients with <5% of the residual viable cancer cells, 
which turned out to be twice for the HfO2 NP treated group.     
Despite the high potential for the Hf-based nanoparticles to be used in the clinic due to 
their favorable properties, the research has been scant and therefore further investigation is 
mandated in this regard.      
1.1.6. Functional Carbon Nanodots for Multiscale Imaging and Therapy1 
As an emerging class of carbon nanomaterials, carbon dots have garnered many 
researchers’ interests in the past decade due to their excellent biocompatibility, replete surface 
functional groups, water dispersibility, and unique photoluminescence. These extraordinary 
properties have opened new avenues for their advanced application in cell labeling, bioimaging, 
drug delivery, sensors, and energy-related devices. In this paper, we critically review recent 
advances in the synthetic strategies and the application of carbon dots for biological purposes, 
                                                 
1 This part of the thesis has been adapted from the following publication: 
Ostadhossein, F., & Pan, D. (2017). Functional carbon nanodots for multiscale imaging and therapy. Wiley 
Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 9(3), e1436.   
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specifically, imaging and therapy. Finally, a perspective has been given on the potential challenges 
facing the translation of these materials from the bench to the market.       
1.1.6.1. Introduction to carbon dots 
Since the introduction of fullerene, other classes of carbon nanomaterials such as carbon 
nanotubes (CNTs) [61],  graphene [62],  nanodiamonds [63, 64], Graphene oxide [65],  carbon 
dots [66] and, very recently, nanothread [67],  have generated a plethora of research interest due 
to their favorable properties that make them suitable for applications in composites, electronics, 
photonics and biomedicine. Of particular interest in this expanding family is the emerging class of 
carbonaceous nanomaterials denoted as carbon nanodots also known as carbon quantum dots or 
simply carbon dots (CDs, not to be confused with Cornell Dots also denoted as CDs [68]) which 
were initially obtained serendipitously in 2004 during the purification and separation of single 
walled carbon nanotubes (SWCNT) via arc discharge method [66]. From then on, CDs have been 
the subject of several biomedical applications at nanoscale (Figure1.4). It is important to demarcate 
the difference between CDs and a close neighbor of these particles, graphene dots (GDs). Despite 
their similarity in chemical and physical properties, GDs can be distinguished in that they are 
graphene fragments extending up to 100 nm in size and are generally more crystalline whereas 
CDs refer to particles with the aspect ratio of 1 and below 10 nm in diameter and are comprised of 
amorphous core with predominant graphitic or turbostratic sp2 hybridized amorphous carbon core 
[69]. This is in contrast with GDs whose core is majorly from graphene and graphene oxide sheets 
fused by sp3 carbon [70]. The abundance of surface functional hydrophilic groups such as 
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carbonyl, carboxyl, epoxy, and hydroxyl along with a quasi-spherical shape; ease of scale-up 
synthesis; and, above all, excellent biocompatibility make CDs potential candidate for biomedical 
applications. In addition, CDs have recently emerged as universal fluorophores by virtue of their 
excellent photostability, comparable sizes with biological entities and tunable photoluminescence 
properties which can make them competent to semiconductor quantum dots and a green fluorescent 
protein (GFP) [71].  
  In this brief review, we cover the synthetic methods of CDs and the current theories on the 
origin of the debatable nature of their unique photoluminescence. We proceed to highlight the 
recent advances in the application of CDs for in vitro and in vivo imaging by various preclinical 
and clinical imaging modalities. Finally, the application of CDs as novel drug and gene delivery 
carriers is discussed. 
1.1.6.2. Synthetic methods of carbon dots 
In general, the synthetic routes of CD can be divided into bottom-up and top-down approaches. 
Top-down approaches basically rely on the oxidative cutting of the carbon resources. A few 
examples include methods such as laser ablation [72], electrochemical reduction [73], metal- 
graphite intercalation [74] and arc discharge [66]. On the other hand, bottom-up approaches utilize 
the carbonization of a carbogenic material under certain conditions to yield CDs such as 
microwave irradiation [75], hydrothermal treatment [76, 77] surfactant extraction [78] and acid 
oxidation [79]. Versatile precursors have been studied for the synthesis of the CDs such as citrate 
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[80, 81], glucose [82],  glycerol [83],  candle soot [79], orange juice [84],  banana juice [85],  tea 
[86], caramel Nescafe® coffee [87] molasses [88] and honey [89] indicating the ease of production 
and the potential of scale-up for these nanoparticles. For more information on the synthetic 
strategies for CDs, readers are referred to the more comprehensive review papers on the CDs with 
focus on synthesis strategies [90-92]. 
 
Figure 1.4. Versatile application of carbon dots for biomedical applications. 
1.1.6.3. Optical properties of carbon dots 
Unfunctionalized or as-synthesized pristine CDs (i.e. with no surface passivation) 
generally indicate absorbance in the UV range (260–320 nm), with a tail extending into the visible 
range which is attributed to the π-π* transition of the aromatic C-C, while the shoulder at 300 nm 
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can be ascribed to the n-π* transition of the C=O bonds. Perhaps the most fascinating optical 
property of CDs is their intrinsic photoluminescence, whose origin is still a gray area and is the 
subject of huge controversy. CDs exhibit relatively symmetrical emission spectra on the 
wavelength scale and the emission peaks are wide with a stokes shift comparable to organic dyes. 
Interestingly, the emission spectra can be tuned by exciting the CDs at various wavelengths, a 
phenomenon known as wavelength-dependent behavior which can potentially be exploited for 
multiplexing [93-95]. Extensive research has been conducted to elucidate the extraordinary 
photoluminescent (PL) nature; the two proposed predominant mechanisms include the radiative 
recombination of surface confined electrons and holes leading to the creation of excitons and 
quantum confinement of emissive deep energy traps or conjugated π domain that become more 
emissive upon the astute choice of surface passivation method [96]. Other explanations are based 
on the presence of fluorescent molecules connected to the interior of the CDs[97] and the 
crosslinked enhanced emission (CEE) effect [98].   
Very recently, Xiong et al. [99]  attributed luminesce of their full- spectrum emitting CDs 
to the surface state. The high quantum yield CDs based on urea and p-phenylenediamine, were 
initially separated using silica column chromatography method. Subsequently, these batches were 
characterized by various methods in terms of their size, morphology and the presence of various 
chemical groups. The role of size and hence quantum confinement effect for justifying the 
observed multi-color emission by a single excitation source was opted out due to the comparable 
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size obtained from various batches. However, XPS investigation bolstered the effect of surface 
states on the PL properties. The authors postulated that various oxygen species would change the 
HOMO-LUMO band gap and therefore, would change the emission properties. This hypothesis 
was further confirmed through the variation of pH leading to the change in the 
protonation/deprotonation states. On the other hand, Bhunia et al. [100]  could tune the size and 
photophysical properties of CDs by the variation of multiple reaction parameters, namely, 
precursor and the corresponding concentration, temperature and solvent through a scalable 
method. They could achieve blue, green, yellow and red emitting CDs through systematic variation 
of the reaction conditions. They attributed this observation to the relationship existing between 
particle size and the sp2 domain in the sp3 bed. As the size increases; so does the sp2 domain, 
resulting in the increase of conjugated moieties leading to redshift in the emission spectra. They 
also emphasized the role of heteroatom on the extent of sp2 domains.  
Figure 1.5. demonstrates morphological features and some of the physicochemical 
characteristics of CDs. Despite the lack of knowledge about the radiation mechanism, CDs have 
already found their way in the in vitro and in vivo fluorescence imaging [101], Raman imaging 





Figure 1.5. Physicochemical characters of carbon dots. (A), (B) and (C) Typical TEM images of 
the CDs indicating semi-spherical morphology. In this case, carbon dots were prepared from 
modified thermal pyrolysis using citric acid as carbon source and polyene polyamine as passivation 
agent. (D) Shows the AFM height profile of the same particles. (E) Excitation dependent emission 
of carbon dots; The black, green, and blue curves correspond to the photoluminescence spectra for 
blue-, green-, yellow-, and red-emitting CDs, respectively. (F) the corresponding optical images 
under visible (left) and UV light (right; 365 nm). Reproduced with permission from (A-D) [103] 
and (E-F) [104].     
 
1.1.6.4. Multiscale bioimaging applications of carbon dots 
In the past few years, extensive research has been directed to exploit the luminescence 
properties of CDs which is urged by the demands in the progressive field of optical imaging. CDs 
are overtaking semiconductor quantum dots by virtue of their excellent biocompatibility as 
opposed to the potential cytotoxicity of conventional QDs due to the presence of heavy metals 
[92]. In addition, they surpass organic dyes in photostability and high quantum yield as well as not 
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indicating photobleaching and blinking artifacts [105]. The fluorescence properties of CDs are 
mainly dependent on the synthetic method and the type of surface passivation. In particular, CDs 
have demonstrated fluorescent emission in the NIR region known as “biological window” where 
the autofluorescence from hemoglobin and native tissue is minimal and thus signal to noise ratio 
can be enhanced while deep tissue penetration is also a feasibility.  
The first report on using CD as fluorescent labels in cells was demonstrated by Sun et al. 
[72]  where surface passivation was achieved by PEG1500N to stain Caco-2 cells. The confocal 
microscopy imaging revealed that the cells have internalized the CDs via endocytosis pathway in 
the cytoplasm with minor penetration in the cell nucleus. The CDs used in this study demonstrated 
4-10% quantum yield and they did not experience any blinking or photobleaching as compared 
with organic dyes and quantum dots. Subsequently, Sun’s group reported on the potential of CD 
in two- photon luminescence microscopy in the MCF-7 (human breast cancer) cell line (Figure 1.6 
A, B) [106]. The two-photon absorption cross section was estimated to be 39,000±5,000 GM 
(Goeppert-Mayer unit, with 1 GM 10-50 cm4 s/photon) at 800 nm. Furthermore, HepG-2 (human 
liver carcinoma) cells have been incubated with CDs and were imaged. Cell internalization of CDs 
was observed by confocal microscopy and even common fluorescence microscopy [107].  
Besides, conventional fluorescence microscopy, super-resolution microscopic techniques 
such as simulated emission depletion (STED) microscopy have been applied to indicate the sub-
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diffraction limit of fluorescent carbon dots with 60-80 nm feature size surrounding the nucleus 
[108]. 
 
Figure 1.6. (A-B) Two-photon luminescence image (800 nm excitation) of human ER(+) breast 
cancer MCF-7 cells with internalized Carbon dots;[106] In vivo fluorescence imaging of carbon 
dots in athymic nude mice using the NIR emitting CDs under various excitation wavelengths. 
Green is the autofluorescence signal from skin while red is signal from carbon dots. The animals 
were injected subcutaneously with the nanoparticles in 3 different sites as has been delineated with 
numbers. (K) The separation of signal from background taken under NIR (704 nm) excitation 
demonstrating the distinct signals from carbon dots representing an enhanced signal: noise due to 
the attenuation of the auto fluorescence from the tissue making the overall ratio more pronounced. 
1 represents the signal from the nanoparticles and 2 is the signal from the autoflouresence [109]. 
Reproduced with permission.  
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In addition to fluorescence imaging, CDs can be exploited for Raman imaging in cells 
[102]. The Raman sensitivity of CDs is ascribed to the presence of D and G bands which potentially 
offer multicolor imaging using this scattering-based technique. Our group has recently utilized this 
capability to track drug loaded CDs in cells [102]. Aside from these examples, CDs has also been 
used in conjunction with other contrast agents as hybrid probe such as being doped by Gd, a known 
T1 contrast agent, to serve as dual fluorescence and MR imaging probe [110]. In a completely new 
approach, our group utilized CDs as probes for hyperspectral dark field imaging for tracking the 
release of various model drugs (Figure 1.7) [111].   
Optical in vivo imaging has also been reported using fluorescent CDs. The first application 
of CDs as in vivo imaging probes was pioneered by the Sun’s group where three routes of 
administration (Intravenous, subcutaneous and intradermal) was applied to deliver PEG passivated 
CD and ZnS doped CD to make distinct contrast with the emission in the green and red region 
[101]. Following this report, many other studies were conducted to demonstrate the feasibility of 
in vivo imaging, an example of which is depicted in Figure 1.6C- K.   
Another example of in vivo imaging was reported by Wu et al. [112] with the quantum 
yield between 6-13% where the Near Infrared Imaging (NIR) method was utilized to map the 
Sentinel Lymph Nodes. The high quantum yield was achieved from honey- derived CDs which 




Figure 1.7. The proof of concept study on the application of hyperspectral imaging for the tracking 
of the drug- loaded CDs for quantitative and visualization assessments inside the cells (MCF-7). 
(A, B) indicate that signal from the drug loaded CDs could be detected in this imaging modality. 
These are the 3D demonstration. (C) side view, (D) top view, (E) horizontal axis of the same. (F-
J) are the same as (A-E) where the cellular features have been removed for better clarity. The 




The hyperbranched particles yielded better optophysical properties compared to their linear 
counterparts, probably due to higher surface area available for surface passivation as a result of 
the presence of polyester ligands. On the other hand, the in vivo results demonstrated sufficient 
uptake of the CDots by lymph nodes merely one minute after intradermal injection, yielding twice 
contrast enhancement. The inspection of the major body organs revealed that the particles followed 
a renal excretion pathway without creating adverse biological affects in vivo. The significance of 
the study lies in the reduction of time and burden of pain for the detection of nodes during sentinel 
lymph node biopsy.     
Photoacoustic (PA) imaging, as a hybrid imaging modality, enjoys the merits of both 
optical and ultrasound imaging for deep tissue penetration as well as high spatial resolution [113]. 
An ideal contrast agent for PA imaging should meet some criteria, such as high photon absorbance 
and efficient ability to convert light to heat [96]. In this regard, our group did a pioneering research 
on CD applications [85].  Specifically, we exploited the honey derived CD as contrast agent for 
PA imaging of sentinel lymph node to monitor the cancer staging in a real-time manner. The CD 
had reasonable lymphatic transport rate and also contributed to more than nine-fold enhancement 
in the PA signal over the rat’s blood suggesting the potential of CDs as contrast agents for PA 




Figure 1.8. Photoacoustic imaging using honey- derived CDs. (A) Red indicates the optical 
absorbance from blood. Blood vessel (BV), lymph vessel (LV) and sentinel lymph node (SLN) are 
shown by arrow. (B) is the 3D photoacoustic image after carbon dot injection. Panel (C) shows the 
accumulation of carbon dots in SLN [85]. Adapted with permission from the publisher. 
 
In a recent study, CDs demonstrated intrinsic targeting capability towards glioma and facile 
translocation across the blood brain barrier (BBB) which could be utilized for imaging [114]. The 
efficient accumulation of the CDs based on the 1:1 mixture of D-glucose and L-aspartic (denoted 
as CD-Asp) resulted in the promoted signal in C6 (glioma cells) vs. L929 (fibroblast) cells while 
the nanoparticles based on either of these precursors or L-Glutamic acid did not yield any 
specificity towards glioma cells in vitro. Subsequently, in vivo results in orthotopic C6 glioma-
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bearing mice revealed that the nanoparticles could pass through the BBB and get localized in the 
tumor site within 5 minutes after tail vein injection while they started to be systemically excreted 
after 15 minutes. The authors provided a tentative explanation on targeting mechanism of these 
CDs. Based on their hypothesis, the CD-Asp could be made more specific towards glioma cells 
due to the formation of an RGD- like functional group on the CD’s edge during the preparation 
from D-glucose and L-aspartic. RGD peptide (a tripeptide based on L-arginine, glycine, and L-
aspartic acid), are known to bind to αVβ3 integrin and demonstrate target specificity towards glioma 
cells. Overall, these studies corroborated the promise of CD as efficient optical nanoprobes.   
It is important to notice that the primary condition for the successful translation of an 
imaging probe lies in its biocompatibility. Based on the current assessment of the data in literature, 
it is quite established that CDs are generally nontoxic, and in some studies it was shown that the 
surface passivizing polymer worsened its toxicity profile [115, 116]. As already discussed, CDs 
surpass their QD counterparts in biocompatibility. In a recent study, the relative toxicity of three 
pristine nanomaterials were examined [117]. It was realized that toxicity of QDs>>Au 
nanoparticles>C-dots with IC50 values for normal NIH/3T3 (Mouse embryonic fibroblast) cells as 
0.98, 62, and 250 μg.ml-1, respectively. MTT and Trypan blue assay were utilized on HepG2 cells 
to evaluate the cytotoxic effect of CDs during 24 h incubation [118]. The cell viability upon 
exposure to 0.5 mg. ml-1 ranged between 90-100%. The concentration was increased to values as 
high as 102 and 103 times more than the dose required for bioimaging, suggesting the minimal 
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toxicity for bioimaging. In addition, Sun et al., explored the in vitro and in vivo cytotoxicity of CD 
[119]. MTT results revealed >80% cell viability for CD in MCF-7 for concentration of 0.1 mg.ml-
1. The in vivo results using CD-1 mice demonstrated that after 4 weeks of intravenous 
administration of CDs, no mice suffered from adverse clinical signs including anorexia, hair loss, 
scab, vomiting, or diarrhea. The bodies’ normal functions were not impaired compared to control 
group and were maintained at similar level irrespective of the dosage and time indicating no 
toxicity. Although the analysis of harvested tissue showed the presence of CDs in liver, spleen and 
kidneys, the level of accumulation was minor. Furthermore, Yang et al. [119] conducted a study 
on CD-1 mice for over 90 days. No mortality, lesion, or considerable weight change was observed 
at the dosage of 20 mg.kg-1. In a more recent study, athymic nude mice bearing subcutaneous 
SCC7 tumors, were exposed to CDs conjugated to NIR dye to track the fate of the CDs in vivo 
[120]. The nanoparticles were administered via three routes namely, intravenous (IV), 
subcutaneous (SC), and intramuscular (IM). All three routes were appropriate for the clearance of 
CDs, with IV being the fastest pathway. The system underwent rapid clearance, yet passive tumor 
targeting. The prime clearance route was through the kidney. Besides, reticuloendothelial system 
(RES) evaluation indicated the minimal uptake of particles by this route and rendered improved 
tumor to background ratio. Furthermore, tumor accumulation was higher in SC and IV injection 
than IM injection.       
One major issue associated with the nanoparticles is the clearance profile of the 
nanoparticles. For instance, for carbon nanotubes, (a closely related brethren of CDs), it is highly 
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probable that the nanotubes get stuck in the body and their accumulation overtime would lead to 
undesired results. Albeit this, CNT’s clearance is dependent upon factors such as their dispersion 
and their length [121]. For CDs, our recent report [122] has indicated the successful degradation 
of these particles through enzymatic activities of human myeloperoxidase in short time which 
could suggest the promise for the biodegradation. Although the current reports mainly validate the 
non- toxicity and high biocompatibility of CDs, the literature lacks the detailed systematic 
evaluation of the in vivo bio distribution to establish the clearance pattern and the mechanism of 
biodegradation. Specifically, there is a potential area of research for the assessment of their long 
term biocompatibility in large in vivo models and non-human primates as has been reported for 
other carbon family members such as detonation nanodiamonds [123]. Therefore, more 
mechanistic studies should further shed light on to their mechanism of their biocompatibility in 
the near future.”           
1.1.6.5. Carbon dots in drug and gene delivery  
CDs can also serve as a platform for controlled drug and gene delivery due to their high 
surface to area ratio, excellent biocompatibility, small size for being taken up by solid tumors and 
most importantly, being rich in surface functional moieties appropriate for the incorporation of 
various compounds for targeting strategies. These features combined with their bioimaging 
potentials have turned them into promising “theranostic” candidates. For instance, Zhou et al. 
[124], came up with a pH-responsive nanocomposites of CDs and mesoporous silica for drug 
delivery and optical imaging purposes. The DOX loaded CD gated nanocarrier exhibited enhanced 
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efficacy in treating cancer cells as the cargo was efficiently taken up by the cancer cells through 
endocytosis pathway as has been confirmed by fluorescence microscopy. Moreover, the 
nanocomposite acted as non- invasive vehicle for in vitro and in vivo tracking of the therapeutic 
agent. Zheng et al. [103] reported on the multifunctional theranostic agent with the conjugation of 
a variant of anti- cancer drug oxaliplatin (Oxa) on the surface of CDs. The formulation of Oxa was 
changed such that it incorporated carboxyl groups to react with amino functionalities of CDs. MTT 
assessment of the nanoformulation on HepG2 cells revealed the IC50=3.4 μg.ml
–1. The nanocarrier 
manifests the ability in eradicating 82.4% of tumor size after three days in vivo after two doses of 
CD-Oxa (0.72 mg.ml-1 of Pt, 20 μl) in Chinese Kun Ming (KM) mice injected with 
hepatocarcinoma 22 cell line (H22) liver cancer. In addition, during the course of treatment, the 
drug can be traced due to fluorescent properties of CDs which helps customize the injection time 
and dosage of medication.  
Very recently, Feng et al. [125] reported on the synthesis of charge convertible pH 
responsive CDOT carrier with the capability of being imaged by strong fluorescent signal of CDot. 
The nanoparticles release payload based on the reduction of pH in the tumor microenvironment 
compared to the healthy cells, a principle known as Warburg effect [126]. Their pH responsiveness 
of the nanoparticles basically originated from the coating applied on the CDot core. The CDot core 
was covalently conjugated to a model drug (cisplatin prodrug) through NHS/ EDC chemistry. This 
layer was carrying a positive charge. Subsequently, another negatively charged layer based on 
26 
 
PEG- (PAH-DMMA) was non- covalently bound to the first layer through electrostatic interaction. 
Upon exposure to the acidic environment of cancerous cells, the negatively charged coating would 
undergo hydrolysis to generate a positively charged polymer which can be dissociated from the 
positively charged drug- carrying core due to the electrostatic repulsion. In vivo studies in mice 
reveled the therapeutic effect of these nanoparticles in harnessing the tumor growth compared with 
control group. Furthermore, the histopathological assessments of the mice major organs revealed 
no particular abnormality while the tumor tissue indicated signs of tissue damage.              
Our group has pioneered on the application of luminescent carbon dots (LCN) for 
synchronized imaging and delivery of pentoxifylline (PTX), an anti-inflammatory drug which has 
been repurposed for targeting melanoma [102]. The surface tuning of the particles was achieved 
either by PNIPAM polymer which was labeled as temperature responsive (TR-LCN) set or 
multiarm polyethylene glycol (MA-PEG) called MA-PEG-LCN. Two nanoparticle surface 
coatings were compared with each other in terms of therapeutic efficacy and release pattern. Due 
to the choice of coating, LCN could emit in NIR region. The in vitro release behavior revealed that 
the two delivery systems contrasted in drug release behavior where MA-PEG-LCN exhibited 
higher loading efficiency compared to TR-LCN. Moreover, the total drug release in MA-PEG-
LCN particle was lower compared with TR-LCN. It was also realized that TR-LCN exhibited burst 
release at room temperature as opposed to gradual release at 37 °C. The authors conjectured that 
the former can be utilized for immediate therapy purposes. Subsequently, incubation of C32 
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melanoma cells with MA-PEG-LCNs and TR-LCN was executed and the cells were observed 
using infrared and Raman imaging where it was shown that the two formulations treated their 
cargo differently. Although MA-PEG-LCN indicated distribution all over the cells, TR-LCNs 
adopted more selective localization. No significant difference was conceivable in the imaging 
ability of TR-LCNs and MA-PEG-LCNs, although the stimuli- responsiveness of TR-LCNs can 
be exploited for therapeutic and imaging purposes simultaneously. The author further utilized the 
unique properties of CDs for ex vivo fluorescence, NIR and Raman imaging on the pigskin (Figure 
1.9). They could successfully image the TR-LCNs particles incubated in the pig skin where they 
observed homogenous distribution of the particles in the samples. Furthermore, as a proof of 
concept to show deep skin imaging in NIR region, pig skin treated with MA-PEG-LCNs were 
employed and they could localize signal at approximately 100 μm from the surface. Although 
similar experiment for TR-LCNs treated skin was impeded due to fluorescence quenching from 
the particles, it was concluded that the particles hold promise for further investigation in NIR 
imaging in vivo.  
Ostadhossein et al. [122] have applied a novel nanoscale host-guest chemistry approach on 
CDs to enhance the solubility of a highly hydrophobic Signal Transducer and Activator of 
Transcription factor 3 (STAT-3) inhibitor. In their work, niclosamide, a repurposed FDA approved 
antineoplastic agent was controllably delivered to inhibit STAT-3 pathway which is known to be 




Figure 1.9. Proof of concept experiment of using carbon dots for Raman tissue imaging. (A) The 
pig’s skin was incubated with NIR fluorescent carbon dots and were subsequently imaged using 
Raman vibrational imaging. (A) shows the schematics of the experiment indicating that after the 
injection of the nanoparticles to the skin, Raman imaging can be used to identify the chemical 
signatures on the surface while fluorescent imaging can indicate the imaging in depth. (B) is the 
average Raman spectrum of the I treated and II untreated skin with CDs. Panel (C) and (D) 
represent the image formed by the integration of the C-H peak (2900 cm-1) of the treated and 
untreated pig skin, respectively. Panel (E) and (F) are the corresponding 3D light sheet 
fluorescence images of untreated and treated samples demonstrating an enhancement of 100 μm 
inside the skin surface. LCN stands for luminescent carbon nanoparticles [102]. Reproduced with 
permission. 
 
They developed nanoplatforms based on carbon nanoparticles tethered with cucurbit[6]uril 
(CB6) as the molecular container to treat breast cancer model in vitro and in vivo. It was 
hypothesized that host-guest chemistry between cucurbit[6]uril and niclosamide makes the 
delivery of the hydrophobic drug feasible while carbon nanoparticles enhance cellular 
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internalization. Extensive physicochemical characterizations confirm successful synthesis. The 
~100 nm negatively charged pristine nanoparticles indicated almost no cytotoxicity in an MCF-7 
breast cancer model, a property highly desired for serving as the drug carrier. On the other hand, 
though, drug delivered by these agents demonstrated ca. two-fold enhancement in IC50 while 
increasing the cell apoptosis ~1.5 fold compared to free drug. In addition, the chemical features of 
CB6 and Nic were utilized for FT-IR chemical imaging in cells while unique fluorescence of 
CDots overlaid with the Raman spectra were employed to probe CDot in vitro. Using these 
imaging modalities allowed the authors to confirm the efficient cellular internalization of the 
agents as compared with the free formulation. Furthermore, to indicate the actual therapeutic 
efficiency on a preclinical level, athymic nude mice were intratumorally injected with CB6 CDot 
Nic, and their treatment was observed over the course of 40 days (Figure 1.10A). During this 
period, no mice suffered from adverse clinical effects, distress or weight loss compared to the 
control group, testifying to the lack of in vivo toxicity. After this period, the excised tumors were 
examined for their size (Figure 1.10B-J) and histological features (Figure 1.10K-M). 
The treatment group showed a controlled tumor growth of 200% vs. higher growth of 400% 
in DPBS group (Figure 1.10I). H&E staining revealed nuclear fragmentation and retracted 
cytoplasm in the nanoparticle treated group indicating the occurrence of apoptotic features in 




Figure 1.10. In vivo treatment of the MCF-7 tumor bearing mice with a STAT-3 inhibitor 
delivered via the host guest chemistry approach on the surface of the Carbon nanoparticles 
(CDots). (A) shows the treatment stages. (C), (E) and (G) represent the mice treated with saline, 
CB[6] drug (CB6 Nic) and CDots decorated with CB[6] delivering the drug (CB6 CDot Nic), 
respectively. A size reduction in the tumor is visible according to the data in (H-J). (K), (L) and 
(M) show the H&E staining of the tumor tissue treated with saline, CB6 Nic and CB6 CDot Nic 




Importantly, the downregulation of STAT-3 pathway was seen to occur through 
immunohistochemical assessment. In another study on the theranostic application of CDots, Misra 
et al. [128] synthesized CDots which could incorporate multiple functionalities in a single 
platform. The CDots used in this study was ‘enclosing’ β- carotene molecules, a terpenoid-based 
antioxidant with unique optical absorptive properties. These nanoparticles were further coated with 
a single layer of phospholipid for the enhanced cellular uptake and efficient interaction with the 
cell membrane. The design relies on the fact that carotenoid benefits from preferential uptake by 
the cellular membrane due to their ability to be deeply fused with the lipid hydrophobic center 
[129]. On the other hand, it possesses intrinsic therapeutic efficiency against cancer, demonstrating 
antioxidant as well as anti-metastatic properties. Furthermore, the abundant conjugated moieties 
would impart carotenoids with unique absorption signature peaks in the visible region. Considered 
together, the platform would integrate dual therapy and diagnostic capabilities due to the 
incorporation of β- carotene in CDs under both in vitro and ex vivo conditions. The biological 
assessment using MTT assay in human skin melanoma cells (C32) and late stage human breast 
cancer MDA- MB 231 cells, indicated significantly smaller IC50 values (300 ± 30 μM and 250 ± 






Table 1.1. Recent advances in the application of carbon dots for theranostic applications. 
 
Precursor QY Model Application Ref 







A549 lung epithelial cell 








Glycerol NA HeLa cells, PC-3 cells Gene transfection [133] 
Bovine serum 
albumin 





NA MCF-7 cells Drug delivery 
Photothermal therapy  
Biological imaging 
[135] 
Graphite NA HeLa cells, HEK 293T Drug delivery  
Donor of FRET pair 
Two photon imaging 
[136] 
Raw carbon soot NA MGC803 cells, MGC803 tumor-





Citric acid 21% HeLa cells, HepG2 cells, H22 









Cyanobacteria NA CHO-K1, COS-7, HepG2, and 
MCF-7 cells, CT26 tumor-bearing 
nude mice 
Drug delivery carrier [139]  
Citric acid 25.5% A2780 cells, U14 tumor-bearing 
Kunming mice 
Charge convertible 














2.3%  HeLa cells, HBE cells, HeLa 










19.7% U87MG cells, normal nude mice, 





Glucose NA DU145 human prostate cancer 
cells, C57BL/6 mice 








NA αvβ3 positive 4T1 cells and 
αvβ3negative MCF-7 cells, 4T1 






NA Human embryonic kidney (HEK) 
















Apple juice 4.27% M. tuberculosis, P. 
aeruginosa and M. oryzae cells 
Fluorescent imaging [147] 
Citric acid  75.8%  MCF-7 Cell nucleus imaging [148] 
Citric acid 
β-Ala 
22.5% HeLa cells, 4T1-luc2 tumor 










Moreover, these nanoparticles were tracked by vibrational spectroscopic methods where 
energy mediated pathway was considered to play a role in the nanoparticles’ cellular uptake. Cells 
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incubated with nanoparticles at 4°C demonstrated minimal uptake while the characteristic IR 
features of β- carotene became detectable upon incubation at 37°C, therefore taken as evidence for 
cellular internalization. The idea of multiplexing with these nanoparticles was further tested for 
fluorescence imaging of skin where the nanoparticle treated skin demonstrated marked signal 
distinguishable from intrinsic auto florescence. Overall, this strategy would bring together multiple 
functions into a single platform. Table 1.1 summarizes some of the researches executed using CDs 
as drug delivery, gene delivery or theranostic agent. 
1.1.6.6. Concluding remarks and future outlook on carbon dots 
In this review, the synthesis, basic properties, and the theories governing the luminescence 
properties of carbon dots have been briefly discussed. Moreover, more emphasis was placed on 
the application in the bioimaging and drug/ gene delivery. As the newcomer of the carbon family, 
this field is still at its infancy, and therefore there is room for tremendous research. The most 
perplexing feature of carbon dot is their photoluminescence properties whose origin is still 
controversial [151]. Therefore, there is an urge to carry out fundamental research in this area. This 
includes the determination of the contribution of the known mechanisms of the photoluminescence 
such as the quantum confinement effect, surface state and the fluorescent moieties on the surface 
and making a specific conclusion about the actual mechanism based on the type of the synthesized 
CDs. These are open-ended questions which requires more studies for developing theories. The 
outcome, of course, would revolutionize the field of bioimaging and other fields where CDs are 
potentially applicable such as optoelectronic devices and sensors which have not been covered in 
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this review articles. Another area of research interest would be to precisely curb the unique 
photoluminescence properties of CDs; an achievement that is still elusive due to the wide emission 
spectrum of CDs and their low quantum yield. This would require more standardized methods to 
tune the size, morphology and structure of these emerging nanodots. While studies at the frontier 
of biotechnology have proven the efficiency of the on these particles on in vitro and in vivo level, 
their true translation from bench to bedside would require clinical studies in human which have 
not been tried yet in literature. Albeit all the challenges and many unresolved issues, CDs hold a 
promising role for diverse applications ranging from nanomedicine and bioimaging to 
optoelectronic devices in the near future. 
1.2. Aims and Scope of the Thesis 
The nanoparticles in biological applications have a huge potential to change the face of the 
modern medicine. However, as discussed above, there are still many obstacles in their translation 
from bench to bedside. Problems such as drug leaking, lack of control over the release of the drugs, 
potential toxicities of the nanoplatforms, and lack of imageable signal from the nanoparticles urge 
us to develop new nanoparticles which are more amenable for biological purposes.   
The main objective of my dissertation is the synthesis and characterization of novel 
inherently theranostics for improved treatment of systemic and localized diseases. Specifically, I 
worked on the design, synthesis and characterizations of nanoparticles based on hafnium and 
carbon dots which can be utilized for the CT imaging and optical based fluorescent imaging as the 
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major workhorse for biomedical imaging in the clinic. Via the judicious choice of the precursors 
and the emancipation of the surface properties interesting therapeutic effects emerged which have 
been utilized to image and treat cancer, biofilm issues, and bone microdamages. This vast range 
of diseases has been investigated to highlight one message that there is no end to the possible 
opportunities of the nanoparticles for biomedical applications and they can overcome diseases 
from the localized level to the systemic level. The evidence for the efficacy of these nanoparticles 
has been derived from the vast in vitro and in vivo analysis in each case on the molecular, cellular, 
tissue and anatomical level. Throughout this thesis, I will describe both the fundamental 
understanding underpinning the materials behavior, the optimization of several of the desired 
properties and finally the application of these nanoparticles in various biomedical settings.  
In the first chapter of this document, the optimization of carbon dots has been pursued with 
special focus on the chiral properties which can govern the nanoparticles’ cellular internalization, 
their extent of cytotoxicity and their binding to the DNA grooves.  
In the Chapter 2, I delineated the potential of the nanoparticles for multiscale imaging 
which can range from cells to tissue to the anatomical whole- body imaging level. I showed in this 
chapter the utility of the carbon dots as probes in the hyperspectral dark field imaging for tracking 
and  
quantifying the drug being delivered in the cells. In another work, I indicated how another variant 
of the carbon dots which I coined as oligodots can be applied as multicolor imaging probes not 
37 
 
only due to their distinct fluorescent wavelength but also because of the differentiable fluorescent 
life time. I corroborated this utility in vitro in the cells, at the tissue level and ultimately in vivo.  
After demonstrating the concept of the malleability of the nanoparticles based on their 
chemical compositions and potential capability for imaging on the multiscale, I shifted my 
attention to three specific health- related issues and synthesized, optimized and applied novel 
nanoprobes for the early detection and treatment of those problems. I started off with the topical 
applications of the nanoparticles for combating bacterial dental biofilm which can be classified as 
a localized disease in Chapter 4. Specifically, in the first part of this chapter, I used hafnium-based 
nanoparticles which can specifically target the dental biofilm and would aid the dentists to 
recognize the biofilm mass during the routine X-ray examination while the therapeutic version of 
these nanoparticles was employed in vitro, ex vivo and in vivo for eradicating the dental plaques 
merely by topical application. On the other hand, a spin- off of this project with focus on 
engineered carbon dot was implemented where I verified its antibiofilm properties in vivo while 
still maintaining the microbiota diversity.  
In Chapter 5, I continued my problem-solving approach for the localized diseases while I 
proposed the utility of the developed nanoparticles in the previous chapters for, yet another health 
problem i.e. bone microdamages. Here, I demonstrated in the in vitro, ex vivo and in vivo models 
that modern CT imaging technologies combined with the nanoparticles proper choice of targeting 
ligands can ally to inform us of the location of the microdamages, which if go unnoticed may lead 
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to the catastrophic bone failure. Similarly, I indicated that the microscopic evaluation of the bone 
damages is possible using the targeted fluorescent carbon dots which can be a surrogate for the 
conventional dyes with multiple limitations (non-specificity, photobleaching, etc).  
In Chapter 6, I indicated how the natures’ own natural resources can be utilized in our favor 
to develop activatable nanoparticles for cancer treatment. In this chapter, I used carbon dots from 
algae which can be activated by the external UV source to generate cytotoxic chemicals in the 
cancerous cells to induce apoptosis.   
The final chapter (Chapter 7) the major findings from the studies carried out in this 




CHAPTER 2: PROPERTY TUNING OF NANOPARTICLES 
2.1. Chirality Inversion on the Carbon Dot Surface via Covalent Surface Conjugation of 
Cyclic α-Amino Acid Capping Agents2 
2.1.1. Abstract 
Manipulating the chiroptical at the nanoscale is of great importance in stereoselective 
reactions, enantioseparation, self-assembly, and biological phenomena. In recent years, carbon 
dots have garnered great attention due to their favorable properties such as tunable fluorescence, 
high biocompatibility, and facile, scalable synthetic procedures. Herein, we report for the first time 
the unusual behavior of cyclic amino acids on the surface of carbon dots prepared via microwave-
based carbonization. Various amino acids were introduced on the surface of carbon dots via EDC: 
NHS conjugation at room temperature. Circular dichroism results revealed that although most of 
the surface conjugated amino acids can preserve their chirality on negatively charged, ‘bare’ 
carbon dots, the ‘handedness’ of cyclic α-amino acids can be flipped when covalently attached on 
carbon dots. Moreover, these chiroptical carbon dots were found to interact with the cellular 
membrane or its mimic in a highly selective manner due to their acquired asymmetric selectivity. 
Comprehensive inhibitor study was conducted to investigate the pathway of cellular trafficking of 
                                                 
2 This part of the thesis has been adapted from the following publication: 
Ostadhossein, F., Vulugundam, G., Misra, S. K., Srivastava, I., & Pan, D. (2018). Chirality Inversion on the Carbon 
Dot Surface via Covalent Surface Conjugation of Cyclic α-Amino Acid Capping Agents. Bioconjugate 
Chemistry, 29(11), 3913-3922. 
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these carbon dots. Overall, it was concluded that chirality of amino acid on the surface of carbon 
dots could regulate many of the cellular processes.    
2.1.2. Introduction 
 
Surface modification of nanoparticles (NPs) has been established to demonstrate selective 
biological interactions [152]. For instance, the chirality of the modifying ligand of NPs is an 
important factor that dictates cellular interaction. Chiroptical nanoscale materials offer great 
potential in stereoselective reactions, memory applications [153], asymmetric catalysis [154], 
hyperbolic meta-surfaces [155], sensors [156], and plasmonics [157]. Different chiral properties 
of biomolecules may regulate how to interact with other biomolecules and thereby modulate a 
range of downstream processes. Since conformation and molecular reorganization play a critical 
role in these diverse application areas, the pursuit of developing novel materials with 
enantioselectivity is constantly rising. Chiral nanomaterials can be synthesized using molecularly 
imprinting methods, or by introducing chiral imprinting polymers [158, 159]. Some other 
techniques include enantiomeric biomolecular recognition using chiral CdSe quantum dots assays 
[160] or by using simple esterification reaction to achieve chiral nanoparticles [161].  
Conventional inorganic nanoparticles such as Au, Ag, CdSe, CdTe, PbTe etc. have 
attracted enormous attention owing to their unique optical and biochemical features [162].  
However, the concerns regarding toxicity, colloidal stability and environmental hazards attributed 
to heavy metals severely undermine their utility [163, 164]. Chirality-linked regulation of cellular 
metabolism and biological function further stresses the importance of designing safer 
nanomaterials with chiroptical properties. Carbon dots (CDots) have been proved to be extremely 
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useful in this direction due to ease of synthesis, being environmentally-friendly, and possessing 
interesting optical properties [71, 165-167]. 
With an overarching goal of synthesizing chiroptical carbon dots, herein, we report that the 
chirality on the surface of CDots could be achieved by chiral capping ligand while at the same 
time can be inverted by covalent modification using cyclic -amino acids (Scheme 1). The 
chiroptical properties could be altered by the capping ligands which can influence the chemical 
and electronic properties of Cdots [75].  
 
 
Figure 2.1. Chiroptical carbon dots. Covalent surface conjugation of cyclic α-amino acid leads to 




2.1.3. Experimental Section 
2.1.3.1. Materials and methods 
Sucrose, L-/D-proline, L-/D-phenylalanine, L/D-proline methyl ester, L-/D-cysteine were 
purchased from Sigma-Aldrich (USA). Dialysis cassettes, 10 kDa MWCO were purchased from 
Thermofischer (USA). All reagents were of analytical grade and used as received without any 
further purification. 
2.1.3.2. Preparation of CDots and AA@CDots 
Pristine CDots were synthesized by dissolving sucrose (1g) in 5 mL of nanopure water (18 
MΩ) and subjected to microwave irradiation in a domestic microwave oven for 10 min. Microwave 
power was set at 1200 W with an output power of 50%. The resultant deep brown mass was 
resuspended in 5 mL nanopure water followed by probe sonication (Q700TM, Qsonica Sonicators, 
CT, USA) (Amp:1, On 2 sec, Off 1 sec). The suspension was passed through a syringe filter with 
a 0.2 μm pore size (Millex ®, Merck Millipore Ltd., County Cork, Ireland) and then was subjected 
to dialysis (10000 Da cutoff) to remove unoxidized small molecules to afford a bright yellow 
suspension. 
 The chiral CDots, AA@CDots, were synthesized by conjugating each of the amino acids 
with CDots using EDC/NHS coupling. Briefly, to an aqueous suspension of pristine CDots (100 
mg in 10 mL), EDC.HCl (100 mg) and NHS (100 mg) were added and stirred at RT for 2 h to 
activate the CDots. To this, each of the amino acids, L/D-proline, L/D-phenylalanine, L/D-
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histidine, L/D-proline methyl ester, L/D-alanine, L/D-tryptophan and L/D-alanine were added and 
stirred for 24 h at room temperature. The unreacted amino acid and other reactants were removed 
by dialysis (MW cut off 2000 Da). The AA@CDots sample was freeze-dried and resuspended in 
aqueous media of known concentration for all the studies.  
2.1.3.3. Dynamic light scattering and Zeta potential measurements 
The hydrodynamic diameters and zeta potential of CDots were determined by a Malvern Zetasizer 
Nano ZS90 (Malvern Instruments Ltd., Worcestershire, UK). Scattered light was collected at a 
fixed angle of 90°. A photomultiplier aperture of 400 mm was used, and the incident laser power 
was adjusted to obtain a photon counting rate between 200 and 300 kcps. 
Only measurements for which the measured and calculated baselines of the intensity 
autocorrelation function agreed to within ±0.1% were used to calculate nanoparticle hydrodynamic 
diameter values. The averaged hydrodynamic diameter was obtained from the peak values of the 
number distribution for five successive measurements for each sample.  
For zeta potential measurements, the data were acquired in the phase analysis light scattering 
(PALS) mode following solution equilibration at 25 °C. Calculation of ζ from the measured 
nanoparticle electrophoretic mobility (μ) employed the Smoluchowski equation: μ = εζ/η, where ε 
and η are the dielectric constant and the absolute viscosity of the medium, respectively. 
Measurements of ζ were reproducible to within ±5 mV of the mean value given by 20 
determinations of 10 data accumulations. 
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2.1.3.4. UV-Vis and fluorescence measurements 
Ultraviolet-visible (UV-Vis) absorbance of CDots was recorded via GENESYSTM 10S UV-Vis 
Spectrophotometer (Thermo Scientific, MA, USA). The emission spectra of fluorescence 
measurements were obtained through NanoDrop 3300 Fluorospectrometer (Thermo Scientific, 
MA, USA). The excitation maximum was set to 360 nm and the wavelength covered an emission 
range between 400 and 750 nm.  
2.1.3.5. Fourier transform infrared spectroscopy (FT-IR) measurements 
For Fourier transform infrared spectroscopy (FT-IR) measurements, the aqueous suspensions of 
the CDots were drop-casted and dried onto MirrIR IR-reflective glass slides (Kevley Technologies, 
Chesterland, Ohio, USA). The measurements were performed using a Nicolet Nexus 670 FTI-IR 
(MRL facility, UIUC).  
2.1.3.6. X-ray photoelectron spectroscopy (XPS) 
XPS was obtained on a thick vacuum-dried layer of the NPs applied on the glass surface using 
Physical Electronics PHI 5400 spectrometer with Al Kα (1486.6 eV) radiation. The spectrum was 
referenced to the adventitious C 1s feature at 284.8 eV.  
2.1.3.7. Nuclear magnetic resonance (NMR) spectroscopy  
NMR measurements were performed on VARIAN UNITY 500 (Varian, Inc., Palo Alto, CA) 
spectrometer at RAL, UIUC. The machine operated at 500 MHz and was equipped with 5 mm 
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Nalorac QUAD probe. Chemical shifts were reported in ppm and referenced to the solvent proton 
impurities. The samples were freeze-dried and were redispersed in 600 μl of Deuterium oxide 
(D2O). A total of 256 acquisitions were made for 1H NMR, and the data were processed and 
analyzed with MestRenova 8.1 software (Mestrelab Research SL; Santiago de Compostela, Spain). 
2.1.3.8. Transmission electron microscopy (TEM) observation 
The samples for transmission electron microscopy (TEM) were prepared by placing a 10 μL 
aliquot of diluted stock of CDots suspension on 200-mesh Quantifoil® holey carbon grids 
(Structure Probe, Inc., PA, USA) for 1 min. The excess fluid was removed by a filter paper 
followed by drying of the sample. TEM images were recorded on JEOL 2010 LaB6 and JEOL 
2100 Cryo (JEOL Ltd., Tokyo, Japan) operating at 200 kV. 
2.1.3.9. Circular dichroism measurements (CD) 
Circular dichroism measurements of the aqueous suspensions were carried out in a 2 mm quartz 
cuvette with a Jasco 710 CD spectrometer (Mary’s Court Easton, MD, USA) at room temperature. 
For each sample, three measurements, each consisting of 5 sub runs were performed and the 
average spectrum is obtained from the software provided by the manufacturer. 
2.1.3.10. Lipid vesicle interaction with AA@CDots 
To mimic the cellular membranes, a lipid bilayer model study was carried out where L-α-
phosphatidylcholine (Soy PC) vesicles were prepared by hydration and sonication method. Briefly, 
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Soy PC (2mM) was dispersed in water and then the sample was sonicated for 5 min (2 sec on, 1 
sec off) until a transparent suspension was achieved. To simulate the interaction between the 
vesicles and the chiral NPs, CD spectroscopy was carried out on a Jasco 715 spectro-polarimeter 
(Mary’s Court Easton, MD, USA) using a quartz cuvette (Starna Cells, Atascadero, CA) with 2 mm 
pathlength. The nominal concentration of the amino acids on the NPs was adjusted to 1.9 mM. 20 
μl of CDot was added to 450 μL of vesicles and their spectra were recorded after full mixing. All 
spectra were acquired from 180 to 300 nm and are indicated as the average of three accumulations 
with the scanning resolution of 0.5 nm 
2.1.3.11. The effect of chiral inversion on biological processes 
Presence of chiral phospholipids, enzymes in charge of their synthesis, glycolipids, and sterols 
found in biological membranes make them distinctly chiral and can significantly regulate and/or 
facilitate the entry of foreign molecules or entities based on their chirality. [168] We performed 
experimental procedures to explore the extent of cellular entry of chiral carbon nanoparticles in 
the model in vitro cultures. Cellular enrichment of cell monolayer and their cell growth inhibition 
were studied by flow assisted cell assay and MTT assay respectively. 
2.1.3.12. Effect of CDot chirality on cell internalization 
MCF-7 cells (4 x 105) were grown in 6 well plate for 24h to gain ~80% confluence. Cells were 
treated with L-Pro@CDot, D-Pro@CDot, L-Phe@CDot, and D-Phe@CDot (1 mg/mL) for 4h. 
Experiments were performed in triplicate. At the end of the incubation, cells were trypsinized and 
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collected in 0.1% FBS containing DPBS. Cells were analyzed on GUVAVA flow machine under 
488 nm laser.  
2.1.3.13. The effect of CDot chirality on cell growth inhibition (MTT Assay) 
Induced cellular entry of D-Pro@CDot was further corroborated by their effect on cells 
growth inhibition by performing MTT assay. MCF-7 cells (10 x 103) were grown in 96 well plate 
for 24h to gain ~80% confluence. Cells were treated with L-Pro@CDot, D-Pro@CDot, L-
Phe@CDot, and D-Phe@CDot (1, 0.5 and 0.25 mg/mL) for 48h. Experiments were performed in 
triplicate. At the end of the incubation, cells were further incubated with 10% (v/v) MTT reagent 
(5 mg/mL) for 4h. Produced formazan crystals were dissolved in DMSO and absorbance was 
collected at 592 nm. % cell viability was calculated by the following formula: 
%cell viability = [(A592 cells treated with CDots- A592 DMSO blank)/ (A592 cells untreated - A592 
DMSO blank)] x 100 
 The % cell viability correlates indirectly proportional to cell growth inhibition and death 
implying the lower cell viability of D-Pro@CDot treatments with low viability and high cell death 
and growth inhibition.  
2.1.3.14. Inhibitor Studies 
The DOX- containing CDots were prepared by using the hot plate synthesis as stated 
previously while adding DOX (1 mg.ml-1) to decrease the cell viability further and observe the 
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effect of the inhibitors on the cell viability. If the pristine CDots were to be utilized extremely high 
concentrations of NPs were required. The surface of the CDots were then modified via EDC/ NHS 
chemistry as mentioned before with the amino acid of interest.   
MCF-7 cells grown for 24 h in 96 well plates were treated with various endocytic inhibitors 
(sodium azide/ 2-Deoxy-D-glucose (NaN3/DOG): 10/50 mM, Dyansore hydrate: 80 μM, 
Chlorpromazine (CPM): 28 nM, Nystatin: 180 nM, Methyl-β- cyclodextrin: 2 µM, Cholesterol: 1 
µM) for 1 h. The old media was replaced with the NP suspensions (1 mg.ml-1). MTT assay was 
conducted as previously described to assess the cell viability after 48 h in the absence or presence 
of NPs. 
2.1.4. Results and Discussion 
Negatively charged, ‘bare’ CDots were synthesized by the microwave irradiation of sugars in a 
facile route to produce particles having an excellent aqueous solubility, and stable luminescence 
emission. During the synthesis, gradual degradation of carbohydrate molecules occurs resulting in 
nucleation of CDots with a dense abundance of hydrophilic functional groups, e.g. carboxylate, 
hydroxyl, and esters. For chiral capping, the carboxylates on the surface of pristine CDots were 
subjected to carbodiimide-mediated activation using N-hydroxy succinimide (NHS) and 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDCI) (Figure 2.1). The amino acid conjugated chiral 
CDots, AA@CDot (L/D-AA@CDot, AA= proline (Pro), phenylalanine (Phe), histidine (His), 
tryptophan (Trp), alanine (Ala) and proline methyl ester (ProOMe)) were synthesized by the 
49 
 
controlled incubation of the activated particles with amino acids which resulted chirality on the 
nanoscale surface. Interestingly, the utilization of cyclic α-amino acid in this step results in a 
chirality inversion as confirmed by circular dichroism studies (vide infra). The calculations for the 
density of modification per nanoparticle are provided in the supporting information. 
 
Figure 2.2. The synthetic scheme used for the conjugation of the AA on the surface of CDots. 
  
The hydrodynamic diameter measured by dynamic light scattering (DLS) indicated that they 
were sub 10 nm (Figure 2.2 A, B). The hydrodynamic diameters (number averaged) of unmodified 
CDots were 8 ± 3 nm while the L-/D-Phe@CDot and L-/D-Pro@CDot were found to be 14 ± 4 
nm and 10 ± 3 nm, respectively. Anhydrous diameters of the AA@CDots were obtained from 
transmission electron microscopy (TEM) measurements. TEM analysis showed that the 
AA@CDots are nearly spherical and uniform with a narrow size distribution. TEM did not show 
any sign of self-assembled nanostructure with the chiral orientation. As indicated in Figure 2.2 C, 
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D (Figure 2.2 C: L-Phe@CDot and Figure 2.2 D: D-Phe@CDot). The CDots from L-/D-
Phe@CDots and L-/D-Pro@ CDots showed a diameter of 13 ± 3 nm and 10 ± 3 nm, respectively. 
These results agree with the DLS measurements in size increase after AA conjugation. The 
increase in size might be because of multi layers of AA on the surface of CDots and not necessarily 
a monolayer. The anhydrous and hydrodynamic diameters are reported in Table 2.1.  
Table 2.1. Summary of the size, electrophoretic potential and CD signals of various AA@CDots 
 
Dav: hydrodynamic diameter; : zeta potential; 
 
Figure 2.3 E, F show the UV-Vis spectra of the L-/D- Phe@CDot and L-/D- Pro@CDot, 
respectively. The characteristic strong absorption peak of unmodified CDots appeared at 282 nm 
related to n-π* transition of the carbonyl group. This peak for the L- and D-Phe@CDot was slightly 
blue-shifted and appeared at 275 nm and 273 nm, respectively; presumably due to change in 
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surface chemistry (Figure 2.3 E). The same trend was observed for the conjugated L- and D-
Pro@CDot. This hypsochromic shift could be due to the substitution of the surface groups with 
the electron withdrawing group because of conjugation. The normalized fluorescence spectra of 
the chiroptical CDots were recorded by exciting at λex = 350 nm since at lower excitations 
biological materials would interfere. The emission was monitored within λem = 400-800 nm (Figure 
2.3 G, H). The unmodified CDot displayed a strong emission at 489 nm while the L-/D-Phe@CDot 
displayed an emission at 486 nm (Figure 2.3 G).  
To get further insight into the chemical composition of the synthesized NPs, multiple 
characterization tests were carried out. First, 1H NMR studies were conducted in D2O (Figure 
2.3A).  
For CDot spectrum, peaks occurring in the range of 3.5-4.2 ppm could be due to protons 
adjacent to hydrophilic functional groups such as hydroxyl, ether, etc in the CDots structure after 
the carbonization. It is hypothesized in general the steps involved in CDot formation are 
dehydration, polymerization, carbonization, and passivation during which an abundance of 
hydrogen functional groups is introduced. The comparison of native proline NMR peaks and the 
Pro@CDot peaks revealed that the peaks have moved downfield due to the increased de-shielding 
upon conjugation at site 1. This effect is particularly prominent on protons at site 2 and 5 
accompanied by line broadening. This is probably originating from the slower tumbling at larger 
sizes of NPs thereby losing the peak resolution. [169] From 13C NMR spectroscopy (Figure S2.1) 
it can be comprehended that the comparison of Pro and Pro@CDots the peak at 175 ppm is 





Figure 2.3. Characterization of the chiral CDots. (A) and (B) the hydrodynamic diameter of the 
CDots as measured by dynamic light scattering; (C) and (D) the anhydrous morphology of the 
CDots by TEM indicating nearly spherical nanoparticles; (E) and (F) the UV-Vis absorption 
spectrum of the achiral NPs in water and upon conjugation with the chiral ligands (NP 
concentration= 1μg.ml-1); (G) and (H) the emission profile of the NPs in water under 




Moreover, X-ray photoelectron spectroscopy (XPS) was employed to demonstrate the surface 
chemical composition of the NPs (Figure 2.3C, Figure S2.2). In the survey spectrum, C, N, and O 
elements were detected. The spectrum was referenced to the adventitious C1s at 284.8 eV to 
account for the charging effects [170]. The C-C hydrocarbon and C-H peaks were detected at 285 
eV while C=O peak was observed at 287.5 eV. The peak around 286 eV can be attributed to C-O 
and/ or C-N (Figure 2.3D). Besides, the decomposition of N1s peak revealed the amide N occurring 
around 400 eV (Figure 2.3F).  
FTIR spectrum of AA@CDots was performed to understand the surface functional 
composition and to affirm the success of conjugation. As shown in Figure 2.3 B, the FTIR 
spectrum of L-Pro@CDots illustrated the characteristic peaks such as stretching vibrations of O-
H/N-H at 3298 cm-1, C-H at 2935 cm-1 and C=C at 1550 cm-1. The characteristic stretching 
vibrations of C=O at 1647 cm-1 and C-N stretching of the amide group at 1431 cm-1 confirmed the 
covalent conjugation of the amino acids to the CDots. The peak at 1074 cm-1 is the stretching peak 
of C-O-C bond. The unmodified CDots have the C=O stretch of the carboxylic acid group at 1670 
cm-1 which gets shifted to 1647 cm-1 upon the carbodiimide-activated coupling reaction. 
The chiroptical activity of the AA@CDot was investigated by recording their circular 
dichroism (CD) spectra. Firstly, CD of pristine CDots did not indicate any inherent chirality 
(Figure S2.3). The structure of the capping amino acid (L- or D- enantiomer) had a pronounced 
effect on the CD spectra of the AA@CDot. As shown in Figure 2.4A, L- and D-Phe conjugated 




Figure 2.4. Chemical properties of the as-synthesized CDots and AA@Cots. (A) 1H NMR 
spectrum indicating the de-shielding of the protons in Pro in the proximity of CDots upon 
conjugation; (B) FT-IR peaks of the Pro@CDot confirming the success of amidation; (C) The 
survey XPS spectrum of Pro@CDots and the narrow scan of (D) C1s and (F) N1s. 
 
The CD spectra of free L- and D-Phe showed, as expected, near symmetrical spectra with a positive 
and negative cotton effect, respectively, at 215 nm. The sign of CD signature from L-/D-
Phe@CDot were similar to their parent L-/D-Phe, respectively, with a slight blue shift of the peak 
maxima/minima of ~5 nm. Similarly, in the case of other AA@CDots, L-/D-Ala, L-/D-Trp@CDot, 
L-/D-His@CDot and L-/D-Cys@CDot exhibited similar CD peaks following those of parent 
amino acid (Figure S2.4-2.7). Contrastingly, in the case of L-/D-Pro@CDot, we found that the L-
Pro@CDot displayed a negative cotton effect while the free L-Proline showed a positive cotton 
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effect. Similarly, D-Pro@CDot displayed a positive cotton effect which is opposite to that of D-
Proline. 
To further explore the scope of the CD inversion, we studied the CD of L-/D-ProOMe@CDot 
with respect to free L-/D-Proline methyl ester. We observed CD band for L-ProOMe@CDot to 
have a negative cotton effect while free L-Pro methyl ester displayed a positive cotton effect in the 
same wavelength (Figure S2.8). Similarly, D-ProOMe@CDot displayed a CD band of opposite 
sign as compared to free D-Proline methyl ester. Thus, we can observe that when the capping 
ligand has a secondary amine, as in the case of L-/D-Proline and L-/D-Proline methyl ester, the 
CD peak for the resultant L/D-Pro@CDot and L-/D-ProOMe@CDot was inverted to that of the 
corresponding free amino acid. When the capping ligand involved a primary amine containing 
amino acid, we did not observe this chiral inversion.  
 
Figure 2.5. The chiroptical properties of (A) phenylalanine and (B) proline enantiomers and their 
respective chiral CDots.  
This process can be explained based on the generation of a highly strained intermediate during 
surface conjugation of amino acid via carbodiimide coupling in case of cyclic amino acid and is 
possibly due to the chirality inversion of amino acid itself. It is presumably allowing the ring 
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structure of amino acid to ‘flip’ its chirality leading to inverse handedness which could be detected 
on CDots. Extensive circular dichroism studies revealed that this inversion of chirality can only be 
observed for L-/D-Proline and L-/D-Proline methyl ester. A similar effect was not seen for 
cysteine, phenylalanine, tryptophan, and histidine. (Table 2.1) The chiroptical properties, in this 
case, are not merely an additive effect of the tethered chiral ligand electronic state and achiral 
CDots. Moreover, the dilution of the Pro@CDots did not affect the CD signal and therefore it was 
concluded that chiral aggregation or self-assembly of the Pro@CDots were not the causes of the 
observed chirality inversion (Figure S2.9). Hence, it can be concluded that the chiral inversion 
heavily depends on the arrangement of the chiral ligand at the nanoscale, possibly a stable 
orientation of the transition state and not necessarily reflect the original chirality of the organic 
capping agent.  
Having demonstrated that the configuration of the ligand on the CDot would undergo change 
compared to the original ligand, it is imperative to investigate the effect of this change in the 
chirality- associated cellular metabolism [171]. The presence of chiral phospholipids, enzymes, 
glycolipids, and sterols in biological membranes can significantly regulate and/or facilitate the 
entry of foreign molecules or entities based on their chirality [172]. We explored if the intracellular 
trafficking of chiroptical CDots gets influenced by the membrane chirality. We hypothesized that 
the chirality inversion on D-Pro@CDots will be recognized by the similar asymmetric features 
present in the cellular membrane and may lead to higher cellular internalization. An improved 
cellular internalization of D-Pro@CDots compared to L-Pro@CDots will lead to higher 
intracellular concentration and in turn may result in higher cell growth inhibition. Cellular 
enrichment of cell monolayer and their cell growth inhibition were studied by flow assisted cell 
sorting (FACS) and MTT assay, respectively. Induced cellular entry of D-Pro@CDots was 
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corroborated with their effect on cell growth inhibition by performing MTT assay. MCF-7 cells 
were treated with L-/ D-Pro@CDot, L-/D-Phe@CDots and CDots (1, 0.5 and 0.25 mg. mL-1) for 
48h. Cell viability correlates indirectly with cell growth inhibition and death, implying the lower 
cell viability of D-Pro@CDots treatments with low viability and high cell death and growth 
inhibition at the concentration of 1 mg. mL-1 (Figure 2.5A, B).  
 
Figure 2.6. The MTT assay and their comparison for (A) Phe@CDot series and (B) Pro@CDot 
series (p-value<0.001 is indicated by **); The flow cytometry indicating the interaction of the 
MCF-7 cells treated with (C) control (D) D-Phe@CDot (E) D-Pro@Cdot (F) L-Phe@CDot (G) L-




To further understand the interaction of the cellular membranes with the CDots a simplified 
model of the cell membrane was devised using lipid bilayer vesicles. L-α-phosphatidylcholine 
(Soy PC) vesicles were prepared by the facile dispersion of lipid in water and subsequent 
ultrasonication. The native CD spectrum of the vesicle was recorded first as the dominant signal 
and the effect of CDot addition was observed. The native CD features of lipid were evident in the 
range of 180-200 nm (Figure 2.6). 
As can be inferred from the spectra, only the addition of D-Pro@CDot to the lipid vesicle 
would result in the change in the CD signal from lipid. In contrast, the other AA@CDots did not 
inverse the signal from lipid membrane. Hence, this result corroborates the previous observation 
in the cell, where the chiral inversion of the L-Pro@CDots directly affected the cell’s viability.  
Furthermore, we investigated the cellular entry as a function of fluorescence from NPs in the 
model in vitro cultures (Figure 2.5C-H). MCF-7 cells were treated with L-/D- pro@CDots, L-/D-
Phe@CDots, L-Phe-CDots, and CDots at a concentration of 1 mg.ml-1 for 4h. Flowcytometric 
analysis (488 nm) revealed that D-Pro@CDots were able to enrich maximum cell population. This 
observation is presumably because of chiral inversion of D-Pro@CDots mimicking the 
asymmetric signature of L-isomers and L-chirality of cell membranes allowing their facile cellular 
entry. 
Similar behavior was observed for D-Phe@CDots, however, the effect was not as pronounced 
as Proline case presumably due to lack of cyclic amino acid. Both the biological processes of 
cellular internalization and cell growth inhibition were found to be directly proportional and 




Figure 2.7. CD spectra of the interaction of the chiral NPs with the L-lipidic base vesicles. It can 
be concluded that the D-proline effectively interacts with the L-lipid due to the similarity in chiral 
features. 
The extent of chirality dependent cytotoxicity was found to be statistically significant by both cell 
viability assay and later by FACS analysis at a certain particulate concentration (Figure 2.5B, 
p<0.001). This observation was found to be consistent with the results obtained from the flow 
cytometric analysis. The chirality dependent cyctotoxicity is a consequence of cellular 
internalization and should be directly proportional to this characteristic. The cellular 
internalization process follows multiple steps and one of the first steps is the adhesion to the 
cellular bilayer followed by an endocytic uptake. This internalization process will be highly 
dependent on the availability of the particles at the cellular bilayer and the abundance of chirality 
on the surface of the carbon dots. As a result of this complex particle-cell surface interaction and 
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abundance of chirality, finding the optimized concentration is non-trivial and out of the scope of 
this preliminary communication. 
Finally, the trafficking of the CDots containing doxorubicin (DOX) modified with various 
aminoacid enantiomers was investigated using a thorough inhibitor study (Figure 2.7). DOX was 
used during the preparation of the CDots to decrease the cell viability more effectively than CDots 
themselves. The high cell viability of MCF-7 in the presence of pristine CDots would bar us from 
observation of the actual effect of the surface modification by amino acids. Based on our previous 
studies, we concluded that DOX incorporation does not have any effect on the preference of the 
nanoparticles for selecting certain pathways in cells [173]. 
 
Figure 2.8. MTT cell viability of the cells pretreated with various endocytosis inhibitors after 48 




The MCF-7 cells were treated with various pharmacological inhibitors for 1 h prior to being 
exposed to the nanoparticles and their internalizations. The extent of the uptake of the NPs would 
determine the cell viability and the more effectively the pathway would block the NPs (Figure 
2.8), the higher the cell viability will be. The adopted chemicals are responsible for inhibiting the 
following endocytosis pathways: Sodium azide/ DOG: energy dependent pathway, Nystatin: 
clathrin mediated endocytosis, Chlorpromazine: clathrin independent endocytosis, Dynasore: 
dynamin-dependent endocytosis, Methyl- β- cyclodextrin: Lipid raft mediated endocytosis, 
Cholesterol changes the rigidity of membrane.   
From the student’s t-test analysis, it became clear that D-Pro@DOX CDots have preference 
to be taken by dynamin-dependent endocytosis as the cells pretreated with Dynasore indicated 
significantly different cell viability as NP treated cells. On the other hand, the cells treated with L-
Pro@Dox CDots, D-Phe@DOX CDots and L-Phe@DOX CDots did not indicate preference for 
any of the pathways investigated. It was also noticed that conjugated D-amino acid preferred the 
cellular entry with dominance in case of Pro@Dox CDots. 
2.1.5. Concluding Remarks 
Chirality plays a prominent role in chemistry in biology. In summary, we synthesized the CDots 
via the facile microwave carbonization and subsequent surface modification with a gamut of amino 
acids. We report for the first time the unprecedented chirality inversion of cyclic amino acid when 
conjugated to the surface of carbon dots. Various physicochemical measurements confirmed the 
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transfer of handed-ness from surface conjugated amino acids to achiral carbon dot.  The inversion 
was proposed to be the result of the generation of a highly strained intermediate during surface 
conjugation of amino acid via carbodiimide coupling. We observed that the chirally inverted D- 
proline would interact preferably with L-membrane of the cells or its mimic of liposome. As chiral 
molecules are critically important in chemistry, biology, and medicine, this study will further help 
to understand how enantiomerically pure chiral nanoscale materials can be synthesized while 





2.2. Synthesis of Chiral Carbo-Nano-Tweezers for Enantiospecific Recognition and DNA 
Duplex Winding in Cancer Cells3   
2.2.1. Abstract  
Targeting the DNA of tumor cells with small molecules may offer effective clinical 
strategies for transcriptional inhibition. We unveil synthesis and characterization of ~20 nm chiral 
carbon nanoparticles for enantiospecific recognition of DNA. Our approach inculcates chirality in 
carbon nanoparticles by controlled tethering of minor groove binders, i.e. TrÖger’s base.  The 
chiral particles positively enriched the cellular nucleus in MCF-7 breast cancer cells irrespective 
of the TB asymmetry tethered on the particle surface but negatively- induced chiral carbon 
nanoparticles exhibited improved efficiency at inhibiting cell growth. Further studies indicated 
that these chiral particles act as nano-tweezers to perturb the genomic DNA and induce apoptosis 
cascade in cancer cells.  
2.2.2. Introduction 
Biological functions of genomic DNA are found to be associated with its elastic properties 
[174-178]. Bending and twisting of genomic DNA lead to the structural changes which can affect 
DNA’s interaction with the cell machinery and particularly transcription system [179-182]. This 
effect can be functionally supported by evaluating the post-inhibited transcriptions. Cancer cells 
are generally identified with uncontrolled divisions via repetitive transcriptions. Induced twisting 
and torsions may inhibit unwinding of DNA during transcription cascades and it can play 
important role in impeding cancer cell divisions and eventual tumour regression [183-187]. 
                                                 
3 This part of the thesis has been adapted from the following publication: 
Tripathi, I. §, Misra, S. K.§, Ostadhossein, F., Srivastava, I., & Pan, D. (2018). Synthesis of Chiral Carbo-Nanotweezers 
for Enantiospecific Recognition and DNA Duplex Winding in Cancer Cells. ACS applied materials & interfaces, 
10(44), 37886-37897. 




Targeting the DNA of tumour cells with small molecules has been one of the most effective clinical 
strategies for transcriptional inhibition [188]. 
One group of small molecules which have emerged as an answer to this question are the 
groove binders [189, 190]. These molecules are known to interact with specific regions of the 
genome and show significant in vitro and in vivo toxicity towards cancer cells. Molecular 
asymmetry is another important factor to determine the fate of DNA interactions where one 
enantiomer could be better in binding genomic DNA compared to the other and/ or a racemic 
mixture [191, 192]. It is fundamentally interesting to see if enantiospecific recognition of DNA 
can be bestowed by chiral particles presenting groove binders at their nanoscale and help induce 
apoptosis cascade in cancer cells [193, 194]. It will also be interesting to reveal potential of this 
chemistry on surface as previous reports have shown the advantageous expression of other 
chemistries at nanoscale [195, 196].  
 
Figure 2.9. Schematic representation of plausible pathways of CNTWZ interaction with 





Although studies with gold nanoparticles (GNPs) assembled via DNA sequences have been 
used for enhancing plasmonic CD signal in the visible range [197], chiral mesoporous silica 
nanoparticles in delivering doxorubicin [198], chiral selectivity of delivering MDR-siRNA for 
reversal of multidrug resistance [199], among others are known to show changing interaction 
patterns of chiral nano-chemistries and biological systems, but influence of surface chirality of 
carbon nanosurface with DNA duplex in influencing cancer cell growth is not well studied yet.  
Towards this goal, in this work, we disclose synthesis of chiral carbon nanoparticles 
"Carbo-Nano-Tweezers" (CNTWZ) for the inhibition of transcriptional processes leading to 
cancer regression with or without induced apoptosis cascade (Figure 2.9).   
 Our approach inculcates chirality in carbon nanoparticles by controlled tethering of chiral 
molecules, i.e. TrÖger’s base. It is a diamine, which exhibits chirality due to the presence of two 
bridgehead stereogenic nitrogen atoms and resembles a unique tweezer shaped geometry. TrÖger’s 
base geometry makes it pertinent as molecular receptors, in the development of molecular torsion 
balances, in asymmetric catalysis, chiral solvating agent and most recently as a DNA minor groove 
binder [200]. The molecule has been shown to intervene in the regular replication and transcription 
processes to lead the host cell to death with or without triggering apoptosis cascades.  
2.2.3. Experimental details 
2.2.3.1. Materials 
Unless stated otherwise, all material and reagents were purchased from Sigma–Aldrich, St. 







2.2.3.2. Preparation of CNTWZ  
Carbo-nano-tweezer particles ((+)-CNTWZ, (-)-CNTWZ and (±)-CNTWZ) were prepared 
using three stereo isomers of TrÖger’s base (+)-TB, (-)-TB and (±)-TB), respectively. In a typical 
process, a 1:1 (w/w) mixture of TB and agave nectar was stirred in 10 mL of water to make 1 
mg/mL of mixture and allowed for solvatothermal method using a domestic microwave. Prepared 
brownish solid was suspended in 10 mL water and incubated at RT overnight. Sample was probe 
sonicated at Amp 1, on 2 sec and off 1 sec cycle for 20 min. Suspension was filtered through 0.45 
µ followed by 0.22 µ cellulose filter. Obtained suspension was used to calculate the CNTWZ 
concentration by solvent evaporation method. Samples were stored at 4 C in germfree condition. 
Samples were found stable for more than six months without showing any coagulation or floccule 
formation. To make sure the purity of CNTWZ samples were centrifuged at 120,000 rpm for 30 
min and pelleted CNTWZs were re-suspended in water. Samples were dialyzed using 10kDa 
MWCO cellulosic membrane against water medium. Samples were further freeze-dried and re-
suspended in aqueous media of known concentration for all the studies. 
2.2.3.3. Dynamic Light Scattering 
The hydrodynamic size distribution of the carbon nanoparticles was determined using 
dynamic light scattering measurements on Malvern Zetasizer ZS90 instrument (Malvern 
Instruments Ltd, United Kingdom) at a fixed angle of 90. A 10 μL of particle suspension was 
mixed with 990 μL of nanopure water (filtered through 0.2 µ cellulose filter) to run the samples in 
DLS machine. A photomultiplier aperture of 400nm was used and the incident laser power was so 
adjusted to obtain a photon counting rate between 200 and 300 kcps. Measurements were used 




values. All measurements were carried out in a triplet of more than 10 consecutive measurements 
as adjusted by the machine software. 
2.2.3.4. Zeta potential measurement 
Zeta potential (ζ) values were determined using a Malvern Zetasizer (Malvern Instruments 
Ltd, United Kingdom) of Nano series. The experiments were performed at 25 °C and pH 7 at the 
light scattering mode in the phase analysis light scattering (PALS) mode following solution 
equilibration at 25 °C. Calculation of ζ from the measured nanoparticle electrophoretic mobility 
(μ) employed the Smoluchowski equation: μ = εζ/η where ε and η are the dielectric constant and 
the absolute viscosity of the medium, respectively. Measurements of ζ were reproducible within 
±3 mV of the mean value, given by 3 determinations of 12 data accumulations. 
2.2.3.5. Transmission Electron Microscopy 
The morphology of the NPs was observed with Philips CM200 the transmission electron 
microscopy (TEM) machine (FEI company, Oregon, US) equipped with Peltier-cooled Tietz 
(TVIPS) 2k x 2k CCD camera.  
2.2.3.6. AFM imaging  
The (+) CNTWZ was drop cast on a mica surface attached to the steel substrate. It was 
allowed to dry overnight in a vacuum chamber and then was imaged using Bruker MultiMode 
Nanoscope IIIA (Billerica, MA, US) in the tapping mode.  
2.2.3.7. UV-Vis absorption study  
Ultraviolet-visible (UV-Vis) absorbance of CNTWZs was recorded on GENESYSTM 10S 
UV-Vis Spectrophotometer (Thermo Scientific, MA, USA). Absorbance spectra were collected at 




study DNA interaction. A plasmid DNA (50 µM) concentration in Tris-HCl buffer (pH 7.4) was 
incubated with TB or (-)-CNTWZ at a molar ratio of 1:2. 
2.2.3.8. Fluorescence emission study 
Fluorescence emission of CNTWZs was recorded on TECAN Infinite F200 PRO. 
Experiments were performed at concentration of 0.1 mg/mL. Spectra were collected ranging from 
400-750 nm after excitation at different excitation wavelengths of 360, 400, 450 and 500 nm. 
2.2.3.9. XPS Study 
X-ray photoelectron spectroscopy (XPS) measurements for CNPs was obtained on a thick 
vacuum dried layer of the NPs applied on the glass surface using Physical Electronics PHI 5400 
spectrometer with Al Kα (1486.6 eV) radiation. The spectrum was referenced to the adventitious 
C 1s feature at 283.5 eV.  
2.2.3.10. 1H-NMR studies 
The freeze-dried NPs were resuspended in D2O for NMR studies. (Cambridge Isotope 
Laboratories, Inc., MA). Since TB is not soluble in D2O, it was initially dissolved in a small 
amount DMSO and then diluted with D2O.   The 1H NMR spectra were obtained on a multi-
nuclear, 500-MHz Ultrashield Plus (Bruker Daltonics Inc., MA, USA) machine, equipped with 5-
mm CryoProbe (CB500) (Bruker) and the samples were referenced to internal standards. The 
analysis was carried out on MestRenova 8.1 software (Mestrelab Research SL; Santiago de 
Compostela, Spain).  
2.2.3.11. Gel electrophoresis 
Selective DNA interaction studies with TB and CNTWZs were performed by gel 
electrophoresis. Plasmid pBR322 vector DNA (New England Biolabs, Ipswich, MA) was used for 




complexing 100 and 200 ng of DNA at room temperature for 1 h at different molar ratios, as 
described in figure caption. Samples were run on a 1% agarose gel at 100 V for 30 min. A 1X 
TAE-EDTA buffer was used as running medium. Gel was then stained in 3% ethidium bromide 
solution (10 mg/mL) for 5 min, and excess ethidium bromide was washed in 1x TAE buffer for 5 
min before being imaged under Universal Hood III, Bio-Rad, Hercules, CA. 
2.2.3.12. Circular dichroism 
The DNA’s native CD spectra and the changes upon nanoparticles titration were obtained 
on a Jasco 715 spectro-polarimeter (Mary’s Court Easton, MD, USA). The samples were titrated 
sequentially in a quartz cuvette (Starna Cells, Atascadero, CA) with 2 mm path length. All spectra 
were acquired from 185 to 260 nm and are indicate as the average of three accumulations with the 
scanning resolution of 0.5 nm. The titration was terminated when no noticeable change was 
observed in the spectra pattern.  
2.2.3.13. Nuclear localization study  
The samples were imaged on Leica SP8 UV/Visible Laser Confocal Microscope (Leica 
Micosystems, Germany) with 63x/1.40 HC PL APO Oil CS2 objective lens and excitation 
wavelengths of 488 nm. For analysis purposes, Image J software was used to make defined 
boundaries around the cytoplasmic regions and the nuclear regions of the cells and determining 
the green intensity with color histogram option. The average of 10 measurements were made for 
each treatment group. The 3D stacked images are generated for the cells incubated with the 
nanoparticles. In addition, videos are generated from the Z stack screening of the slides. For the 
videos, the samples are first brought out of focus and with the change in the Z direction, the cells 




2.2.3.14. MTT assay  
The cell viability of CNTWZ formulations were investigated by using MTT (3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) reduction assay in the presence of 10% 
FBS in antibiotic free media. The yellow tetrazolium salt (MTT) is modified by mitochondrial 
dehydrogenases to its purple formazan derivative (MTT-formazan) with maximum absorbance at 
560−590 nm. The intensity of purple formazans indirectly reveals the mammalian cell survival 
and proliferation. Experiment was performed in 96 well plates (Cellstar; Germany) growing 
10,000 cells per well 24 h before treatments. Experiments were performed for various 
concentrations of CNTWz ranging from 100 to 25 µM of TB present as free or in the form of 
CNTWZs. Cells were incubated for 48 h before performing the MTT assay. At the end of the 
incubation period, cells were treated with MTT (20 μL, 5 mg/mL) per well and further incubated 
for 4 h. At the end of the incubation the entire medium was removed from the wells and 200 μl of 
DMSO was added to dissolve blue colored formazan crystals produced by mitochondrial 
respirations. The percentage cell viability was obtained by calculating absorbance values and 
calculated. 
2.2.3.15. Intra-cellular DNA interaction study   
Cells were plated in a 24 well plate at a cell density of 100,000 cells per well for 24h. Cells 
were then treated with respective samples and incubated at 37 C for additional 4h. Following this, 
it was successively washed with DPBS, followed by 1% FBS in DPBS and then re-suspended in 
a 96 well plate. Samples were then analysed using a Guava EasyCyte Plus Flow cytometer. For 
each sample, data from 5000 single cell events were collected for 3 minutes, in triplicates, at an 




2.2.3.16. MTT assay in more cell lines 
More cell lines of different origin (MDA-MB231, human triple negative breast cancer and 
C32, human melanoma) were used for verifying the activity of CNTWZs in broad range of cancers. 
CNTWZs were also tested in human non-cancerous fibroblasts (NIH3T3) to compare the 
significance of uncontrolled division process in cancer cells with controlled divisions non-
cancerous cells. 10,000 cells were plated in per well of 96 well plate and grown for 24h before 
treating with various CNTWZs at concentration of 100, 50 and 25 µM for 48h. At the end of the 
incubation period MTT assay was performed as described above. 
2.2.3.17. Cell internalization inhibitor studies  
Cellular entry mechanism of CNTWZs respective to cell entry inhibitors were investigated 
in MCF-7, MDA-MB231 and NIH3T3 cells. Cells were either only incubated with CNTWZs (100 
μM) or pre-incubated with inhibitors reconstituted in culture medium including sodium azide 
(NaN3) and 2-deoxyglucose (DOG), chlorpromazine (CPM), nystatin, dynasore hydrate, Methyl-
β-cyclodextrin and cholesterol at a concentration of 10 × 10−6 M, 50 × 10−6 M, 28 × 10−6 M, 180 
× 10−9 M, 80 × 10−6 M, 2 × 10-6 and 1 × 10-6 M, respectively before incubating with CNTWZs 
(100 μM). Cells were post incubated with CNTWZs for 48h before performing MTT assay. MTT 
assay was performed as described above. 
2.2.3.18. TUNEL assay  
TUNEL assay was performed on MCF-7 and MDA-MB231 cells. Cells (10,000) were 
plated in 96 well plate. Cells were imaged under 10X magnification after performing TUNEL 
assay on cells treated with different CNTWZs for 48h. TUNEL assay was performed using 
manufacturer’s protocol. Fold change in red fluorescence originated from TUNEL reagent bound 




untreated cells. Cells treated with DNase I for 30 min were used as positive controls for DNA 
fragmentation. 
2.2.3.19. Annexin V Staining Assay 
Annexin V assay was performed on MCF-7 and MDA-MB231 cells. MCF-7 cells 
(400,000) were plated in 6 well plate. Cells were treated with different CNTWZs (100 µM) for 
48h. At the end of the incubation Annexin V assay was performed using manufacturer’s protocol. 
Cells were collected in Annexin V staining buffer and stained with Annexin V reagent and PI for 
20 min at RT. Stained cells were processed on FACS machine in Red and Green channel for PI 
and Annexin-V staining, respectively.  
2.2.3.20. Statistical Analysis  
A one-way ANOVA followed by Tukey’s multiple comparison test was used on confocal 
images to perform the bio-statistical analysis. P values 0.05, 0.01, 0.001 and 0.0001 represent *, 
**, *** and ****, respectively. 
2.2.4. Results and discussion 
Three carbo-nano-tweezer particles (+)-CNTWZ, (-)-CNTWZ and (±)-CNTWZ were prepared 
using three stereo isomers of TrÖger’s base ((+)-TB, (-)-TB and (±)-TB), respectively. In a typical 
process, a 1:1 (w/w) mixture of TB and agave nectar [201] was allowed to react by solvatothermal 
method using a domestic microwave. As-synthesized particles were purified by multiple re-
suspension-centrifugation and dialysis using 10kDa MWCO cellulosic membrane. Prepared 
particles were characterized using dynamic light scattering and representative (-)-CNTWZ were 
found to have a hydrodynamic diameter of 20±5 nm (Figure 2.10 A) while their anhydrous state 
size varied as 15 ± 2 nm in transmission electron microscopy (TEM) (Figure 2.10 C). A slight 




the preparation of TEM grids. Similarly, hydrous sizes for (+)-CNTWZ and (±)-CNTWZ were 
found to reduce from 95±15 and 120±15 to 40± 10 and 70± 20, respectively. Polydispersity indices 
for CNTWZs were found to increase from 0.4, 0.6 to 0.7 for (-)-CNTWZ, (+)-CNTWZ and (±)-
CNTWZ, respectively indicating a good particle size distribution for CNTWZs. Colloidal stability 
of these CNTWZs could be predicted by measuring their electrophoretic (zeta) potential values. 
With zeta potential value of around -16 mV all the CNTWZs were found to be significantly stable 
(Figure 2.10 B). The average anhydrous height of the (+) CNTWZ was found to be 1.43±0.26 nm. 
(Figure 2.10 D) The height profile of the selected lines is provided in Figure S2.10.  
 
Figure 2.10. Physico-chemical characterization of CNTWZs for their (A) hydrodynamic diameter 
(0.1 mg/mL); (B) Zeta potential (0.1 mg/mL); (C) TEM image of representative (-)-CNTWZ and 
(D) Representative AFM image of (+) CNTWZ. Height profile is shown with color scale. 
  
Surface chemistry of (+)-CNTWZ as a representative ‘nano tweezer’ system was studied 
by 1H-NMR spectroscopy to confirm the presence of (+)-TB on particle surface (Figure 2.11 A). 




of CNTWZs. It was further verified through X-ray photoelectron spectroscopy (XPS) studies. A 
deconvolution study performed on (-)-CNTWZ resulted in spectra revealing the presence of C-O, 
C=O, N-H, -COOH and C-N-C chemical entities which suggested the presence of H-bonds (Figure 
2.11 B-D).  
 
Figure 2.11. Surface characterization of CNTWZs. (A) Representative (+)-CNTWZ showing 
presence of (+)-TB characteristic peaks on particle surface by 1H-NMR analysis. (B) XPS analysis 
of (-)-CNTWZ particles and their deconvoluted plots for (C) O1s and (D) C1s.   
 
  Once we established their basic physico-chemical characterization, DNA interaction 
properties of these CNTWZs were evaluated by UV-Vis absorption studies and confirmed by 
circular dichroism (CD) measurements. UV-Vis measurement showed absorbance for (-)-CNTWZ 
at 350 nm and lower in case of (±)-CNTWZ and (+)-CNTWZ in same order (Figure 2. 12A). 




bond present on the carbonaceous surface in form of oxidized functional groups, e.g. –COOH 
[202]. Autofluorescence properties of CNP and CNTWZs were studied in aqueous solution at a 
concentration of 0.1 mg/mL. It was found that irrespective of the used CNT or CNTWZ, all the 
nanoparticle suspensions showed similar emission patterns after being excited at 360, 400, 450 
and 500 nm (Figure S2.11). This indicates the non-significant role of TB inclusions and their 
asymmetry on emission properties of CNTWZs.  
 Success of CNTWZs in cancer therapeutics would rely on their genomic DNA interaction 
abilities. To study the DNA interaction patterns of prepared CNTWs, a simplified system of 
plasmid DNA was used for various studies. A representative DNA interaction study with (-)-
CNTWZ (0.01 mg. mL-1) revealed the shift of DNA UV absorbance peak from 260 nm to 275 nm 
presumably due to surface interaction with (-)-CNTWZs (Figure 2.12 A). The shift in UV 
absorbance is indicative of strong interaction of DNA with these entities [203]. The absorbance 
peak for DNA can shift to longer (bathochromism) or shorter (hypsochromism) wavelengths, 
indicating structural changes of DNA due to intercalations and grove bindings (Figure 2.12) [204-
206]. The effect of increased DNA binding by (-)-CNTWZ was also verified by gel electrophoresis 
experiment (Figure 2.12 C, D) where DNA duplex was interacted in order of (-)-CNTWZ, (+)-
CNTWZ and (±)-CNTWZ with DNA binding % of ~70, 85 and 20, respectively. Conclusion is 
based on a fact that a free electrophorated DNA will move out of well toward the electrode of 
opposite charge while DNA interacting entities may cause associative inhibition of DNA 
movement and could be directly proportional to binding ability of the interacting entities. Thus, an 
isomeric selectivity toward DNA binding was achieved as (-)-CNTWZ showed better affinity 




(Lane 2) was found to be sufficient to retard all (200 ng) of the used plasmid DNA (Figure 2.12 
C).  
 
Figure 2.12. Interaction studies of CNTWZs with DNA duplexes. (A) UV-Vis absorption spectra 
of different CNTWZs, (B) Change in UV-vis absorption spectra of (-)-CNTWZ formulation with 
changing λmax from 260 nm for DNA to 270 nm for DNA interacting with (-)-CNTWZs. (C) Gel 
electrophoresis pattern of plasmid DNA (100 ng) after interaction with different molar 
concentrations of (-)-TB in (-)-CNTWZ compared to plasmid DNA varying from 1 to 6 molar ratio 
(Lane 2-7). Molar concentration of TB in CNTWZ was calculated based on initial concentration 
of TB used respect to total particle concentration. (D) Gel electrophoresis pattern of plasmid DNA 
duplex (200 ng) after interaction with (+)-CNTWZ, (-)-CNTWZ and (±)-CNTWZ and compared 
with electrophoresis pattern of (+)-CNTWZ, (-)-CNTWZ and (±)-CNTWZ alone at a ratio of 1:1. 
A plasmid DNA vector pBR322 was used as a duplex DNA. (E) Circular dichroism spectra of (a) 
(+)-CNTWZ and (b) (-)-CNTWZ before and after interaction with plasmid DNA duplexes. Color 
codes are same for both the CD spectrum set from (a) and (b) as presented in (a).  
 
A further increase in ratio did not reveal any noticeable change in DNA binding pattern (Lane 3-




through gel of a specific pore size under the influence of applied electric field and DNA interacting 
with external species certainly varies the 3D orientations leading to inhibition in DNA movement 
[207].  Firstly, for ratio optimizations, it was found that a molar ratio of 2:1 for (-)-CNTWZ with 
DNA (Lane 2) was found to be sufficient to retard all (100 ng) of the used plasmid DNA and a 
further increase in ratio did not reveal any noticeable change in DNA binding pattern (Lane 3-6) 
(Figure 2.12 C). It could be concluded that a higher DNA amount was required to see better DNA 
bands while a ratio of 1:1 should be better for comparing DNA interactions efficiencies across 
different samples due to possibility of revealing higher and lower band intensities rather than 
disappeared bands at higher ratios. It was further revealed (-)-CNTWZ showed better affinity 
compared to (+)-CNTWZ and (±)-CNTWZ at a molar ratio of 1:1 using 200 ng of plasmid DNA 
(Figure 2.12 D). 
 It was found that (+)-CNTWZ interacting with DNA showed only a trivial increase in CD 
and could be due to increase in gradual concentration increase of (+)-CNTWZ (Figure 2.12 Ea). (-
)-CNTWZ, on the other hand, clearly showed a noticeable change in enhanced CD at 210 nm 
which sequentially shifted to 205 nm along with improved CD values (Figure 2.12 Eb). It clearly 
showed the enantiospecific recognition and high DNA interaction ability of (-)-CNTWZ compared 
to (+)-CNTWZ.  
 Interaction of CNTWZs with plasmid DNA duplex studied by UV-Vis, circular dichroism 
spectroscopy and gel electrophoresis unequivocally established significant DNA interaction 
abilities of these CNTWZs with maximum effect exerted by a (-) chirality of TB present in (-)-
CNTWZ. The highly specific interaction of CNTWZs can be explained by minor groove binding 
abilities of surface-tethered TBs. It is evident from the results that one enantiomeric form 




duplex. This enantiospecific interaction further revealed the possibility of DNA duplex association 
mediated disruptive transcriptions and eventual cellular death.    
Minor-groove binding agents such as TBs and their derivatives usually have structures that 
allowed them to adopt a crescent shape that fits into the minor-groove [208]. Within the minor-
groove, close contacts are formed in the deep, narrowed space between the two complementary 
strands of a duplex DNA. These minor-groove binder complexes involve hydrogen bonds (HBsa), 
van der Waals contacts, and/or ionic interactions for stabilization [209]. 
 We anticipate that CNTWZs, owing to the presence of, minor-groove-binding TBs will 
exert the similar functional features. The fate of such interactions in biological systems was 
verified by studies at preliminary levels in vitro. 
 Generally, plasmid DNA are known to have more than one bands representing supercoiled, 
relaxed and open forms of DNA with different ratios but there are multiple reports representing 
only one visible major form i.e. supercoiled [210-212]. In our study, the interaction with different 
CNTWZs did not reveal any additional bands. This is presumably due to the interaction of with 
supercoiled form of plasmid DNA, negligible amount of the same form of DNA gets converted to 
circular or open forms leading to no secondary visible bands. 
 Cell studies were performed to evaluate nuclear localization, cancer cell growth inhibition 
and cell cycle analyses to evaluate efficiency of chiral selectivity in CNTWZs. A cancer cell line 
of breast origin (MCF-7) was used as a representative in vitro model for biological studies. Cells 
were grown for 24h before being treated with different CNTWZs for different biological studies. 
Cells (4x105) were treated with CNTWZs for 4h at a concentration of 100 µM respect to TB 




A) as characteristics of typical carbon nanoparticles (CNPs) (Figure 2.13 B), (-)-CNTWZs were 
also found to significantly emit in green fluorescence range (Figure 2.13 C).  However, it was 
found that all the CNTWZs were uniquely located higher within cellular nucleus compared to 
CNPs alone enriching maximally cytoplasmic compartment (Figure 2.13 D) of MCF-7 cells. The 
3D stacked images generated for the cells incubated with the nanoparticles and videos generated 
from the Z stack screening of the slides could confirm the nuclear localization of CNTWZs.  
 
Figure 2.13. In vitro nuclear localization of CNTWZs in MCF-7 cells. Green fluorescence in 
MCF-7 cells of (A) intrinsic origin; originated by (B) CNPs and (C) (-)-CNTWZs. (D) 
Comparative abundance of green fluorescence of CNTWZs origin in cell nucleus. A bio-statistical 
analysis was performed by two-way ANOVA considering cells alone as base system. Here **** 
represents p value less than or equal to 0.0001.     
 
As can be comprehended from Figure S2.12 and the videos (1-4), the nanoparticles are clearly 




differences, they did not show any difference in nuclear localization among each other with no 
significant difference. This signifies the no specific role of CNTWZ morphology in cellular 
enrichment. 
 With proven efficiency of DNA interactions and nuclear localization, CNTWZs were 
investigated for their cancer cell viability inhibition efficiency. MTT assays were performed for 
the same by using 10x103 cells in 96 well plate. CNTWZs and TBs with TB concentration of 25, 
50 and 100 µM were treated for 48h before performing the MTT assay. CNTWZs were found to 
be most effective in cell growth inhibition at 100 µM of TB concentration and (-)-CNTWZ were 
the most effective enantiomer with only ~30% cell viability among all (Figure 2.13 A).  As control, 
TB alone was used and found that (-)-TB could allow greater than 50% of cells to remain viable 
(Figure 2.13 B). The advantage of using TB in form of CNTWZ were corroborated with nearly 
two-fold decrease in cell viability (-)-CNTWZ compared to (-)-TB (Figure 2.13 C) and one third 
in case of (+)-CNTWZ compared to (+)-TB (Figure 2.13 D). Interestingly, we noticed that a 
racemic (±)-CNTWZs did not improve their cell growth inhibition efficiency and rather increased 
their cell viability (Figure 2.13 E). It was also found that use of TB on CNP nano-surface for 
growth inhibition efficiency against MCF-7 was slightly better to some of the known nanoparticle 
systems in similar condition [213].  
 This observation presumably can be explained due to the loss of their ability to bind in 
crescent shape minor groove of DNA in cellular nucleus due to asymmetric surfaces. Biological 
activities of CNTWZs against cancer cells were verified for progression through genomic DNA 
interactions. A considerable change in DNA duplex orientation, flexibility and shape changing 
ability during transcription process would highly affect the cell cycle processes. Interestingly, cell 




MCF-7 cells. This observation can be explained because of the presence of less binding enantiomer 
bearing CNPs (+)-CNTWZ in racemic mixture hindering the binding of effective enantiomer (-)-
CNTWZ present in racemic mixture and eventually losing cell growth inhibition property.  
Although (+)-CNTWZs alone has demonstrated less affinity to DNA duplex, binds without any 
significant hindrance. 
 A cell cycle study was therefore performed using the representative enantiomeric chiral 
carbon nanoparticle, namely (-)-CNTWZ. Cells (4x105) treated with (-)-CNTWZ for 4h at a 
concentration of 100 µM respect to TB concentration present in CNTWZ, were prepared for cell 
cycle study (Figure 2.14 F, G) followed by PI staining. Propidium iodide (PI) interaction to 
genomic DNA is known to induce red fluorescence after cellular treatment which was found to be 
decreased with loss in integrity of DNA duplex. Out of many possible reasons for decreasing PI 
interaction with DNA duplex, the interaction of secondary molecule to DNA duplex could be of 
high importance. In this case, it was found that (-)-CNTWZ could decrease the PI-DNA 
interactions and hence decreased red fluorescence in treated cells compared to untreated PI stained 
cells (Figure 2.14 G) while comparison with (+)-CNTWZ and (±)-CNTWZs, established the better 
interaction of that (-)-CNTWZ with maximum hindrance in PI-DNA interactions (Figure 2.14 F; 
S2.13). These changes in PI interactions with genomic DNA leads to decreasing cell population 
with high PI fluorescence after (-)-CNTWZ treated cells were compared to cells treated with (+)-
CNTWZ (Figure S2.13 E) and (±)-CNTWZ (Figure S2.13 F), indicating the possibility of early 
induction of DNA fragmentation or apoptotic cascades. In similar conditions untreated and 
unstained cells were with minimum PI fluorescence and untreated PI stained cells with highest 






Figure 2.14. In vitro cell viability and DNA binding studies in MCF-7 cells. (A) MTT assay 
performed after 48h of treatment using CNTWZs at concentration of 25, 50 and 100 µM and 
compared with (B) different TBs at same concentration range. Improvement in cell growth 
inhibition with surface decoration of TBs on CNP established for (C) (-)-CNTWZ; (D) (+)-
CNTWZ and (E) (±)-CNTWZ. Cell cycle analysis performed on cells treated with (-)-CNTWZ for 
4h at a concentration of 100 µM respect to TB concentration present in CNTWZ when compared 








Figure 2.15. Cell viability assay in (A) MDA-MB231; (B) C32 and (C) NIH3T3 cells. Cells were 
incubated for 48h before performing the assay.   
Broad range use of CNTWZs as anti-cancer nanomedicine would require studying their 
effect in more cancer cell lines as well as non-cancer cells. Cell viability studies were further 
extended to triple negative breast cancer MDA-MB231 cells and melanoma cells C32 along with 
non-cancerous fibroblast NIH3T3 cells (Figure 2.15). It was found that (-) CNTWZs were most 
effective in reducing the cell growth of MDA-MB231 and C32 cells while in NIH3T3 all the used 
CNTWZs were equally ineffective. Where (-)-CNTWZ could decrease cell viability to less than 
5% in MDA-MB231, in C32 ~30% cells were viable. In NIH3T3, no significant change in cell 
viability was reported. Probably, a normal DNA unwinding process, which is generally slower 






2.2.4.1. Cellular Internalization of CNTWZs 
 
 Cellular internalization of nanoparticles is known to follow different pathways which can 
be correlated with nanoparticle mediated cell toxicity.48 Cellular internalization of various 
CNTWZs were studied by blocking known endocytic or metabolic pathways using corresponding 
pharmacological manipulators or inhibitors. Cells were pre-incubated with inhibitors before 
treatment of effective doses of CNTWZs for inhibition of pathways, e.g. lipid raft, metabolic, 
energy, clathrin, and/or caveolar. 
 
Figure 2.16. Cellular entry mechanism of CNTWZs respective to cell entry Inhibitors in (A) MCF-
7, (B) MDA-MB231 and (C) NIH3T3 cells.  Cells were either only incubated with CNTWZs (100 
μM) or pre-incubated with inhibitors reconstituted in culture medium including sodium azide 
(NaN3) and 2-deoxyglucose (DOG), chlorpromazine (CPM), nystatin, dynasore hydrate, Methyl-
β-cyclodextrin and cholesterol at a concentration of 10 × 10−6 M, 50 × 10−6 M, 28 × 10−6 M, 180 
× 10−9 M, 80 × 10−6 M, 2 × 10-6 and 1 × 10-6 M, respectively before incubating with CNTWZs 





A 100 µM concentration of CNTWZs was used for the study (Figure 2. 16). Among the various 
inhibitors used, chlorpromazine (CPM), dynasore and sodium azide (NaN3) and 2-deoxyglucose 
(DOG) had preferential effect in cellular entry of CNTWZs in MCF-7 cells. Some of the other 
inhibitors used were nystatin, dynasore hydrate, methyl-β-cyclodextrin and cholesterol. In MDA-
MB231 cells, CPM, nystatin and cholesterol found regulating cellular entry. A similar inhibitory 
effect was also seen for NIH3T3 cells upon using CPM, nystatin and cholesterol. Blocking of these 
pathways resulted in increasing the cell viability to significant levels indicating the preferential 
dynamin, clathrin, energy- dependent endocytosis and lipid raft mediated cellular entry of 
CNTWZs in MCF-7, MDA-MB231 and NIH3T3 cells. Interestingly, CNTWZs were found not to 
discriminate the cellular entry pathway based on their surface stereochemistry. 
 After entering cell cytoplasm, it is required for CNTWZs to get translocated into nucleus 
for interacting with DNA duplex. Some of the major pathways for nanoparticle entry include 
nuclear pores, importins, histone chaperones, and nuclear localization signals [214-216]. Size 
[217] and surface charge [218] of CNPs are found to decide the nuclear entry of CNPs where a 
smaller than 9 nm particle can enter through nuclear pores by diffusion. Negatively charged 
particles interact more with nuclear membrane due to lower pH and can enter in nucleus by lipid-
flipping and also during cell division when nuclear membrane disappears to facilitate the division 
process [219, 220]. As CNTWZs were found to be negatively charged and bigger than 9 nm, 







2.2.4.2. TUNEL Assay for Induced Apoptosis 
 
 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay is a method 
for detecting DNA fragmentation which is widely used to identify and quantify apoptotic cells. 
This assay relies on the use of terminal deoxynucleotidyl transferase (TdT), an enzyme that 
catalyzes attachment of deoxynucleotides, tagged with a fluorochrome or another marker, to 3'-
hydroxyl termini of DNA double-strand breaks. TUNEL assay was performed on cell population 
(MCF-7 and MDA-MB231) incubated with (-)-CNTWZs (Figure 2.17 A5, B5, C and D) showed 
considerably higher relative fluorescence intensity (**** is p-value<0.0001), supporting the higher 
apoptosis induced DNA fragmentation ability of (-)-CNTWZs compared to CNP (Figure 2.17 A2, 
B2, C and D) at same treatment concentration. Positive control of DNase I (Figure 2.17 A6, B6, C 
and D) were found to be equally effective with higher level of fluorescence. Treatments of (+)-
CNTWZ (Figure 2.17 A3, B3, C and D) and (±)-CNTWZs (Figure 2.17 A4, B4, C and D) could 
also generate the significant level of fluorescence but lower than (-)-CNTWZs. (-)-CNTWZs were 
found to be best in inducing apoptosis mediated DNA fragmentation, irrespective of the used cell 
lines.   
2.2.4.3. Annexin V staining assay 
Annexin V assay was performed on MDA-MB231 cells as representative of in vitro cancer model 
to study CNTWZ induced apoptosis. (-)-CNTWZ (Figure 2.18 E) at 100 µM was equally efficient 
as 10 µM of nifuroxazide (Figure 2.18 F) in inducing apoptosis to MDA-MB231 cells with 12.7 
and 12.8% cells were found to be Annexin V positive, respectively. Other treatments of (+)-
CNTWZ (Figure 2.18 C) and (±)-CNTWZ (Figure 2.18 D) were found to induce insignificant 






Figure 2.17. TUNEL assay performed on (A, C) MCF-7 and (B, D) MDA-MB231 cells. Cells 
were imaged under 10X magnification after performing TUNEL assay on cells treated with 
different CNTWZs for 48h. Fold change in red fluorescence originated from TUNEL reagent 
bound to fragmented DNA post induced apoptosis were calculated compared to red fluorescence 
from untreated cells.  Cells treated with DNase I for 30 min were used as positive controls for 
DNA fragmentation and showed highest level of red fluorescence. 
 
2.2.5. Conclusion 
Carbo-Nano-Tweezer (CNTWZ) particles were successfully synthesized with decorated TrÖgers 
base (TB) of different asymmetries and negative electrophoretic potential. XPS and NMR studies 
confirmed the presence of TB molecules on carbon nanoparticle surface. TB decorated CNTWZs 
were found to be interacting with duplex DNA as supported by UV-Vis, gel and CD studies. The 
prepared particles were found to be positively enriching the cellular nucleus in MCF-7 breast 
cancer cells irrespective of the TB asymmetry decorated on the particle surface but (-) CNTWZ 




we presented synthesis and characterization of chiral carbon nanoparticles with surface presented 
TrÖger’s moiety for enantiospecific recognition of DNA and minor groove binder. 
 
Figure 2.18. Annexin V assay was performed on MDA-MB231 cells as representative in vitro 
model to study CNTWZ induced apoptosis. Quadrant R1 represents scattered viable cell 
population, quadrant R2 and R4 represent cells undergoing apoptosis and quadrant R3 indicates 
necrotic cells. Cells were stained with Annexin V and PI before performing the FACS analysis at 
the end of 48h of incubation with CNTWZs and positive control of nifuroxazide, a known 
apoptosis inducer in MDA-MB231 cells.  Cells were treated with (C) (+)-CNTWZ, (D) (±)-
CNTWZ, (E) (-)-CNTWZ (100 µM) and (F) nifuroxazide (10 µM) and compared with (A) 
unstained and (B) stained cells. 
 
Even after being morphologically and optically different, CNTWZs did not show the difference in 
cellular entry and nuclear enrichment among each other but only the cell growth inhibition where 
(-)-CNTWZ was found to be most effective and found to be at least two times better than (-)-TB 




duplex with different chirality CNTWZs defines effectivity against cancer cell growth inhibition 
not the morphological property itself. Studies with MDA-MB231 and C32 cells showed broad 
range effectivity of CNTWZs in cancer cell growth regression while no significant effect in 
NIH3T3 indicate their non-effective nature against non-cancerous cells.  Additionally, CNTWZs 
were found not to discriminate the cellular entry pathways based on their surface stereochemistry. 
TUNEL and Annexin V assays established role of these CNTWZs in anti-cancer approach via 
induced apoptosis. Results indicated that these chiral particles act as nano-tweezers to wind the 





2.3. (-)/ (+)-Sparteine Induced Chirally-active Carbon Nanoparticles for Enantioselective 
Separation of Racemic Mixtures4 
2.3.1. Abstract 
Chiral carbon nanoparticles (CCNP) were developed by surface passivation using chiral 
ligand (-)-sparteine or (+)-sparteine (named (-)-SP/CNP and (+)-SP/CNP, respectively). The 
chirality of the prepared ccnps was demonstrated by circular dichroism and polarimetry and 
employed as an enantioselective separation platform for representative racemic mixtures. 
2.3.2. Introduction 
Chirality is an important phenomenon in materials of both synthetic and natural origin. 
Carbohydrates, peptides and amino acids are some of the common chiral molecules present in 
living systems. Chiral recognition and separation has a vital relevance in various fields like 
agrochemicals, consumer products and especially in pharmaceutical industry where one of the 
enantiomers of the same molecule may exhibit remarkable disparity in terms of pharmacological 
potency, pharmacokinetics, toxicity, metabolic pathways and recognition by immune system [221, 
222]. Thus, it is highly desirable to separate a specific enantiomer from their racemic mixture 
before using for any decided application. 
  Considerable effort has been expended in the last few years for the development of 
nanoscale structures with chirality for diverse applications like asymmetric synthesis, liquid 
crystals and chiral recognition [154, 223, 224]. Chiral particles in the nanometric scale would 
increase the area of interaction significantly and open up various advantages associated in process 
of chiral separation. Metallic chiral nanoparticles and quantum dots (QDs) have been previously 
                                                 
4 This part of the thesis has been adapted from the following publication: 
Vulugundam, G.§, Misra, S. K.§, Ostadhossein, F., Schwartz-Duval, A. S., Daza, E. A., & Pan, D. (2016). (−)/(+)-
Sparteine induced chirally-active carbon nanoparticles for enantioselective separation of racemic mixtures. Chemical 
Communications, 52(47), 7513-7516. 




prepared using chiral molecules like DNA, peptides, or small organic ligands like cysteine, 
glutathione and penicillamine as capping agents [225-229]. The chirality induced in nanoparticles 
play a crucial role in their application as biosensors, recognition of chiral molecules and fabrication 
of chiroptical nanomaterials [230-232].   
In spite of various emerging beneficial applications of the metal based nanoparticles, they 
are plagued with potential disadvantages related to toxicity to the environment when used in large 
scale and biological toxicity [164]. To avoid such disadvantages, another category of chiral 
nanomaterials has been reported as chiral polymeric particles that were explored for potential 
applications in chiral resolution by crystallization and stereo selective synthesis [233-235]. But 
restriction of using polymer-based particles with many reactive racemic mixtures, directed the 
search for a commercially exploitable base material with better universality in regard to having 
lesser chances of reacting with racemic mixtures.   
 Carbon nanoparticles (CNPs) provide an environmentally benign alternative by virtue of 
their tunable biocompatibility, reactivity, ease of preparation and cost effectiveness. To the best of 
our knowledge, an optically active, chiral carbon nanoparticles (CCNPs) for separation of 
enantiomer from racemic mixtures has yet to be explored. With this unmet need, our approach 
introduces chirality in CNPs by controlled surface passivation with chiral molecules, i.e. sparteine. 
In its both enantiomeric form the compound has long been used as a chiral base for various 
asymmetric reactions often leading to highly enantioselective transformations [236-239]. The 
choice of sparteine to induce chirality into the CNPs is due to its unique structural feature. 
Sparteine contains a rigid bisquinolizidine structure with the asymmetric center present adjacent 




inversion. Consequently, this property would restrict inversion of chirality of prepared CCNPs 
under conditions of enantiomeric separation.  
2.3.3. Materials and methods 
2.3.3.1 Materials and methods 
Sucrose, L-cysteine, D-cysteine, L-proline and D-proline were purchased from Sigma-
Aldrich (USA). (-)-Sparteine and (+)-sparteine were purchased from TCI chemicals and AK 
Scientific (USA) respectively. 
2.3.3.2. Preparation of (-)-SP/CNP and (+)-SP/CNP 
Sucrose (1g) and (-)-sparteine or (+)-sparteine (appropriate amount, such that the final 
ratios of sparteine:sugar are 1:10, 1:5 and 2:1) were dissolved in 5 mL of nanopure water (0.2 μM, 
18 MΩ ·cm). Then the aqueous solution was subjected to microwave irradiation in a domestic 
microwave oven for 10 min. Microwave power was set at 1200 W with an output power of 50%. 
The resultant dark brown mass was resuspended in 5 mL nanopure water followed by probe 
sonication (Q700TM, Qsonica Sonicators, CT, USA) (Amp:1, On: 2 sec, Off: 1 sec). The 
suspension was passed through a syringe filter with a 0.2 μm pore size and then subjected to 
dialysis (10000 KDa cutoff). Other ratios of sugar:sparteine (for eg 20:1 and 30:1) were also 
explored but resulted in poor CNP solubility in water possibly due to inadequate surface 
passivation of the carbon core by the chiral ligand.  
2.3.3.3. Dynamic Light Scattering and Zeta Potential Measurements 
The hydrodynamic diameters and zeta potential of CNPs were determined by a Malvern 
Zetasizer Nano ZS90 (Malvern Instruments Ltd., Worcestershire, UK). Scattered light was 
collected at a fixed angle of 90°. A photomultiplier aperture of 400 mm was used, and the incident 




measurements for which the measured and calculated baselines of the intensity autocorrelation 
function agreed to within ±0.1% were used to calculate nanoparticle hydrodynamic diameter 
values. The averaged hydrodynamic diameter was obtained from the peak values of the number 
distribution for five successive measurements for each sample. For zeta potential measurements, 
the data were acquired in the phase analysis light scattering (PALS) mode following solution 
equilibration at 25 °C. Calculation of ζ from the measured nanoparticle electrophoretic mobility 
(µ) employed the Smoluchowski equation: µ = εζ/η, where ε and η are the dielectric constant and 
the absolute viscosity of the medium, respectively. Measurements of ζ were reproducible to within 
±5 mV of the mean value given by 20 determinations of 10 data accumulations. 
2.3.3.4. UV-Vis and Fluorescence Measurements 
Ultraviolet-visible (UV-Vis) absorbance of CNPs was recorded via GENESYSTM 10S 
UV-Vis Spectrophotometer (Thermo Scientific, MA, USA). The emission spectra of fluorescence 
measurements were obtained through NanoDrop 3300 Fluorospectrometer (Thermo Scientific, 
MA, USA). The excitation maximum was set to 360 nm and the wavelength covered an emission 
range between 400 and 750 nm.  
2.3.3.5. Fourier transform infrared spectroscopy (FT-IR) measurements 
For Fourier transform infrared spectroscopy (FT-IR) measurements, the aqueous 
suspensions of the CNPs were drop-casted and dried onto MirrIR IR-reflective glass slides (Kevley 
Technologies, Chesterland, Ohio, USA). The measurements were performed using a Nicolet 
Nexus 670 FTI-IR (MRL facility, UIUC). For each measurement 100 × 100 μm images were 
collected at 1 cm−1spectral resolution with 64 scans per pixel and a 25 × 25 μm pixel size and 




2.3.3.6. Raman Measurements 
All Raman measurements were taken on a Nanophoton Raman instrument (MRL facility, 
UIUC) with a 532 nm wavelength laser for one min at 0.2% laser power using a 20-x objective. 
For each spectrum a grating (600 l mm-1) scan was taken over the range of 120–2700 cm-1. An 
average of 20 spectra were recorded and averaged per sample. 
2.3.3.7. 1H-NMR Measurements 
1H-NMR measurements were carried out on Varian VXR 500 (Varian, Inc., Palo Alto, CA) 
spectrometer operating at 500 MHz equipped with 5mm Nalorac QUAD probe. Chemical shifts 
were reported in ppm and referenced to the solvent proton impurities. D2O was used as the 
deuterated solvent for all samples. A total of 256 acquisitions were made and were averaged out. 
The data was processed and analyzed with MestRenova™ 8.1 software (Mestrelab Research SL; 
Santiago de Compostela, Spain).  
2.3.3.8. Transmission Electron Microscopy Measurements (TEM) 
The samples for transmission electron microscopy (TEM) were prepared by placing a 10 
µL aliquot of diluted stock of CNPs suspension on 200-mesh Quantifoil® holey carbon grids 
(Structure Probe, Inc., PA, USA) for 1 min. The excess fluid was removed by a filter paper 
followed by drying of the sample. TEM images were recorded on JEOL 2010 LaB6 and JEOL 
2100 Cryo (JEOL Ltd., Tokyo, Japan) operating at 200 kV.  
2.3.3.9. Atomic Force Microscopy Measurements (AFM) 
For AFM, 5μL of the CCNP sample was placed on clean glass and allowed to stabilize for 
5 min. filter paper was used to remove liquid, and the sample was further dehydrated using vacuum 
chamber. AFM images were obtained using an Asylum Cypher (Asylum Research, Santa Barbara, 




AFM probe (Budget Sensors, Sofia, Bulgaria) at a set point of 0.63 V, a 1 Hz scan rate, and a drive 
frequency of 750 kHz.  
2.3.3.10. Circular Dichroism Measurements (CD) 
Circular dichroism measurements of the aqueous suspensions were carried out in a 2 mm 
quartz cuvette with a Jasco 710 CD spectrometer (Mary’s Court Easton, MD, USA) at room 
temperature.  For each sample, three measurements, each consisting of 5 sub runs were performed 
and the average spectrum is obtained from the software provided by the manufacturer. 
2.3.3.11. Optical Rotation by Polarimetry 
Optical rotation measurements were performed on a Jasco P-2000 digital polarimeter using 
a quartz cell of 10 mm path length at a wavelength of 436 nm, and all measurements were made 
at room temperature. For each sample, three measurements, each consisting of 10 sub runs were 
performed and the average observed optical rotation value is calculated by the software provided 
by the manufacturer. 
2.3.4. Results and discussion 
 Both (-)-sparteine and (+)-sparteine were used to bestow chirality on the CNPs through 
surface passivation and generate (-)-SP/CNP and (+)-SP/CNP, respectively. Synthesized CCNPs 
were demonstrated to be a novel chiral recognition platform and as an efficient adsorbent for 
separation of enantiomers.  
 Sucrose was used as the carbon source for the synthesis of CNPs and the surfaces of the 
CNPs were passivated by the chiral ligands, (-)- and (+)-sparteine by pre-passivation using a facile 
and economical microwave irradiation route. During the course of microwave irradiation, the 
colorless solution changed to dark brown solution followed by evaporation of water, finally turning 




sparteine is purely physical and electrostatic in nature, presumably arising from the tertiary amines 
of sparteine and surface abundant carboxylic acids groups in CNPs. The (-)-SP/CNP and (+)-
SP/CNP were well dispersed in aqueous medium and were stable for several months without any 
noticeable precipitation. The morphology and chemical integrity of the prepared (-)-/(+)-SP/CNP 
nanoparticles were extensively characterized by transmission electron microscopy (TEM), 
dynamic light scattering (DLS), atomic force microscopy (AFM), electrophoretic potential (Zeta), 
Raman spectroscopy, Fourier Transform infrared (FT-IR), nuclear magnetic resonance (NMR), 
UV-Vis, Fluorescence and circular dichroism (CD) and optical rotation measurements, which 
confirmed the successful preparation of CCNPs presenting chiral ligands at the nanoscale. Three 
different weight ratios of (-) or (+)-sparteine and sucrose (1:1, 1:2, and 1:5 respectively) were 
attempted for surface passivation.  
DLS measurements revealed that CCNPs were monodispersed in nanopure water (0.2 µM) and 
there was an increment in the size of CCNPs upon increase in the concentration of sparteine on 
the surface (Table S2.1). The number-averaged hydrodynamic diameters of aqueous suspensions 
of (-)-SP/CNP and (+)-SP/CNP (sparteine:sugar = 1:10) were 21±5nm and 24±5 nm respectively, 
while the pristine CNPs without any passivation showed 50±7nm (Figure 2.20 A). The aqueous 
suspensions of CCNPs prepared from higher ratios of sparteine:sugar resulted in particles in the 
size range of 50-200 nm. Electrophoretic mobility studies for various suspensions of CCNPs 
revealed that with increasing feed ratio of sparteine, the resultant CCNPs possessed more negative 
zeta potentials (Table S2.1). TEM was performed to study the morphology of the CCNPs and the 







Figure 2.19. Schematic representation for the (A) synthesis of (-)- and (+)-sparteine passivated 
CCNPs, (-)-SP/CNP and (+)-SP/CNP; (B) Optical photograph of aqueous suspension of CCNPs; 
(C, D) schematic representation and optical photograph of CCNPs as chiral adsorbent in a column. 
Representative transmission electron microscopy images of (-)-SP/CNP 1:10 (E), particle size 
distribution curve from TEM (F), (-)-SP/CNP 2:1 (G) and (+)-SP/CNP 2:1 (H) (scale bar 200 nm); 
atomic force microscopy image of (-)-SP/CNP 1:10. 
 
AFM images were acquired from drop casted samples on clean and polished glass slides 
to study the surface pattern of these CCNPs. The average height value (Hav) of representative 
samples was found to be 71 nm (Figure 2. 19 I). The UV-Vis absorption spectra of (-)-sparteine 
revealed a peak at 220 nm which is characteristic of n-σ* due to the tertiary amine.  Pristine CNP 
displays a characteristic strong absorption peak at 282 nm related to the n-π* transition of carbonyl 
group. This peak is slightly red-shifted to 283 nm for (-)-SP/CNP. In the fluorescence spectra, 




 The FT-IR spectrum for the (-)-SP/CNP exhibited stretching vibrations of C-OH at 3350 
cm-1, C-H at 2928 cm-1 and 2860 cm-1, and the C-N stretch at 1280 cm-1. The peak at 1064 cm−1 
can be identified as stretching peak of the C–O–C bond. (Figure 2.20 C) We also observed the low 
frequency C-H stretching bands in the region 2800-2500 cm-1 called “trans bands” which are 
typical for sparteine that depends on its conformational and configurational arrangement.9 Raman 
spectra of CNP, (-)-SP/CNP and (+)-SP/CNP are shown in Figure 2.20 D. We observed the 
characteristic D (~1370 cm-1) and G (~1600 cm-1) bands of CNPs. The G band originates due to 
the in-plane vibration of sp2 carbon atoms while D (defect/disorder) band is related to a hybridized 
vibrational mode of graphene edges and is an indicator of some disorder in the graphene structure. 
We found that the intensity ratio (IG/ID) was slightly increased after passivation of CNPs with 
(-)/(+)-sparteine. The marginal increase in IG/ID of (-)-/(+)-SP/CNP than pristine CNP is plausibly 
arising from induced graphitic nature due to presence of sparteine during preparation. 
To demonstrate the chiroptical properties of CCNPs, we performed circular dichroism 
measurements of the aqueous suspensions of (-)- and (+)-SP/CNPs. CD spectra of CCNPs 
suspended in water showed clear CD responses which are mirror images of each other in the region 
of 195-220 nm, while the aqueous CNP suspensions without passivation showed no CD signal 
(Figure 2.20 E). Optical activity of the CCNPs was also probed by polarimetry. The optical rotation 
of (-)-SP/CNP and (+)-SP/CNP prepared using sparteine:sugar = 1:10 was found to be -0.08° and 
+0.108°, respectively (Table 2.2). With the increasing passivation by the chiral ligand, a 
corresponding increase in the optical rotation of the respective CCNPs has been observed. CD and 
polarimetry studies revealed that the achiral CNPs were transformed into CCNPs by surface 







Figure 2.20. Physico-chemical characterization of the chiral carbon nanoparticles (CCNPs) 
prepared from sparteine:sugar = 1:10. (A) Hydrodynamic diameter; (B) UV-Vis spectroscopy and 
Normalized fluorescence emission spectra (λex = 360 nm) (C) FT-IR; (D) Raman spectra and (E) 
Circular dichroism spectra (F) 1H-NMR spectra of (-)-sparteine before (1) and after (2) microwave 




 We also examined the effect of microwave irradiation of (-)-sparteine by 1H-NMR and 
found that the structural integrity was retained even after microwave treatment (Figure 2.20 F). 
Figure 2.20 G shows the 1H-NMR of (+)-SP/CNP. We observed the presence of a multiplet at δ 
1.1-1.2 in the spectrum of (+)-sparteine which retained in (+)-SP/CNP, revealing the presence of 
(+)-sparteine in CCNP formulation. However, other important peaks of sparteine got overlapped 
by those of CNPs.  
Then we proceeded to investigate the enantioselective interactions of chiral molecules with 
CCNPs. In this study, L- and D-cysteine were chosen as a representative model system to 
demonstrate the chiral recognition ability of the CCNPs. In order to quantify the adsorption of each 
enantiomer of L-/D-cysteine by CCNPs individually, chiral adsorption studies were performed. 
Adsorption studies were performed by preparing aqueous solutions of L- or D-cysteine (2 mM) 
and measured their CD responses. Then (-)-SP/CNP or (+)-SP/CNP was added such that the final 
concentration of CCNPs was 0.5 mg/mL and the mixture was stirred for 12 h. The CCNPs were 
separated from the reaction mixture by ultra-centrifugation (95,000 rpm). The CD spectrum of 
supernatant was measured, and the amount of adsorption was calculated from the change in the 
peak intensity at 202 nm. Alternatively, a prototype column with the solid CCNPs was prepared 






Figure 2.21. Circular dichroism spectra and adsorption ratio of L-/D-cysteine by (A, B) (-)-
SP/CNP and (C, D) (+)-SP/CNP. Absorbance of L- and D- cysteine solution (circles and squares, 
respectively) by (-)-SP/CNP (A) and (+)-SP/CNP (C). Blank symbols correspond to signals from 
the solution of 2 mM concentration before treatment while filled symbols correspond to signals of 
the spectra after treatment with (-)-SP/CNP or (+)-SP/CNP. Chiral CNPs were prepared from (-)- 
or (+)-sparteine: sugar = 2:1. Bar chart of the adsorption ratio for both the chiral CNPs (B, D). 
 
Figure 2.21 A shows that (-)-SP/CNP has adsorbed 33% of L-cysteine enantiomer from the 
solution, whereas only 14% of D-cysteine was adsorbed. This results in an enantiomeric excess of 
19% ee for L-cysteine. In the case of (+)-SP/CNP, the selectivity of adsorption was found to be in 
opposite direction. (+)-SP/CNP showed enantiomeric excess of 15% ee for D-cysteine enantiomer 
(Figure 2.21 B). As a control, we also checked if the unmodified CNPs bind to L-/D-cysteine. We 
found there was no binding by pristine CNPs (data not shown). We chose two other ratios of (-)- 
or (+)-sparteine:sugar (1:5 and 1:10) during the preparation of (-)-SP/CNP and (+)-SP/CNP to 
study the effect of surface passivation of CNPs on the specific binding of the enantiomers. We 
found that enantiospecific adsorption by the chiral carbons decreased with the decrease in the 
amount of the chiral ligand deposited on the CNPs (Figure S2.17). As the initial ratio of (-)-




Similarly, (+)-SP/CNP showed enantiomeric excess of 9% and 4.7% towards D-cysteine for the 
ratios of (+)-sparteine:sugar = 1:5 and 1:10 respectively. However, when an excess of the chiral 
passivating agent was used as in the case of (+)-SP/CNP prepared from an initial ratio of (+)-
sparteine:sugar of 10:1, there was only a marginal improvement in the % ee for D-cysteine up to 
17.4% (Figure S2.18). To further verify the enantiospecific adsorption capability of CCNPs, we 
measured the optical rotation before and after treatment of the L-/D- cysteine with the chiral CNPs 
(Table 2.2). L-Cys (25 mM) showed an optical rotation of +0.021° which reduced to +0.015° after 
its treatment with (-)-SP/CNP showing the adsorption of 28.1%. However, D-Cys induced an 
optical rotation of -0.022° and -0.019° before and after treatment with (-)-SP/CNP, showing a 
lesser adsorption of 11.4%. In order to check the versatility of the enantioselective binding of 
CCNPs, chiral adsorption measurements of proline enantiomers were also performed onto the (-)- 
and (+)-SP/CNP (Figure 2.22).  
Table 2.2. Polarimetry study of adsorption of cysteine enantiomers into (-)-SP/CNP.a 
 
aA solution of [L-/D-Cys] or [L-/D-Pro] = 25 mM was treated with 6 mg of (-)-SP/CNP prepared 





Figure 2.22. Circular dichroism spectra and adsorption ratio of L-/D-Proline by (A, B) (-)-SP/CNP 
and (C, D) (+)-SP/CNP. Absorbance of L- and D- cysteine solution (circles and squares, 
respectively) by (-)-SP/CNP (A) and (+)-SP/CNP (C). Blank symbols correspond to signals from 
the original solution of 2mM concentration before treatment while filled symbols correspond to 
signals of the spectra after treatment with (-)-SP/CNP or (+)-SP/CNP. Chiral CNPs were prepared 
from (-)- or (+)-sparteine:sugar = 2:1. Bar chart of the adsorption ratio for both the chiral CNPs 
(B, D). 
 
The adsorption pattern and ratio were similar to those of cysteine. (-)-SP/CNP resulted in 17% ee 
of L-proline enantiomer whereas (+)-SP/CNP resulted in 14% ee for D-proline enantiomer. These 
results were also supported by polarimeter studies (Table 2.2).  
The observed enantioselectivity is presumably due to the preferential binding of the 
optically pure amino acids with the chiral surfaces of carbon nanoparticles induced by the 
abundance of (-) or (+)-sparteine functionalities. In order to experimentally confirm this, we 
studied the effect of incremental additions of L-Cysteine on (-)-sparteine by CD spectroscopy 




of L-Cys (Figure S2.19 A). A negligible shift was observed for (+)-sparteine demonstrating that 
L-Cys has significantly higher enantioselective interaction with (-)-sparteine than (+)-sparteine.  
2.3.5. Conclusions 
In conclusion, we report the development of chiral CNPs by surface passivation with a 
chiral ligand of high asymmetric response with restricted points of chiral inversion, (-)-/(+)-
sparteine. The physico-chemical integrity of the obtained CCNPs was investigated by UV-Vis, 
fluorescence, FT-IR, NMR, Raman, DLS, AFM, TEM and zeta potential studies. As a result of the 
passivation using (-)-/(+)-sparteine, the CNPs were rendered chiral. Their chiroptical response was 
confirmed using circular dichroism and polarimetry techniques. We demonstrated that these 
CCNPs could be used as a chiral adsorbent for enantiospecific binding. The % ee obtained in this 
work is better or comparable than that of similar adsorbants. The method excels due to its 
simplicity and low cost of the materials used. The general method to prepare chiral CNPs described 
here opens a new route to prepare a broad variety of chiral CNPs with other chiral passivating 









CHAPTER 3: MULTISCALE IMAGING WITH NANOPARTICLES 
 
3.1. Hyperspectral Imaging Offers Visual and Quantitative Evidence of Drug Release from 
Zwitterionic-Phospholipid-NanoCarbon when Concurrently Tracked in Three-dimensional 
Intracellular Space5   
Spatial and spectral information of a nano-carrier and its payload is crucial for the 
advancement of luminescence-based imaging, disease detection and treatment in complex 
biological environment. However, it remains challenging to track and quantify the delivery and 
co-localization of drugs lacking inherent fluorescence. We demonstrate that sub 30 nm 
phospholipid-stabilized nanoparticles can be detected and quantified using hyperspectral 
transmitted light microscopy without the need of a fluorophore. In two proposed model systems, 
phospholipid-passivated carbon nanoparticles incorporate the drug in either free form or as a lipid-
based prodrug. Following a rigorous characterization of these nanoparticles and their controls, in 
vitro toxicities via loss in cell growth density and mitochondrial respiration was studied in MCF-
7 breast cancer cells. Furthermore, a detailed inhibitor-based study revealed that these particles 
were internalized based on a clathrin-mediated pathway irrespective of the choice of drug delivery 
platform. Hyperspectral imaging was performed to obtain the co-localization of CNP and drug 
molecules intracellularly and could successfully be tracked while therapeutic release is quantified 
in 3D space. The present work demonstrates that nanoparticles and therapeutic agents can be 
mapped and measured simultaneously barring the requirement of a dye, thus providing new 
                                                 
5 This part of the thesis has been adapted from the following publication: 
Misra, S. K., Ostadhossein, F., Daza, E., Johnson, E. V., & Pan, D. (2016). Hyperspectral Imaging Offers Visual and 
Quantitative Evidence of Drug Release From Zwitterionic‐Phospholipid‐Nanocarbon When Concurrently Tracked in 




avenues in the spatio-temporal characterization and synchronous detection and quantification of 
payload and carrier.  
3.1.1. Introduction 
Nanocarriers for drug delivery applications must overcome numerous barriers including 
external, en route, and cellular aspects to eventually attain their anticipated function [19]. Due to 
this complexity, the defined process of internalization and release of drug from nanoparticles 
within living cells must be fully understood. Synchronized tracking of drug and nanocarrier is 
therefore of great significance in the field of nanoparticle mediated drug delivery [240-242]. 
Spatial and spectral information of a nanocarrier and its therapeutic payload is likely to bring 
clarity on the drug delivery mechanism in complex biological environment with much needed 
control on cytoplasmic trafficking [243]. However, it is often challenging to track delivery and co-
localization of drugs lacking characteristic fluorescence. Moreover, it is even difficult to quantify 
the release of drug molecule from their carrier. Quantifying the rate and the amount of drug 
entering live cells is a critical part of the drug delivery process. Chemically selective 
nondestructive means for analyzing the composition of live cells in culture to quantify, in situ, the 
amount of drug being released from the carrier is an important task. Nanoparticles generally 
require the use of fluorophores for being tracked inside the cells to reveal cellular internalization, 
membrane interaction, endosomal escape and cytoplasmic distribution. However, the mode of 
membrane interactions, chemistry of endosomal escapes and trafficking of cytoplasmic 
distributions are not yet fully explored. The use of fluorophores or dye molecules is common 
through encapsulation or electrostatic complexations, which often leads to the loss of drug loading, 
release, or kinetics [244]. While the static microscopic disposition of the drugs (e.g. doxorubicin) 




membrane, the rate of transfer of compounds into the cytosol, the rate of release of the drug within 
the membranes and the accumulation into the nucleus are unknown [124, 201, 245]. Furthermore, 
it remains challenging to track delivery and co-localization of drugs lacking inherent fluorescence.   
 
 
Figure 3.1. Schematic representation of CNPs, their plausible mechanism of cellular entry and 
concept behind using hyperspectral imaging for tracking drug and CNP in 3D intracellular space. 
(A) three possible scenario of drug encpasulated CNP; Drug-CNP: doxorubicin encapsulated CNP; 
Prodrug-CNP: SN2-lipase labile bexarotene prodrug passivated CNP; Lipid-CNP: a control 
nanoparticle where CNP has been passivated with phospholipid with no inclusion of any drug.; 
(B) various endocytic pathways for intracellular delivery of CNP and drug encapsulated 
nanoparticles.; (C) conceptual represntation of 2D hyperspectral image of treated cell localizing 
the presence of drug and nanoparticle followed by compilation of equally spaced 2D slices to 




In this work, we developed a sub 30 nm zwitterionic phospholipid-stabilized nanoparticles 
and demonstrate that drugs encapsulated in free or prodrug form, can simultaneously be detected 
using hyperspectral transmitted light microscopy without the need of a fluorophore (Figure 3.1). 
This technique offers the capability of performing three-dimensional (3D) co-localization and 
spectroscopic identification of nanoparticles in fixed cancer cell preparations along with the loaded 
drug. Furthermore, quantitative evidence can be gathered to throw light into the rate of the release 
of the drug from the nanoparticle once they are internalized. The present work demonstrates that 
nanoparticle and therapeutic agents can be mapped and quantified simultaneously barring the 
requirement of a dye, and thus providing new avenues in the spatio-temporal characterization and 
synchronous detection of payload and carrier.  
Luminescent carbon nanoparticles (CNP) have recently emerged as tools to deliver and 
track various drugs intracellularly [102]. Different passivating agents used during the preparation 
of CNPs are found to regulate not only size and stability of the particles but also their blood contact 
and cell toxicity properties [201]. Our studies combined with others have extensively detailed the 
passivation of CNPs with positive, negative, and neutral molecules for bioimaging and drug 
delivery [245-248]. Loading of drug could be furnished by two different methods including a) free 
drug encapsulated as an additional passivating molecule and b) in pro-drug form, where drug can 
be covalently conjugated with phospholipids to be used as passivating agent. With these two 
possibilities in mind, synthesis of CNPs as nucleating particles through passivation with 
zwitterionic phospholipids would be of great interest in terms of cell interactions, internalization, 
and post incubation imaging [249]. In two proposed model systems, phospholipid-passivated 
carbon nanoparticles incorporate the drug in either free form or as a lipid-based prodrug. The 




3.1.2. Materials and Methods 
3.1.2.1. Materials 
Agave nectar (18% glucose and 56% fructose by weight, HoneyTree’s® Organic Agave 
Nectar, MI, USA) was obtained from a local grocery store. Doxorubicin hydrochloride, 
Bexarotene, sucrose, sodium azide, DOG (deoxyglucose), Nystatin, Dynasore hydrate and CPM 
(chlorpromazine) were purchased from Sigma-Aldrich (USA). Phospholipid soy lecithin was 
purchased from NOF America Corporation. The hydrodynamic diameter was measured on a 
Malvern Zetasizer machine equipped with 633 nm laser. ζ-Potential measurement was performed 
on a Malvern Zetasizer instrument, from the MRL facility, UIUC. The TEM images were acquired 
on a JEOL 2100 cryo-TEM machine and imaged by a Gatan UltraScan 2kx2k CCD. MTT 
reduction assay was ended by performing an absorption assay on a plate reader (Synergy HT, Bio-
Tek). Brightfield imaging was performed on a DMI3000 B microscope, Leica Microsystems, 
Buffalo Grove, IL.  
3.1.2.2. Preparations of Phospholipidic CNPs  
Phospholipidic CNPs were prepared by hydrothermal method. CNPs constitute 1 g of 
agave nectar, lipid-CNP 1 g of agave nectar with 100 mg of soy lecithin, drug-CNP 1 g of agave 
nectar with 100 mg of soy lecithin and 2 mg of DOX and prodrug-CNP 1 g of agave nectar with 
100 mg of soy lecithin and 2 mg of probexarotene. These constituents were homogeneously mixed 
in 5 ml of nanopure water (0.2 μM, 18 MΩ ·cm). This aqueous mixture was heated on a hot plate 
at 300 °C for roughly 1 hr till it converts to dried brownish mass. Dried mass was soaked in 5 ml 
of nanopure water for 2h. Followed by 30-minute probe sonication (Q700TM, Qsonica Sonicators, 
CT, USA) (Amp:1, On: 2 sec, Off: 1 sec), the solution was passed through a syringe filter with a 




size (Millex® , Merck Millipore Ltd., County Cork, Ireland). The particle concentration was made 
up to 20 mg/mL in all the cases and used with required dilutions per the experimental requirements 
and mentioned in appropriate section of the manuscript. 
3.1.2.3. Size and Zeta Potential Measurements 
The hydrodynamic diameters and surface charges of CNPs were determined by a Malvern 
Zetasizer Nano ZS90 (Malvern Instruments Ltd., Worcestershire, UK). The averaged 
hydrodynamic diameter was obtained from the peak values of the number distribution with 3 ≤ n 
≤ 6 and the results were reported as mean± standard deviation. Transmission electron microscopy 
(TEM) images were collected by JEOL 2010 LaB6 and JEOL 2100 Cryo (JEOL Ltd., Tokyo, 
Japan). Samples were deposited on 200-mesh Quantifoil® holey carbon grids (Structure Probe, 
Inc., PA, USA) to visualize their anhydrous morphology.  
3.1.2.4. UV-Vis Spectroscopy and Fluorescence Spectroscopy 
Ultraviolet-visible (UV-Vis) absorbance of CNPs was recorded via GENESYSTM 10S 
UV-Vis Spectrophotometer (Thermo Scientific, MA, USA). Absorbance spectra were collected at 
an interval of 0.5 nm from 200–800 nm. The emission spectra of fluorescence measurements were 
obtained through NanoDrop 3300 Fluorospectrometer (Thermo Scientific, MA, USA). The 
excitation maximum was set to 365 nm and the wavelength covered an excitation range between 
400 and 750 nm. 
3.1.2.5. Raman and FT-IR spectroscopy 
All Raman measurements were taken on a Nanophoton Raman instrument (MRL facility, 




For each spectrum a grating (600 l mm-1) scan was taken over the range of 120–3900 cm-1. An 
average of 20 spectra were recorded and averaged per sample.  
For Fourier Transform Infrared (FT-IR) analysis, aqueous suspensions of particles were drop cast 
onto MirrIR IR-reflective glass slides (Kevley Technologies, Chesterland, Ohio, USA) for 
measurements using a Nicolet Nexus 670 FTI-IR (MRL facility, UIUC). For each measurement 
100 × 100 μm images were collected at 1 cm−1spectral resolution with 64 scans per pixel and a 
25 × 25 μm pixel size and individual spectra were corrected for atmospheric contributions.  
3.1.2.6. Nuclear Magnetic Resonance (1H NMR) Spectroscopy 
1H NMR measurements were performed using Varian VXR 500 spectrometer operating at 
500 MHz equipped with 5 mm Nalorac QUAD probe. Chemical shifts were reported in ppm and 
referenced to the solvent proton impurities. The spectra were recorded in either D2O or DMSO-d6 
depending on the solubility of the samples in each of the solvents. The data was processed and 
analyzed using MestRenova 8.1 software (Mestrelab Research SL; Santiago de Compostela, 
Spain). 
3.1.2.7. Human Breast Cancer Cell Culture 
Cell toxicity assay was performed on human breast cancer ER (+) MCF-7 (ATCC) cells. 
Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum (FBS) in T25 culture flasks (Cellstar; Germany) and were incubated at 37 °C in a 99% 
humidified atmosphere containing 5% CO2. Cells were regularly passaged by trypsinization with 
0.1% trypsin (EDTA 0.02%, dextrose 0.05%, and trypsin 0.1%) in DPBS (pH 7.4). 




3.1.2.8. MTT Assay  
MCF-7 cells (10 x 103) were plated in 96 well plates. The cytotoxic effect of CNPs was 
investigated with a 3-(4,5-dime thylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
(Sigma-Aldrich, MO, USA). MCF-7 cells were grown for 24h to achieve ~80% cell confluence. 
Grown cells were exposed with various CNPs for 48 h at 37 °C with a concentration ranging from 
10, 5, 2.5, 1.25, 0.625, 0.31 and 0.15% (v/v). Cells were also incubated with the same equivalence 
of lipid, DOX and Bexarotene. Cells were further grown for 42 h and at the end of incubation, a 
20 μL (5 mg/mL) of MTT solution was added to each well. Cells were further incubated for another 
4.5 h. After incubation, media were aspirated and 200 μL of dimethyl sulfoxide (DMSO, ≥ 99%, 
MP Biomedicals, USA) was added to dissolve formazan crystals. Absorption of the samples was 
determined by Synergy HT (BioTek, USA) with a reference wavelength of 592 nm. The percentage 
cell viability was determined by the following equation: 
% Cell viability = [(A592 treated cells) − (A592 background) / (A592 untreated cells) − (A592 
background)] x 100 
3.1.2.9. Inhibition Studies 
MCF-7 cells (10 x 103) were plated in 96 well plates. Cells were grown for 24h before 
incubated with various endocytic inhibitors. Inhibitor formulations were made with reconstituted 
medium having sodium azide, DOG (deoxyglucose), CPM (chlorpromazine), sucrose, Nystatin 
and Dynasore hydrate at a concentration of 10 μM, 50 μM, 28 μM, 450 μM, 180 nM and 80 μM, 
respectively.  Cells were incubated with inhibitors for 1h at ambient condition. Inhibitors were 
replaced with CNPs at two different concentrations including 5 and 10% v/v. All the additions 
were performed in triplicate. Cells only with inhibitor treatments were considered as negative 




positive controls. Cells were also treated with small molecule components of CNPs including lipid, 
DOX and Bexarotene at equivalent concentrations. The cytotoxic effect of CNPs were investigated 
with a 3-(4,5-dime thylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-
Aldrich, MO, USA) as described above.  
3.1.2.10. Enhanced Darkfield Hyperspectral Imaging 
Optical and hyperspectral images were captured at 60X magnification using enhanced 
darkfield illumination at CytoViva hyperspectral imaging system (Auburn, AL). This 
hyperspectral imaging system includes enhanced darkfield illuminator with optical and 
hyperspectral CCD cameras. The hyperspectral image, called as datacubes, was collected using 
the “pushbroom” method. The spectral data (400 – 1000 nm) was acquired one-pixel row at a time 
while acquisition was facilitated by a motorized stage. The hyperspectral analysis software ENVI 
was used to compile the spectral and spatial data into a datacube, in which each pixel contained 
spectral data. Spectral libraries corresponding to the CNPS were built from the images of exposed 
cells. Using the Spectral Angle Mapper (SAM) algorithm, the spectral libraries were compared to 
their respective images. 
3.1.3. Results and Discussion 
3.1.3.1. Synthesis of Prodrug, Lipid-CNP, Drug-CNP and Prodrug-CNP 
A natural carbohydrate, nectar agave, was used as an inexpensive source of carbohydrates 
with surface pre-passivated with zwitterionic lecithin PC (Lipid-CNP) using a cost-effective, 
simple hydrothermal technique. Anticancer drug doxorubicin (DOX) was considered for an in-situ 
co-passivation of as-synthesized nucleating carbon nanoparticles (CNPs) with lecithin PC to 
produce drug loaded nanoparticles (Drug-CNP). The synthesis of the pristine (bare, uncapped) 




(4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl2-naphthalenyl)ethenyl] benzoic acid, 
Targretin®), an FDA-approved drug, currently in limited use for cutaneous manifestations of T-
cell lymphomas (CTCL). It is a known orphan nuclear agonist and a member of a subclass of 
retinoids that selectively activate retinoid X receptors (RXRs). The synthesis and characterization 
of the prodrug version of bexarotene (denoted as pro-bexarotene) followed a previously reported 
procedure from our laboratories [250]. Briefly, 1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphocholine (16:0 Lyso PC) (24.8 mg, 0.05 mmol), EDC (19.1 mg, 0.1 mmol) and DMAP 
(catalytic amount) were mixed in anhydrous CHCl3 solution (1 ml) and stirred for 15 mins at 
ambient temperature. To this mixture bexarotene (17.4 mg, 0.05 mmol dissolved in 0.5 ml 
anhydrous CHCl3) was added and allowed to stir for 24h at room temperature. The completion of 
the reaction was monitored by thin layer chromatography (silica). The resultant organic solution 
was then washed for several times with water and extracted with excess dichloromethane. 
Dichloromethane was evaporated under reduced pressure to afford compound 23 mg in 56% yield 
as light yellow solid (Scheme S1). 1H NMR and Mass spectroscopy studies were used to confirm 
the characteristics of the desired prodrug. The susceptibility of pro-bexarotene can be studied in 
the presence of enzyme and acidic pH. The prodrug (500 µl) was incubated for 2h with 0.278 mg 
(3.36 x 10-7 mole) phospholipase A2 or acidic pH (pH=4.1). The samples were continuously 
agitated on a nutator to prevent settling. The mixture was isolated and analyzed by high resolution 
mass spectrometry (HR MS) to observe signature peaks of cleaved and liberated bexarotene. HR 
MS confirmed the release of bexarotene from the prodrug under enzymatic or low pH condition 
(Figure S 3.1). This compound was used for the in-situ co-passivation of nucleating carbon 




3.1.3.2. Physico-chemical Characterization 
In typical protocols, CNPs were synthesized from agave nectar as carbon source (1g/ 5 mL 
of water) with passivation using zwitterionic phospholipid (soy lecithin; 100 mg/5 mL of water) 
with or without doxorubicin (10 mg) or pro-bexarotene (10 mg) molecules at 250 ̊C for 1h. As-
synthesized CNPs were characterized for their hydrous sizes, morphologies and surface charge 
distribution. Particles were characterized for their hydrodynamic diameter by dynamic light 
scattering measurements. 
Figure 3.2A shows the hydrodynamic diameters of in situ-synthesized Lipid-CNP to be 
44±2 nm, DOX loaded particles were 97±8 nm, which further decreased to 25±5 nm after Pro-
bexarotene coatings. It was found that the passivation of CNPs with zwitterionic phospholipids 
with or without additional DOX or Pro- bexarotene produced significantly smaller particles (~30 
nm) compared to non-passivated particles (~80 nm) with slight improvement in particle size 
distribution of PDI ~0.35 from 0.5 (Figure 3.2A, Table S3.1). 
Similarly, significant changes were reported in surface charge potential for phospholipid 
coated CNPs with DOX, Pro- bexarotene or without any inclusion of drug i.e. -30 mV compared 
to -20 mV in the case of pristine CNPs (Table S3.1). UV-Vis spectroscopic measurements 
confirmed strong absorption with a λmax of 275 nm (Figure 3.2B) and a fluorescence peak at λmax 
of 450 nm (Figure 3.2C) (λexcitation=360 nm) with no significant shift in λmax all across the CNP 
formulations. Chemical analysis via Fourier Trasnform Infrared (FTIR) (Figure 3.2D) and Raman 
(Figure 3.2E) spectroscopy revealed that small molecule amide peaks from DOX and bexarotene 
were present in the passivated CNPs [251-253]. Additionally, the graphitic (sp2 hybridization) to 
diamond (sp3 hybridization) like carbon ratios increased with lipid passivation (Lipid-CNP or 




Anhydrous stage morphology of prodrug-CNP was found to be a spheroid with smaller diameter 
of ~20 nm in TEM imaging (Figure 3.2G) compared to hydrodynamic diameter.  
 
Figure 3.2. Physico-chemical characterization of phospholipidic nanocarbon including Lipid-
CNP, Drug-CNP and Prodrug-CNP for (A) hydrodynamic diameter; (B) UV-Vis absorption 
spectroscopy; (C) fluorescence spectroscopy; FT-IR spectroscopic signature of (D) prodrug-CNP 
and (E) bexarotene; (F) representative TEM images of prodrug-CNP (stained with 1% uranyl 
acetate).  
 
Similarly, anhydrous state morphology of drug-CNP and lipid-CNP were found to be 
smaller than hydrodynamic diameter (not shown). Probably, the decrease in size of CNP occurred 
due to loss of hydration layer involving water molecules with zwitterionic phospholipids. 1H NMR 




DMSO-d6 or D2O on a 500 MHz machine. Subsequently, the peaks were analyzed and assigned 
as seen in Figure 3.2H, I and Figure S3.2 A-D. It is conceivable that the multiplet with the chemical 
shift at 3.62 ppm and the doublet at 7.34 ppm observed in the DOX spectrum were preserved in 
drug-CNP formulation while most of the peaks were masked by the prominent peaks from CNPs. 
Similarly, Pro- bexarotene proton with the chemical shift of 2.12 ppm was observed to occur at 
2.06 ppm in the case of Prodrug-CNP. In addition, the doublets at 6.59 ppm and 7.37 ppm were 
shifted to 6.68 and 7.53 ppm, respectively. Thus, it can be concluded that drug signatures have 
remained intact during hydrothermal synthesis. 
3.1.3.3. Cell Toxicity Studies 
Following a rigorous characterization of these nanoparticles and their controls, in vitro 
toxicity, via loss in cell growth density and mitochondrial respiration, was studied in MCF-7 
human breast cancer cells. An MTT assay was used for the evaluation of cell viability and inhibitor 
efficiency against formulations of CNP, Lipid-CNP, Drug-CNP, Prodrug-CNP, (0.15-5% v/v) and 
their equivalent form of lipid, DOX and bexarotene compounds for 48h. A non-synchronized 
population of cells (10 x 103 cells/well) were plated in 96 well plates for 24h before performing 
the cell treatment. Cells were treated with formulations for 48h before performing the MTT assay. 
It was found that Drug-CNP formulations were equally efficient as free DOX molecules at 
reducing cell viability while Prodrug-CNP was found to be more efficacious when compared to 
small molecule bexarotene. Pristine-CNP, Lipid-CNP and lipid were found to be non-affecting to 
the cell growth at all tested concentrations of 0.15-5% (v/v) equivalence (Figure 3.3 and 3.4A, B). 
This confirms that the passivation of nucleating CNPs with a phospholipidic pro-drug improves 




density and morphology was visualized by bright field imaging (Figure 3.3 and S3.4-S3.7). A sub-
toxic concentration of CNPs was used to determine their localization in intra-cellular space. 
 
Figure 3.3. Bright field images of MCF-7 cells (A) untreated and treated with (B) CPM (28 nM; 
for 1h) alone and additional Incubation with (C) CNP (1 mg/mL); (D) Lipid-CNP (1 mg/mL); (E) 
Drug-CNP (1 mg/mL); (F) Prodrug-CNP (1 mg/mL); (G) Lipid (2 μg/mL); (H) DOX (2 μg/mL) 
and (I) bexarotene (2 μg/mL) making a concentration of 5% (v/v) in growth medium for further 
48h. A non-synchronized population of cells (10 x 103) were plated in 96 well plates for 24h before 
performing the cell treatment. A non-synchronized population of cells (10 x 103) were plated in 96 
well plates for 24h before performing the cell treatment. Experiments were performed in 
triplicates.  
 
3.1.3.4. Mechanism of Cell Entry    
Nanoparticles can enter mammalian cells through different pathways including endocytic 
pathway [254, 255]. The final intracellular transport would depend mainly on the surface chemistry 




particular cell can delegate better therapy and imaging strategy beforehand with higher chances of 
success [256]. This can be studied by using different pharmacological manipulators or inhibitors 
before allowing the internalization of desired nanoparticles via energy, clathrin and/or caveolar 
mediated pathways. The energy dependence of nanoparticle uptake can be studied by the use of 
the ‘metabolic poisons’ sodium azide (NaN3) and 2-deoxyglucose (DOG) for inhibiting 
glycogenolysis and cellular respiration, respectively [257]. The clathrin dependent entry can be cut 
off by hypertonic treatment of the cells using 0.45 M sucrose solution. It reduces the number of 
clathrin coated pits on the cell surface and changes the morphology to much flatter and smaller 
than normal [258]. Clathrin-coated pit formation can also be reduced by a reversible translocation 
of clathrin and its adapter proteins from the plasma membrane to intracellular vesicles by using 
chlorpromazine [259]. Additionally, Clathrin dependent coated vesicle formation would be 
influenced by cell-permeable small molecules that inhibit the GTPase activity of the mitochondrial 
dynamin. Dynasore, the inhibitor of the dynamin GTPase, could be used for the inhibition of 
dynamin-dependent endocytosis in cells [260]. The Inhibition of endocytic entry without affecting 
clathrin-dependent internalization pathway could lead to better understanding of the nanoparticle 
entry. Nystatin, a sterol-binding agent that disassembles caveolae and cholesterol in the membrane, 
could be used to study clathrin-independent inhibition of endocytosis [261]. To investigate the 
mechanism of CNPs entry in MCF-7 cells, we performed CNP internalization inhibition assay. 
Assay was performed on 10 x 103 cells plated in 96 well plate for 24h. Cells reached ~80% 
confluence before incubation with various inhibitors for 1h (Table S3.2). Cells were incubated 
with mixed solution of NaN3 (10 mm) and GOD (50 mM) or solutions of CPM (28 nM), Sucrose 
(450 nM), Nystatin (180 nM) and Dynasore (80 μM). These chemicals are known for inhibiting 




mediated endocytosis, and endosomal escape. Caveolar endocytosis and dynamin interfere with 
both clathrin- and caveolae-mediated endocytosis, respectively (Figure 3.4C-H). After 1h of 
incubation with inhibitors, cells were further incubated with 5% (v/v) of CNP, lipid-CNP, drug-
CNP and prodrug-CNP and equivalent concentration of lipid, DOX and pro-bexarotene for 48h 
before performing the MTT assay. Negative controls included cells alone, cells treated with only 
inhibitors, and cells treated with only CNPs.  
 
Figure 3.4. MTT assay for the evaluation of cell viability and inhibitor efficiency against 
formulation of CNP, Lipid-CNP, Drug-CNP, Prodrug-CNP, (5%; v/v) and its equivalent in form 
of Lipid-CNP, DOX and bexarotene compounds for 48h. A non-synchronized population of cells 
(10 x 103) were plated in 96 well plates for 24h before performing the cell treatment. Cells were 
firstly incubated with inhibitor formulations NaN3/GOD (10/50 mM), CPM (28 nM), Sucrose (450 





A detailed inhibitor-based study revealed that these particles were internalized via clathrin-
mediated pathway. A significant change was reported in the case of cells treated with Drug-CNP, 
Prodrug-CNP, DOX, and Bex after pre-incubation with clathrin mediated endocytosis inhibitors, 
dynasore and CPM, while treatments with CNP, lipid, and Lipid-CNP were found to be ineffective. 
MTT assay analysis further revealed that all the CNP formulations including CNP (Figure 3.4C), 
Lipid-CNP (Figure 3.4D), Drug-CNP (Figure 3.4E), and Prodrug-CNP (Figure 3.4F) were 
responsive to inhibitors of clathrin mediated endocytosis by decreasing the cell internalization and 
in turn increasing the overall cell viability.  Interestingly, cellular entry of DOX (Figure 3.4G) and 
bexarotene (Figure 3.4H) was found to be controlled by both clathrin- and caveolae-mediated 
endocytosis while lipid could be influenced by the inhibition of clathrin mediated endocytosis 
alone. It indicates that CNPs are internalized by clathrin mediated endocytosis and presumably 
dominates the entry process even after being passivated with different small molecule drugs.  
3.1.3.5. Hyperspectral Imaging (HSI) of Phospholipid-CNPs. 
Hyperspectral imaging (HSI), which combines spectrophotometry and imaging while using 
advanced optics and algorithms, can capture a spectrum from 400 to 1000 nm at each pixel in an 
enhanced dark-field microscopic (EDFM) image. This information can be used to confirm the 
identity of the materials of interest in a sample. It can also be used to generate an image “map” to 
reveal the presence and location of desired chemicals in a biological sample. Results demonstrate 
that EDFM-HSI mapping could locate and identify nanomaterials in biological samples more 
efficiently than other conventional methods [262, 263]. Intracellular tracking of these CNPs 
needed to be followed by utilizing intrinsic fluorescence of CNPs. Various imaging modalities 
have been explored for tracking CNPs in cellular systems including confocal [251], Raman [128], 




co-localization of CNP and drug molecules in 3D intracellular space. Hyperspectral microscopic 
imaging was performed on CNPs in aq. solution and in intracellular space after 4h of incubation 
with 5% concentration of formulations (v/v). HSI that captures spectral data per pixel in the VNIR 
region, revealed the presence of Lipid-CNP (Figure S3.8), Drug-CNP (Figure 3.5), and Prodrug-
CNP (Figure 3.6) particles with integral fluorescence.  
 Hyperspectral microscopy for the evaluation of spectral variation of Lipid-CNP in aq. 
medium (Figure S3.8A-F) and in cellular systems (Figure S3.8G-J) was used to visualize particles 
of small (Figure S3.8D), medium (Figure S3.8E), and large (Figure S3.8F) CNP localization. The 
hyperspectral imaging was also performed to track Lipid-CNP inside the cellular system revealing 
the spectral library with variations in the overall intensity (Figure S3.8H) and localization of 
particles. Hyperspectral images showed intracellular localization of Drug-CNP particles (Figure 
3.5A) generating fluorescent spectra with emission maxima at λ580 nm, plausibly representing 
fluorescence from DOX and a side hump at lower wavelength of λ500 nm due to intrinsic 
fluorescence from Lipid-CNP (Figure 3.5B).  
Hyperspectral imaging was also able to differentiate internalized Lipid-CNP (green) with 
and without passivated DOX in the form of Drug-CNP (red) nanoparticles (Figure 3.5C-E). 
Spectral analysis of the Drug-CNP populations confirm the presence of DOX as it showed 
fluorescence spectra with signature emission maxima at λ580 nm corresponding to DOX. Probably 
some of the internalized Drug-CNP nanoparticles released the DOX during 4h of incubation to 
populate cells with Lipid-CNP and responsible for fluorescence maxima at λ500 nm. All the 
hyperspectral images were background corrected with respect to hyperspectral images from 




covered with Lipid-CNP and Drug-CNP population as 0.001 and 0.029%, respectively (Figure 
3.5G).  
 
Figure 3.5. Co-localization of Lipid-CNP particles and DOX molecules present in Drug-CNP 
particles inside MCF-7 cells after 4h of incubation. (A) Hyperspectral image shows intracellular 
location of Drug-CNP and (B) generated spectral library showing fluorescence emission pattern. 
(C) Generated fluorescence distinguishability between localized Lipid-CNPs (green) and Drug-
CNP (red) on 1X digital zoom and (D) 6X digital zoom. (E) Drug-CNP localization represented 
as spectral library against (F) hyperspectral image from untreated MCF-7 cells revealing the 
quantified % of intracellular area covered with Lipid-CNP and Drug-CNP population (G). Cells 
were grown at 37 °C, 99% humidity and in presence of 5% of CO2. Imaging was performed on 





Similarly, detectability of Prodrug-CNP particles in solution phase and inside MCF-7 cells, 
after 4h of incubation grown at 37 °C, 99% humidity and 5% of CO2, was established by 
hyperspectral imaging. Imaging was performed on Prodrug-CNP particles in solution phase 
(Figure 3.6A-E) and inside the cells (Figure 3.6F-I). The Prodrug-CNP clusters (big, medium, or 
small) in aqueous solution imaged under hyperspectral microscope were distinguishably potent to 
be seen as highly fluorescent entities with λmax at 450 nm (Figure 3.6A-E). Probably solvent 
evaporation from aqueous sample of Prodrug-CNP during hyperspectral imaging allows 
nanoparticles to make clusters of different sizes, as shown in Figure 3.6A and B. The generated 
spectral library showed fluorescence maxima at λmax of 500 nm, irrespective of the size of the 
clusters (Figure C-E). Intracellularly located Prodrug-CNPs were imaged and verified 
spectroscopically to reveal fluorescence spectra at λmax of 580 nm probably due to intrinsic 
fluorescence of CNP passivated with probexarotene (Figure F-H). Prodrug-CNP was visualized in 
cellular background with distribution of 0.047% of covering area. Overall analysis revealed the 
shift of λmax of CNPs from 450 to 600 nm in the case of intracellular HSI compared to solution 
phase analysis, indicating the intracellular interactions of these CNPs irrespective of the 
passivation and type of drug or pro-drug involved. The co-localization of CNP particles and 
passivated drug and prodrug were investigated in 3D space with quantitative pixel analysis. 
The analysis revealed the abundance of Drug-CNP (29X) compared to free Lipid-CNP 
(1X) particles. This indicates that a 4h of incubation was adequate to observe release ~3.3% of 
DOX from the particles (Figure 3.6). Although 4 h time interval is not enough to release all the 
payload of drug, the release of ~3.3% of drug indicates the sustained release over the extended 




very beginning of the release and can be followed in very time dependent manner as per 
requirement of the study.  
 
 
Figure 3.6. Hyperspectral imaging for establishing co-localization of Prodrug-CNP particles 
inside MCF-7 cells after 4h of incubation grown at 37 °C, 99% humidity and 5% of CO2. Imaging 
was performed on Prodrug-CNP particles in (A-E) solution phase and inside the cells (F-I). (A) 
Prodrug-CNP clusters in aqueous solution imaged under hyperspectral microscope and (B) image 
at 6X optical zoom. Fluorescence spectra generated from particle clusters of (C) small, (D) medium 
and (E) big size. Intracellularly located Prodrug-CNPs imaged at (F) 1X and (G) 6X optical zoom 
and respective spectral library (H). (I) Distribution of Prodrug-CNP visualized in cellular 






3D visualization of HSI was performed on MCF-7 cells treated with Drug-CNP for 4h. 
Localization of Drug-CNP (red, white arrow) in 3D intracellular space was visualized along with 
cellular building blocks. 3D orientation of hyperspectral images was acquired from side view 
(Figure 3.7A, B), top view (Figure 3.7C), and horizontal axis (Figure 3.7D) with cellular signature 
building blocks (Figure 3.7E). Hyperspectral images were also acquired without cellular building 
blocks showing an array of localized Drug-CNP populations (Figure 3.7F-I) compared to position 
building blocks alone (Figure 3.7J).  Thus, in 3D-space, these particles could be mapped for the 
exact location using hyperspectral imaging (Figure 3.7; Movie 1). 
3.1.4. Conclusion 
To conclude, we developed a sub 30 nm zwitterionic phospholipid-stabilized nanoparticles as a 
model system for the delivery of fluorescent and non-fluorescent drugs. Drugs were encapsulated 
as free or used as prodrug form to passivate nucleating carbon nanoparticles. To the best of our 
knowledge, this represents the first example of a one-step, facile procedure to synthesize prodrug-
passivated carbon nanoparticle. By the virtue of simplicity of the prodrug chemistry and 
nanoparticle synthesis, we envision that the methodology can be applied to wide ranges of drug 
molecules. Hyperspectral transmitted light microscopy of the drug-laden nanoparticles offers 
capability of performing three-dimensional (3D) co-localization and spectroscopic identification 
of nanoparticles and drug molecules in fixed cancer cell preparations. Mechanistic studies were 
performed to probe the cellular internalization mechanism which confirmed that irrespective of 
the chemistry performed at the nanoscale to incorporate drugs, the particles were internalized by 
clathrin-mediated pathway. To the best of our knowledge, this is the first known attempt to 
mechanistically understand the intracellular delivery of carbon dots. Furthermore, quantitative 




they are internalized. The present work demonstrates that nanoparticle and therapeutic agents can 
be mapped and quantified simultaneously barring the requirement of a dye, thus providing new 




Figure 3.7. 3D visualization of hyperspectral imaging performed on MCF-7 cells treated with 
Drug-CNP for 4h at 37 °C, 99% humidity and 5% of CO2. (A) Localization of Drug-CNP (red, 
white arrow) in 3D intracellular space showing cellular building blocks. 3D orientation of 
hyperspectral images from (A-B) Side view, (C) top view, (D) horizontal axis (E) with and without 
cellular building blocks showing array of localized Drug-CNP populations (F-I) compared to 
building blocks alone. Imaging was performed on fixed cells with 4% paraformaldehyde. White 





3.2. Oligodot Nanoparticles: a new class of fluorescent nanoparticles with defined chemical 
composition for multiscale imaging and multiplexing in vitro and in vivo6 
3.2.1. Abstract 
 The development of the nanoscale fluorescent probes which do not suffer from the 
limitations of common fluorophores such as organic dyes and fluorescent proteins bear high 
importance due to their high potential for duly imaging and diagnosis of various diseases. Herein, 
we disclose for the first time the synthesis of ultrasmall oligodots for multicolor imaging on 
multiscale in vivo. The oligodots were prepared via a condensation and curing process in one-step 
during hydrothermal method. By engineering the solvent during the synthesis, nanoparticles with 
green emission (𝜆𝑒𝑚 = 550 𝑛𝑚) and red emission range (𝜆𝑒𝑚 = 650 nm) were obtained and 
characterized extensively for their physicochemical properties. The difference in the photophysical 
properties of these nanoparticles were attributed to the various oligomeric compositions formed 
during the synthesis as revealed by detailed studies of mass spectroscopy, nuclear magnetic 
resonance spectroscopy, X-ray photoelectron spectroscopy and density functional theory 
calculations. Subsequently, the potential of these nanoparticles for multicolor imaging was 
demonstrated in vitro and in vivo. In addition, their different fluorescent lifetime provided another 
dimension for the multicolor imaging as was shown in the microscopic evaluation of the coinjected 
tissue in vivo. The red emitting variant of these nanoparticles were employed for whole body 
imaging in nude mice and their dynamic imaging was done to monitor their biodistribution during 
the course of 24 h. These nanoparticles did not indicate any adverse effect in vivo as was revealed 
by the histopathological examinations of the major organs. It is envisioned that the oligodots have 
                                                 
6 This part of the thesis has been adapted from the following publication:  
Ostadhossein, F., Sar, D., Graham, C., Tripathi, I., Soares, J., Remsen, E., Pan, D., Oligodot Nanoparticles: a new 
class of fluorescent nanoparticles with defined chemical composition for multiscale imaging and multiplexing in vitro 




the potential for multicolor imaging of various biomarkers in complex diseases such as cancer 
where various molecular and metabolic phenotypes work in concert in its emergence. 
3.2.2. Introduction 
Biological imaging is an indispensable component of modern medicine which can shed 
light up on the biological phenomena to the molecular level and can be utilized for the early 
diagnosis of a wide gamut of deadly diseases such as cancer [264-269]. Conventional imaging 
methods such as Ultrasound (US), computed tomography (CT), and magnetic resonance (MR) are 
commonly being used in the clinic to diagnose physiological and anatomical abnormalities [270-
273]. Despite their high spatial resolutions, these methods are incompetent when compared with 
the optical imaging methods as the latter offers high sensitivity, real-time screening, and 
intraoperative feedback while also being safe because of the lack of harmful radiation [274-276]. 
Of importance is optical imaging in the first biological window aka NIR imaging where the 
interference from tissue scattering and tissue autofluorescence is minimal, leading to the enhanced 
depth of penetration [265, 277-279]. 
In particular, the great potentials of fluorescent imaging have led to the development of 
various probes including organic dyes [280, 281] and quantum dots (QDs) with high quantum 
yield [282, 283]. However, small molecules tend to get renally cleared in a short time span making 
the imaging practically cumbersome [284, 285]. On the other hand, although QDs might address 
the fast-renal exertion of the small organic dyes, their toxicity due to the presence of heavy 
elements has always been a bottleneck slowing their application for the in vivo imaging [286, 287]. 
Multicolor imaging is of high importance in the biological applications although most of 
the efforts so far have been focused on the utilization of fluorescent probes for the development of 




imaging while many diseases happen as a result of the failure of multiple biomarkers concurrently 
e.g. cancer which has a multifaceted progression nature [292, 293]. Therefore, the design of 
multicolor probes for the in vivo multiplexing is necessary to broaden the library of fluorescent 
probes for improved molecular diagnosis and informed therapy decision. To further build upon the 
capabilities of the fluorescent probes, their properties can be tuned for the generation of 
‘characteristic’ luminescence decay lifetimes [294-296]. Curbing such property can open further 
opportunities for multicolor fluorescent lifetime imaging.  
Carbon dots, polymer carbon dots, and polymer dots are three distinct classes of emerging 
photoluminescent probes for imaging which attracted a host of research interests lately due to their 
alluring photophysical properties, low toxicity and degradability [69, 71, 297-299]. These various 
classes of NPs have been vastly utilized for cell labeling and single-color in vivo imaging. 
Meanwhile, a unifying definition and consensus over their chemical composition are lacking while 
some pieces of literature refer to the long chain polymeric nature depending on the source being 
used [95, 151].   
Herein, we disclose for the first time the synthesis of ultrasmall fluorescent nanoparticles 
obtained by the hydrothermal treatment of carbonaceous source while the judicious choice of the 
precursors resulted in properties that could not be explained based on the generally accepted school 
of thought about the polymeric and/ or graphitic nature of these particles. Therefore, the term 
‘oligodot’ was coined after the comprehensive mass spectroscopy and nuclear magnetic resonance 
spectroscopy (NMR) analysis unveiled, the oligomeric nature of these nanoparticles which did not 
fit into former definitions. Comprehensive DFT calculations were implemented on the suggested 




Inspired by the methodology applied in hair dyes, we used a para-substituted aromatic 
amine (2, 5 diaminotoluene sulfate) alongside with a catecholamines nucleophile (dopamine) in 
aqueous solution to form well- defined red emitting oligodots via condensation [300]. The 
dissociation of water under high pressure and temperature acted analogously to the oxidant needed 
for the hair dye development. In addition, photoluminescence tuning was achieved by the slight 
modification of solvent and change in alkalinity to yield green emitting oligodots. Size exclusion 
chromatography, AFM and TEM all corroborated the formation of sub 20 nm NPs. To gain insight 
into the photophysical properties of these NPs, extensive photoluminescent characterizations were 
carried out. The red emitting NPs were tracked in vivo after tail vein injection to light up various 
organs and their clearance pattern in vivo. Having demonstrated their feasibility for biological 
studies, we indicated the potential of multiplexing with these nanoparticles in vivo upon 
intradermal injection and spectral unmixing leading to correct localization in each of the mouse’s 
flanks. Importantly, the skin tissue collected from these animals were used for the fluorescent 
lifetime imaging where the green and red oligodots could clearly be distinguished in a mixed 
population as a result of their unique lifetime decays. Inhibitor studies and cell viability assays 
were subsequently performed to recognize the mode of internalization in cells. These NPs did not 
have any adverse effects on the function of major organs in vivo as confirmed by histopathological 
examinations. Considering the desirable spectroscopic properties, safety, and proper 
pharmacokinetics, oligodot nanoparticles can offer a new platform as novel fluorescent imaging 




3.2.3. Experimental Section 
3.2.3.1. Materials 
Unless otherwise stated all the chemicals were purchased from Sigma (St. Louis, MO). 2,5-
Diaminotoluene sulfate (DAT) and Dopamine hydrochloride (DOP) were purchased from Alfa 
Aesar (Ward Hill, MA) and Sigma, respectively. Sulfuric acid was obtained from Fluka (Morris 
Plains, NJ). Nanopure water (0.2 × 10−6 m, 18 MΩ cm) was used throughout the experiments for 
the synthesis of the nanoparticles. 
3.2.3.2. Nanoparticles synthesis and characterizations 
 For the synthesis of R- oligodots, 1 mol of DAT and DOP were dissolved in 10 ml of water 
and vortexed vigorously before transferring it to a Teflon lined autoclave for hydrothermal 
synthesis. The oven temperature was set to 150, 175, 225 °C for 8 h.  
For the G- oligodots synthesis the same procedure was followed except the NPs were first 
dissolved in 10 ml of 7.3 M sulfuric acid, water mixture and then underwent the heating cycle. 
After cooling down the autoclaves, the green NPs were first neutralized with NaOH and then were 
centrifuged for 10 min at 4200X rpm to get rid of the formed salt. Both NPs were then passed 
through the syringe filters (0.45 and 0.22 μm mesh size) and were then dialyzed against 1X PBS 
(pH=7) to adjust the pH (Mw cutoff= 2000 Da). They were kept in the fridge for long term storage 
and were briefly tip sonicated before each of the experiments.  
Subsequently, comprehensive NP characterization was carried out to further elucidate their 
physicochemical properties. The morphology of the samples in the dry state was observed with a 
transmission electron microscopy (TEM) instrument (FEI Company, Oregon, US) equipped with 
a Peltiercooled Tietz (TVIPS) 2k × 2k charge-coupled device camera. Five microliters of the 




US) and the extra liquid was removed with filter paper and the sample was dried overnight before 
imaging. Atomic force microscopy in the tapping mode was done on Bruker MultiMode 
Nanoscope IIIA (Billerica, MA). The samples were diluted 106 fold and were then deposited 
(100μl) on a mica wafer fixed on a steel disc. The extra liquid was wicked after 5 min and then the 
discs were vacuum dried overnight.  
The size of the NPs was next determined in the hydrous state by various techniques. 
Initially, dynamic light scattering (DLS) was used for measuring the average hydrodynamic 
diameter on Malvern Zetasizer ZS90 instrument (Malvern Instruments Ltd., United Kingdom).    
The electrophoretic ζ potential was measured on Anton Paar LiteSizer500. 
X-ray diffraction (XRD) patterns were collected on a Siemens-Bruker D5000 (Madison, 
WI) with Cu–Kα (1.54 Å) radiation in the θ-2θ configuration (30 kV and 40 A). The scan rate was 
adopted to be X, and the step size was set to be 0.02°. The spectrum was smoothed using a 10-
point Savitzky–Golay algorithm. 
The photophysics of the oligodots were characterized by UV- Vis spectroscopy (UV-Vis), 
fluorescence spectroscopy, and Time-Resolved Photoluminescence (TRPL). The absorbance 
spectra were recorded on a GENESYS 10 UV−vis spectrometer (Thermo Scientific, MA). The 
excitation-emission spectra were obtained on an Infinite 200 PRO multimode microplate reader 
(Tecan, NC, US) in the dark well plates (Falcon Black/Clear Sterile 96 Well Imaging Plate). The 
2D excitation emission contours were measured on Horiba Aqualog Scanning Spectrofluorometer 
(Horiba scientific, Edison, NJ). The first order Rayleigh scattering was corrected, and all the 
spectra were normalized to 1 mg·L–1 quinine sulfate. Photoluminescence (PL) and PL lifetime data 
were acquired using a home-built setup based on a NKT SuperK and a doubled Spectra Physics 




Quantique ID100 single-photon avalanche detector, a Becker and Hickl SPC-130 time-correlated 
single-photon counting module giving a time resolution <100 ps. 
We proceed to characterize the chemical composition of the NPs using Fourier transform 
infrared spectroscopy (FTIR) and Raman vibrational spectroscopy. For FTIR sample preparation, 
sample was repeatedly drop case and dried on MirrIR IR-reflective glass slides (Kevley 
Technologies, Chesterland, OH, USA). Their transmissions were subsequently recorded in the 
attenuated total reflectance (ATR) mode on a Nicolet Nexus 670 FT-IR instrument (ThermoFisher 
scientific, Waltham, MA, US).  
Further chemical insight was obtained by X-ray photoelectron spectroscopy (XPS), nuclear 
magnetic resonance spectroscopy (NMR), and mass spectroscopy (MS). The samples were 
deposited on a glass slide and were totally dried for XPS sample preparation before acquisition on 
a Physical Electronics PHI 5400 spectrometer using Al Kα (1486.6 eV) radiation. The spectra were 
corrected to the C-C bond at 284.8 eV and all the analyses were done on CasaXPS software [301]. 
1H NMR was done on multinuclear, 500-MHz Ultrashield Plus (Bruker Daltonics, Inc., Billerica, 
MA, USA) system, equipped with a 5 mm CryoProbe (Bruker, Model CB500) in D2O (Cambridge 
Isotope Laboratories, Inc., Cambridge, MA). The nanoparticles were freeze-dried and then were 
redispersed in D2O. The results were analyzed on MestRenova 11.0 software (Mestrelab Research 
SL; Santiago de Compostela, Spain). Finally, both Electrospray ionization (ESI) and, matrix-
assisted laser desorption/ionization (MALDI) Quad Time of Flight (Q-tof) MS was done at mass 





3.2.3.3. In vitro evaluation of oligodots for biological applications 
 
Cell viability assay 
NIH 3T3 fibroblast cells and MCF-7 breast cancer cell line were purchased from American 
Type Culture Collection, ATCC (VA, US) and was subcultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and 1% pen-strep 
under 99% humidity and 5% CO2. The cells were passaged following, washing, trypsinization and 
splitting into various batches. For the cell viability assessment, MTT assay, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was dissolved in PBS (5 mg.ml-1). The 
cells were plated at 9,000 cells/ well in 96 well plate and were allowed for 24 h. Subsequently, the 
cells were incubated with serial dilution of NPs for 24 h. twenty microliters of the dye was added 
to each well and incubated for 4 h. The formazan salt was dissolved with dimethyl sulfoxide 
(DMSO) at the end of the experiment and the absorbance at 550 nm measured with multiwell plate 
reader (BioTek Synergy HT, USA) was correlated to the cell viability. The cells that were not 
treated with NP were used for determining the viability.           
Inhibitor studies 
MCF-7 and NIH 3T3 cells grown for 24 h in 96 well plates were first treated with endocytic 
inhibitors sodium azide/2-deoxy-D-glucose (NaN3/DOG): 10/50 mM, Dyansore hydrate: 80 μM, 
Chlorpromazine (CPM): 28 nM, Nystatin: 180 nM, Methyl-β- cyclodextrin: 2 μM, Cholesterol: 1 
μM) for 1 h. The old media was removed next and was replaced with the NP formulations (2.5 
mg.ml-1) for 20 h and then MTT assay was done as prescribed above. The untreated cells (no 





Confocal imaging of the NP incubated cells  
MCF-7 cells were grown on the coverslips (1 million cells suspended in 500 μl) for 24 h 
and then were treated with NPs for 4 h to allow internalization. They were washed 2-3 times with 
PBS, fixed with chilled paraformaldehyde (4 wt% in PBS) for 20 min and then were washed again. 
The coverslips were fixed on the low E microscope glass slide and then were sealed with nail 
polish. The imaging was performed on Leica SP8 UV/Visible Laser Confocal Microscope (Leica 
Microsystems, Germany). The analysis was done on Fiji software (NIH, Bethesda, MD, USA). 
3.2.3.4. In vivo assessment of the NPs for imaging  
 
Animal imaging 
All the animal studies were carried out according to the Guidelines delineated on the Care 
and the Use of Laboratory Animals at the University of Illinois at Urbana−Champaign. NU/NU 
nude mice were purchased from Charles River laboratory (Wilmington, MA) and were housed at 
Beckman animal facilities, UIUC. They were allowed one week for acclimation. Animals were 
anesthetized with isoflurane gas and then were injected based on the requirements of the 
experiments. They were sacrified with asphyxiation with CO2 stream.  
Tail vein injection was carried out with R- oligodots (100 μl, 156 µg.ml-1 concentration) 
for the whole-body imaging experiment. The animals were imaged with a Xenogen In vivo 
fluorescence images (IVIS) instrument (Caliper Life Sciences, Hopkinton, MA) at λexc=605 nm 
and λem=720 nm obtained after 10 min, 30 min, 1h, 2h, 3h, 6 h, and 24 h post-injection. Meanwhile, 
the animals were anesthetized with the isoflurane gas and were laid sideways. After 24 h the 
animals were sacrificed, and the major organs were obtained to visualize with IVIS to determine 




For the multicolor imaging experiment, the animal was injected with the G- and R- 
oligodots on each of the flanks and were imaged on IVIS followed by the spectral unmixing 
algorithms in the instrument’s software to separate the red and green signal.  
Similarly, for lifetime imaging, the animals were marked with four regions: injected with 
Red NPs, Green NPs injected with both green and red NPs in the same spot and no injection. The 
animals were allowed 15 minutes before scarification and defleshing the skin. These samples were 
embedded in the optimal cutting temperature compound (OCT), flash froze in liquid nitrogen and 
sectioned (30 μm thick) with a cryostat device. The sections were collected on glass slide.   
Histopathological evaluation 
After the organs were imaged with IVIS, they were immediately transferred to formalin for 
preservation. The tissues were embedded in Paraffin cassettes according to an established protocol 
[302]. They were subsequently stained with Mayer hematoxylin solution and eosin-phloxine B 
solution (or eosin Y solution). Images were obtained on NanoZoomer Digital Pathology System 
(Hamamatsu, Japan). 
3.2.4. Results and Discussion 
Oligodots were prepared in one step through the hydrothermal reaction occurring in an 
autoclave at 175 °C for 8 h. Briefly, 1 mol of 2, 5 diaminotoluene and 1 mol of dopamine were 
mixed in 10 ml of water and underwent heat treatment to yield red emitting oligodots (R-oligodot). 
This temperature was chosen because at higher temperatures (200 and 225 °C) we observed a slight 
blue shift in the emission spectra (Figure S 2.9). On the other hand, for the preparation of green 
emitting oligodots (G-oligodots), the same amount of precursors were dispersed in 7.3 M of 




samples were subjected to the dialysis overnight against 1X PBS (See experimental section for 
further details). The sample extracted from the autoclave from water solvent had a purple like tint 
(Figure 3.8 A inset) in the daylight and indicated strong red photoluminescence as observed under 
UV lamp with an excitation wavelength of 365 nm (Figure 3.8 B). On the other hand, after 
neutralization, the G- oligodots showed a green tint in the daylight and green fluorescence under 
UV lamp (Figure 3.8D). The laser path (550 nm excitation for G for R oligodot) is shown in Figure 
3.8 C and E.  
The nanoparticles’ size was characterized in the anhydrous state using transmission 
electron microscopy (TEM) where the ultrasmall size of the NPs was determined to be 9±4 nm 
(Figure 3.7A) and 15± 5 nm (Figure 3.7 B) for the R- and G- Oligodots respectively. Furthermore, 
AFM analysis in the tapping mode was utilized to determine the height of these NPs and the 
average height turned out to be 0.49± 0.06 nm (Figure 3.7 C) and 1.21±0.39 nm (Figure 3.7 D) for 
the R- and G- Oligodots, respectively. The difference between TEM and AFM reading might have 
been due to the flattening effect of the NPs on the mica that is typical of soft materials.  
For these nanoparticles, the electrophoretic ζ potential (Figure 3.8 F) was determined to be 
18.5 ± 0.3 and 10.4±0.8 mV for R- and G- oligodots, respectively. The positive electrophoretic 
potential can be due to the exposures of the amine on the surface. The absolute value of the ζ-
potential for these NPs, signifies reasonable stability given the bare surface of these NPs. Indeed, 
we did not observe precipitation and aggregation over the course of a few months. X-ray diffraction 
pattern (XRD) of R- oligodots indicated a sharp peak at 19° and a broad peak at 24° which can be 
attributed to the (002) plane in amorphous graphitic structure (Figure 3.8E).   
Subsequently, the photophysical properties of the developed NPs were thoroughly studied 




(Figure 3.9 A) of the nanoparticles showed absorbance in the UV and visible region. The peaks 
for G- oligodots was identified at 283 nm with FWHM=46 nm while for R- oligodots the first peak 
was seen at 279 nm with FWHM=26nm and 580 nm with FWHM=76 nm. The peak observed in 
the UV region can be attributed to the π to π* transition in the C=C and C=N of the carbon core 
while the excitonic peak for the red NPs could be due to n to π* transition in the surface state. 
These low energy bands are typically seen as a result of the narrowing of the band gap.       
 
Figure 3.8. Physical investigation of the oligodots; TEM micrographs of (A) red oligodots and (B) 
green oligodots; Height characterizations with AFMfor (C) red and (D) green oligodots, 




The excitation-emission spectra for the G- and R- oligodots (Figure 3.9 F, G) and their 
respective 2D ex- em maps as shown in Figure 3.9 H, I properly indicate the green emission in the 
visible region and red in the 600-700 nm range. Moreover, it is important to appreciate the lack of 
excitation-dependent emission phenomenon in the R oligodots (Figure 3.8 G), that typically occurs 
in the conventional CDots as could be seen by the fixed emission at various excitations (both the 
maps and the spectra point to this). On the contrary, the red edge excitation shift (REES) is a 
lingering effect in the G oligodot (Figure 3.9 F) considering the asymmetric emission map that 
extends into the visible region which would break the Kasha−Vavilov’s rule. This is possibly due 
to the more homogenous scattering centers in the red NPs compared to the G ones. In the G- 
oligodots the electron deactivation might have happened via various functional groups leading to 
the radiative recombination by various surface traps and thereby the red shift in the spectrum by 
longer excitation wavelengths [303].   
To further unveil the transfer pathways in the NPs, time-resolved photoluminescence 
(TRPL) was conducted at 550 nm excitation laser. For the G oligodots excited at 550 nm the decay 
could be fitted to double exponential decay with lifetime of 0.05 ± 2.29E-4 ns and 1.92 ± 0.05 ns 
(Figure 3.9 J i) while for the R- oligodots a monoexponential fitting is possible with the lifetime 
of 2.27 ± 0.01 ns (Figure 3.9 J ii). The time scale for the fluorescence lifetimes is on the nanosecond 
order suggesting the singlet type of the emission. The multiple emissive sites in the G- oligodots 
could have contributed to the two-lifetime values observed which can be correlated to the π to π* 
transition in the carbon core (for the fast component) and the slow component could be attributed 
to the oxygen-containing functional groups [304]. The longer lifetime for the R- oligodots implies 
the non-radiative decays are less pronounced. The difference in the lifetime decay of these NPs 




XPS spectra of the NPs were examined where the peaks of C, O, N, and S could be detected in the 
samples. The carbon adventitious peak was corrected to 284.8 eV. The survey spectrum and the 
decomposed peaks in XPS spectrum of R-oligodots and G- oligodots are shown in Figure 3.10. 
The core state analysis of C1s indicated various types of C in the two samples. For G-oligodots, 
the peaks observed at 284.8, 286.07, and 288.14 eV could be attributed to aliphatic C/C=C/C-H, 
C-O/C-N, and C=O/ C=N, respectively while for R- oligdots, peaks identified at 284.4, 285.9, 
288.32 and 290.85 eV were related to C-C/C=C/C-H (sp3 C), C-O/C-N (sp2 C), C=O/C=N and 
high binding energy amide carbon (N-C=O), respectively. The high-resolution XPS analysis of 
N1s revealed the peaks for pyrrolic N (399.45 eV), graphitic N (400.28 eV), and amino N (401.65 
eV) for G- oligodot and primary amines/ pyrrolic N (399.95 eV), graphitic N/ protonated amide/ 
amine/ amino (401.63 eV), and -NO2 (406.02 eV) for R- oligodots. In addition, the O1s core state 
consisted of bands related to C=O and CO/OH observed for both G-oligodots (531.45 and 532.39 
eV) and R-oligodots (531.36 and 532.44 eV) although their distribution is different in the two 
samples.  Finally, the high resolution XPS peaks ascribed to S2p in both samples was decomposed 
to 168.5 and 169.5 eV related to C–SOx (x = 3, and 4) while the amount found in both NPs was 
approximately similar and minimal.  
The quantification of the results pointed to a 25% decrease in C/N content observed in the 
R- oligodots compared with the Green counterpart suggesting the extent of higher N dopant. Here 
the red shifted fluorescence can be attributed to the surface states suggesting the radiative 





Figure 3.9. photophysical properties of the oligodots; (A) UV- Vis absorbance spectra, the inset 
indicates the appearance of the as-synthesized nanoparticle suspension in daylight; The 
photoluminescence of the (B) red and (C) green oligodots under UV lamp (365 nm); (C) and (E) 
The emission of the NPs when excited with green 550 nm laser; The excitation-emission spectra 
for (F) green and (G) red oligodots; The 2D excitation-emission maps for (H) green and (I) red 




The higher N doping content in R oligodots can lead to the red shifted fluorescence due to 
the creation of the N defects.  The reduction of O, on the other hand, in the R- oligodots can 
decrease the surface states while N doping can inject the electrons and act as electron donor hence 
lowering the LUMO band and decreasing the bandgap. The higher content of O in the G oligodots 
is due to the strong oxidative effect of H2SO4. O is responsible for excitation-dependent emission 
which is effectively suppressed in the R oligodots indicating an excitation independent spectrum.  
In addition, the comparison of the components in each region also justifies the differences 
observed in these two NPs: The sp2 of (C-O and C-N) is larger in the R- oligodots compared with 
the G- Oligodots suggesting the possibility of extended conjugation. This will lead to the swarming 
of high-density sp2 trapped in between sp3 hybridized islands. On the other hand, the sp3 domains 
seem to be bigger in the G- oligodots which can also lead to the weakening of the excitons 
generated in the sp2 domain via non- radiative pathway. On the other hand, it is prominent that the 
content of pyridinic N is enhanced in the R- oligodots. As the content of N increases to a greater 
extent, the edge state of N atom is becoming predominately pyrrolic type. For the pyrrolic N to 
form, two π bonds need to form with the adjacent C while in the graphitic N, N would replace one 
C in the hexagonal ring of graphene forming a σ bond with the neighboring C. The rigidity of the 
structure then is not confined in the pyrrolic N as is usually the case with graphitic N and can more 
freely be involved in the non-radiative pathway, more vibrational modes and easier transfer of 
energy to the surface defect sites suggesting a red shift in the PL [305]. In addition, we noted that 
only in presence of H2SO4 for G-oligodots did we observe amino N in XPS, which indicates the 
presence of aromatic NH2 group in NH3
+ form. In the absence of H2SO4 (which is the case for R 
oligodots) the aromatic NH2 group undergoes condensation reaction and we did not observe amino 




clarify this explanation further. The decrease in the carbonyl group can also be conceived from 
green to red particles. Carbonyl is an electron withdrawing group and can widen the band gap so 
is the observed photoluminescence in the samples.     
 
Figure 3.10. The XPS spectra in the decomposed mode for (A) green and (B) red oligodots; for 
both of these graphs the peaks decomposed are for (i) C1s, (ii) N1s and (iii) O1s binding region; 
(C) the percentage distribution of the elements in the nanoparticles (i) the overall atomic 






On the other hand, it is also evident that the size of the green oligodots are bigger than the 
red oligodots which would be ideally leading to the redshift as a result of the decrease in the 
HOMO- LUMO level. However, the factor of size may not justify the observed red shift. It is 
likely that the large surface area in green NPs induce more surface defects that can result in an 
ineffective emission. Thus, the emission behavior of these NPs cannot be justified best based on 
their size but rather their chemical compositions. 
We scrutinized the chemical composition of these NPs using mass spectroscopy and NMR 
analysis (Figure 3.10). The proposed scheme for the reaction is shown in Figure 3.11 C, D as being 
predicted based on mass spectroscopy method using both Electrospray ionization (ESI) and, 
matrix-assisted laser desorption/ionization (MALDI) Quad Time of Flight (Q-tof) (Figure 3.11 A, 
B). From NMR spectroscopy (Figure 3.12), the peaks of methyl proton, methylene proton, 
aromatic proton, hydroxyl proton, and aromatic and aliphatic N-H protons of G- oligodots were 
identified. In addition, peaks of methyl proton, methylene proton, aromatic proton, and aliphatic 
N-H protons of R- oligodots were also identified. Successive analysis of ESI spectroscopy led to 
the detection of more intermediate species such as oxidized products from oligodots. The products 
corresponding to mass to charge (m/z) values of 120, 153 and 151 being observed, indicating the 
formation of p-benzoquinonediimine A’, aminoethylhydroxycyclohexanone B’, and 5,6-
dihydroxyindoline B’’ by the oxidation of 2,5-diamino toluene (A) and Dopamine (B), 
respectively (Figure 3.11 D). Furthermore, ESI spectroscopy showed peaks at m/z values of 257 
and 392. These results indicated that 2,5-diamino toluene and oxidation of B led to dinuclear (C) 
and trinuclear (D) oligomers, respectively through the condensation reaction. Based on the above 





Figure 3.11. mass spectrum in (A) high-resolution QTof mode and (B) MALDI mode for green 
and red oligodots; The predicted chemical reaction mechanism as concluded from NMR and mass 
spectroscopy for (C) red oligodots and (D) green oligodots.  
 
We presume that G- oligodots and R- oligodots are due to the formation of C and D 
respectively (Figure 3.11 C). After 8 h of reaction in presence of water for R- oligodots, several 




Additionally, the products corresponding to m/z values of 1221, 1398 and 1530 were observed in 
MALDI/TOF, indicative of presence of octadopamine, nonadopamine and undecanedopamine 
unit. Furthermore, peaks at m/z values of 430, 437 and 488 were observed for reaction in presence 
of sulfuric acid and water mixture of G- oligodots, indicating the formation of B’’ and C. 
 
Figure 3.12. The 1H NMR for dopamine, 2, 5 diaminotoluene, green and red oligodots. 
 
 
 The predicted UV Vis spectra from DFT calculation in indicated in Figure 3.13 C where 
the absorbance in the red region can be understood for molecules C and D, further verifying their 
contribution in the observed optical properties. Also, the frontier orbital shapes for each of these 
molecules were calculated (Figure 3.13 A, B) while their band gap was calculated to be 2.35 and 





Figure 3.13. The simulation outcome for the predicted molecules formed during the reaction for 
(A) molecule C and (B) molecule D, (i) electrostatic potential map, the frontier orbital (ii) HOMO 
and (iii) LUMO distribution; (C) the calculated UV Vis spectra from the density functional theory 
for molecules C and D, the inset table summarizes the energies for the first excited state, band gap 
energy and the dipole moment polarization factor in debye.    
 
Having demonstrated the remarkable optical properties which can be differentiated among 
the two samples, we carried out studies to indicate the potential of these NPs for multicolor 
imaging. Initially, the MCF- 7 breast cancer cells were incubated with 2500 μg.ml-1 NPs for 4 h 




microscopy (CLSM). The prospect of these NPs for the cellular labeling is highly promising with 
the strong photoluminescence being observed in the images when excited at (𝜆𝑒𝑥𝑐= 633 nm, 𝜆𝑒𝑚𝑖= 
650-800 nm) for red NPs. Compared to the control cells, the incubated cells had a strong 
fluorescence as is shown in Figure 3.14 A, B). Indeed, for R- oligodots, nuclear localization was 
observed in some of the cells. 
In order to understand the pathway of the entry of these NPs in the cells, comprehensive in 
vitro inhibitor studies were implemented (Figure 3.14 C-F). NIH-3T3 (fibroblast cells) and MCF-
7 cells were subjected to the various pharmacological inhibitors (dynasore: inhibitor of dynamin 
dependent endocytosis, 2-deoxyglucose (DOG)/ NaN3: energy mediated pathway inhibitor, 
chlorpromazine (CPM): clathrin-independent endocytosis, nystatin: caveolin/lipid raft-mediated 
endocytosis endocytosis inhibitor, Methyl-β-cyclodextrin: lipid-raft-mediated endocytosis, 
Cholesterol: changes the rigidity of membrane) for one hour. Then the NPs (500 μg.ml-1) were 
incubated for 24 h and the cell viability was determined with the standard MTT assay. The higher 
cell viability implies the more active the pathway has been in blocking the NPs entry. The cells 
did not show a preference for any of the pathways studied.   
After establishing the excellent in vitro imaging capability of these nanoparticles, they were 
applied for multicolor imaging in vivo and their distribution in the animal’s body was investigated 
as well. Nude mice were injected with 20 μl of R and G- oligodots in each of the flanks 
transdermally and then were imaged on In Vivo Imaging System (IVIS) after 5 minutes with 
(𝜆𝑒𝑥𝑐 = and 𝜆𝑒𝑚 for G- oligodots and 𝜆𝑒𝑥𝑐 = and 𝜆𝑒𝑚 =   for R- oligodots). Spectral unmixing 






Figure 3.14. The multicolour fluorescent cell imaging of MCF-7 cells incubated with (A) green 
and (B) red oligodots, the left panel in each picture is the control non- incubated cells to account 
for any autofluorescence; The inhibitor study carried out for (C) and (D) MCF-7 and (E) and (F) 
NIH 3T3 cells incubated with green and red oligodots, respectively.    
 
The NPs could be easily distinguished from the background without interference. The red 
and the green NPs could be appropriately detected at the injection site signifying the potential for 
multiplexed imaging in the future. The areas of research which can benefit from this property are 
countless and can be used in spatial colocalization, multiple biomarkers imaging, and 
quantification in tumours to name a few.  
On the other hand, NIR I window, or the first biological window, is of prime importance 
in the biological imaging considering the minimal absorbance, scattering, and fluorescence from 
Hb, proteins, etc. Furthermore, renally clearable NPs are desired to this end with proper circulation 
time. Dynamic imaging of the nude mice injected via tail vein (100 μl and 156 µg.ml-1 
concentration) with the R- Oligodots is demonstrated in Figure 3.15 A with the 𝜆𝑒𝑥𝑐 = 605 nm 




be perceived from the images, the NPs showed remarkable signal-to- noise ratio for the whole-
body imaging which tended to initially get enhanced and then decreased with time. The diminished 
signal with time implies the clearance of these NPs, with the strongest signal appearing in the 
stomach. The strong signal in the periphery of the small intestine might suggest the NPs route of 
exertion was via the alimentary canal. Additionally, the biodistribution of the NPs was studied by 
imaging the harvested organs after 24 h and calculating the average radiant efficiency in each 
organ vs the control animal. The fluorescence signal of the stomach, small intestine and large 
intestine was consistently higher than the rest of the organs as shown in Figure 3.15 B. On the 
hand, the signals in these organs are also larger than the control suggesting that the NPs may have 
exerted through this pathway as mentioned above. However, the statistical analysis did not result 
in significant difference among the treatment and control group, indicating similar signal to 
background and clearance of the nanoparticles with time.      
The safety of the NPs in vivo was evaluated by carrying out the H&E histopathological 
examination on the organs harvested above. As shown in Figure 3.16, the animals treated with NPs 
did not show any tissue injury on the lung, heart, liver, kidney, spleen, stomach, large and small 
intestine demonstrating the low toxicity of the NPs. For instance, in the lung tissue shows 
collections of alveolar macrophages with no visible phagocytosed NPs and no significant 
difference in the RBCs filling the alveoli. Also, there is no significant inflammation and 
lymphocyte infiltration in both control and treatment. On the other hand, no detectable histological 
changes in heart tissues of mice in the control or treatment group were perceivable showing normal 
heart architecture with no signs of, inflammation, degeneration or deformation in the myocardium. 






Figure 3.15. (A) The in vivo photoluminescence of the nanoparticles when injected via tail vein 
and its dynamic biodistribution over the period of one day; (B) the average radiant efficiency of 
each of the harvested organs after being sacrificed after 24 h circulation; (C) multicolour 
fluorescence in vivo imaging when injecting green and red oligodots in each of the flanks of the 





Figure 3.16. The histopathological examination of the major organs via H & E staining for the 
control and red oligodot injected nude mice. 
 
3.2.5. Conclusions 
In this manuscript, the nanoparticles composed of oligomeric components were 
presented for the first time which possessed dual emission by tuning the solvent in the synthesis 
procedure. These nanoparticles were characterized extensively for their physicochemical 
properties and it was determined that they have sub 5 nm anhydrous and hydrodynamic size. 
Furthermore, extensive photophysical characterizations on their fluorescent intensity, quantum 
yield and fluorescent lifetime were carried out and it was determined that these nanoparticles 
have distinguishable photoluminescent behaviors. These emergent properties were aptly 
correlated with the chemical composition and a predicted chemical reaction scheme was 
proposed and concluded based on results from mass spectroscopy, NMR, XPS as well as 




mechanism, we utilized oligodots for multicolor in vitro imaging in confocal imaging and more 
importantly in vivo in the nude mice model by wavelength-resolved imaging. In addition, red 
emitting oligodots were demonstrated to be a feasible option for deep tissue whole body 
imaging and tend to get cleared with the proper retention time as was revealed by dynamic IVIS 
imaging. We have also indicated that the difference in the fluorescent lifetime of these 
nanoparticles was applicable for differentiating them in the ex vivo tissue collected from the 
animals. It was determined by the histopathological examinations that the oligodots did not 
exert any cytotoxic effect in vivo and can offer a safe platform for the multicolor imaging in 







CHAPTER 4: NANOPARTICLES FOR TOPICAL APPLICATIONS AGAINST 
BIOFILMS 
 
4.1. Dual purpose Hafnium Oxide Nanoparticles Offer Imaging Streptococcus mutans Dental 
Biofilm and Fight It In vivo via a Drug-Free Approach7 
 
4.1.1. Abstract 
The removal of tenacious dental plaque is of paramount importance; however, early 
diagnosis can be a challenging task in dental clinics due to the limitations of current approaches, 
specifically X-ray-based techniques. We have approached this problem by integrating antibacterial 
properties and X-ray contrast enhancement in a single probe specific to colonies of Streptococcus 
mutans as the most predominant and carious inducing oral bacteria. We report the synthesis of an 
inherently therapeutic polymeric silane conjugated hafnium oxide nanoparticles (Hf PS NPs). 
Using a high-affinity pathogen-selective peptide, the concept of molecularly targeted X-ray 
imaging of cariogenic pathogen S. mutans was demonstrated. Ex vivo studies using extracted 
human tooth demonstrated striking X-ray attenuation of NPs vs. tooth. Additionally, Hf PS NPs 
exhibited significant bactericidal properties against cariogenic pathogens. Electron microscopy 
revealed that the antibacterial activity occurred via a ‘latch and kill’ mechanism. Mechanistic 
studies determined that these NPs fragmented bacterial DNA components to exert their 
antimicrobial effect. Importantly, Hf PS NPs effectively inhibited the growth of a mature biofilm 
on an ex vivo human tooth model. Finally, the NPs were applied to the rodent model of dental 
biofilm. Topical administration of the Hf PS NPs for 8 days (1X daily) could effectively attenuate 
the S. mutans biofilm challenge. This report is the first of its kind to demonstrate that HfO2-based 
                                                 
7 This part of the thesis has been adapted from the following publication: 
Ostadhossein, F., Misra, S. K., Tripathi, I., Kravchuk, V., Vulugundam, G., LoBato, D., ... & Pan, D. (2018). Dual 
purpose hafnium oxide nanoparticles offer imaging Streptococcus mutans dental biofilm and fight it In vivo via a drug 




NPs can be used for simultaneous diagnosis and antibacterial treatment without requiring an 
additional drug. 
4.1.2. Introduction  
Infectious diseases are strongly correlated (up to 80%) with persistent virulent biofilms, 
including those inhabiting the oral environment. [306] A biofilm is defined as a functionally and 
structurally well-defined, organized community of bacterial cells that adhere to a surface. [307, 
308] Bacteria in the biofilm reside in an extracellular polymeric substance (EPS) which protects 
them from outside hazards and facilitates cooperation through the quorum sensing. [309, 310] Oral 
biofilms can contribute to the host of diseases that compromise the quality of life and systemic 
health and incur economic costs such as bacterial pneumonia, diabetes mellitus, abnormal 
pregnancy outcomes and atherosclerosis. [311-315] In light of the many secondary complications 
and healthcare costs attributed to biofilm-associated diseases, early intervention is crucial to 
treatment success. Unfortunately, bacterial biofilms are much more challenging to treat than 
bacteria in planktonic form because of their strong adherence to surfaces and tendency to calcify 
into dental calculus, which can lead to dental caries. [316, 317] 
One of the primary culprits of dental decay is a strain of Gram-positive bacteria in the 
biofilm known as Streptococcus mutans (S. mutans). [317, 318] S. mutans contribute to 
cariogenesis by exerting acidogenic and aciduric properties by modulating the sugar metabolic 
pathway. [319] 
Dental biofilms (plaques) are generally invisible and conventional indices used in the clinic 
are highly subjective and might fail to give information on the location of small plaques. [320] 
‘Plaque disclosing agents’, for instance, are used in the clinic to differentiate the areas covered 




removal of biofilm can lead to secondary complications such as gingivitis, periodontitis, etc. [321] 
Therefore, there is a perpetual demand to enhance visual aids for the dentists, to properly localize 
the plaques.  
On the other hand, oral cavity harbors a host of mixed bacterial species which have different 
implications for human health or disease. [322, 323] It is of utmost importance to develop a probe 
that selectively targets and eliminate S. mutans sparing indigenous microflora found at human 
mucosal surfaces.   
The mainstay diagnostic tool in the dental clinic is intraoral radiographic examination. 
[324] Contrast agents are used in clinical settings to enhance the tissue visualization on radiographs 
or computed tomography (CT). Recent developments in the application of nanoparticles (NPs) 
comprising high atomic number elements have facilitated accomplishing this goal. Some of the 
most studied X-ray/CT contrast NPs include gold (Au) and bismuth (Bi). [325] While these NPs 
may fulfill the high Z condition, there are obstacles in their clinical translations; Au is not cost-
efficient for scale-up, whereas Bi has intrinsic toxicity. [325] There is an unmet need to enhance 
visualization of biofilms in dental clinics using novel nanomaterials that can act as radiocontrast 
agents. 
We propose the application of hafnium oxide NPs (HfO2 NPs) as a contrast agent because 
of their reasonable cost and comparable X-ray attenuation coefficient (Hf, 4.15 and Au, 5.16 cm2 
/ kg at 100 keV) [326] resulting from its high atomic number (Z=72). [35, 272, 327] The potential 
of Hf metal as an X-ray/ CT contrast agent is largely unexplored, except for its application as a K-
edge contrast agent for phantom imaging. [328] 
A number of reported NPs have shown promise as antibacterial agents against biofilm. 




two strategies: damaging the pathogenic microorganism or inhibiting the attachment and 
colonization of bacteria on the surface. [335, 336] We envision that metallic NPs can enable 
bactericidal properties via the introduction of surface functionalities, such as polymers, [337, 338] 
antimicrobial peptides [339, 340] and enzymes. [341]  
The inadequate inherent contrast of biofilm in the radiographic techniques led us to design 
the NPs to complement the X-ray/CT imaging technology for biofilm detection. We report the 
synthesis of water-dispersible HfO2 NPs (anhydrous diameter <5 nm) with inherent therapeutic 
properties. The particles demonstrated remarkable contrast enhancement (ca. 30%) in suspension 
compared to that of the equimolar commercially used iodinated contrast agent iohexol (Figure 
4.1A). Therefore, as a proof of concept, surface modified HfO2 NPs were molecularly targeted to 
S. mutans by the introduction of a short peptide sequence to overcome the relatively low inherent 
contrast within the soft tissue and distinguish a bacterial strain in a highly selective manner. The 
specificity of ligand-directed HfO2 NPs homing is dictated by the high affinity peptide. Hence, we 
could successfully localize the mature bacterial biofilm on a human tooth using dental X-ray 
radiographic method.  
On the other hand, detailed electron microscopy examination revealed the bactericidal 
efficiency of the NPs arising from their ‘latching’ onto the bacteria and rupturing of the bacteria’s 
cellular membrane. This approach is different from the previously reported investigation of the 
potential antibacterial activity of crystalline Hf NPs in non-aqueous suspension.[342] These NPs 
effectively treated mature biofilm in an ex vivo human tooth model. 
Importantly, we indicated the efficacy of the NPs in suppressing the biofilm formation and 
inhibiting S.mutans in the rodent model of mature bacterial biofilm (developed for 10 days after 5 




cultivatable bacteria was significantly reduced compared with control animals implying excellent 
antibiofilm activity against S. mutans. Histologically, we confirmed inertness of the probe towards 
the biological tissue. 
This highly versatile probe represents a stride towards synchronous diagnosis and 
expedited treatment barring a conventional antimicrobial agent. We believe that this study of HfO2 
NPs for dental imaging and therapy provides valuable experimental evidence for the application 
of nanomaterials as functional imaging probes while preventing biofilm-related diseases such as 
caries.  
4.1.3. Materials and Methods 
4.1.3.1. Materials 
IGEPAL® CO-520 (average Mn: 441), sodium hydroxide, cyclohexane, hexane and diethyl 
ether were purchased from Sigma-Aldrich Inc. (Saint Louis, MO, USA). trimethoxysilylpropyl-
modified polyethylenimine (PEI-silane) was obtained from Gelest Inc. (Morrisville, PA). Hf 
ethoxide was purchased from Alfa Aesar (Ward Hill, MA). Human teeth were procured from 
Buyamag Inc. (Carlsbad, CA). Nanopure water (0.2 × 10−6 m, 18 MΩ cm) was used throughout 
the experiments unless otherwise stated. For the bactericidal assessments, S. mutans Tube Culture 
was obtained from VWR International (Chicago, IL) and was cultured in either planktonic form in 
BHI broth or inoculated on BHI agar plates (Becton Dickinson, Franklin Lakes, NJ).   
4.1.3.2. Synthesis of Hf PS NPs 
The synthesis of the HfO2 NPs was conducted based on the confined sol-gel method in a 
microemulsion. The oil phase consisted of cyclohexane (150 ml), IGEPAL® CO-520 (17.25 g), 




hotplate (65 C) for approximately 10 min to achieve homogeneity. In the meantime, water (375 
µl) was added dropwise to form the microemulsions. Subsequently, 0.8071 g of Hf ethoxide was 
added, and the reaction was allowed to run to completion overnight. To tune the surface properties 
of the prepared HfOx NPs, 3.75 ml of PEI Silane was added at a rate of 20 drops/min to the original 
mixture of Hf-oxide NPs. The temperature was increased to 55 C, and the reaction was conducted 
for 2 h. The turbid mixture became transparent, suggesting that silane coupling had successfully 
been achieved. Finally, the solvent was evaporated using a rotary evaporator, and the final NPs 
were precipitated in a mixture of hexane/diethylether (1:1 vol/vol). These particles were 
resuspended in methanol, centrifuged and washed several times with diethyl ether. The produced 
powder was dried overnight in a vacuum oven. For further characterization, the NPs were 
resuspended in water after probe sonication for 5 min (Q700, Qsonica Sonicators, Newtown, CT) 
in an ice bath (1-amp pulse; 2 s on and 1 s off).         
4.1.3.3. Physicochemical characterizations 
To visualize the morphology of the NPs, TEM micrographs were acquired using a JEOL 
2100 Cryo TEM instrument (Tokyo, Japan) equipped with a Gatan UltraScan 2k × 2k charge-
coupled device (CCD) camera. The samples were probe sonicated briefly prior to imaging, and a 
5-µl sample was drop-cast onto a holey carbon-coated copper grid. The anhydrous diameter was 
determined from 100 random measurements of the NPs using ImageJ software (NIH, Bethesda, 
MD, USA). The nanostructural features were further characterized using TEM in SAED mode.  
The electrophoretic potential was determined using a Malvern Zetasizer Nano series 





 1H NMR spectroscopy was conducted on a Varian VXR 500 (Varian, Inc., Palo Alto, CA) 
spectrometer operating at 500 MHz and equipped with a 5-mm Nalorac QUAD probe in deuterium 
oxide (D2O) (Cambridge Isotope Laboratories, Inc., MA, USA). A total of 128 acquisitions were 
averaged. The data were further analyzed using MestRenova™ 8.1 software (Mestrelab Research 
SL; Santiago de Compostela, Spain). Coupling of the silane onto the NP surface was confirmed 
via 29Si ssNMR.  
DPMAS and CPMAS studies were performed using a Varian Unity Inova spectrometer 
(59.6 MHz, 25 C). A 4-mm APEX HX Chemagnetics probe was used for all of the MAS 
experiments, using a MAS rate of 10 kHz and proton decoupling. The 29Si chemical shifts were 
referenced to an external standard sample of powdered octakis(dimethylsilyloxy)silsesquioxane 
(Q8M8, δiso=11.45 ppm, relative to the primary standard, tetramethyl silane [TMS] at 0 ppm). A 
total of 1276 scans were collected using a 29Si DPMAS pulse width of 0.75 µs (π/4) and a 30-s 
recycle delay. For the 29Si CPMAS spectra, the 1H selective pulse width was 2.5 µs, and the contact 
time was either 2 or 8 ms. A total of 1800 scans were acquired using a 10-s recycle delay.  
ICP-OES (PerkinElmer 2000DV, Norwalk, CT) was used to determine the Hf and Si 
contents in the NPs. The sample was fully dissolved using the 511FAR (5 ml of HNO3, 1 ml of 
HCl, and 1 ml of HF) acidic mixture and digested using a Discover SPD 80 (CEM Corporation, 
NC, USA) digestion system. The final digested solution was clear and transparent, indicating 
complete digestion and dissolution. Standards were prepared with 511FAR as the background 
solution to create a calibration curve using ICP-OES. The calibration curves were used to 
interpolate the concentration of the sample.  
XPS was performed on a Physical Electronics PHI 5400 spectrometer using Al Kα (1486.6 




To determine the primary amine density of the NPs, a ninhydrin colorimetric assay was 
conducted. Briefly, 250 µl of ninhydrin solution (20 mg.ml-1 in water) was added to 500 µl of 2-
mg.ml-1 suspended NPs in water. The samples were heated at 80 C in a water bath for 15 min. 
After the solution had cooled, 1.25 ml of ethanol was added to reach a total sample volume of 2 
ml. The alanine standards were prepared at various concentrations to obtain a calibration curve of 
the absorbance at 570 nm vs. the concentration (Figure S 4.12). The samples were diluted as 
required to conform to the linear region of Beer-Lambert’s law. The amine concentration was 
determined via a linear regression interpolation of the calibration curve. 
4.1.3.4. Synthesis of the peptide targeted Hf PS NPs  
The peptide with a sequence of TFFRLFNRSFTQALGKGGG was covalently linked on 
the HfO2 PS NPs using the well- known NHS-EDC chemistry to afford Hf PS CSPc16 NPs. The 
peptide was custom- synthesized by GenScript® (Piscataway, NJ, USA). The sequence was 
adopted based on the previous report where TFFRLFNRSFTQALGK (coined as CSPC16) targets 
specifically S.mutans while having minimal effect on the other streptococci. Moreover, it has been 
investigated that CSPC16 has no antimicrobial effect per se unless linked to an antimicrobial 
peptide. Herein, 2.4 mg of peptide was conjugated to 100 mg of NPs using the 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDCI) and N-Hydroxysuccinimide (NHS) coupling 
reagents. Initially, the NPs were activated with EDC/ NHS for 30 min and then the peptide was 
added to the container and was stirred overnight. The excess NHS/ EDC were removed by dialysis 
of the NPs against water in the dialysis bags (Mwcutoff=10 kDa). Subsequently, the samples were 
concentrated by removing water in a lyophilizer and the samples were redispersed in water by mild 




Similarly, a scrambled peptide with comparable number of amino acids 
(FLSLIPKLVKKIIKAFK) was conjugated on the surface of Hf PS NPs via EDC-NHS route (for 
40 mg of Hf PS NPs, 0.9 mg of peptide was used) as discussed above. 
4.1.3.5. In vitro CT imaging 
To assess the efficacy of the NP CT contrast enhancement, various dilutions (0-172mM 
Hf) of the HfO2 PS NPs were prepared as determined by ICP-OES in microcentrifuge tubes. 
Equimolar concentrations of iohexol were also prepared in water. The samples were scanned on a 
General Electric Light speed 16-slice CT scanner (GE, Milwaukee, WI, USA) using the following 
parameters: slice thickness: 0.625 mm; tube voltage: 80 kV; tube current: 100 mA; gantry rotation 
time: 0.8 sec; and pitch: 9.38 mm. Subsequently, the intensity was converted to HU. Using 
Carestream Vue PACS software, the intensity of the image was calculated and converted to HU 
using Equation 1: 
𝐻𝑈 = 1000 ×
𝜇−𝜇𝑤𝑎𝑡𝑒𝑟
𝜇𝑤𝑎𝑡𝑒𝑟−𝜇𝑎𝑖𝑟
                      Eq. 1 
where µ is the linear attenuation coefficient. The CT intensities of the air and water were measured 
using an empty vial and a vial filled with water, respectively (data not shown).   
The bacterial samples were prepared for the CT studies in micro centrifuge tubes using the 
following combinations: broth alone; broth with grown bacteria; broth with grown bacteria treated 
with 0.5-, 1- and 1.5-mg.ml-1 Hf PS NPs; broth with grown bacteria treated with 0.5-mg.ml-1 
bacitracin; and water with 0.5-mg.ml-1 Hf PS NPs. 
4.1.3.6. Specificity of Hf PS CSPc16 NPs 
S.mutans at OD600=0.6 was incubated with 0.5 mg.ml
-1 of Hf PS CSPc16 NPs, Hf PS Scr or 
water for 20 min and was then passed through a syringe filter (0.45 µm) to filter out unbound NPs. 




4.1.3.7. Ex vivo X-ray attenuation using radiographic X-ray and micro-CT 
For the ex vivo sample preparations, the chicken breast meat was used to mimic the 
surrounding tissue and was cut to fit into a radiolucent plastic container. The human tooth was then 
pushed into the tissue. The internal structure of the tooth was investigated using micro-CT 
(MicroXCT 400, Xradia, Concord, CA, USA) operated at 80 kV and 8 W of power with a 1-sec 
exposure time at 0.5X zoom, yielding a spatial resolution of 29 µm. The sample was rotated from 
-180° to 180°. A total of 721 images were acquired. The images were not filtered. Subsequently, 
the images were reconstructed using Xradia TXMReconstructor software. The 3D rendering was 
accomplished using Amira (Visage Imaging, Inc., Berlin, Germany) software. Subsequently, 100 
µl of the 172-mM Hf PS NP sample was spread onto the tooth surface, which was then scanned 
using the parameters stated above. The radiographic dental X-ray was conducted at the University 
of Illinois at Urbana-Champaign (UIUC) School of Veterinary Medicine Teaching Hospital using 
an Image Vet DC veterinary intraoral dental X-ray system, operated at 70 kV and 8 mAs. 
Mature biofilm was grown on the human tooth for 48 h. 100 μl of Hf PS CSPc16 NPs (172 
mM) was spread for 3 min. The tooth was then gently washed with water to remove unbound NPs. 
The tooth was imaged before and after NPs application on the dental X-ray machine mentioned 
above. The formation of the biofilm and its localization was further confirmed by applying GC Tri 
Plaque ID Gel™ Disclosing Solution (GC America, Inc, Alsip, IL) with a swab.   
4.1.3.8. Investigation of the antibacterial properties via microdilution assay 
Planktonic S. mutans, a cariogenic and biofilm-forming bacterium, was maintained in BHI 
broth and grown under anaerobic conditions in a GasPak™ Container System (Becton Dickinson, 
Franklin Lakes, NJ) in a 37 °C chamber containing 5% CO2 to a mid-exponential phase. The 




0.016 mg.ml-1 to 2 mg.ml-1. At the 2-h and 24-h time points, the samples were transferred into 96-
well plates. The absorbance at λ=600 nm was recorded using a multi-well plate reader (BioTek 
Synergy HT, US). The MIC50 was determined as a measure of the antibacterial efficiency.   
4.3.1.9. Assessment of the bacterial kinetics assay 
The kinetics of the bacterial growth and/or inhibition was investigated in the presence of 2 
mg.ml-1 Hf PS NPs and bacitracin by assessing the optical density at 600 nm. Two milliliters of S. 
mutans bacteria grown until the mid-exponential phase were incubated with 2 ml of sample (20 
mg.ml-1). The bacteria were supplemented with BHI broth to a total volume of 20 ml. At the 
specified time points, 200-µl aliquots were plated on 96-well plates, and the absorbance at 600 nm 
was monitored for 120 h. Three replicates of each sample were tested. The results were reported 
as the mean ± the standard deviation.     
4.3.1.10. Live/dead bacterial viability assay 
The live/dead assay was conducted using the LIVE/DEAD® BacLightTM Bacterial 
Viability Kit (L7012, ThermoFisher Scientific, Grand Island, NY, USA) according to the 
manufacturer’s protocol. Viable and dead cells were distinguished based on differential staining: 
Cells with compromised membrane integrity were stained red, and viable cells were stained green. 
The bacterial suspension turbidity was adjusted to OD600=0.3 and treated with various formulations 
for 2 h or 24 h. At the end of the experiment, the samples were centrifuged at 4400 rpm for 10 min 
and washed twice with Tris-HCl buffer to reduce the background fluorescence. The samples were 
then suspended in 400 µl of Tris-HCl buffer. Equal volumes of PI and STYO®9 at 2X the working 
concentration was added to the treated bacteria in the dark (400 µl of each dye solution) and 
incubated for 15 min. The bacterial samples were transferred to 96-well plates. The fluorescence 




relative fluorescence intensity was reported. Five-microliter aliquots of these samples were placed 
between a microscopy slide and a cover slip for CSLM. The imaging was performed on a Leica 
SP8 UV/Visible Laser Confocal Microscope (Leica Micosystems, Germany) in immersion oil 
medium with a refractive index of 0.6. 
4.1.3.11. Sample preparation for TEM 
The bacterial suspension was adjusted to OD600=0.6 and treated with Hf PS NPs 
(concentration=2 mg.ml-1) for 2 h or 24 h under constant shaking at 200 rpm. At the end of this 
period, the samples were spun, the medium was discarded, and the samples were fixed using 2.0% 
paraformaldehyde and 2.5% glutaraldehyde (both EM grade) in 0.1-M Na-cacodylate buffer (pH 
7.4) on ice for 2 h. Subsequently, the samples were stained with 1.0% uranyl acetate and incubated 
for 5 min. The samples were spun and dehydrated in a graded ethanol series (50, 70, 90 and 100%) 
for 5 min. An aliquot of this suspension was drop-cast onto Cu-coated TEM grids for observation. 
To visualize the inner structure of the bacteria and determine the effects of the NP treatment over 
a short time period, bacteria grown to OD600=0.6 were treated with Hf PS NPs (2 mg.ml
-1) for 
either 20 min or 120 min. Then, the bacteria were spun down at 4000   g for 2 min, and the 
medium was discarded. The cells were washed three times with Tris buffer and subsequently fixed 
with EM-grade fixative reagent (2.0% paraformaldehyde and 2.5% glutaraldehyde) overnight 
under mild vacuum at 4 C. The samples were spun into a tight pellet, embedded in epoxy resin, 
and allowed to harden overnight in an 80 C oven. The samples were then sectioned using an 
ultramicrotome (Ultracut UCT, Leica Micosystems, Germany). The images were obtained using a 




4.1.3.12. ROS generation assay 
2′,7′-Dichlorofluorescin diacetate (DCFH-DA) was purchased from Sigma Aldrich and a 
10 mM stock solution was prepared in DMSO. DCFH-DA is a non- fluorescent cell permeable 
dye which becomes highly fluorescent in the presence of reactive oxygen species. 30 ml of S. 
mutans with OD600=1 was centrifuged and then were resuspended in 12 ml broth containing 7 µM 
of DCFH-DA. The cells were incubated for 1 h in dark at 37 °C. They were then centrifuged at 
1500g for 10 min and were washed with Tris HCl (1X) thrice to remove the unbound dyes. The 
bacteria were then resuspended in 20 ml of broth which was split into 4 samples (Hf PS NPs=2, 
0.2, 0.02 mg.ml-1, and water) as treatment (37 °C). After 24h, 200 µl of each sample (n=3) was 
aliquoted into 96 well plate and the samples’ fluorescence were quantified with a plate reader at 
𝜆𝑒𝑥 = 488 nm and 𝜆𝑒𝑚 = 515 nm.      
4.1.3.13. Sample preparation for SEM 
The S. mutans bacteria were treated according to the procedure described in the previous 
section. At the end of treatment, the samples were gently passed through 0.45-µm syringe filter 
paper and fixed with an EM-grade fixative reagent for 2 h on ice. Next, the samples were washed 
with Tris-HCl buffer and dehydrated in a graded ethanol series (37% ethanol, 10 min; 67% ethanol, 
10 min; 95% ethanol, 10 min; 100% ethanol, 3×10 min). The samples were subjected to critical 
point drying (Autosamdri®-931, Rockville, MD), Au-Pd sputter coated for 70 s, and imaged with 
an XL30 ESEM-FEG Field-Emission Environmental SEM instrument (Philips/FEI, Hillsboro, 
OR).  
For the observation of the biofilm, the biofilm was grown on the tooth and HA discs for 48 h and 




procedure. The elemental spectra and mapping were obtained on the energy dispersive 
spectroscopy (EDS) accessory available on SEM machine.  
4.1.3.14. Laddering assay for the fragmented genomic DNA 
The bacteria grown for 2 days in BHI broth (OD=1.5) were treated with various 2-mg.ml-
1 Hf PS NPs 20 min. Subsequently, the genomic DNA was extracted using the PurElute™ Bacterial 
Genomic Kit (EdgeBio, Gaithersburg, MD, USA) according to the manufacturer’s protocol. An 
untreated sample served as the control. The genomic DNA was washed with ethanol. After it was 
fully dried, the DNA was dissolved in Tris HCl buffer (10 mM). 25 µl of DNA were incubated 
with 5 μl of gel loading dye (blue 6X, New England BioLabs Inc., Ipswich, MA, USA) for 2 min 
and run on an agarose gel (2 wt%) at 120 V for 30 min. At the end of the experiment, the gel was 
stained with 3% ethidium bromide solution (10 mg.ml-1) for 5 min and was then washed with 
ethidium bromide solution for another 5 min. The samples were imaged using the Gel doc system 
(Bio-Rad, Hercules, CA, USA). A 1-kb DNA ladder (TrackItTM, Invitrogen, Carlsbad, C, USA A) 
served as the control.  
4.1.3.15. Laddering assay for the fragmented plasmid DNA 
The Hf PS NPs (2, 0.2, 0.1, 0.01 and 0.001 mg.ml-1) were incubated with 20 µl of 10 ng.µl-
1 of pBR322 vector DNA (pDNA) for a period of 20 min. 5 µl of loading dye was added. The 
samples electrophoresis of these samples was conducted on a 2 wt% agarose gel for 30 min at 120 
mV in 1x Tris-borate EDTA buffer at pH 8.0.  
4.1.3.16. Protein gel pattern and mass spectroscopy 
The protein content of 25 ml of bacteria grown to OD600=0.6 was extracted using the 
Qproteome Bacterial Protein Prep Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 




served as the control. Subsequently, the extracted protein was analyzed using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and low-resolution matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry on an AB Voyager instrument. 
4.1.3.17. Ex vivo antibacterial evaluation  
The human teeth were sterilized by dipping them in 70% ethanol. The teeth were then air-
dried, placed onto agarose gel (2 wt%) and immersed in 3 ml of S. mutans adjusted to OD600=0.3. 
The bacterial biofilm was grown for the next 48 h. At the end of the growth period, the teeth were 
gently transferred to a newly prepared agarose gel and treated with 3 ml of 2 mg.ml-1 Hf PS NPs 
and chlorhexidine (3 ml, 2 mg.ml-1) for 20 min. Samples treated with BHI broth served as the 
control. Subsequently, the biofilms were gently scraped off and resuspended in 200 µl of broth. 
The samples were inoculated on BHI agar plates, and the bacteria were grown for another 48 h 
under anaerobic conditions. ImageJ software was used to count the total number of grown colonies. 
4.1.3.18. In vivo antimicrobial evaluation 
Ethical approval for this study was obtained from the Illinois Institutional Animal Care and 
Use Committee at University of Illinois Urbana Champaign (protocol number: 17103). 12 female 
Sprague Dawley rats (5-week old) were purchased from Charles River Laboratories (Chicago, IL). 
The rats were screened for indigenous S. mutans infection using Saliva-Check mutans kit (GC 
America Inc, Alsip, IL) prior to inoculation. Any S.mutans positive animal was excluded from 
further experiments. Topical infection of the animals was done by an actively growing culture 
(mid-logarithmic) of S.mutans for two consecutive days and were reinfected on days 7,8, and 9. 
Then they were allowed to develop infection for 10 days. The animals were checked again for the 
S.mutans using the kit to confirm the infection on day 20th. They were then randomly divided into 




were treated daily by the topical administration with 100 μl of 0.2 mg.ml-1 using a swab. The 
treatment was continued for 8 days and then the animals’ saliva was collected using the S.mutans 
kit before being euthanized with CO2 influx. The jaws were dissected aseptically and were washed 
by copious amount phosphate buffer saline (PBS). The teeth were then transferred to the BHI broth 
and were briefly sonicated in a bath sonicator for 3 min. 100 μl of this suspension was plated on 
the BHI agar (n=3 for each animal) to estimate cultivable S. mutans.  
For the bio-distribution studies, the harvested major organs and the gum were weighed with high 
precision (n=3). The digested solution was used for ICP-OES (PerkinElmer 2000DV). 
4.1.3.19. Histopathology assessments 
The mandibular, teeth and gums were preserved in formalin before further histological 
assessments. Hematoxylin and Eosin (H&E) Staining: Paraffin-embedded sections (7 μm) were 
subjected to hematoxylin and eosin (H&E) staining following the standard protocol supplied at 
core facility VetMed, UIUC. Staining was performed in Mayer hematoxylin solution for 3 min 
followed by counterstaining in eosin-phloxine B solution (or eosin Y solution) for 3 min. The 
morphological changes of H&E-stained tissue with each fixation were analyzed at magnification 
×40. 
4.1.3.20. Statistical analysis 
The results were expressed as the mean ± the standard deviation, and the data were analyzed 
with the analysis of variance (ANOVA) Bonferroni correction for post hoc analyses using 




4.1.4. Results and Discussion 
HfO2 NPs were synthesized by the sol-gel chemistry performed in a water-in-oil 
microemulsion, as demonstrated in Figure S4.1. This reaction was followed by surface 
modification of the Hf oxide core with trimethoxysilylpropyl modified (polyethylenimine) 
polymer- silane (PS NPs). The hydrolysis and condensation reactions occurred on the surface of 
the prepared HfO2 NPs, rendering them cationic. The nanoparticles were then dispersed in water 
by sonication and were mildly vortexed before each experiment as required at higher 
concentration. The samples resisted centrifugational forces at 0.2 mg.ml-1 up to 3000 rpm and up 
to 1000 rpm at the concentration of 2 mg.ml-1 (Figure S4.2 and S4.3)   
Transmission electron microscopy (TEM) revealed monodispersed HfO2 modified polymer 
silane NPs (denotated as Hf PS NPs) with nearly spherical shape (Figure 4.1B, Figure S4.4 A, B). 
TEM images determined the anhydrous NP size to be 3.7 ± 0.6 nm (Figure S4.4 C).  The selected 
area electron diffraction (SAED) result of the Hf PS NPs is presented in Figure 4.1B (top inset), 
respectively. The SAED ring patterns as indicated by the broad halo rings in the reciprocal space 
(Figure 4.1B top inset), suggested that the NPs were mostly amorphous. The semi-crystalline 
features of the NPs could also be inferred from the Moiré fringes on the high-resolution TEM 
(HRTEM) micrograph (Figure 4.1B lower inset).  
The success of the silane grafting to the NP surface was assessed using various 
characterization methods. Initially, X-ray photoelectron spectroscopy (XPS) of the decomposed 
peak of Hf4f indicated the presence of two of doublet pairs (Figure 4.1C; Top inset); The first pair 
at 13.4 and 15.2 eV was attributed to the Hf 4f7/2 and 4f5/2, respectively for the Hf in the oxidation 
state of II. The other pair at 16.2 and 17.9 eV could be assigned to Hf 4f7/2 and 4f5/2, respectively 




implies that the oxide was in non- stoichiometric form (HfOx) where x can vary between 1-2. This 
observation was further confirmed by the decomposition of the oxygen peak (Figure 4.1C; lower 
inset). Moreover, the O1s peak (the dominant feature) at approximately 530 nm was attributed to 
Hf-O-Si and HfO2. [343] The intensity of the N1s photoelectron is consistent with the results of 
the CHN analysis (~13 wt%) and indicates the presence of various amino groups on the NP surface 
(Figure S4.4E). In addition, X-ray fluorescence (XRF) spectroscopy was used to validate the 
presence of Hf in the system. The characteristic bands associated with Hf Lα and Hf Lβ were 
detected in the prepared sample at ca. 7.8 and 9 keV, respectively (Figure 4.1D).   
1H nuclear magnetic resonance (NMR) spectroscopy of the Hf PS NPs and PS was 
conducted in D2O (Figure 4.1E). The 
1H NMR spectrum of the Hf PS NPs (Figure 4.1E, ii) was 
compared to the original PS peaks (Figure 4.1E, i). It is plausible that the characteristic broad 
amine peaks were preserved in the NPs as well. However, there are slight shifts in the positions of 
most of the peaks signifying variations in the magnetic environments of the incorporated silane 
after coupling on the NP surface with slower tumbling. Solid-state (ss) 29Si NMR (ssNMR) was 
used to further elucidate the success of the silanol groups grafting onto the NP surface (Figure 
4.1F) (Direct-polarization magic-angle spinning (DPMAS): (Figure 4.1F i) and cross-polarization 
MAS (CPMAS): (Figure 4.1F ii, iii)). In the Hf PS NP spectrum, two distinct peaks at -50.4 and -
58.2 ppm were corresponding to silicon connected to T1 (geminal silanol, -OSi(OH)2R) and T
2 
(single silanol-O2Si(OH)R) structures, respectively; while the small shoulder at ca. -63 ppm could 
be attributed to the T3 species (-O3SiR). [344] Besides, the proper coupling on HfO2 NPs was 





Figure 4.1. Physiochemical properties of Hf PS NPs; (A) Schematic representation of the 
antibacterial effects of the HfO2 based NPs against S. mutans and imparting biofilm radiopacity 
for detection by X-ray methods. (B) HRTEM of the Hf PS NPs, indicating nearly spherical, well-
dispersed NPs. Bottom inset: The representative Moiré fringe patterns of the NP crystallographic 
planes. (scale bar: 2 nm); Top inset: representative electron diffraction ring patterns demonstrating 
minor crystallinity. The patterns were mostly dominated by the amorphous phase. (C) Chemical 
characterization of the Hf PS NPs by XPS showing the signature peaks and confirming the 
synthesis of the PS conjugated NPs; The corresponding narrow scan regions for top: Hf4f and 
bottom: O1S; (D) XRF of the NPs with the assigned chemical signature peaks of Hf. (E) 1H NMR 
spectroscopy of (i) polymer silane and (ii) Hf PS NPs and the corresponding assigned peaks. (F) 
29Si ssNMR spectra of the Hf PS NPs with the highlighted T1, T2, and T3 bands reflecting the 
mixture of silanol bonds on the surface of the NPs. (i) The DPMAS spectrum. (ii) and (iii) are the 




The feasibility of utilizing Hf PS NPs as an X-ray contrast agent was evaluated by 
comparing their X-ray attenuation with an equimolar concentration of the clinically applied iodine-
based contrast agent, iohexol, water and CaSO4 (Figure 4.2A). The Hf content was quantified by 
ICP-optical emission spectroscopy (ICP-OES) prior to the experiment (determined to be ~20 wt% 
of total nanoparticle weight). The units are converted to the mM of the heavy element as it is more 
practical. A ~30% enhancement in the signal relative to iohexol was observed. Subsequently, 
various sample dilutions were prepared and compared to the corresponding iohexol dilution 
(Figure 4.2B, C). Based on Figure 4.2A-C, two major conclusions can be drawn: first, the X-ray 
attenuation was greater than iohexol. Second, the X-ray attenuation in Hounsfield scale units (HU) 
was linearly correlated (R2=0.999) with the Hf concentration (mM). Indeed, the X-ray absorption 
coefficient (µ) is directly proportional to the fourth power of the atomic number (𝜇 ∝ 𝑍4), leading 
to contrast enhancement. Collectively, these results demonstrated the potential of Hf- PS NPs as 
X-ray contrast agents. 
To evaluate the efficiency of these NPs as dental X-ray contrast material, an ex vivo model 
was developed (Figure 4.2D, E, and Figure S4.5). The extracted human tooth was embedded into 
chicken breast meat and molded into a radiolucent plastic container to mimic the soft gingival 
tissue. Subsequently, a thin layer of Hf PS NPs (100 µl) was spread onto the tooth surface. Dental 
X-ray radiographic images (operated at 70 kV) were acquired before and after application of the 
NPs. As shown in Figure 4.2E, the X-ray contrast between the NPs and the tooth was clearly 
distinguished, suggesting that the tooth and NPs could be differentiated via X-ray exposure. The 
pixel intensity analysis indicated a statistically significant improvement for the NP-deposited 
sample (Figure 4.2F). It was indicated that the pixel intensity in the NP deposited section 




experiment was conducted to better observe the anatomical features of the tooth (Figure S4.5A, 
B). The results confirmed the contrast enhancement obtained using this method (Figure S4.5C).  
The above experiments confirmed that the NPs can effectively attenuate the X-ray intensity 
and can be used to distinguish between the dense Ca in tooth and the NPs. We utilized this property 
and targeted the Hf PS NPs to the S. mutans bacteria by the conjugation of a peptide sequence 
specific to these bacteria with no inherent antibacterial effect. TFFRLFNRSFTQALGK (coined as 
CSPC16) [345, 346] was conjugated to the Hf PS NPs via the 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCI) and N-Hydroxysuccinimide (NHS) amidation 
reaction (Hf PS CSPc16 NPs). This synthesis resulted in nominally 20 peptides per nanoparticle. 
The binding affinity of the active peptide sequence TFFRLFNRSFTQALGK is 60 µM for S. 
mutans. This translates to an effective binding affinity of 3 µM for a NP considering nominally 20 
conjugated peptides on the surface.  
As a control, a scrambled peptide with comparable number of amino acids 
(FLSLIPKLVKKIIKAFK) was conjugated on the Hf PS NPs (Hf PS Scr). Initially, the specificity 
of Hf PS CSPc16 NPs was evaluated vs. the scrambled peptide conjugated NPs. S. mutans was 
exposed to various formulations and the internalization of the NPs was investigated with ICP 
analysis of the filtered bacteria. The amount of Hf in the bacteria treated with Hf PS CSPc16 NPs 
was found to be 4040 ppm while for Hf PS Scr, it was determined to be 2172 ppm (for control ICP 
detected 0 ppm). The uptake of the targeted Hf PS NPs turned out to be ~1.9 fold more than the 






Figure 4.2. X-ray attenuation enhancement by Hf PS NPs; CT scans of the Hf PS NPs (172 mM 
of Hf) (1) vs. water (2), iohexol (172 mM I) (3), calcium sulfate (172 mM Ca) (4) and air (5) 
arranged in a mouse phantom. The HUs for the given equimolar concentrations of the NPs and 
iodine were calculated to be 1631±20 and 1441±33, respectively (scale bar: 1 cm). (B) Serial 
dilution of the Hf PS NPs showing the decrease of the X-ray contrast with dilution (scale bar: 1 
cm). (C) The constructed calibration curve of the HU intensity vs. the concentration of the NPs 
and its comparison with iohexol. A linear trend with a high correlation factor (R2=0.999) was 
observed for Hf PS NPs; The equations is the correlation between CT attenuation (A) and the 
concentration (C). Radiographic dental X-ray of a human tooth embedded in chicken meat to 
mimic a tooth and the gingivae without NPs (D) and with NPs (E); the arrows in (E) indicate the 
NPs. (F) Comparison of the pixel intensities of the dental X-rays in (D) and (E). The feasibility of 
the biofilm detection with X-ray using the targeted Hf PS NPs. The X-ray radiographic image of 
a tooth with biofilm before (G) and after (H) NP application where the color shows the biofilm. (I) 
The biofilm formation as indicated with a disclosing agent. The color code is indicated as well. 




The mature biofilm was grown on the tooth for 48 h and was imaged with a dental X-ray 
machine. Subsequently, the biofilm was treated with the Hf PS CSPc16 NPs for 3 mins and then 
excess NPs were washed off by water and the tooth was imaged again. As shown in the Figure 
4.2H, there is a signal enhancement in the regions with the biofilm vs. non- treated tooth (Figure 
4.2G). The localization of the biofilm was verified by the GC Tri Plaque ID Gel™ Disclosing 
Solution (Figure 4.2I) which turns into various colors in different stages of biofilm development. 
To evaluate the antibacterial properties of the developed particles, a turbidity test was 
conducted using S. mutans grown in brain-heart infusion (BHI) broth. Hf PS NPs (2 mg.ml-1) were 
incubated with bacterial cultures. The optical density at 600 nm was recorded at various time points 
using bacitracin antibiotic as the positive control (Figure 4.3A). Bacitracin is a cyclic poly peptide 
whose mechanism of action is based on the inhibition of the bacterial cell wall synthesis. [347] 
The growth kinetics of the untreated bacteria were monitored for 120 h. The exponential growth 
did not change significantly after 72 h, at which point the curve decayed because of the depletion 
of nutrients in the media (data not shown). Hence, growth kinetics was only monitored during the 
first 3 days. Interestingly, Hf PS NPs were observed to be statistically more effective than 
bacitracin for the entire test in killing the S. mutans. We have also conducted the experiment at 
doses of 2, 1, 0.5, 0.2 mg.ml-1 and monitored the optical density for 5 h. The results (Figure S4.6), 
indicated the bactericidal action of the Hf PS NPs as opposed to bacteriostatic at such doses. 
To quantify the antibacterial efficiency, LIVE/DEAD® BacLightTM Bacterial Viability 
staining was conducted. Quantitative assessments of the bacterial population after 2 h of treatment 
(Figure 4.3B) revealed that at lower doses, the Hf PS NPs were comparably effective at inhibiting 




outperformed the control. The results obtained after 24 h of treatment (Figure S4.7) confirmed 
those of the previous experiments and they agree with the results of the turbidity assay. 
 
Figure 4.3. Bactericidal properties of the NPs against planktonic S. mutans; (A) A bacterial 
kinetics study indicating the long-term efficacy measured based on the OD600. (B) the live/dead 
population ratios after 2 h obtained via fluorometric assay using a plate reader. (C-H) 
Representative confocal scanning microscopy images of the S. mutans using BacLightTM viability 
staining after 2 h of treatment at two different magnifications. The viable cells are green, whereas 
the dead cells with compromised membranes appear red. The applied treatments (2 mg.ml-1) were 
as follows: (C, D, E) Bacitracin (F, G, H) Hf PS NPs. The scale bars correspond to 75, 10 and 7.5 
µm in the first and second and third row, respectively. The red signal is more dominant for the Hf 
PS NP than for bacitracin. p-values of 0.0001 and <0.0001 are indicated by *** and ****, 
respectively. (I) Fold change in ROS level as obtained by DCFH dye. 1-way ANOVA analysis, p-





Confocal laser scanning microscopy (CLSM) of the live/dead-stained sample exhibited a 
high red signal density associated with dead bacteria after 2 h of treatment with Hf PS NPs (2 
mg.ml-1) (Figure 4.3F-H). These images contrast with the green-dominated images of viable cells 
observed in bacitracin treated sample (Figure 4.3C-E). Morphological differences were also noted 
with several aggregates of dead bacteria having blurred cell walls.  
To elucidate the underlying antibacterial mechanisms and probe the morphology changes 
further, scanning electron microscopy (SEM) and TEM were conducted after applying a lethal 
dose of Hf PS NPs (2 mg.ml-1) at two different time points (2 h and 24 h) (Figure 4.4). SEM of the 
untreated S. mutans revealed that the cellular structure was intact and that the membrane integrity 
was maintained and the cytoplasmic content evenly distributed (Figure S4.9A and S4.9B). After 
treatment with the Hf PS NPs, membrane lysis was evident, accompanied by significant 
morphological changes (Figure 4.4A, Figure S4.9C, and S4.9D). Of note was the appearance of 
enlarged, swollen bacteria at each treatment time point (indicated by the arrows in Figure S4.9E, 
F). The cytoplasmic contents tended to accumulate within the membrane and eventually burst into 
an amorphous mass of cellular debris. [348] 
To mimic the bacterial biofilms on teeth, bacteria were grown for 6 h on hydroxyapatite 
disks with similar composition to teeth. The SEM micrographs of the disks with Hf PS NPs (Figure 
4.4B, Figure S4.9F) revealed similar debris-like morphologies, like those observed after 2 h of 
treatment.  
The changes to the cellular morphology of bacteria were investigated further by imaging 
S.mutans treated with the NPs for 2 and 24 h with TEM (concentration: 2 mg.ml-1) (Figure 4.4C-
H). The NPs formed dense aggregates on the bacteria by ‘latching on’ to the membrane, suggesting 




This exuded material on the cell surface can be a combination of cellular materials and 
nanoparticles. This observation could be explained by electrostatic interactions between the 
negatively charged cell membrane and positively charged cationic NPs [349-351]. Furthermore, 
using contrast differentiation, some of the NPs taken up by the bacteria were clearly visible inside 
the cells (indicated by the white arrow in Figure 4.4D). The antibacterial effect was more 
pronounced after longer treatment (Figure 4.4E-H). The formation of blebs, fibriform cell 
fragments, and debris chains (Figure 4.4H and Figure S4.10A) and the stark change in the cell 
morphology were of interest (Figure 4.4G).  
In addition, TEM imaging was applied to the sectioned bacteria samples to further assess 
the changes in the cellular membrane during the shorter treatment period (20 min-120 min) and to 
elucidate the structure of the bacteria (Figure 4.4I-K and Figure S 4.10B-C). These data were 
compared with the untreated bacteria (Figure 4.4I and Figure S4.10A). The images were consistent 
with previous observations indicating the rupture of the cellular membrane and cellular 
internalization. The cellular membrane seen in the control cells was completely absent in the 
treatment group; this effect was observed even after the 20-min treatment. 
Further confirmation of the NPs internalization was derived from ICP analysis of the 
bacteria treated with NPs for 20 min. They were then filtered and the amount of Hf was quantified 
to be 0, 1456 and 6319 ppm for control, 0.05 and 0.5 mg.ml-1 treated cells, respectively. The 
electron microscopy images suggest a plausible mechanism for the antibacterial action of Hf PS 
NPs. The positively charged NPs attached to the S. mutans bacterial cell walls through interactions 
with the peptidoglycan of this gram-positive strain and were located near the membrane after 20 






Figure 4.4. Microscopic antibacterial mechanism investigation; SEM images of the bacteria with 
(A) Hf PS NP treatment for 2 h (2 mg.ml-1), (B) demonstrate the feasibility of growing biofilm on 
the hydroxyapatite disc and the subsequent NP treatment leading to morphological changes. TEM 
images of S. mutans treated with 2 mg.ml-1 Hf PS NPs for (C-D) 2 h and (E-H) 24 h. After 2 h 
incubation, the NPs attachment to the cell membranes were visible. The arrows indicate the NPs 
attached to and/or being taken up by the bacteria. At the 24 h, significant morphological changes 
could be observed, as shown in (G); the arrows indicate abnormal morphologies corresponding to 
cell deformation. (H) Bacterial debris was seen throughout the sample. TEM images of the internal 
structure of the (I) untreated bacteria and (J) bacteria treated for 20 min and (K) 120 min, indicating 
the NP interactions and cellular membrane disruption that arose even after short periods of time. 
The insets show a magnified image of the same. 
 
The adherence of NPs to the cell wall of S. mutans disrupted the cytoplasmic membranes, 
causing them to shrink and detach from the cell wall. The intracellular content accumulated, which 




intracellular content to discharge, followed by the collapse and fragmentation of the cell. In this 
case, the antibacterial properties rely on the accessibility and flexibility of the outer polymer shell 
to facilitate interactions with the bacterial membrane. Therefore, a ninhydrin assay confirmed that 
the amounts of accessible reactive amine groups in the Hf PS NPs to be determined as 1.94 ± 0.09 
mM (Figure S4.12).  
These results hold true for the bacteria treated with 0.2 mg.ml-1 Hf PS NPs where the 
damage to the cell membrane was obvious in the SEM images (Figure S4.13). 
Moreover, we investigated if the generation of reactive oxygen species (ROS) could have 
contributed to the cell death besides the suggested route. The amount of ROS was compared with 
the control non-treated cells after 24 h using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) (Figure 
4.3I). Indeed, it was seen that the ROS level was more significant compared with control at a lethal 
or sublethal dose of Hf PS NPs (2, 0.2, 0.002 mg.ml-1).    
To investigate the possible mechanisms of death-inducing stress, the treated bacteria were 
subjected to DNA fragmentation and protein analysis. Genomic DNA was extracted, and the gel 
electrophoresis was conducted as shown in Figure 4.5A. Interestingly, the genomic DNA got 
cleaved and moved past the fragments of DNA ladder implying severe DNA fragmentation. On 
the other hand, the DNA from the control cells were containing higher molecular weight species 
and did not travel much beyond the well. 
Moreover, the potential of the sample for the degradation of plasmid DNA (pBR322 vector 
DNA) was investigated. It can be inferred from the Figure 4.5B that, at concentrations of 2, 0.2, 
0.1 mg.ml-1 of Hf PS NPs, the pDNA (2 μg at a concentration of 2 μg/30 μl) could be totally 
degraded after 20 min at room temperature. At these concentrations, both the forms of plasmid 




Hf PS NPs, only relaxed form of plasmid band (closer to wells) could be seen. Probably 0.01 
mg.ml-1 of Hf PS NPs was only enough to convert supercoiled form plasmid to relaxed form. 
Further decrease in concentration of Hf PS NPs, could not affect the integrity of any of the forms 
of plasmid DNA and both the bands could easily be seen on the gel. Hence, the degradation ability 
of Hf PS NPs at ≥0.01 mg.ml-1 merely within 20 mins of incubation was concluded. It is probable 
that the physical interaction of NPs caused the DNA degradation in bacterial samples after 
exposure. It also negates the role of enhanced apoptosis in bacteria for DNA degradation which 
caused no signature DNA ladder appearance in gel electrophoresis. 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay is a method 
for detecting DNA fragmentation, widely used to identify and quantify apoptotic cells. This assay 
relies on the use of terminal deoxynucleotidyl transferase (TdT), an enzyme that catalyzes 
attachment of deoxynucleotides, tagged with a fluorochrome or another marker, to 3'-hydroxyl 
termini of DNA double-strand breaks. TUNEL assay performed on bacterial population incubated 
with Hf PS NP showed considerably higher relative fluorescence intensity (**** is p-
value<0.0001), supporting the higher DNA fragmentation ability of Hf PS NPs compared to 
commercial product chlorhexidine at same treatment concentration; while control and bacitracin 
were equally ineffective with only background fluorescence (Figure 4.5C). Gel electrophoresis 
experiments and TUNEL assay collectively suggest the DNA fragmentation with complementary 
results. It should be noted that TUNEL can label cells with DNA damaged by other means than 
apoptosis. On the other hand, in gel electrophoresis, apoptosis has well-defined ladders whereas 





 Figure 4.5. The effect of Hf PS NPs on the DNA fragmentation and protein pattern; (A) The gel 
electrophoresis data from the genomic DNA extracted from (1) control non-treated bacteria; (2) 
NP treated bacteria for 20 min; (3) DNA ladder; (4) duplicated of 1 and (5) duplicate of 2 (B) Gel 
electrophoresis from pDNA exposed to various concentrations of nanoparticles (1) ladder; (2) 
control no treatment; (3) 2; (4) 0.2, (5) 0.1, (6) 0.01, (7) 0.001 mg.ml-1 and (8) ladder; (C) DNA 
fragmentation as confirmed by TUNEL assay, the fluorescence intensity of the TUENL positive 
cells in Hf PS NP treated sample was significantly higher than other samples (**** is p-
value<0.0001 as obtained by one-way ANOVA analysis); The proteins extracted from the control 
(untreated cells) vs. Hf PS NP treated samples (2 mg.ml-1) exhibit no significant differences, as 
indicated by (D) SDS-PAGE assay (E) mass spectrometry; suggesting that the activity of the NPs 
occur at the DNA level rather than at the protein expression level in 20 min. 
 
In addition, proteins collected from the treated and untreated bacteria presumably exhibited 
no significant degradation or change, as evident by the gel patterns and mass spectrometry data 
after 20 min of treatment (Figure 4.5D, E). The extracted intensity profile of each lane (Figure S 




change the protein expression pattern. However, this time frame was sufficient to induce genomic 
DNA degradation.  
To mimic the biofilm environment, an ex vivo study was conducted on 48-h-old bacterial 
biofilms deposited on the surface of human teeth (Figure S 4.15A-E). The antibacterial properties 
of NPs were also compared with chlorhexidine, a cationic polybiguanide widely applied in dental 
medicine for the treatment of periodontal diseases, and for clinical and surgical purposes [90]. 
Each tooth was placed on the surface of agarose gel and immersed in a bacterial suspension with 
OD600=0.3 for 48 h to grow a mature biofilm. Subsequently, the samples were treated with various 
formulations for 20 min. One sample was treated with BHI medium only and served as the control. 
At the end of this period, the microbial mass was scraped off and resuspended in 200 µl of BHI 
medium and was spread on the culture plates for 48 h (Figure S 4.15A). The grown colonies were 
then counted to evaluate their colony-forming efficiencies (Figure S 4.15B-E). As demonstrated 
in Figure S 4.15E, the numbers of colonies were significantly reduced. The samples treated with 
the Hf PS NPs inhibited bacterial growth effectively when compared with the control and 
chlorohexidine, suggesting that the NPs had a high capacity to inhibit not only planktonic bacteria 
but also mature 48-h-old biofilms.  
We have also grown the mature biofilm on the surface of tooth by the same method and 
treated it with 2 mg.ml-1 of Hf PS NPs for 20 min for observation of morphological changes by 
SEM (Figure S 4.16A-C). As arrows point to, the damage to the cells were obvious even in the 
biofilm form. Energy dispersive spectrum of the marked region in Figure S 4.16C, was also 
conducted and confirmed the presence of Hf in the sample (Figure S 4.16D).  
To indicate theranostic properties, and as a proof of concept, planktonic S. mutans grown 




to imaging. Bacteria without NP treatment, broth alone, and treated with bacitracin (0.5 mg.ml-1) 
and NPs suspended in water (0.5 mg.ml-1) served as the control samples. As shown in Figure 
S4.15F, the signal originating from the flocculated bacteria after NP exposure intensified as the 
NP concentration increased. Upon exposure to the Hf PS NPs, the bactericidal action of the NPs 
kicks in and the higher is the concentration, the higher is the effective killing of the cells. The 
bacteria tend to settle down after treatment and this would allow for the enhancement in the CT 
attenuation. These results demonstrated the feasibility of tracking bacteria using NP-enhanced CT 
based on the CT attenuation by the NPs attached to the bacterial debris.   
Prompted by the in vitro and ex vivo results, we further investigated the efficacy of the NPs 
against the induced biofilm virulence in the rodent in vivo model. The in vivo study is a unique 
method to mimic the pathogen-host interaction while it can account for the complex biofilm 
architecture. Figure 4.6A shows the timeline of the in vivo experiment. The rats were placed 
randomly into three treatment groups after the induction of the virulence: (1) Hf PS NP (100 μl, 
0.2 mg.ml-1) (n=6); (2) chlorohexidine (100 μl, 0.2 mg.ml-1) (n=3); (3) water (100 μl) (n=3) and 
were treated once daily for 8 days. The number of animals was chosen to minimize the animal 
numbers as required by the institutional animal care and use committee (IACUC). All the rats 
survived until the experimental endpoint and they equally gained weight with minimal difference 
between the groups (P>0.05). Before euthanization, the teeth physical appearance was examined 
(Figure 4.6C-E) and was compared with their initial stage before the treatment (Figure 4.6B). As 
can be observed the rats treated with Hf PS NPs (Figure 4.6E) indicated improved dental hygiene 
as compared with chlorohexidine (Figure 4.6D) and water group (Figure 4.6C). 
Furthermore, the efficacy of NPs in the treatment of the S. mutans biofilm was further 




mutans via an immunochromatography process and has two monoclonal antibodies to solely detect 
S. mutans with a limit of detection of 105 CFU/ml. 
The results turned out to be negative for the Hf PS NP treated group (Figure 4.6H) and 
chlorohexidine group (Figure 4.6G) while it was positive for the water treated group (Figure 4.6F).  
After sacrificing the animals, the number of the cultivatable colonies were counted for comparison 
(Figure 4.6I-K). Figure 4.6L demonstrates the number of colonies for each animal and Figure 4.6M 
indicates the combined results of each group. As is evident from the results Hf PS NPs could 
effectively suppress the number of pathogenic S. mutans in the rodent model compared with water 
treatment group. 
Importantly, the NPs seemed to be more effective than chlorohexidine. This result is not in 
contradiction to the detection kit result since the bacteria grown here are a mixture of overall 
microbiota that harbor the rats’ mouths. Indeed, these results are in good agreement with the in 
vitro and biofilm ex vivo observations.  
To assess the safety profile of the NPs upon exposure to gingival cells, NIH 3T3 was used 
as model fibroblast cells. (Figure 4.7A) The cells were incubated with working concentration for 
the in vivo treatment (0.01-0.2 mg.ml-1) for 20 min, which is comparable to the time frame 
suggested for biofilm treatment. As shown in Figure 4.7A, when compared to chlorohexidine at 
the given concentrations, the NPs yielded significantly higher cell viabilities, indicating that they 
are safer than their commercial counterpart. Indeed, using the NPs, almost all the cells survived, 
and they proliferated, whereas for the ‘gold standard’ formulation, chlorhexidine, the cell viability 
was only ~20% during this timeframe at 0.2 mg.ml-1. This high toxicity was reported previously 
in a wide array of cell lines [352]. Chang et al. [353] reported the complete inhibition of 




after 120 s at a concentration of 0.125%. Even after the cells were rinsed, the cell recovery was 
reported to be slow, suggesting that this compound has limited long-term applications.  
As expected, the concentration of Hf was more in the gum with a maximum of 15 ppm 
(Figure 4.7B). In addition, the accumulation of the Hf was relatively low and only in the ppb range 
which did not seem to have any adverse effect on the organ functionalities.  
To further assess the in vivo Hf PS NPs toxicity, histopathological examinations were 
carried out to verify the in vitro toxicity observations (Figure 4.7C-H). Several sections of oral 
tissues were histologically assessed by a veterinary histopathological expert to observe any 
morphological changes following the treatment. Sections of oral mucosa with underlying 
connective tissue and skeletal muscle were examined in addition to mandible with incisors and 
molars. No significant inflammation or evidence of tissue damage in any of the sections examined 
were seen. Three of the animals had minimal to mild lymphoplasmacytic gingivitis and stomatitis, 
which may be within normal limits for oral mucosa. Some animals had mild inflammation which 
often extended to the pulp cavity. There were similar mandibular bony changes within all animals, 
interpreted as within normal limits. There was no associated inflammation found in these tissues.  
Considering the functional properties of HfO2 nanoparticles combined with excellent 
safety, this intrinsic theranostic system could be a suitable next-generation antibacterial agent for 
use in dentistry.  
4.1.5. Conclusions  
In this proof of concept study, we utilized surface modified HfO2 NPs to demonstrate the 
potential translational capabilities of NPs for biofilm diagnosis with clinical X-ray/CT devices and 
subsequent treatment feasibility with the same platform. HfO2 NPs were synthesized using the 





Figure 4.6. In vivo efficacy of Hf PS in the rodent model of S. mutans biofilm; In vivo rodent 
model (Sprague Dawley rat) of the dental biofilm and its treatment. (A) the protocol used for the 
S. mutans biofilm inoculation, development and treatment with water, chlorohexidine (0.2 mg.ml-
1) or Hf PS NPs (0.2 mg.ml-1). The tooth appearance (B) after biofilm formation and after treatment 
with (C) water; (D) chlorhexidine, and (E) Hf PS NPs for 8 days. Improved dental hygiene can be 
distinguished for the NP treated a rat. The corresponding S. mutana detection kit used on the 8th 
day of the treatment for (F) water (result: +); (G) chlorohexidine (result: -) and (H) Hf PS NPs 
(result: -). Cultivatable S. mutans after sacrificing collected from incisors of (I) water; (J) 
chlorohexidine and (K) Hf PS NP treated group. The colony count for (L) individual animal and 
(M) group. As quantified, the number of colonies were significantly reduced for NP treated group 





tuned via the hydrolysis and condensation of polymer silanes (3.6 ± 0.6 nm) to impart the NPs 
with positive zeta potentials. Subsequently, several physicochemical characterization methods 
were utilized to comprehensively characterize the NPs. The enhancement of X-ray contrast by the 
NPs was demonstrated in vitro and compared with commercial iodine-based contrast agent. The 
ex vivo radiopacity of Hf PS NPs were also shown in a phantom of a human tooth. The NPs targeted 
to the S. mutans biofilm could successfully localize the biofilm. 
 
Figure 4.7. Safety investigation of Hf PS NPs in vitro and in vivo; The safety of Hf PS NPs; (A) 
The in vitro cytotoxicity of the Hf PS NPs obtained by MTT assay for the NIH 3T3 fibroblast cells 
in the experimented concentrations (20 min incubation). It is observed that the Hf PS NPs are more 
cytocompatible than chlorohexidine; (B) the distribution of Hf in various organs as measured by 
ICP; in vivo toxicity examination in rats by H & E staining assay showing no significant 
inflammation or damage in (C) and (D) control; (E) chlorhexidine and (F-H) Hf PS NPs treated. 
For the statistical analysis, two-way ANOVA was conducted, p-value <0.01 and <0.0001 are 





Significant inhibition of the bacterial activity was quantified through either optical density 
measurements or a fluorescence-based live-dead assay. The results were compared with antibiotic 
agents against S. mutans, the major cariogenic species responsible for tooth decay. In addition, a 
combination of TEM and SEM imaging techniques clarified the bactericidal mechanisms based on 
the electrostatic interactions between the NPs and the outer bacterial membrane, leading to cell 
lysis and cytoplasmic exudation. Ex vivo analysis of an infected human tooth with a mature 48-h-
old biofilm demonstrated that the bacterial colonies were effectively inhibited after 20 min of 
treatment. Importantly, the in vivo studies in the rodent model of S. mutans biofilm demonstrated 
that the rats’ incisors treated with the Hf PS NPs lacked the S. mutans biofilm compared to negative 
control group. This was confirmed by the S. mutans kit and subsequently by the number of the 
cultivatable colonies derived from the harvested teeth. No adverse effect from the Hf PS NPs was 
identified from the histopathology data.  
Collectively, these results demonstrate the high theranostic capabilities of HfO2 NPs. From 
the perspective of fundamental science, we stress that the goal of this manuscript is to describe a 
probe with the capability to find a specific bacterial strain in a complex biofilm network using a 
non-invasive imaging technique. Furthermore, it is demonstrated that these probes can be 
chemically tweaked to achieve therapeutic properties barring the need for an encapsulated 
antibiotic. The targeting aspect can now open new avenues for the field.  
The data presented in this manuscript were generated on the conventional CT and X-ray 
imaging scanner and are the first targeted nanoparticle results for diagnostic imaging. This 
conceptual demonstration indicated that feasibility of rapid detection of specific bacterial strain 
potentially in the dentist’s office (Figure 4.8). This may allow early, complete diagnosis and 




For future work, we anticipate introducing advanced photon-counting based imaging for 
simultaneous discrimination of highly attenuating dental calcium from metal-rich hafnium contrast 
agents based on the element's unique X-ray K-edge energy signature.  
 
 
Figure 4.8. the flow process of the application of HfO2 nanoparticles. During the dentist’s visit, 
intraoral imaging with the targeted Hf PS NPs determines whether or not the patient requires a 
follow-up based on the severity of the biofilm. If so, the patient will be prescribed the therapeutic 
Hf PS NPs (for instance as paste) for given numbers of repetition until the biofilm is eliminated.   
 
Periodontal treatment is merely one area of knowledge where this approach might find an 
application. However, the ability to molecularly target and stratify specific bacterial strain will 
also impact the diagnosis and therapeutic approaches for other systemic diseases caused by 
bacterial invasion. We propose that the concept presented here could broaden the application of 
NP X-ray contrast agents as versatile platforms for tracking the treatment of bacterial infections in 
a range of conditions, such as gastrointestinal and periodontal diseases, for which X-ray/CT is 





4.2. An antibiotic free nanoapproach for topical eradication of dental biofilm without 
disturbing microbiota balance in vivo8 
4.2.1. Abstract 
Dental plaques are one of the most widely acknowledged types of biofilm which can lead 
to dental caries due to the demineralization processes caused by the acidogenic bacteria. The 
bacteria in the biofilm live in a protective sheath of polysaccharides and proteins named 
extracellular polymeric substance (EPS) which can act as a diffusion barrier to the drugs and 
making the treatment challenging. Herein, by utilizing the acidic pH of the biofilm, we proposed 
a strategy to disrupt the biofilm without applying the conventional antibiotics. Several therapeutic 
nanoparticles of the carbon dot core decorated with phosphonium ions were entrapped in a pH-
responsive polymer shell of poly(styrene)-b-poly(n,n-dimethylaminoethyl methacrylate) (PS-b-
PDMA). Extensive physiochemical characterizations were carried out to indicate the formation of 
the nanoparticles and subsequently their release in the acidic buffer. Initially, the efficacy of the 
NPs was investigated against the planktonic stage of Streptococcus mutans (S. mutans) which is 
the most carious bacteria residing in the oral biofilm. Furthermore, mechanistic studies were done 
to determine the mode of the interaction of the nanoparticles which was revealed to be electrostatic 
interaction of the nanoparticles and the membrane and excessive ROS generation. The analysis of 
the DNA of the treated bacteria indicated that interestingly, the NPs were also disrupting and 
fragmenting the DNA as was confirmed by TUNEL and gel electrophoresis analysis. Ex vivo 
studies on the mature biofilm grown on the human tooth indicated a significant decrease in S. 
mutans colonies. In addition, in vivo examination of the nanoparticles in the animal models of the 
dental biofilm was carried out and it was determined from the S. mutans detection kit and the 
                                                 
8 This chapter is part of the following publication: 
Ostadhossein, F., Altun, E., Tripathi, I., Dutta, D., Hsiao, S. H., Nie, S., Pan, D., An antibiotic free nanoapproach for 




cultivatable bacterial count assay that the nanoparticle could effectively suppress the biofilm. The 
nanoparticles did not have any adverse side effects in vivo based on the histopathological 
examinations of gingiva and major organs while they could be biodegraded in the artificial saliva. 
Importantly, 16S rRNA analysis of the collected microbiota did not show any significant change 
in the diversity and richness of the species, implying the safety and efficacy of these nanoparticles 
compared to the drug delivery approach. 
4.2.2. Introduction 
As a unique niche for inhabiting the microbiota, the oral cavity harbors a wide array of 
bacteria, yeasts, protozoa, and viruses which if perturbed, would result in the loss of mutualistic/ 
symbiotic balance leading to diseases [354-357]. The aggregates of these microorganisms can 
orderly lay on the hard surface of teeth in a protective sheath coined as extracellular polymeric 
substance (EPS), to form oral biofilm a.k.a. dental plaque [358-360]. There is now mounting 
evidence that the dental biofilm can be the culprit of several diseases such as dental caries, 
periodontitis, and systemic diseases such as respiratory and brain abscesses, diabetes mellitus, 
rheumatoid arthritis, and infective endocarditis [313, 361-363]. Indeed, dental caries is the most 
prevalent chronic childhood condition with a precipitous increase in occurrence, affecting 2.4 
billion people and comprising ~$544 billion of the global expenditure [364].  
In the biofilm, the fermentation of the dietary carbohydrates, in particular, sugars cause 
the organic acids production with pH~4.5 which would subsequently demineralize the teeth 
enamel and would create caries [365-367]. The most common carious pathogen involved in the 
dental biofilm is the gram-positive bacteria called streptococcus mutans (S. mutans) which actively 





Unfortunately, the rigorous solution to the dental caries is confounding due to the 
multifactorial nature of the disease although preventative strategies are currently being pursued in 
the clinic with little success in the EPS eradication [354, 370]. For instance, the mechanical 
debridement of the biofilm (e.g. brushing, irrigation), drug-eluting devices and chemoprophylactic 
agents such as fluoride are few examples [361, 371-374]. Among them, the ‘gold standard’ 
antiseptic agent in the dental clinic, is a cationic phenyl-bisbiguanide named chlorhexidine (CHX) 
[353, 375, 376]. This antibiotic interacts with the negatively charged species of bacteria such as 
sulfates and phosphate to exert the integrity damage and death [377]. Despite its vast use, however, 
the antiplaque and anti-caries properties of this agent are highly debated in addition to its adverse 
side effects in long run including tartar formation, teeth staining, allergic reaction and dysgeusia 
[378-381]. 
Nanoparticles (NPs) can offer an unequivocal solution to the biofilm issue with the 
privilege of multifunctionality, on- demand controlled release of drugs, high loading efficiency, 
selectivity, and trackability [267, 382-385]. Importantly, the nanoparticles can be designed to be 
‘self-contained’ and exert the therapeutic effects without the utilization of conventional antibiotics 
which have the prospect of developing bacterial resistance. Nevertheless, as a major group of 
nanobiotics, the experimentation with metallic nanoparticles has raised concerns regarding their 
accumulation and non-degradation [329, 386]. 
Carbon dots (CDots) are the emergent class of carbon family which have attracted a host 
of research in recent years due to the ease of fabrication, tunable luminescent properties, and the 
abundance of functional groups [75, 151, 387-389]. These properties combined with their 




investigation of antibacterial properties of CDots is rare in the literature while their antibiofilm 
properties are unexplored to date and certainly, they deserve more attention [391-393].       
Herein, we present for the first time, a ‘particle in particle’ approach for targeting the EPS 
with its characteristic pH to release the load of inherently therapeutic CDots to kill notorious S. 
mutans (Figure 4.9). Specifically, phosphonium containing CDots have been wrapped in a layer 
of poly(styrene)-b-poly(n,n-dimethylaminoethyl methacrylate) (PS-b-PDMA) which shows pH 
responsiveness in acidic pH. Moreover, phosphonium ions have been utilized to confer 
antibacterial properties to the NPs as they have been established to have a more pronounced 
inhibitory effect compared to their ammonium counterparts [394]. This effect presumably 
originates from the bigger ionic radius of P ion and higher ionization effect which can lead to the 
easier association to the negatively charged bacterial membrane [394].  
 
Figure 4.9. Schematic representation of the action of the nanoparticles as antibiofilm agents. The 
inherently antibiofilm carbon dots modified with phosphonium ions were entrapped in a pH 
responsive diblock copolymer. In the low pH of the biofilm, the polymer shell would open and 





The retained load of therapeutic CDots will get liberated only in low pH of EPS. This 
approach would not only lead to the biofilm dispersal and enhanced the bacterial susceptibility but 
would also exert the antibacterial properties in situ without needing any external drugs. Moreover, 
as opposed to the widely applied strategies, no external stimuli (e.g. H2O2 and photostimulation) 
has been utilized which is a boon reducing the unintentional toxicity. These properties, as well as 
their biodegradability in saliva, make them favorable for the in vivo treatment. 
We have demonstrated that these NPs could suppress the biofilm EPS and decrease the S. 
mutans viability in the in vitro human tooth model of the biofilm. The mechanism of action can be 
classified as ROS generation and fragmentation of genomic DNA on the subcellular level.  We 
have shown, in vivo, in the rat model of dental biofilm that these nanoparticles could successfully 
decrease the cultivatable S mutans within 13 days while the gene expression profiling indicated no 
change in the microbial communities’ diversity. 
4.2.3. Materials and Methods 
4.2.3.1. Materials 
All the starting materials for the synthesis were purchased from Sigma Aldrich (St. Louis, 
MO, US) unless noted otherwise. Nanopure water (0.2 × 10−6 m, 18 MΩ cm) was used throughout 
the experiments. S. mutans tube culture was bought from VWR International (Chicago, IL, US) 
and was subcultured in either BHI broth or BHI agar both obtained from Becton Dickinson 
(Franklin Lakes, NJ, US).  
4.2.3.2. Nanoparticles synthesis and characterizations:  
CHX and CHX PR4
+ NPs were prepared in a facile hydrothermal method. In a typical 
process, 300 mg of Chlorhexidine (CHX) (CAS No. 55-56-1) or 210 CHX plus 90 mg of 




then were subjected to the heat treatment in an autoclave synthesizer at 180 °C for 24 h. The 
obtained CDots were sonicated for 5 minutes by probe sonication instrument (Q700, Qsonica 
Sonicators, Newtown, CT) at Pulsed Amp, 1; 2 s on, and 1 s off. The CDots were passed through 
the syringe filter with a mesh size of 0.45 and 0.22 μm (Biomed Scientific), respectively. 
Subsequently, the solvent was evaporated on a rotary evaporator and the sample was allowed 
overnight in a vacuum oven to remove any remaining methanol. For CHX NPs and CHX PR4
+ 
NPs synthesis, 100 mg of the above CDots were dispersed in 8 ml of water and tip sonicated for 
15 min to yield dispersed NPs. At this stage, it was noticeable that the CDots (especially CHX 
NPs) did not have desirable water dispersibility and formed oily suspension due to the 
hydrophobicity of the CDots from the CHX precursors. In order to prepare the CHX polymer NPs 
and CHX PR4
+ polymer NPs, additional steps were taken to wrap the NPs in the pH-responsive 
shell. 100 mg of Poly(styrene-b-N,N-dimethyl amino ethyl methacrylate) (Mn×10
3= 6.7-b-9.2, 
PDI=1.06) (PDMA) procured from polymer source, Inc. (Quebec, Canada) and 100 mg of CHX 
NPs or CHX PR4
+ NPs were dispersed in 2 ml of chloroform (CHCl3) and sonicated for 5 min on 
ice in a test tube. Then, CHCl3 was evaporated slowly by passing a gentle stream of nitrogen gas 
while rotating the tube rapidly to yield a thin layer of materials on the tube. An oil diffusion pump 
was utilized to remove any residual organic solvent for 2 h and to further ensure the loss of organic 
solvent, the sample was rested overnight in a vacuum oven. The samples were then redispersed in 
8 ml of water (to yield 12.5 mg.ml-1 of CDots) and sonicated for 15 min as detailed above. A 
similar procedure was adopted for the formation of empty micelles; however, the sample was 
sonicated for an additional 8 min (23 min total) to yield stable particles. The samples were stored 
in the fridge until use to maintain their stability and were sonicated and vortexed briefly before 




The samples were characterized extensively to understand their physiochemical 
properties. The morphology of the NPs was inspected with a transmission electron microscopy 
(TEM) instrument (FEI Company, Oregon, US) equipped with a Peltiercooled Tietz (TVIPS) 2k 
× 2k charge-coupled device camera. The samples were drop- deposited on a carbon-coated copper 
grid (TED PELLA Inc., Redding, CA, US) and then the extra liquid was wicked with a filter paper. 
The samples were negatively stained with a 2% solution of uranyl acetate. The average 
hydrodynamic diameter and electrophoretic zeta potential were measured on Malvern Zetasizer 
ZS90 instrument (Malvern Instruments Ltd., United Kingdom). For the Atomic force microscopy 
(AFM) imaging, the samples were diluted and then drop-cast on a mica installed on a steel disc 
before image acquisition on a Bruker MultiMode Nanoscope IIIA (Billerica, MA, US).    
For the further photophysical characterizations, absorbance spectroscopy was done on a 
GENESYS 10 UV−vis spectrometer (Thermo Scientific, MA, US). The emission spectra were 
collected on an Infinite 200 PRO multimode microplate reader (Tecan, NC, US) with excitations 
at 320, 370, 420, 470, and 520 nm adjusting the concentration at 2.5 mg.ml-1 of CDots.  
For the chemical characterizations, initially, mass spectroscopy of the sample was carried 
out in the ESI mode at mass spec facilities at UIUC. 1H NMR, 13C NMR and 31P NMR of the 
samples were acquired on a multinuclear, 500-MHz Ultrashield Plus (Bruker Daltonics, Inc., 
Billerica, MA, USA) system, equipped with a 5 mm CryoProbe (Bruker, Model CB500) in CDCl3 
(Cambridge Isotope Laboratories, Inc., Cambridge, MA). The results were analyzed on 
MestRenova 11.0 software (Mestrelab Research SL; Santiago de Compostela, Spain). Moreover, 
for Fourier-transform infrared spectroscopy (FTIR) sample preparation, they were dried on MirrIR 
IR-reflective glass slides (Kevley Technologies, Chesterland, OH, USA) and their transmission 




670 FT-IR instrument (ThermoFisher scientific, Waltham, MA, US). XPS samples were applied 
on a small piece of a glass slide and subsequently drying them in vacuum overnight. A Physical 
Electronics PHI 5400 spectrometer using Al Kα (1486.6 eV) radiation was utilized for registering 
the spectra. The peak decomposition and referencing to the adventitious C-C bond (284.8 eV) was 
carried out on the CasaXPS software [301]. 
4.2.3.3. In vitro antibacterial assessment 
Microdilution turbidity assay 
The turbidity assay where the absorbance of bacteria at 600 nm (OD600) is an indication of 
the concentration of bacteria. S. mutans was grown in BHI broth overnight under anaerobic 
condition in a GasPak™ Container System (Becton Dickinson, Franklin Lakes, NJ, US) in a 37 °C 
chamber containing 5% CO2 till the OD600=0.6 (mid-exponential phase). The bacteria were 
subculture to OD600=0.4 and then treated with nanoformulations (2.5 mg.ml
-1) for 4 h. They were 
then immediately incubated to a 96 well plate in triplicate and the plate was transferred to plate 
reader (BioTek Synergy HT, US) with constant shaking at 37 °C. The wells’ absorbance was read 
every 30 minutes for 20 h. The MIC (minimum inhibitory concentration) was defined as the 
concentration which completely retards the bacterial growth. The results from absorbance were 
used to calculate the cell viability and then MIC was obtained based Lambert and Pearson’s model 
[395] at the 20 h time point.   
Live/ dead bacterial viability assay 
The SYTO9/ PI (propidium iodide) double staining kit, namely LIVE/DEAD® BacLight™ 
Bacterial Viability Kit (L7012, ThermoFisher Scientific, Grand Island, NY, USA) was used for 
this purpose. The assay was conducted based on the procedure detailed by the manufacturer. The 




exposed to 2500, 1250, 625, 375 μg.ml-1 of various formulations for 4 h. They were then washed 
thoroughly by Tris-HCl buffer twice to remove the nonspecific background. S. mutans were 
resuspended in 400 μl of Tris-HCl and 400 μl of the dye mixture (54 μl of PI and 54 μl of SYTO 
TM 9, 9892 μl DI water) in dark for 15 min. The fluorescence of the bacteria was read on a plate 
reader at λexcitation/λemission = 480/500 and 490/635 nm. Ten microliters of the above mixture were 
entrapped between a cover slip and glass slide for the visualization on Leica SP8 UV/Visible Laser 
Confocal Microscope (Leica Microsystems, Germany).    
Scanning electron microscopy of the planktonic bacteria  
S. mutans with OD600 was treated with 2.5 mg.ml
-1 and were then filtered on a syringe filter 
to collect the bacteria. The filters were separated and fixed with the EM grade fixative using 2.0% 
paraformaldehyde and 2.5% glutaraldehyde in 0.1-M Na-cacodylate buffer (pH 7.4) on ice for 2 h. 
They were then subjected to the graded ethanol series drying (37%; 67%; 95%; 100% ethanol 3 ×) 
for 10 min each and then underwent critical point drying (Autosamdri®-931, Rockville, MD). 
SEM images were acquired on the Au/ Pd sputtered samples on XL30 ESEM-FEG Field-Emission 
Environmental SEM instrument (Philips/FEI, Hillsboro, OR).  
Laddering assay of the DNA 
A further subcellular investigation was achieved with the aforementioned assays. Initially, 
10 ng. μ-1 of pBR322 vector DNA (pDNA) was exposed to 2500, 625, 156, and 39 μg.ml-1 of CHX 
polymer NPs or CHX PR4
+ polymer NPs for 60 min. 5 μl of the loading dye was added next. A 2 
wt% gel agarose gel was run for 30 min at 120 mV in 1× Tris-borate EDTA buffer at pH 8.0. The 
gel was next immersed in 3% ethidium bromide solution (10 mg.ml−1) for 5 min, washed with 




Hercules, CA, USA). A 1-kb DNA ladder (TrackIt™, Invitrogen, Carlsbad, C, USA A) and water 
treated samples were used as the controls.      
In the following step, the genomic DNA from S. mutans treated for 4 h with 2.5 mg.ml-1 
was extracted utilizing the PurElute™ Bacterial Genomic Kit (EdgeBio, Gaithersburg, MD, USA). 
Subsequently, 25 μl of the extracted DNA (in Tris- HCl) and 5 μl of the loading dye were used for 
performing the gel electrophoresis. 
TUNEL assay 
Cell Meter™ TUNEL apoptosis assay kit (Red Fluorescence) was purchased from AAT 
Bioquest, Inc., CA, USA) and was used as prescribed in the accompanying procedure. Briefly, 800 
µl S.mutans (OD600=0.6) was treated with 2.5 mg.ml
-1 of various for 4 h. They were then 
centrifuged, and the supernatant was discarded. The cells were fixed with 400 µl of 4 wt% 
formaldehyde (prepared in DPBS) for 30 min at room temperature. To enhance cell 
permeabilization, 400 µl of 0.1 wt% Tween 20 was added and was allowed for 5 min before the 
bacteria were washed 3 times with DPBS. 200 µl of reaction buffer and 2 µl of 100X Tunnelyte™ 
Red was added to each sample. They were stored at 37C in dark for 60 min and were washed 3-
5times with DPBS. The nuclei were stained with 1X Hoechst and the samples were imaged with 
CLSM at Ex/Em = 350/460 nm and 550/ 590-650 nm. The data was analyzed by Fiji software 







4.2.3.4. In vitro and ex vivo antibiofilm properties evaluation 
Antibiofilm properties on the ex vivo human samples  
Human molar teeth were procured from Buyamag Inc. (Carlsbad, CA, US) and were 
sterilized with 70% EtOH. A thick layer of agarose was made in the wells of six-well plate and 
then the tooth was placed sideways into the well. Three milliliters of S.mutans with OD600=0.6 was 
spread on the teeth and were allowed for 48 h to create the biofilm. The teeth were then transferred 
to a clean six-well plate and were treated for 4 h (3 ml, concentration: 2.5 mg.ml-1 diluted in broth). 
The teeth were then transferred to centrifuge tubes in 3 ml of fresh broth and sonicated mildly in 
water bath briefly to suspend all the cultivatable bacteria to the broth. This media was diluted 
serially (104, 105, 106, 107) and 100 μl of each dilution was spread on the BHI agar plate and the 
colonies were counted after 24 h.  
SEM of the biofilm on teeth and HA disc 
The procedure mentioned in section 5.4.2 was utilized for growing and treating biofilm on 
the tooth and hydroxyapatite discs (3D Biotek, Bridgewater, NJ, USA). The fixation, drying, and 
imaging were similar to section 5.3.3. 
Confocal imaging of EPS matrix 
Biofilm was grown for 48 h and was treated with the formulations for 4 h and 2.5 mg.ml-1 
as mentioned above. The EPS was stained with 25 μM of Dextran conjugated cascade blue™, 
10000 MW (ThermoFisher Scientific, Grand Island, NY, USA) for 30 min and then were imaged 
in Z mode on CLSM with Ex/Em wavelength of 400/420 nm. To evaluate the density of the 




4.2.3.5. In vivo antibiofilm efficacy evaluation 
In vivo infection of the animals 
All the animal experiments were carried out according to the ethical guidelines outlined by 
the Illinois Institutional Animal Care and Use Committee at University of Illinois Urbana 
Champaign and were approved by the board (protocol number: 17103). 12 female Sprague Dawley 
rats (5-week old) were purchased from Charles River Laboratories (Chicago, IL). At first, all the 
rats were prescreened for any protentional indigenous S. mutans biofilm with Saliva-Check mutans 
kit (GC America Inc, Alsip, IL). For the collection of samples, SalivaBio infant swab device 
(Salimetrics, LLC, Carlsbad, CA, US) was used. The rats (n=3) were randomly placed into 4 
treatment groups: 1) water, 2) CHX, 3) CHX PR4
+ NPs, 4) CHX PR4
+ polymer NPs. One hundred 
microliters of S. mutans in the mid-log stage growth were inoculated on the teeth topically by using 
a swab on the incisors for 6 successive days. A resting period of 7 days was given so that the 
infection would set in. At this stage, the S. mutans infection was confirmed with the Saliva- check 
kit. The animals were treated daily with 100 μl of formulations by using swabs dipped in the 
formulation. The treatment concentration was 0.625 mg.ml-1 for 11 days and then increased to 1 
mg.ml-1 doe the last 2 days with a short exposure of 1 min mimicking the clinical condition. Before 
the animals were sacrificed by asphyxiation, they were tested for S. mutans infection with the kit. 
Major organs, teeth, and gum were fixed in formalin and submitted for the histopathological 
examination. 
The extracted teeth were immersed in the BHI broth and the bacteria were sonicated off the 
teeth. The cultivatable bacteria were then grown on the MSB agar plates which is specific for S. 
mutans growth and avoid other microbiota harboring the oral environment. The number of bacteria 




4.2.3.6. Statistical analysis 
The results were expressed as the mean ± the standard deviation and proper statistical analysis 
was performed on GraphPad Prism 6.0 software as noted for the individual experiment. 
4.2.4. Results and Discussion   
The CDots were prepared in a one-pot synthesis using the hydrothermal method in an 
autoclave with high pressure at 180 °C. Briefly, CHX (For CHX NPs) or CHX plus 30 wt% of 
THPB (for CHX PR4
+ NPs) were first dissolved in methanol and then exposed to heat and 
pressure for 24 h to obtain the CDots. For wrapping of the CDots in the pH-responsive polymer, 
a film formation and hydration method was adopted [397]. Fifty milligrams of solid CDots from 
the above batches and 50 mg of the block copolymer (PS-b-PDMA) were dispersed in 2 ml 
chloroform (CHCl3), vortexed vigorously and were sonicated shortly. Subsequently, a stream of 
nitrogen was applied gently to remove the organic solvent and yield a monolayer of CDots and 
PS-b-PDMA. After an overnight rest for removing the residual organic solvent, 8 ml of water 
was added to adjust the concentration of the CDots to 12.5 mg.ml-1. A lack of water dispersibility 
in the CHX NPs and CHX PR4
+ NPs was observed initially, while after the polymer wrapping, 
an improvement was noticed. It is hypothesized that during the assembly process, the 
hydrophobic ethenylbenzene in polystyrene would interact via π- π stacking with the 
hydrophobic CDots from CHX while the PDMA with the hydrophilic moieties (abundance of 
tertiary amines) [398] would emerge in water, forming micelles entrapping multiple CDots. 
The formation of the NPs was confirmed by transmission electron microscopy (TEM) as 
shown in Figure 4.10 A, B. For confirmation of polymer wrapping around the CDots, a negative 
staining procedure was followed. Initially, the nanoparticles were imaged without prior staining 




outline of the NPs appears lighter indicative of polymer coating (Figure 4.10 A). On the other 
hand, AFM of the CHX PR4
+ NPs and CHX PR4
+ polymer NPs are shown in Figure 4.10 C, D. 
As is seen in the figure, there is a significant increase in the height of the assembly after 
entrapping in the polymer. 
The electrophoretic potential of these nanoparticles is of high importance to confirm the 
presence of phosphonium ions on the surface of CHX PR4
+ NPs. The  potential value for CHX 
NPs was close to zero and became more negative upon the introduction of the PS-b-PDMA 
possibly because of the interaction with the styrene block. In contrast, the  of CHX PR4
+ NPs 
was measured as 50±7 mV implying the cationic nature of the formed particles. The positive 
charge became numerically slightly less after polymer entrapping (35±4 mV) perhaps due to the 
shielding effect of polystyrene. The overall absolute value for CHX PR4
+ polymer NPs was 
higher than CHX polymer NPs which resulted in a more colloidally stable construct. In fact, 
CHX polymer NPs fell out of suspension in several of t CHX PR4
+ NPs he experiments during 
antibacterial assessments (vide infra) which resulted in the false positive outcome. 
To get more insight into the chemical structure and whether or not the original source is 
preserved after the harsh carbonization, we carried out mass spectroscopy and nuclear magnetic 
spectroscopy. Interestingly, the data mass spec and NMR both pointed to the fact that the CHX 
did not survive in the process and has been broken into other components (Figure 4.11 A and 
Figure 4.12). On the other hand, 31P NMR results (Figure 4.12 A) indicated that P is maintained 
even after carbonization and therefore this can justify the enhanced antibacterial properties 






Figure 4.10. the physicochemical characterizations of the nanoparticles; TEM images of CHX 
PR4
+ polymer NPs (A) negatively stained with uranyl acetate and (B) unstained samples; AFM 
micrographs of the (A) CHX PR4
+ NPs and (B) CHX PR4
+ polymer NPs, note the increase in the 
height in the polymer packed nanoparticles; (E) the variation in the electrophoretic ζ potential 
as a result of wrapping in the polymer; (F) The UV- Vis absorption spectra of the CHX NPs and 
CHX PR4
+ NPs.        
 
Further studies on the chemical composition and surface functional groups were 
implemented with Fourier transform infrared (FTIR) spectroscopy (Figure 4.11 B). In the CHX 
profile, several characteristic peaks were identified: the peak at 1090, 1518, 1644 and 2934 cm-
1 can be attributed to 𝛿𝐶−𝑁 aliphatic,  𝛿𝑁−𝐻, aromatic C=C, and C-H respectively. On the other 
hand, the broad peak between 3283-3395 cm-1 can be assigned to N-H. After the carbonization 
of CHX to CHX NPs, there is no overlap between the two spectra. In the spectrum of CHX NPs 
several regions can be identified. The region between 3208-3363 cm-1 can be due to OH stretch 
in alcohols and N-H stretch. The strong major absorbance centered at 2938 cm -1, 2856 may be 




several areas: absorbances seen at 1053, 1400-1450, 1524, and 1630-1690 cm-1 can be related to 
C-N/ C-O, OH bend in COOH, C=C, C=N/ amide, respectively. 
 
Figure 4.11. Chemical composition characterizations of the NPs; (A) mass spectroscopy analysis 
of (i) CHX, (ii) CHX NPs, (iii) PR4
+, (iv) CHX PR4
+ NPs where the lack of CHX characteristic 
m/z signal is perceivable after carbonization; (B) FTIR spectra of various NPs for (i) CHX, (ii) 
CHX NPs, (iii) CHX polymer, (iv) CHX PR4
+ NPs, (v) CHX PR4
+ polymer NPs. 
     
The absorption spectra of CHX NPs is lacking any bandgap transition that is due to the 
amorphous nature of the carbon substrate (Figure 4.10 F). The characteristic peak of CHX around 
289 nm was observed and was attributed to the n−π* transition of the carbonyl group and π–π* 
transition of the conjugated C=C band. This peak got slightly red-shifted to 292 nm for CHX PR4
+ 
NPs. The fluorescence spectra of CHX NPs and CHX PR4
+ NPs displayed a typical excitation 
dependent photoluminescence of CDots in the blue-green region. This behavior can be associated 
with the difference in the response of the multiple emission centers of CDots, either on the surface 





Figure 4.12. NMR spectra of the NPs (A) 31P NMR for PR4
+ compound and CHX PR4
+ NPs, note 
that even after carbonization the phosphonium ions are preserved and hence is the observed 
antibiofilm properties; (B) 1H NMR of (i) CHX, (ii) CHX NPs, (iii) PR4
+ compound, and (iv) CHX 
PR4
+ NPs.    
We examined the bactericidal properties of the derived NPs using a turbidity assay 
implemented in a plate reader (37 °C, 5% CO2) as the growth chamber (Figure 4.13 A, B). S. 
mutans was exposed to NPs, water (negative control) and CHX drug (positive control) for a period 
of 20 h and the OD600 was read every 30 minutes till the end of the experiment. As can be perceived 
from Figure 4.13 A there is a constant decrease in the bacterial viability for CHX PR4
+ NPs and 
CHX PR4
+ polymer NPs whereas for CHX NPs and CHX polymer NPs (Figure 4.13 B), S.mutans 
started to grow following an exponential growth despite an initial inhibition. The growth curve is 
similar to the control (water treated) group. The same trend was observed for CHX drug although 
the slope becomes more constant with occasional increases at few time points. The change in the 
slope is more prominently shown in the first order derivate plot where the negative value of the 
slope is preserved all along for CHX PR4
+ NPs and CHX PR4
+ polymer NPs while the trend is 




turbidity and scattering from the NPs. Subsequently, 𝜆600 was read and normalized for various 
concentrations and a viability curve vs. log(concentration) was established to calculate MIC at 20 
h (Figure 4.13 D). The value was determined to be 2.026 mg.ml-1 for both CHX CDots NPs 
(R2=0.999) and CDots THPB polymer NPs (R2=0.975) according to Lambert and Pearson’s 
analysis method [395].  
 
Figure 4.13. the efficacy of the nanoparticles against the planktonic S. mutans; (A) turbidity time 
kill assay for CHX, CHX PR4
+ NPs and CHX PR4
+ polymer NPs where a decreasing trend is 
observed, (B) turbidity time kill assay for CHX NPS, CHX polymer NPs and empty vesicles where 
an increase is observed in OD600, (C) the quantitative live dead fluorescent assay for various 





For further confirmation of the antibacterial properties, a live/ dead fluorescent assay was 
conducted in the planktonic stage on S. mutans (Figure 4.13 C). In this fluorometric assay, a 
combination of two dyes is used for staining the bacteria, namely SYTO9 and PI where SYTO9 
would bind with the nucleic acid of both the live and dead cells whereas PI would displace the 
SYTO9 in the cells with the damaged membrane. The quantitative analysis performed on a plate 
reader, at four different concentrations, indicated that CHX PR4
+ NPs and CHX PR4
+ polymer 
NPs are significantly reducing the number of the live cells while CHX NPs, CHX polymer NPs, 
and empty vesicles have comparable dead cell percentage to the control (water) treatment group. 
This result is in agreement with the time- kill turbidity assay and therefore these samples were 
excluded from the follow-up analysis. Of note, is the statistically smaller number of live cells in 
the NP- treated group vs. CHX drug as confirmed by two-way ANOVA.  
To examine the cellular morphology and membrane integrity upon treatment with the NPs, 
scanning electron microscopy (SEM) imaging of S. mutans was done (Figure 4.14 A, B). The 
control (water) treated group (Figure 4.14A) appeared as cocci with evenly distributed cytoplasmic 
content and no noticeable damage to the cell membrane. On the contrary, the NP treated group 
(CHX PR4
+ NPs and CHX PR4
+ polymer NPs) have remarkable damage to the membrane with a 
significant number of the NPs latching on the membrane (Figure 4.14B). Most of the cells have 
been severely deformed to the point of complete collapsing. The strong interaction between the 
NPs and the cellular membrane could have originated from the electrostatic interaction of the 
cationic NPs with the negatively charged peptidoglycans of the gram-positive S. mutans. The 
interaction could have resulted in the rupture of the bacterial cell membrane leading to the leakage 






Figure 4.14. Antibacterial mechanism governing the cell death; SEM images of planktonic S. 
mutans treated with (A) water and (B) CHX PR4
+ polymer NPs with noticeable damage to 
membrane and loss of cell morphology; (C) ROS fluorometric assay for S. mutans treated with 
various formulations; (D) downstream damage to S. mutans as a result of treatment with NPs as 
investigated with DNA gel electrophoresis assay, lane order is ladder, 1: CHX, 2: CHX NPs, 3: 
CHX polymer NPs, 4: CHX PR4
+ NPs, 4: CHX PR4
+ polymer NPs; (E) pDNA interaction and 
damage after 1 h incubation with CHX PR4
+ polymer NPs and CHX, lane order is: ladder, 1: 2.5 
mg.ml-1 2: 0.62 mg.ml-1, 3: 0.15 mg.ml-1, 4: 0.03 mg.ml-1 of NPs, 5: water, 1’: 2.5 mg.ml-1, 2’: 
0.62 mg.ml-1, 3’: 0.15 mg.ml-1, 4’: 0.03 mg.ml-1 of CHX. As is shown, the lanes for the CHX PR4
+ 
polymer NPs are fainter compared to both CHX and water treatment group implying their effective 
interaction of the pDNA; (F) the results from the analysis of the TUNEL assay confocal images 
analysis where the damage to the DNA was concluded.     
 
Reactive oxygen species (ROS) (such as singlet oxygen, peroxides, superoxides) are 
considered as the major modulators of bacterial cell death when exposed to the nanoparticles. The 




(DCFH-DA), which becomes intensely fluorescent when converted to 2′,7′-dichloro-fluorescein 
in the presence of ROS (Figure 4.14 C). As could be comprehended from the results, there is a 
significant buildup of the ROS in the CHX PR4
+ NPs, CHX PR4
+ polymer NP and CHX groups 
vs. water treated group. Of note is the significantly amplified generation of ROS in the NPs group 
vs. positive control (CHX itself) testifying to the efficacy of NPs to induce cell death. 
Further mechanistic studies on the subcellular level were carried to get a clearer picture of 
the functions of the NPs in inhibiting the bacteria. Initially, the interaction of plasmid DNA 
(pDNA) with CDots THPB polymer NPs and CHX was investigated after 1 h exposure at various 
concentrations of the treatment (2500, 625, 156, and 39 μg.ml-1) (Figure 4.14 E). Here, water 
treatment was considered as a negative control. Interestingly, at 2.5 mg.ml-1 of CHX PR4
+ polymer 
NPs formulation, pDNA could completely get degraded and no lane was observed whereas, for 
CHX, the interaction did not yield any changes to the integrity of DNA. At the lower 
concentrations, this effect is suppressed although the smears from fragmentation can still be seen 
while for CHX, there are sharp bands and the pattern is more similar to the untreated sample. Next, 
S. mutans was treated with CHX PR4
+ polymer NPs and subsequently, the genomic DNA was 
extracted and was subjected to gel electrophoresis for 30 minutes before being imaged on a gel 
doc instrument (Figure 4.14D). Remarkably, the DNA fragments traveled beyond the DNA ladder 
implying the presence of low molecular weight species and severe degradation of DNA by the 
NPs. Finally, to seek further confirmation on the DNA damage, a terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) assay was conducted. In the confocal images red 
shows the enhanced fluorescence as a result of nick in the DNA and blue are nuclei (representing 
the cell numbers). The analysis of the ratio of red: blue intensity revealed that CHX PR4
+ polymer 




group, one- way ANOVA analysis). Collectedly, these results suggest the success of these NPs in 
the fragmentation and bacterial cell inhibition even on the subcellular level. 
 
Figure 4.15. Antibiofilm properties of CHX PR4+ polymer NPs against mature biofilm (48 h old), 
SEM images of the treated biofilm grown on (A) HA disc where the clear surface implies the lack 
of EPS and (B) human tooth, as shown the NPs have attacked the bacteria; (C) the flow chart for 
growing and treating the biofilm on human tooth to indicate the antibiofilm properties of the 
formulation; (D) the colonies counted after treating with positive and negative control and NPs 
where a significant reduction of the biofilm can be understood.  
 
Having established the efficacy of antibacterial CHX PR4
+ polymer NPs in the planktonic 
form, we sought to understand their antibiofilm properties since the elimination of the biofilm is a 
more tenacious task as a result of the barriers set by EPS. An ex vivo model of the dental biofilm 
was developed on the human extracted teeth. Briefly, the mature biofilm was grown on the human 




Subsequently, it was treated with the NPs for 4 h and then the teeth were sonicated mildly for few 
minutes to obtain the cultivatable bacteria (Figure 4.15C).  
These bacteria were seeded on the agar plate for the colony counting assay. As can be noted 
in Figure 4.15D, there is a significant drop in the number of the cultivatable bacteria in the CHX 
PR4
+ polymer NPs group vs. the water treatment group attesting the outstanding antibiofilm 
properties of the NPs in the ex vivo model of the human tooth. Moreover, SEM images of the 
mature biofilm (48 h-old) treated with the NPs on disc and tooth are displayed in Figure 4.15A, B, 
respectively. It can be noted that in the NP treated samples, S. mutans have undergone serious 
deformation and the loss of morphology while being assaulted by the NPs (Figure 4.15B). 
Plausibly, the significant loss of EPS matrix is appreciated in the treatment group. On the low 
magnification (Figure 4.15A), it is evident that not much of EPS have survived nor have S. mutans. 
Similar results have been obtained for the tooth that was treated with the NPs. 
Encouraged by the excellent ex vivo outcome, we created the biofilm virulence in the rodent 
model of dental biofilm. To achieve this aim, 12 Sprague Dawley rats were tested with the S. 
mutans detection kit to be pathogen free and were then randomly divided into four groups. S. 
mutans was inoculated on the rat’s incisors for six consecutive days and then the animals were 
allowed seven days for the induction of the biofilm. At the end of this time point, the infection by 
S. mutans was confirmed by the detection kit for all the animals. A daily regimen of the formulation 
treatment (0.625 mg.ml-1, 100 μl) was followed for 11 days once daily for a brief 1 min exposure 
and then at 1 mg.ml-1, 100 μl for the last two days (Figure 4.16A). Before sacrificing the animals, 
S. mutans kit was performed based on the protocol by the supplier. No loss of animals occurred 
during the experiment and the animals equally gained weight without significant difference 





+ polymer NPs and comparable to CHX whereas, for the water-treated group, the kit result 
was positive (Figure 4.16B). The improvement in dental hygiene was also observed before (Figure 
4.16D) and after treatment (Figure 4.16E). The teeth were harvested from mandible and then the 
extracted bacteria were inoculated on the Mitis salivarius-bacitracin (MSB) agar plates (specific 
for S. mutans growth only) for the cultivable colonies counts. The CHX PR4
+ polymer NPs showed 
a substantial improvement in eradicating the dental biofilm when compared to the negative control 
(p-value= 0.0008). Of note was the superior performance of CHX PR4
+ polymer NPs compared 
to CHX (p-value w.r.t water= 0.0308) and CHX PR4
+ NPs (p-value w.r.t water= 0.1870, not 
significant) (Figure 4.16F). For comparison purposes, representative plates are demonstrated in 
Figure 4.16.   
To assess the safety and biocompatibility of the NPs, histopathological experiment was 
done on the gingiva and the major organs (Figure 4.17, Figure 4.18). The H & E slides were ready 
by a board certified histopathologist. Heart, long, liver, kidney, spleen, and intestine were 
evaluated for all the animals and no significant differences were found across the groups (Figure 
4.18). For the water treated group the gingiva for the individual animals is as follows: I) A part of 
mucosal epithelium is hyperplastic and hyperkeratotic with hints of pink, white and blue layering. 
Subepithelium is slightly hyperemic. Severity of the lesion is mild (+). II) Mucosal epithelium is 
also hyperplastic and hyperkeratotic with hints of pink, white and blue layering, Subepithelium is 
slightly hyperemic. Severity of the lesion is moderate (++). III) A part of mucosal epithelium is 
also hyperplastic and hyperkeratotic with hints of pink, white and blue layering. Subepithelium is 






Figure 4.16. The in vivo efficacy of the NPs in the rat model of the dental biofilm; (A) timeline 
of the in vivo animal treatment; (B) the in vivo S. mutans detection kit outcome where the results 
were positive for the water treated group and negative for CHX and CHX PR4
+ polymer NPs group; 
(C) the cultivatable bacteria collected from the harvested animals’ teeth. The bacitracin- modified 
Mitis Salivarius agar plates have been employed here which can specifically grow S. mutans; The 
dental hygiene in the animal model (D) before the treatment and (E) after the treatment with NPs; 
(F) the collective results from the plate count assay of the cultivatable bacteria after obtaining their 





For the CHX treat group: I) A part of mucosal epithelium is also hyperplastic and 
hyperkeratotic with hints of pink, white and blue layering. Severity of the lesion is minimal (+/-). 
II) NSC, III) A part of mucosal epithelium is also hyperplastic and hyperkeratotic with hints of 
pink, white and blue layering. Subepithelium is slightly hyperemic. Severity of the lesion is mild 
(+). 
 
Figure 4.17. The safety analysis of the NPs; (A) the in vitro degradation of the CDot core in the 
artificial saliva within the timespan of 10 days as monitored with the UV peak at 253 nm; (B) the 
histopathological examination of rat’s gingiva with not significant change across the groups.  
For CHX PR4
+ group: I) Mucosal epithelium is hyperplastic and hyperkeratotic with hints 
of pink, white and blue layering. The top layer consists of anuclear, compact keratin. Spinous 
keratinocytes of the middle layer are swollen and pale with profound, intracellular edema. 
basal/suprabasal layer of keratinocytes is hyperplastic and basophilic with a higher nuclear to 
cytoplasmic ratio. Subepithelium is slightly hyperemic with scattered lymphocytes and plasma 
cells. Severity of the lesion is moderate (++). II) Parts of mucosal epithelium are also hyperplastic 
and hyperkeratotic with hints of pink, white and blue layering. Subepithelium is slightly 




hyperplastic and hyperkeratotic with hints of pink, white and blue layering. Severity of the lesion 
is mild (+). 
 
Figure 4.18. Histology of the major organs: (A) water, (B) CHX, (C) CHX PR4
+ NPs, (D) CHX 
PR4
+ polymer NPs. 
 
For CHX PR4
+ polymer NPs: I) A part of mucosal epithelium is also hyperplastic and 
hyperkeratotic with hints of pink, white and blue layering. Subepithelium is slightly hyperemic. 
Severity of the lesion is minimal (+/-). II) NSC, III) NSC. It can also be concluded that the polymer 
has reduced the nonspecific toxicity of the nanoparticles and hence the least damage was exerted 




We carried out assay in the artificial saliva to demonstrate the biodegradability of these 
nanoparticles. We traced the absorbance of these nanoparticles by UV-Vis spectroscopy in the 
span of 10 days. Interestingly enough, these nanoparticles tend to biodegrade with time (Figure 
4.17A), therefore, ruling out the possibility of toxicity if the traces are maintained.   
Finally, the DNA from the swabs collected from each animal was extracted and then they 
were PCR amplified in the V3 and V4 region and were subsequently analyzed with 16S rRNA 
gene amplicon sequencing. The preliminary results from the agglomerated genus and family levels 
analysis (Figure 4.19-4.22) does not show any significant changes across the groups which implies 
that the treatment did not upset the balance of the microbiota harboring the mouse’s oral 
environment. 
4.2.5. Concluding Remarks 
We reported for the first time, the antibiofilm carbon dots to fight the dental biofilm in vitro 
and in vivo. The nanoparticles were wrapped in a polymer shell via a particles-in-particle approach 
for the on-demand release of inherently therapeutic load of CDots in the low pH of biofilm. We 
have robustly characterized these NPs by TEM, AFM, DLS and chemically by FTIR, NMR, mass 
spectroscopy etc. and confirmed the proper formation of these NPs. The NPs were tested in the 
planktonic S. mutans culture and it was found that they could kill the bacteria not only on the 
cellular level but also on the intracellular level as was verified by various assays. Having 
established their efficacy against planktonic cells, they were utilized in the ex vivo model of the 
dental biofilm using human tooth. It was indicated that the biofilm could be effectively inhibited. 
Finally, the in vivo analysis of the dental biofilm animal model was implemented, and it was 
determined that the nanoparticles have excellent antibiofilm properties in rats as well. Of 




V3-V4 region of the extracted microbiota did not indicate any significant difference among the 
groups. These nanoparticles offer a biodegradable antibiotic free approach to address the issues of 
the biofilm in vivo.           
 
Figure 4.19. The agglomerated genus and family levels analysis of the extracted DNA from rat’s 
oral cavity. Group A: water, (B) CHX, (C) CHX PR4
+ NPs, and (D) CHX PR4
+ polymer NP treated 












Figure 4.20. Basic composition plot.  
 
 
Figure 4.21. alpha diversity of the microbiota. The results from Kruskal-Wallis statistical analysis 





Figure 4.22. Initial beta diversity calculation on the glommed samples information. This is an 





CHAPTER 5: NANOPARTICLES FOR THE DETECTION OF LOCALIZED DISEASES 
5.1. Quantitative Multi ‘Color’ Detection of Bone Microdamages using Ligand Directed 
Hafnium Oxide Nanoparticles and Photon Counting K-edge Imaging9 
 
5.1.1. Abstract 
Bone microdamages are among the health issues which if go unnoticed would lead to the 
thinning, fragility and ultimately catastrophic fracture of bone over time. Therefore, the timely 
diagnosis and evaluation of the damages are crucial to make informed decision about the therapy 
and taking precautionarily treatments. CT imaging as one of the most commonly used imaging 
modalities in the clinic for the evaluation of anatomical features holds great promise in the 
diagnosis of the bone diseases. However, due to the strong attenuation from bone itself, the 
distinction of small features such as microdamages might not be easily feasible. Recent 
innovations in the CT device technologies as well as novel imaging probes can address this 
problem effectively. Herein, the bone microdamage imaging was made viable using targeted 
nanoparticles combined with advanced photon counting spectral CT which benefits from the 
advanced detector technologies. For the first time, HfO2 nanoparticles surface modified with a 
calcium chelator moiety were accumulated in bone microdamages and were spectrally separated 
from the bone and soft tissue of muscle in vivo. The affinity of the targeted NPs towards calcium 
was evaluated in suspension where the targeted nanoparticles showed 6.5-fold higher binding 
compared to the non- targeted counterparts. The ex vivo binding of the targeted nanoparticles in 
the human bone model of microdamage also corroborated the binding to the bone. In vivo, these 
nanoparticles did not trigger any adverse side effects histologically and chemically while due to 
                                                 
9 This part of the thesis is adapted from the following publication: 
Ostadhossein, F., Tripathi, I., Lowe, C., Benig, F., Moghiseh, M., Raja, A., …, Pan, D., Quantitative multi ‘color’ 
detection of bone microdamages using ligand directed hafnium oxide nanoparticles and photon counting k-edge 




their sub 5 nm size, they were exerted through the reticuloendothelial system organs without 
noticeable aggregation. These preclinical studies highlighted the potential of HfO2 based 
nanoparticle contrast agents for the skeletal system diseases due to their well- placed K-edge 
binding energy.               
5.1.2. Introduction 
Bone as a high-performance functional material encounters various mechanical forces such 
as tensile, shear and periodic i.e. fatigue stresses which makes it prone to the mechanical damages 
specially microdamages [399, 400]. Microdamages encompass a variety of planar ellipsoidal 
cracks in the micron size range (major axis ~400 μm and minor axis ~100 μm) and can be 
categorized as linear, parallel, cross-hatch, and diffuse types [401-403]. Although the formation of 
bone microdamages are essential for the toughening mechanism to maintain the bone integrity, 
with aging and certain conditions such as osteoporosis the risk of crack propagation and fracture 
drastically increases [404-406]. Therefore, the duly diagnosis of bone microcracks is crucial to 
estimate the fracture and fragility risk factors and to conduct the proper intervention [407]. 
To date, the assessment of the bone microdamage relies on the invasive histomorphometry 
in which the 2D cross-sections of bone are imaged with fluorochromes specific to the bone 
minerals [408]. Several clinically used imaging modalities are currently being investigated for 
non- invasive three-dimensional assessment of bone microdamage in vivo [389, 409-411]. Among 
them, computed tomography (CT) imaging is an excellent candidate due to being clinically 
amenable and its capability to provide information on the anatomical features rapidly [268, 412]. 
However, the confounding radiographic attenuation from calcium in bone make the damage 




detection of damage on the micrometer scale [414]. A non-invasive method is needed that may 
enable microdamage to be measured and quantified and provide useful data.  
Nanoparticles composed of high atomic number materials can partially resolve the issues 
associated with strong X-ray attenuation from calcium in the conventional CT imaging machines. 
None of the naturally occurring materials in the body can pose enough energy in the diagnostic 
energy range; hence urging for exogenous contrast materials. 
When combined with advances in the CT instrumentation, the best outcome is expected. 
Specifically, the incorporation of photon counting detectors resulted in the multispectral CT 
technology which enables the detection of materials based on their signature K-edge with minimal 
background from hard tissues. With the help of a camera with built-in sensitive photon counting 
CT detector and the associated photon energy, several materials can be distinguished based on 
their unique K- edge. Materials whose K-edge absorption band falls in the range of peak tube 
potential of 80-140 kVp are especially suitable since they can bypass beam hardening effect in 
these practical beam energy ranges [415]. It was indicated that the elements with atomic number 
(Z)=64-73 have the most potential to enhance the K- edge X-ray contrast effectively [415] as 
compared to iodine while higher Z elements would reduce the photon counts sensed by the 
detectors (such as Au, Bi, etc) [416]. The high spatial and spectral resolution, an enhanced contrast 
to noise ratio (CNR) with reduced imaging artifacts make this technique favorable for the 
preclinical and clinical applications even at the molecular level [41, 272, 334, 417, 418].  
Hf with Z=72 is an emerging radiopaque material with well-positioned K-edge energy 
(65.3 keV) has been rarely investigated for contrast agent in CT imaging especially K-edge 
imaging [419]. Previous report revealed that Hf may provide a superior overall performance at 




gold, bismuth and other elements [42]. The K-shell absorption edge of Hf is suitably placed near 
the mean photon energy of the energy spectrum in a clinical CT, ranging from ∼20 keV to peak 
tube potentials of 80–140 kVp.   
HfO2 nanoparticles are currently under clinical trial as a radiosensitizer for soft tissue 
sarcoma (phase II/III) (#NCT01433068), head and neck (#NCT01946867), prostate, liver and 
rectum cancers (phase I) [58-60]. Therefore, Hf-based nanoparticles may have a great potential to 
be utilized as exogenous contrast materials in photon counting CT imaging.  
Herein, we disclose for the first time the synthesis of the ligand-modified sub 5 nm HfO2 
nanoparticles for the sensitive detection of bone microdamage using photon counting CT. 
Bicompatibility of crystalline metallic nanoparticles is always a matter of concern [420].  Most of 
these agents are composed of polydispersed inorganic cores with large hydrodynamic cores >10 
nm. Due to their large hydrodynamic diameters, these particles prevent adequate whole-body 
clearance and predominately accumulate in the body and creates long-term adverse effects. It is 
therefore of great importance to synthesize crystalline nanoparticles within ultra-small size range 
(<5 nm).  
These nanoparticles were targeted to bone minerals by the introduction of an 
aminopolycarboxylic chelating agent i.e. nitrilotriacetic acid. At the site of the microdamage: a 
fracture in hydroxyapatite, the major bone constituent, would result in the exposure of freshly 
charged ions due to the breakage of atomic bonds in the matrix [421]. Hence, the nanoparticles 
targeted to the more concentrated minerals would ‘light up’ the microdamage site. We 
demonstrated that with the distinct spectral properties, HfO2 nanoparticles would show in ‘color’ 
the location and anatomy of the microdamage (Figure 5.1). Moreover, the sub 5 nm size of these 




Haversian canals, canaliculi, Volkmann’s canals, etc.) in the muscle near the bone and microcrack 
itself. We indicated in the in vivo studies that these nanoparticles could effectively indicate the 
microcrack anatomy in the rat’s tibia in the spectral CT while the non-targeted control 
nanoparticles non- specifically accumulated in the muscle. Furthermore, intramuscular injection 
of the nanoparticles did not induce any adverse effects on the liver enzyme functions and neither 
did they histopathologically. Therefore, these ligand-directed HfO2 nanoparticles would open new 
avenues for the safe, non-destructive, sensitive bone microdamage detection in vivo.      
5.1.3. Materials and Methods 
5.1.3.1. Materials 
All solvents were of reagent grade and were purchased from Sigma- Aldrich Inc. (Saint 
Louis, MO, USA) unless otherwise stated. IGEPAL® CO-520 (average Mn: 441), Nitrilotriacetic 
acid, N-Hydroxysuccinimide, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide were obtained 
from Sigma- Aldrich Inc. Trimethoxysilylpropyl-modified polyethylenimine and hafnium 
ethoxide were bought from Gelest Inc. (Morrisville, PA) and Alfa Aesar (Ward Hill, MA), 
respectively. HA rods were acquired from QRM GmbH. Human phalanges were procured from 
Skulls unlimited inc. (Carlsbad, CA). Sprague Dawley rats were purchased from Charles River 
Laboratories (Wilmington, MA, USA).  
5.1.3.2. Gram Scale Synthesis of Hf NTA NPs 
Initially Hf PS NPs were synthesized following the recently reported method by our 
laboratories [268]. Briefly, 300 ml cyclohexane, 34.5 g IGEPAL® CO-520, 11.25 ml ethyl alcohol, 
3.75 ml NaOH (75 mM) were stirred vigorously (500 rpm) under reflux condition at 65 °C in 500 
ml round bottom flask for 30 min to achieve homogeneity. 1.61 g hafnium ethoxide powder was 




overnight during HfO2 nanoparticles nucleated in the water-in-oil microemulsion. 7.5 g 
trimethoxysilylpropyl-modified polyethylenimine was then added dropwise at a rate of 80 μl.min-
1 under the mentioned condition and the stirring continued for another 2 h until the turbid 
suspension became transparent, indicating the reaction completion. The solvent was evaporated in 
rotary evaporator at 55 °C and the polyethylene imine silane modified nanoparticles were washed 
with 100 ml of hexane: ethyl ether (50:50 vol/vol) once. The nanoparticles were washed with ethyl 
ether thrice (50 ml each) and were dried in vacuum oven overnight. For NTA conjugation, (7.18 
mg) NTA was activated with 2.63 mg EDC and 1.58 mg NHS for 1 h in 1 ml of dimethylformamide 
(DMF) and was then added to 200 mg of Hf PS NPs dispersed in 9 ml DMF under stirring condition 
at room temperature and was stirred overnight to ensure complete conjugation. The Hf NTA NPs 
were washed with methyl alcohol repeatedly at 10,000 rpm (at least 4x) and then were dialyzed 
after dispersing in water by sonication.  
5.1.3.3. Physicochemical characterizations 
The NPs were characterized by various methods. For materials characterizations, the NPs 
were resuspended in water by probe sonicating (Q700, Qsonica Sonicators, Newtown, CT). 5 μl 
of NPs were deposited on the carbon coated copper grid and the extra liquid was wicked with the 
filter paper. TEM imaging was carried out on a JEOL 2100 Cryo TEM instrument (Tokyo, Japan) 
equipped with a Gatan UltraScan 2k × 2k charge-coupled device (CCD) camera. The anhydrous 
diameter of 100 nanoparticles were measured on ImageJ software. The zeta potential was obtained 
on a Malvern Zetasizer nano series (Malvern Instruments Ltd., United Kingdom) and the 
electrophoretic potential was calculated based on the Smoluchowski equation.     
For further chemical characterizations, 1H NMR and XPS were conducted. For NMR the 




Palo Alto, CA) spectrometer operating at 500 MHz and equipped with a 5-mm Nalorac QUAD 
probe. The analysis was done on MestRenova™ 8.1 software (Mestrelab Research SL; Santiago 
de Compostela, Spain).  
For XPS, the water dispersed samples were deposited on small pieces of glass slide and 
were dried overnight under vacuum. The samples were characterized by Physical Electronics PHI 
5400 spectrometer using Al Kα (1486.6 eV) radiation for registering the spectra. The spectra were 
referenced to the adventitious C-C bond (284.8 eV) on the CasaXPS software.  
ICP-OES (PerkinElmer 2000DV, Norwalk, CT) was used to determine the Hf content in 
the NPs and it was carried out at the Microanalysis lab at UIUC. The sample was fully dissolved 
using the 511FAR (5 ml of HNO3, 1 ml of HCl, and 1 ml of HF) acidic mixture and digested using 
a Discover SPD 80 (CEM Corporation, NC, USA) digestion system. The final digested solution 
was clear and transparent, indicating complete dissolution. Standards were prepared with 511FAR 
as the background solution to create a calibration curve using ICP-OES. The calibration curves 
were used to interpolate the concentration of the sample. 
5.1.3.4. Affinity of NPs to calcium and ex vivo human bone model sample preparation 
The binding of the NPs to CaCl2 was studied by dispersing 20 mg.ml
-1 of NPs in 200 mg.ml-
1 CaCl2 solution in water. The samples were then centrifuged at 4200 rpm for 20 min and then the 
collected supernatant which consisted of the unbound Ca was submitted for ICP of Ca. The CaCl2 
without NPs were considered as control.    
On the other hand, an ex vivo model of microdamage was improvised. The microdamages 
were created in human bone phalanges with the help of a scalpel. The bone was soaked in the Hf 
NTA NPs (20 mg.ml-1) for 24 h and then were washed to remove the excess of NPs. The bone was 




Hillsboro, OR) after being sputtered with Au/ Pd for 70 sec and applying silver glue to enhance 
the conductivity. The mapping of the elements was done with the energy dispersive spectroscopy 
accessory on the SEM.      
5.1.3.5. Spectral photon-counting CT experimental setup – in vitro 
A small-bore CT system, MARS spectral CT was used to scan specimens. MARS CT 
works in the clinical diagnostic energy range (20-140 keV) [422], is equipped with a standard 
broad-spectrum X-ray source, and the Medipix3RX (Medipix3RX Collaboration, CERN) photon 
counting detector. Medipix3RX detector has eight energy  counters (1 arbitration counter, 4 charge 
summing mode (CSM) counters, and  3 single pixel mode (SPM) counters) that extract more 
information over the wide X-ray spectrum and enables the identification and quantification of 
multiple materials simultaneously [423].  
To cover the K-edge of Hf, energy thresholds in charge summing mode (CSM) were set at 
30, 45, 65, and 80 keV, and an aluminum filter was employed (2mm Al + 1.8 mm Al intrinsic). 
CSM prevents a photons charge/energy being shared over four neighboring pixels. 
For the current study, five Eppendorf PCR tubes (200µl) of Hafnium (2.5, 5, 10, 20, 40 
mg.ml-1), five Hydroxyapatite (HA) rods (54.3, 104.3, 211.7, 402.3 and 603.3 mg HA.cm-3), water, 
and lipid were placed within a custom made 12-hole Polymethyl methacrylate (PMMA) phantom 
(Figure S5.1). MARS CT scanning protocol used 118 kVp, 13 µA tube current, and 300 ms 
exposure time. The sample-to-detector (SDD) distance and sample-to-object (SOD) distance were 
set to 250 and 200 mm, respectively. 720 projections over 360o rotation were acquired, as well as 
720 flat-field (open-beam) projections. A field of view (FOV) of 32 mm, with 2 camera 




Image reconstruction of both the calibration phantom and biological sample was performed 
using MARS Algebraic Reconstruction Technique (mART) [423]. To assess the detection of the 
K-edge effect, the linear attenuations (LA) of each material in all four CSM energies were 
measured and converted into Hounsfield Units (HU). To employ the in-house Material 
Decomposition (MD) software, the effective mass attenuation of each calibration vial were 
calculated and placed in program configuration file [423, 424]. Several slices from the MD datasets 
of the calibration phantom were used to quantify Hf and analyze the accuracy of identification for 
each calibration vial. 
5.1.3.6. Ex vivo model for imaging with PCCT 
 The microdamage in the human bone phalanges was introduced as described for SEM 
sample preparation. The concentration of Hf was adjusted at 104 mM. After the unbound NPs were 
removed, they bone was embedded in agarose gel (1 wt%) to mimic the soft tissue surrounding 
the bone. Spectral CT studies were carried out as detailed above. 
5.1.3.7. In vivo animal studies 
All the animal experiments were carried out according to the ethical guidelines outlined by 
the Illinois Institutional Animal Care and Use Committee at University of Illinois Urbana 
Champaign and were approved by the board (protocol #17125). For the imaging experiment, 7 
five-month-old female Sprague Dawley rates were divided into three groups; 1) control sham 
operated (n=1); 2) Hf PS NPs (n=3); 3) Hf NTA NPs (n=3). The number per group was chosen to 
minimize the overall number of the animals. The fur was shaved around the hind limbs and then 
an incision was made to expose the tibia. A bone damage (1-2 cm long x 0.2 cm deep) was created 
longitudinally in the tibia with a surgical scalpel. The surgery site was sutured and then NPs (100 




were taken care of by applying sterile gas, iodophor and injecting carprofen (1.5 mg.kg-1, SC) at 
12 h intervals for the first 24 h post-surgery to minimize pain. During the surgery the rats were 
anesthetized using isoflurane/oxygen. 
Animals were sacrificed after 30 min or 5 h post injection with asphyxiation by CO2 stream 
and immediately were imaged with General Electric Light speed 16-slice CT scanner (GE, 
Milwaukee, WI, USA) using the following parameters: slice thickness: 0.625 mm; tube voltage: 
80 kV; tube current: 100 mA; gantry rotation time: 0.8 s; and pitch: 9.38 mm. The images were 
processed on 3DSlicer software.     
For PCCT, adjustments were made to accommodate the larger rat specimen. Scanning FOV 
was increased to 68 mm. Furthermore, SDD and SOD were increased to 281.6 mm and 215 mm, 
respectively. To achieve an equivalent photon count, the tube current was increased to 25 µA and 
the exposure time decreased to 150 ms. Energy filtration and energy thresholds/bins remained 
unchanged compared to the ex vivo sample. 
For the safety study, the rats (n=3/ group) were randomly assigned to 3 groups: 1) saline; 
2) Hf PS NPs (259 mM of Hf); 3) Hf NTA NPs (259 mM of Hf); The blood was collected from 
these animals 30 min after injection and then on day 7 before sacrificing. The organs of the animals 
were harvested subsequently and then were split to half for either saving in formalin or for ICP 
analysis as outlined above. The tissues were embedded in Paraffin cassettes according to an 
established protocol [302]. They were subsequently stained with Mayer hematoxylin solution and 
eosin-phloxine B solution (or eosin Y solution). 
The samples for TEM was prepared from the targeted NP injected rat (30 min), as a proof 
of concept to indicate the perseverance of the NPs in the biological environment. The muscle tissue 




and dark (2.0 % paraformaldehyde and 2.5% glutaraldehyde (both E.M. grade) in 0.1 M Na-
Cacodylate buffer) for 2 h. It was then rinsed for 10 min in 0.1 M Na-Cacodylate buffer. Then post 
fixation was carried out for 90 min with 1.0% aqueous osmium tetroxide in 0.1 M Na-Cacodylate 
buffer. The sample was washed with buffer for 10 min and then stained with 2% aqueous uranyl 
acetate overnight. Then it underwent a serial dehydration with ethanol (37%, 67%, 95%, 100% 
3X), then 1:1 100% ethanol:propylene oxide, 1:2 100% ethanol:propylene oxide,1:1 propylene 
oxide:Polybed 812 mixture (without DMP-30), 1:2 propylene oxide:Polybed 812 mixture (without 
DMP-30). Finally, they were embedded in 100% Polybed 812 mixture (without DMP-30), 
overnight in hood and then 100% Polybed 812 mixture with 1.5% DMP-30, in molds, and into 
oven at 60 °C for 24 h. They were microtomed for TEM imaging.           
5.1.4. Results and discussion 
Hf PS NPs were synthesize via a base catalyzed sol- gel water- in- oil microemulsion 
method. In the same pot, polyethyleneimine silane grafting was carried out, resulting in sub 5 nm 
Hf PS nanoparticles with many exposed amines. This surface chemistry made it facile to introduce 
the targeting moiety, nitrilotriacetic acid (NTA), via EDC-NHS amidation and the covalent linkage 
of amino group on Hf PS NPs and carboxylic acid of NTA. NTA as an aminopolycarboxylic, 
polydentate acid has been shown to bind tightly to Ca2+ to form complex with coordination 
numbers more than six [425].  
The transmission electron microscopy images indicated that the NP’s size after NTA 
conjugation was 1.70±0.78 nm (Figure 5.2A, B). The success of conjugation of NTA on Hf PS 
NPs was confirmed by various methods. At first, electrophoretic ζ potential of Hf PS NPs was 




indicating the emergence of -COOH group on the surface of the NPs (Figure 5.2C). The high 
absolute value of the electrophoretic potential ensures the colloidal stability of the NPs. 
 
Figure 5.1. Schematic illustration of the flow of the work. Bone as a functional material would 
experience various stresses and fatigue related issues. For the early detection of microdamages, 
here, targeted Hf NPs were designed and used in the photon counting spectral CT. This advanced 
technology would determine Hf NPs signal from the hard tissue of bone both in the ex vivo model 
and in vivo. 
  
Subsequently, further confirmation was sought by FTIR spectroscopy (Figure 5.3A). For 
Hf PS NPs, the absorbance at 1290, 1450, 1558, 3420 cm-1 correspond to 𝜈𝐶𝑁 stretch, 𝜈𝐶𝐻3, 𝜈𝑁𝐻 
bending, and 𝜈𝑁𝐻, respectively. On the other hand, after the conjugation with NTA, the absorbance 
band centered at 1560 cm-1 and 1620 cm-1 emerge which can be correlated to amide II and amide 
I, respectively. 1H NMR spectra of NTA, Hf PS NPs and Hf NTA NPs were taken and the results 
are demonstrated in Figure 5.2D. The broad peaks in the 2.6- 2.9 ppm correspond to the NH 




8.5 ppm while the amine protons get slightly shifted with more narrowing of the peaks presumably 
due to the change in their magnetic environment after the amidation process. On the other hand, 
the protons on the carboxymethyl attached to aminoethyl in NTA (originally observed at 4.1 ppm) 
get an upfield shift of about 1 ppm in Hf NTA NPs.    
 
Figure 5.2. Characterization of the developed targeted nanoparticles. Non-targeted Hf PS NPs 
were initially synthesized with the sol- gel chemistry and through stepwise silane reaction and 
Carbodiimide EDC- NHS chemistry was converted to the targeted Hf NTA NPs. (A) Transmission 
electron microscopy of the NPs (both scale bars are 20 nm); (B) anhydrous diameter distribution 
as obtained by measuring 100 random NPs with average size of 1.70±0.78 nm; (C) The 
electrophoretic zeta potential where a drastic drop from positive values in the non- targeted NPs 
to negative values for targeted NPs indicates the success of functionalization; (D) 1H NMR spectra 
of (i) NTA, (ii) Hf PS NPs, (iii) Hf NTA NPs. The peaks are assigned, and the amide peak is 





Finally, XPS of the synthesized nanoparticles was conducted to reveal the chemical 
bonding (Figure 5.3B). As shown in the survey mode, the presence of elements of C, N, O, Hf and 
Si was confirmed. High resolution scanning of C1S region reveals the formation of O=C-OH 
(carboxylate) and N-C=O (amide) at 288.9 eV while this peak is absent in the Hf PS NPs spectrum 
(Figure 5.2). Peaks observed at 284.8 and 287.4 eV can be attributed to C-C, C-H and carbonyl 
(aldehydic/ ketonic) in Hf PS NPs, the latter got shifted to 287.8 eV in Hf NTA NPs. The 
investigation of the N1S core state peak is also confirmative of the formation of amide peak. The 
peaks at 398.3 and 399.09 eV were detected in Hf PS NPs spectrum which is associable with 
primary amines and secondary amines. On the other hand, peaks detected at 398.5 and 400.2 eV 
can be attributed to primary amine and amide carbonyl (CO-NH), respectively.  
We further explored the binding efficiency of Hf NTA particles vs. the non-targeted NPs 
i.e Hf PS NPs by exposing equal amounts of the NPs to the saturated solution of CaCl2 for 24 h 
and measuring the unbound Ca by ICP. The relative bound Ca as calculated from the unbound Ca 
in the supernatant was approximated to be 6.5-fold higher for the targeted Hf NTA nanoparticles 
compared with the Hf PS nanoparticles (Figure 5.4F), verifying the capability of these 
nanoparticles for effective binding to the major bone component.      
The first evidence of the binding of the nanoparticles to bone came from an ex vivo 
experiment on human phalanges. Artificial microdamages were created with a surgical scalpel and 
subsequently the bone samples were immersed in Hf NTA solution for 24 h. The samples were 
then washed excessively with water to remove the unbound NPs and imaged with scanning 
electron microscopy. As is demonstrated in Figure 5.4A-D, a remarkable number of nanoparticles 




was corroborated with energy dispersive spectroscopy with the dominant peaks from Hf binding 
energy (Figure 5.4E).  
 
Figure 5.3. Chemical characterizations of NPs; (A) FTIR spectra of Hf PS NPs and Hf NTA NPs 
in the fingerprint region and CH region; (B) XPS spectra of the Hf NTA NPs, left: survey spectra, 
(i) Hf 2p, (ii) N 1s, (iii) C1s.   
 
A phantom study was designed to determine the possibility of using Hf in the photon 
counting spectral CT imaging. A PMMA (polymethyl methacrylate) phantom held 200 µl tubes 
containing aqueous Hf NTA NP solutions of various concentrations (40, 20, 10, 5, 2.5 mg.ml-1 




(HA) rods to mimic the calcium rich area in bone (HA50, 100, 200, 400 600 g.cm-3 which translate 
to 49.8, 99.6, 199.2, 398.4, 598.6 mM), water, and lipid was prepared. The attenuation caused by 
the material was described in Hounsfield unit (HU) (Figure 5.5A). The linearity response in the 
monochromatic curve was verified on the MARS spectral CT for both Hf and HA for each of the 
single energy bins (E1= 30-45 keV, E2= 45-65 keV, E3= 65-80 keV, E4= 80-118 keV) as seen in 
Figure 5.5B). As indicated this linearity holds true for Hf in the tested range with R2 close to 1 
(E1=0.99, E2=0.99, E3=0.99, and E4=0.97) in all the energy bins as was the case with HA (Figure 
5.5C). Establishing linearity of attenuation for each energy bin results in a single polychromatic 
CT essentially becoming multiple monochromatic CTs. 
Furthermore, the resulting attenuated signal is plotted against energy bins in Figure 5.5D 
with fast switching between the energy bins from 30-118 keV. The obtained image is shown in 
Figure 5.5A. Further analysis of the ROI demonstrated that HUs for Hf increase after the second 
threshold energy and then decrease after the third threshold energy. Considering the K-edge of Hf 
which is equal to 65.4 keV, the K-edge effect was observed in the third energy bin (65-80 keV). 
In addition, lipid increases with detector energy, whereas HA decreases with energy until the 
fourth energy bin. The spectral response of the materials (Hf, HA, water, and lipid) is consistent 
with the attenuation coefficients for those materials. A lack of K-edge enhancement in the 
diagnostic energy range implies that HA, lipid, and water have no enhancement in attenuation, 






Figure 5.4. Binding of the nanoparticles to the bone (A-D) SEM images of the binding of the 
nanoparticles to the human bone phalanges, the arrows point to the nanoparticles; (E) EDS spectra 
of the region marked in D; (F) The absorbed calcium by the targeted and non-targeted NPs where 
the targeted NPs have ~6.5 times more affinity to Ca.      
 
Another outcome of this study was the establishment of the quantification curves for 
interpolation of the concentrations based on the measured HUs. As could be inferred from Figure 




with a linear plot (slope= 1.0 and R2=0.98) which could be utilized in the following studies to 
calculate the concentration of Hf.    
Subsequently, the materials decomposition methods were applied to distinguish the 
contents of the tubes. Fusing the material channels resulted in the image seen in Figure 5.6 (2D 
and 3D views shown) and Figure 5.7A. Each channel was attributed to the material being used and 
is indicated by a certain color code. As could be perceived, the signal from Hf, lipid, air, water and 
iodine could be separated in the phantom studies. Therefore, photon counting CT enabled the 
multicolor quantitative assessment of Hf NPs in the aqueous media at this stage.      
For the ex vivo studies, we devised a model of the human bone microdamage similar to the 
one stated before for the SEM binding experiment and the sample was fixed in an agarose gel to 
represent the soft tissue (Figure 5.7B). Impressively, the 3D reconstructed image of the bone 
demonstrated that the microdamage could be differentiated from strongly attenuating signal of 
bone. The Hf NTA NPs selectively targeted the freshly exposed surface of the bone and the 3D 
image clearly indicated its signal which can be separated by virtue of its unique K-edge.    
Motivated by the ex vivo results, an in vivo bone microdamage model was developed where 
Sprague Dawley rats were split in 3 groups, namely control sham operated animals, Hf PS NPs 
injected animals and Hf NTA NPs. All animal protocols were proven by University of Illinois 
Urbana Champaign’s IACUC system. Animals had free access to water and food ad libitum. The 
animal’s tibia was operated in the left hind limb where a small crack was induced by surgical 







Figure 5.5. Reconstruction of the calibration phantom for each energy bin (as indicated). 1: HA 
800, 2: HA 600, 3: HA 400, 4: Hf NTA NPs 5 mg.ml-1, 5: Hf NTA NPs 10 mg.ml-1, 6: Hf NTA 
NPs 20 mg.ml-1, 7: water, 8: lipid.  FOV 68 mm; (B, C) Linearity of attenuation of (B) Hf NTA 
NPs and (C) HA. The result of the linear regression shows that the CT response is linear; (D) 
Spectral response of the detector for calibration vials. E1, E2, E3, and E4 are 30-45, 45-65, 65-80, 
and 80-118 keV, respectively. Attenuation enhancement observed in energy bin 3 (65-80 keV) 
indicates the k-edge of Hf; 65.4 keV. (E) The comparable values between the vials of known 
concentration and the measured concentration from the images. Linear relationship with R2 value 
of 0.99 allows the quantification of unknown concentrations of Hf and HA from MD images. The 
standard errors for each data point are in the range of 1-7 HU. 





Figure 5.6. Hf NTA NPs with Iohexol scan-material images (i) The scanned energy channel is 30-
45 keV; (ii) iodine channel; (iii) lipid channel; (iv) Hf channel; (B) fused and 3D reconstructed 
image of the phantom.  
 
After suturing the surgical site, the animals were injected intramuscularly. The 
nanoparticles were allowed to circulate for 30 min and 5 h and then were imaged by multislice 
conventional CT in the first place. As shown in Figure 5.8A and Figure 5.8B, for the animals 
injected with Hf NTA NPs, the NPs were more accumulated close to bone at shorter time point 
(30 min) while with longer circulation time (5 h), they were getting accumulated in the bone 
damage site. This was in contrast to non-targeted nanoparticles where they tended to quickly be 






Figure 5.7. The 3D reconstruction of the second phantom; (B) Ex vivo human bone microdamage 
and the distribution of Hf NTA NPs. Hafnium (red) in the sample is differentiated from bone 
(Hydroxyapatite; white/grey) separated with the magic lens option for Hf. The arrows point to the 
damage site.  
 
The muscle tissues from the surgical site were dissected after euthanization and was 
processed for TEM (Figure 5.8C). In the figure, general features of the skeletal muscle are shown, 
specifically the sarcomere, I band, Z band, A band and mitochondrion are labelled. Of note is the 
presence of sub 5 nm Hf NTA NPs in the sarcoplasmic reticulum even after being exposed to the 





Figure 5.8. In vivo investigation of the Hf NTA NPs for bone microdamage imaging with 
conventional CT. (A) (i) the microdamage was induced in the hind limb of Sprague Dawley rat by 
scalpel and the nanoparticles were injected intramuscularly after suturing and subsequently were 
scanned, The conventional CT images for (ii) control sham operated animal, (iii) Hf PS NPs 30 
min, (iv) Hf PS NPs 5 h, (v) Hf NTA 30 min, (vi) Hf NTA 5 h, the arrows point to the accumulation 
of Hf NPs and its contrast against bone; (B) The 3D reconstructed image of (A) (i) control sham 
operated animal, (ii) Hf PS NPs 30 min, (iii) Hf PS NPs 5 h, (iv) Hf NTA 30 min, (v) Hf NTA 5 
h; (C) The TEM image of the harvested muscle at the injection site, No significant aggregation of 
the NPs is perceived even in the biological tissues. Mitochondria, sarcomere, sarcoplasmic 
reticulum and NPs are marked on the image.  
 
Figure 5.9 indicates the 3D reconstructed spectral CT images of the animals injected 
intramuscularly with the nanoparticles. It is evident that the spectral CT can delineate the signal 




for Hf PS NPs and Hf NTA NPs clarifies the targeting capabilities of the former. Furthermore, 
figures D and E are examples of the quantification carried out by spectral CT in vivo.   
 
Figure 5.9. The in vivo evaluation of the nanoparticles for bone microdamage imaging using 
spectral CT; (A) The nanoparticles based on Hf can be distinguished from bone and soft tissue 
(non-targeted nanoparticles); 3D spectral CT image of (B) non-targeted nanoparticles and (C) 
targeted nanoparticles where the signal from Hf can correctly point to the site of the surgery. Base 
line is set to 70mg/mL of Hf which provide almost 100% correct Hf identification; (D) and (E) 
quantification of Hf in the limbs.     
 
We also investigated the safety and biodistribution of the nanoparticles at the injected dose 




injection. On day 7, the animals were sacrificed, and their organs were assessed for Hf 
accumulation by ICP. The results of ICP are shown in Figure 5.10D. As can be inferred, most of 
the NPs migrated to the spleen and kidneys suggesting that the major organs in reticuloendothelial 
system were involved during the nanoparticles drainage. These results suggest that the majority of 
Hf nanoparticles are cleared through the renal route. Interestingly, the amount of Hf in the muscle 
was close to the baseline suggesting the clearance during the intramuscular injection. Of note, is 
the total amount of Hf in each organ which fell in the ppb range where this minute concentration 
is not expected to pose any particular toxicity.  
However, to further corroborate this observation, the histology of the organs was 
performed after they were being fixed in formalin sectioned for H & E staining (Figure 5.10A). 
The RES organs, i.e. liver and spleen, were stained with Prussian blue as well. The sections were 
interpreted by board certified veterinary pathologist. Overall, findings in examined tissues were 
largely within normal limits in all animals. There was no evidence of organ pathology in response 
to Hf NTA NPs administration in any of the examined tissues. Within the spleen in both control 
and treated animals, the marginal zone was moderately to markedly expanded by hyperplastic 
lymphocytes. Rats normally have some degree of marginal zone hyperplasia, so much of this 
change is likely within normal limits, though it may suggest mild response to systemic antigen 
exposure. There was moderate extramedullary hematopoiesis within the splenic red pulp, which is 
a common finding in adult rats. The observed extramedullary hematopoiesis was likely incidental. 
In the Hf NTA NP treated animals, there was significant golden granular material within 
macrophages within the splenic red pulp, and within hepatic Kupffer cells. Prussian blue special 
staining (for iron) was conducted to determine whether this material is hemosiderin. The lack of 




material was not hemosiderin. This material was therefore interpreted as accumulated 
nanoparticles. Splenic macrophages around the marginal zone were shown to display the heaviest 
degree of nanoparticle accumulation. It was therefore possible that some of the splenic marginal 
zone hyperplasia may be associated with nanoparticle administration in these animals.  
The animals were also tested for the changes in the blood biochemistry 30 min and 7 days 
after the injection (Figure 10C). The liver enzymes were selected as the indicative of any 
abnormality in the animals namely GGT, bilirubin, albumin, and ALT. There was no discernible 
difference in the control group and the NP injected group which further unveils the safety of these 
NPs.  
5.1.5. Conclusions 
In conclusions, we have utilized the surface modified targeted HfO2 nanoparticles for the 
sensitive detection of bone microdamage ex vivo and in vivo. Nanoparticle core was synthesized 
in a sol- gel chemistry process and NTA was introduced by a facile EDC-NHS chemistry. 
Physicochemical properties and the conjugation process were investigated using various methods. 
These NPs showed the response in the spectral CT imaging in the corresponding K- edge of Hf 
which is properly located and does not suffer from photon starvation. The quantification was also 
achieved in the spectral CT and the calculated values were commensurate with the actual 
concentrations. The decomposition algorithms could accurately differentiate between Hf, lipid, air 
and HA in the phantom studies. Ex vivo human bone microdamage model was subsequently used 
to confirm the binding of the NPs to the crack site while Hf could be distinguished from bone 
itself. Finally, the imaging of the animals with the induced microdamage and injected with the 
targeted NPs revealed the accumulation in the region of interest and the signal from soft tissue, 




histopathologically, their small size, stability in the biological media, and their favorable imaging 
properties, these HfO2 based nanoparticles could potentially be used for the anatomical evaluations 
in the future.    
 
Figure 5.10. The histopathological evaluation of the rats injected intramuscularly with the (A) 
control: PBS and (B) treatment: Hf NTA NPs obtained at 20x magnification (scale bar represents 
50 μm). The organs are annotated accordingly. The Prussian blue staining of spleen at 40x 
magnification (scale bar represents 20 μm). A lack of Prussian blue positivity of the macrophage 
pigments, rules out iron accumulation; (C) The liver enzyme functions namely gamma-glutamyl 
transferase (GGT), bilirubin, albumin and alanine aminotransferase (ALT) for the control and 
treated rats; (D) The bio distribution of Hf in the major organs and the baseline obtained from the 




5.2. Fluorescence Detection of Bone Microcracks using Monophosphonated Carbon Dots10 
5.2.1. Abstract 
Phosphonated compounds, in particular, bis-analogs are widely applied in clinical settings 
for the treatment of severe bone turnovers and recently as imaging probes when conjugated with 
organic fluorophores. Herein, we introduce a bone seeking luminescent probe that shows a high 
binding affinity towards bone minerals based on monophosphonated carbon dots (CDs). The 
spheroidal CDs tethered with PEG monophosphates are synthesized in a one-pot hydrothermal 
method and are physico-chemically characterized where the retention of phosphonates is 
confirmed by 13P NMR and XPS. Interestingly, the high abundance of multiple monodentate 
phosphonates exhibited strong binding to hydroxyapatite, the main bone mineral constituent. The 
remarkable opto-physical properties of monophosphonated-CDs were confirmed in an ex vivo 
model of bovine cortical bone where the imaging feasibility of microcracks, which are calcium 
rich regions, were demonstrated. The in vivo studies specified the potential application of 
monophosphonated-CDs for imaging when injected intramuscularly. The biodigestible nature and 
cytocompatibility of the probe presented here obviate the demand for a secondary fluorophore 
while offering a nanoscale strategy for bone targeting and can eventually be employed for potential 
bone therapy in the future. 
5.2.2. Introduction 
Bone is a metabolically active tissue which maintains the integrity of other tissues by 
providing structural support [426, 427]. While bone is prone to several disorders such as 
osteoarthritis, osteoporosis, osteogenesis imperfecta and Paget’s disease, it also is consistently 
                                                 
10 This part of the thesis is adapted from the following publication: 
Ostadhossein, F., Benig, L., Tripathi, I., Misra, S. K., & Pan, D. (2018). Fluorescence Detection of Bone Microcracks 




bearing compressive and tensile stresses and strains which may result in stress or fatigue-related 
microcracks [401, 428]. Hence, non-invasive imaging is crucial to evaluate these conditions. 
Conventional imaging methods such as X-ray radiography, computed tomography (CT), and 
magnetic resonance are commonly used in the clinic to diagnose physiological and anatomical 
abnormalities [429, 430]. Despite their high spatial resolutions, these methods are incompetent 
compared with optical imaging methods as the latter offer high sensitivity, real-time screening, 
and intraoperative feedback while also being safe due to the lack of harmful radiations [431, 432]. 
The use of nanoparticle (NP)-based agents for bone imaging have predominantly focused on the 
design of MRI based contrast probes [433], nuclear, and CT imaging agents where the majority of 
these NPs were based on either metallic materials or polymeric micelles encapsulating 
fluorescence dyes [434]. 
One of the issues that threatens bone strength is bone microcracks which, when go 
unnoticed, would lead to certain conditions such as osteoporosis and crack propagation. Bone is a 
highly calcified tissue and therefore can be targeted by virtue of its chemical composition [435, 
436]. Specifically, at the bone microcrack site, due to the discontinuity of the bone matrix, the 
bonds connecting the atoms get cleaved. This would result in the abundant exposure of ions in the 
vicinity of the bone microcracks.  
Phosphonated compounds have garnered research interest for the treatment of various bone 
pathologies due to their high affinity to hydroxyapatite (HA) minerals [437]. The high affinity of 
bisphosphonates for bone originates from P-C-P backbone formation when two phosphonated 
groups are brought together in close proximity leading to the chelation of calcium ions on HA 
surfaces [438]. Bisphosphonates can be fluorescently tagged to investigate the metabolic activities 




organic or inorganic origin of phosphates [439-441]. However, small organic fluorescent dyes are 
poorly bioavailable due to compromised aqueous solubility issues that arise due to their aromatic 
structure or presence of pi-conjugated system. Furthermore, the more red-shifted the emission of 
a dye is the degree of vibrations increases, leading to an increasing number of non-radiative decay 
pathways and poor fluorescence quantum yield. Their photostability is also a matter of serious 
concern [442]. On the other hand, despite the high promise for the application of bisphosphonates, 
there are concerns about their side effects such as osteonecrosis of the jaw (ONJ) and atrial 
fibrillation [443, 444]. 
Luminescent carbon dots (CDs) have emerged as promising imaging probes compared to 
the conventional quantum dots due to their extraordinary properties such as excellent 
photostability, good biocompatibility, tunable fluorescence, and enhanced water dispersibility [71, 
248]. These properties alongside with their inexpensive synthetic chemistry have made them 
advantageous in a wide array of biological applications such as cell labeling, in vitro and in vivo 
bioimaging, drug delivery, and sensing [445, 446].  
Herein, we introduce CDs tethered with monodentate phosphonate group as a single-
domain fluorescence probe and investigate if multiple copies of monodentate phosphates can serve 
as an efficient homing strategy for bone imaging (Figure 5.11). The result will be effective since 
a cognate receptor (calcium) has been identified that is sufficiently abundant in bone. Considering 
the high surface area on the walls and the troughs of the microcrack and Ca2+ abundance at the 
site, we investigated the current probe for the sensitive imaging of the bone cracks with various 





Figure 5.11. The monodentate ligand can come close together on the CD surfaces to chelate Ca2+ 
which gets exposed abundantly at the site of microcrack. The fluorescence from the CD can be 
utilized for the detection of bone microcracks. 
 
5.2.3. Experimental Section 
5.2.3.1. Synthesis and Characterizations  
The monophosphonated CDs were prepared based on the previously reported method 
[383]. Briefly, 300 mg of food grade agave nectar (HoneyTree's Organic Agave Nectar, Onsted, 
MI) and 300 mg of α-Methoxy-ω-phosphate poly-ethylene glycol with PEG Mw=5kDa 
(Chemicell, Berlin, Germany) were dissolved in 4.5 ml of water and were carbonized at 250 C on 
a hot plate (Corning). Subsequently, the charred carbon residue was redispersed in 5 ml of water 
by probe sonication (Q700, Qsonica Sonicators, Newtown, CT) on an ice bath for 45 min at Pulsed 
Amp, 1; on, 2 s; off, 1 s. The obtained monophosphonated CDs were filtered (Acrodisc syringe) 
with a mesh size of 0.45 and 0.22 μm, respectively. The morphology of the NPs was observed with 
Philips CM200 the transmission electron microscopy (TEM) machine (FEI company, Oregon, US) 
equipped with Peltier-cooled Tietz (TVIPS) 2k x 2k CCD camera. The NPs were drop deposited 




electrophoretic zeta potential was measured on measured on a Malvern Zetasizer ZS90 instrument 
(Malvern Instruments Ltd., United Kingdom) [195]. The absorbance spectrum of 
monophosphonated CDs was recorded on a GENESYS 10 UV−vis spectrometer (Thermo 
Scientific, MA). X-ray photoluminescent spectrum (XPS) was obtained on a dried sample applied 
on a glass slide with a Physical Electronics PHI 5400 spectrometer using Al Kα (1486.6 eV) 
radiation. The chemical composition was further evaluated by nuclear magnetic spectroscopy 
(NMR). The freeze-dried NPs were redispersed in D2O (Cambridge Isotope Laboratories, Inc., 
MA). The 1H NMR, 13C NMR, and 31P NMR were obtained on a multi-nuclear, 500-MHz 
Ultrashield Plus (Bruker Daltonics Inc., MA, USA) machine, equipped with 5-mm CryoProbe 
(CB500) (Bruker) and the samples were referenced to internal standards. The analysis was done 
on MestRenova 8.1 software (Mestrelab Research SL; Santiago de Compostela, Spain). Raman 
spectrum were obtained on a Nanophoton RAMAN 11 laser Raman microscope (Osaka, Japan) 
with a 532 nm wavelength (grating 600 g.mm−1). Fourier transform infrared spectroscopy was 
done on the NPs dried on MirrIR IR-reflective glass slides (Kevley Technologies, Chesterland, 
Ohio, USA) for measurements using a Nicolet Nexus 670 FT-IR (MRL facility, UIUC). 
Florescence spectra were collected on Infinite® 200 PRO multimode microplate reader (TECAN, 
NC, US). Time resolved photoluminescence (TRPL) was collected on a custom-made setup. A 
mode-locked femtosecond pulsed Ti:sapphire laser (Coherent, Chameleon Ultra II) system was 
used as an excitation source, and with wavelengths of the pulsed Ti:sapphire laser of 385 nm. A 
streak camera (Hamamatsu, C7700-01) was utilized to measure the decay profile of the PL spectra 




5.2.3.2. In vitro Hydroxyapatite (HA) Binding Experiment 
HA (reagent grade, powder, synthetic) (Sigma) suspension with a concentration of 25 
mg.ml-1 was prepared in water and was incubated with monophosphonated CDs with starting 
concentration of 50 mg.ml-1. Subsequently, seven other samples were prepared with a half dilution 
of monophosphonated CDs relative to its previous sample while maintaining the concentration of 
HA. The HA incubated with water was taken as control. The samples were vigorously stirred on 
an orbital shaker for 24 h. Then, they were centrifuged at 15 000 rpm for 5 min and the CD 
supernatants were collected. The HA pellets were washed with water three times before they were 
imaged with an IVIS SpectrumCT In Vivo Imaging System (PerkinElmer, MA, US) in a 96 well 
black plate (Falcon). The supernatant of the monophosphonated CDs incubated with HA with the 
concentration of 50 mg.ml-1 was compared with the non-treated monophosphonated CDs via FTIR 
studies.     
For the confocal imaging, the freshly cut bovine cortical sample was procured from 
slaughterhouse and was squished into smaller flat pieces while being cleaned thoroughly from 
meat and marrow. A sharp microtome knife was utilized to artificially create small cracks in the 
bone structure. The bone was soaked in the NP sample for 18 h and then was thoroughly washed 
with DI water before being imaged on Leica SP8 UV/Visible Laser Confocal Microscope (Leica 
Microsystems, Germany) with 10x objective lens and excitation wavelengths of 488 or 514 nm. 
The 3D images were reconstructed from 2D sections using Bitplane Imaris software.  
5.2.3.3. Animal Studies 
Guidelines on the care and the use of laboratory animals at University of Illinois at Urbana 
Champaign were followed for all animal experiments. Athymic nude mice were exposed 




buffered saline solution (nontoxic control) at pH 7.4. The concentration used in this research for 
monophosphonated CDs was their volume concentration, which was nominally calculated based 
on the weight of monophosphonated CDs samples per unit volume of water. In vivo fluorescence 
images were acquired with a Xenogen IVIS imaging system (Caliper LifeSciences, Hopkinton, 
MA, USA). Monophosphonated CDs suspension (Cv=100 mg/mL, 1 ml/kg) was administered 
locally into the tibia of the mouse and the fluorescence images were acquired at 600 nm emission 
upon excitation at = 430nm. Fluorescence emission was normalized to photons per second per 
centimeter squared per steradian (p/sec/cm2/sr), deducted the influence of backgrounds. The 
photon count was calculated for the control animal and the animal injected in tibia where a 
statistically significant enhancement was detected for the treatment animal (p-value <0.05). The 
3D reconstruction of the optical images alongside with the anatomical CT images was also 
performed. During image acquisition, anesthesia was maintained with isoflurane (1L/min oxygen 
and 0.75% isoflurane, Euthanex Corp.) and vital signs and pulse oximetry (NONIN Medical INC., 
8600V) was monitored continuously. Hydration was maintained by infusing 8 ml of 0.9% saline 
subcutaneously into the animal at a distal site as needed. After image acquisition, the animals were 
euthanized by pentobarbital overdose. 
5.2.3.4. Cell Viability Assessment 
MG-63 human osteosarcoma cell line was purchased from American Type Culture 
Collection (ATCC, VA, US) and was cultured in Dulbecco's Modified Eagle's Medium (DMEM) 
supplemented with 10% heat inactivated fetal bovine serum (FBS) and 1% pen-strep under 99% 
humidity and 5% CO2. For passaging, the cells were washed briefly with trypsin and then were 
detached via trypsinization (0.1%) containing 0.02% ethylenediaminetetraacetic acid (EDTA). For 




treated with monophosphonated CDs in the range of 39-2500 µg.ml-1 for 44 h. Next, 20 μL of 
MTT solution (5 mg·ml−1) were added to each well and they were incubated for an additional 4 h. 
The old media was replaced with 200 μl of DMSO to solubilize the formed formazan salt and the 
absorbance at 570 nm measured on multiwell plate reader (BioTek Synergy HT, USA) was 
correlated to the cell viability. 
5.2.3.5. Enzymatic Degradation of Monophosphonated CDs by Human Myeloperoxidase 
(hMPO) 
Four freeze dried NPs samples were dispersed in DPBS with the concentration of 10 mg.ml-
1 containing 200 mM of hydrogen peroxide. Then the samples were treated with 100 μg of hMPO 
with activity> 50 units.mg−1 at 37 °C except for one sample which was taken as control. The 
activity of the enzyme was impeded at 4 °C after specified time points. These samples were dried 
and further characterized by Raman spectroscopy using the parameters indicated above.       
5.2.3.6. Blood Smear Assay  
To test the compatibility of the blood cells with the monophosphonated CDs, freshly 
harvested bovine blood was incubated with NPs (2 mg.ml-1) for 48 h and was imaged after 2, 24h 
and 48 h using the bright field microscope. A drop of blood was deposited on a glass slide and was 
subsequently smeared with another glass slide to form a monolayer. The blood without treatment 
was considered as control at the given time points. 
5.2.3.7. Statistical Analysis 
The results were expressed as mean ± standard deviation and the data were analyzed using 





5.2.4. Results and Discussion 
The synthesis step consisted of the carbonization of the mixed solution of agave nectar and 
the sodium salt of PEG-PO4
3-. Subsequently, it was sonicated and passed through 0.45 and 0.22 
µm filters to yield the monophosphonated-CDs. To remove any unbound small molecule the CDs 
were dialyzed against water (MwCO=10,000 Da) for 24 h. The numbered-averaged hydrodynamic 
size of the NPs was determined to be 40 ± 16 nm (polydispersity index=0.2) (Figure 5.12A). The 
anhydrous state morphological features of the NPs were observed using transmission electron 
microscopy (TEM) where spherically shaped particles (Figure 5.12B) were seen. The 
electrophoretic zeta potential distribution of the NPs is shown in Figure S 5.2 and it was measured 
to be -4.5±4 mV. The UV-Vis spectrum of the NPs is shown in Figure 5.12C. The broad absorption 
peak at around 280 nm can be attributed to the n–π* transition of the C=O bond and the π–π* 
transition of the conjugated C=C bond of the CDs [383]. 
 
Figure 5.12. Physical properties of monophosphonated CDs; (A) Number averaged hydrodynamic 
size distribution by DLS; (B) TEM nanoscale images; (C) UV-Vis spectrum Schematic 
representation of monophosphonated-CD based probe targeted to the bone minerals and 





The composition of the monophosphonated-CDs is of high interest to understand their 
emerging properties. Therefore, FT-IR studies were conducted which revealed the presence of 
functional groups such as –OH (hydroxyl), –CH, –CH2, -NH, and C=O (carbonyl) formed on the 
CD (Figure 5.13B). Of note is the structural C-O-C ethereal bond and C-P bonds detected in the 
spectrum which is presumed to be originating from PEG as the modifying polymer. The abundance 
of the hydrophilic functional groups enhances the water dispersibility of the NPs.  
The Raman spectroscopy further showed the typical D (diamond) and G (graphite) bands 
at 1365 cm-1, 1600 cm-1, respectively (Figure 5.12D). The G band originates from the E2g phonon 
of sp2 hybridized carbon bonded to carbon or an oxygen attached to carboxyl or carbonyl group. 
On the other hand, the D band arises from the vibration of dangling bonds in termination plane of 
amorphous carbon.  
 
 
Figure 5.13. Chemical characterizations of the monophosphonated-CDs. (A) XPS survey 
spectrum and insets are the narrow scan of left: phosphorus and right: carbon regions; (B) FTIR 
spectrum of monophosphonated-CDs; (C) NMR spectrum of the monophosphonated-CDs (a) 1H 




Moreover, X-ray photoelectron spectroscopy (XPS) was employed to demonstrate the 
surface chemical composition of the NPs (Figure 5.13A, Figure S5.3). The survey spectrum was 
conducted in the 0-1100 eV and C, N, O, P elements were detected in the spectrum. The spectrum 
was referenced to the adventitious C1s at 284.8 eV to account for the charging effects. The C-C 
hydrocarbon and C-H peaks were detected at 285 eV (16.9%) while C=O peak was observed at 
287.5 eV (11.1%). The strong 286.5 eV (72.0%) can mainly be attributed to the C-O of the PEG. 
The narrow scan of P2p region demonstrated a doublet corresponding to elemental phosphorous 
in different spins of P2p1/2 and P2p3/2 of phosphates.  
The 1H, 13C and 31P NMR spectra of monophosphonated CDs are shown in Figure 5.13C 
and were compared with PEG phosphate and CDs (Figure S5.4). In the 1H NMR, the peaks from 
PEG phosphate occurring at 3.30, 3.58, 3.63 and 3.67 ppm were retained after synthesis in the 
monophosphonated-CD. Moreover, the 1H NMR of the NPs became broader in the range of 3-4 
ppm which could be due to protons in the vicinity of hydrophilic functional groups such as 
hydroxyl, carbonyl, and ether in the CDs structure. The 13C NMR spectrum can be basically split 
into two major regions viz. 20-80 ppm and 80-100 ppm which correspond to sp3 carbon and 
carbons attached to hydroxyl groups, and carbon with ethereal linkage, respectively. The 
verification of the retention of P was further reinforced by 31P NMR where the peak at -14 ppm 
could probably be associated with O=P(OR)3, where R could be a methyl. This peak was originally 
detected at the -9.5 ppm in the PEG-phosphate implying a change in the local P environment after 
condensation (Figure S5.5).     
The optical properties of monophosphonated-CDs were studied in detail in the next step. 
The fluorescence emission spectra of monophosphonated CDs under various excitation 




photoluminescence behavior of CD was observed with the red shift at higher excitation 
wavelengths and dwindling intensity. This phenomenon is supposedly originating from multiple 
emission centers on the CDs such as surface fluorophores and graphitic cores which respond 
drastically differently under various excitation conditions [93]. To further characterize the opto-
physical properties of monophosphonated-CDs, time-resolved photoluminescence spectroscopy 
(TRPL) was carried out to determine the time evolution of photoluminescence intensity with 
excitation of 385 nm at 298 K (Figure 5.14B). The decay curve indicated a multiexponential fit on 
the data with two-phase exponential decay (R2=0.998) with 𝜏1 and 𝜏2 of 0.58 and 2.8 ns, 
respectively. The multiple lifetime values could be attributed to the presence of diverse 
fluorophores and energy levels in CD samples [447]. The lifetime can be also influenced by factors 
such as viscosity and volume [95].  
 
Figure 5.14. Fluorescence characterization of monophosponated-CDs; (A) excitation dependent 
emission spectra of NPs with red shift at higher excitation wavelengths. (B) TRPL spectrum and 
the fitted multiexponential decay model with 𝜏1 and 𝜏2 of 0.58 and 2.8 ns; (C) Top: The HA 
binding assay and the respective IVIS fluorescence image. Increase of concentration of NPs from 
left to right (𝜆𝑒𝑥 =430 nm, 𝜆𝑒𝑚 =600 nm). Bottom: The fluorescence radiance vs. the NPs 
concentration calculated from ROI of images with the same pixel area. 
 
In order to indicate the affinity of the prepared particles towards calcium salt of the bone, 
we carried out a fluorescence dilution assay using HA powder as the bone-mimicking salt. HA is 




The binding of the NPs to HA was further explored and confirmed using IVIS fluorescence 
imaging system by excitation at 𝜆𝑒𝑥 =430 nm, and emission at 𝜆𝑒𝑚 =600 nm. As could be 
observed in Figure 5.14C, the NPs were showing affinian ty towards HA since the fluorescence of 
monophosphonated-CDs bound to HA was maintained even after the washing step. Here, Ca2+ is 
in the form of ionic calcium and is bound to the crystals of HA and is unlikely to get washed away. 
It was also concluded that the correlation between the fluorescence radiance and concentration 
reaches a saturation after 25 mg.ml-1 of CDs (Figure 5.14C bottom). The fluorescence affinity is 
probably originating from the chelation of Ca2+. We hypothesize that each of the PEG phosphates 
can act as monodentate ligand for binding to Ca2+. Interestingly, due the spacer length of PEG, the 
binding can become more facile because of flexibility of the PEG chains. This observation was 
further supported by tracking and shifting of the characteristic vibration of C-P bond in the FTIR 
peak (Figure S5.6) 
To indicate the specific binding of the NPs towards Ca2+, a model of microcracks was 
utilized as it was hypothesized that microcracks are Ca2+ rich accumulation sites. This abundance 
stems from the hydrolysis of bone minerals (mostly similar to HA) as following [449]: 
𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2 + 12 𝐻2𝑂 → 10 𝐶𝑎
2+ + 6𝐻2𝑃𝑂4
− + 14 𝑂𝐻− 
The walls and the troughs of the microcrack would generate suitable surface area as well as high 
concentration of Ca2+ particulate that is unlikely to be influenced by the Ca2+ cellular metabolism 
even in the in vivo condition. Upon the Ca2+ release, they would be chelated by NPs, which is more 
likely to occur in the microcrack regions.  
Freshly cut bovine cortical sample was collected from a local slaughter house and the 
cleaned sample was soaked in the NP dispersion for 18 h after washing and drying the sample. 




images clearly demonstrated the microcrack features including the ridges and troughs (Figure 
5.15A, Movie S1, and S2). 
Demonstrated in Fig 5B-D are the different cross sections of the sample with stack 5D 
being lower compared to 5B. As could be inferred, the intensity of stack Figure 5.15D is much 
stronger than Figure 5.15B or the intermediate layer (Figure 5.15C), suggesting that concentration 
of the bound CDs was more in the troughs where Ca2+ deposits are more abundant. This experiment 
has a great implication in the diagnosis of micro damages since the undetected microcracks can 
lead to the fragility and likely osteoporosis and osteoarthritis [450]. 
 
Figure 5.15. Feasibility of bone microcrack detection via fluorescence-based method in an ex vivo 
porcine model (A) 3D confocal image of the NPs residing in the bone microcracks (𝜆𝑒𝑥 =488 nm) 
(B-D) fluorescence overlaid on the bright field confocal images (𝜆𝑒𝑥 =514 nm) at (B) 4.8 (C) 40.9 





To ensure the safety of the monophosphonated-CD, an MTT cell viability assay was 
conducted in a model MG-63 (human osteosarcoma) cells present in the bone. 10×103 cells/well 
were incubated with various concentrations of NPs with maximum of 2500 µg.ml-1 for 44h (~two 
days). The MTT measures the mitochondrial activity of the cells where the MTT turns to formazan 
blue salt in the presence of metabolically active cells. As could be seen in Figure 5.16A, the cells 
maintained their high level of cell viability (~90%) up to 2500 µg.ml-1, implying that these NPs 
are safe for in vitro and in vivo application at significantly high concentrations. Moreover, to 
further explore their compatibility with blood, we performed blood smear assay for samples 
incubated with 2000 µg.ml-1.  
As could be observed in Figure 5.16B, there is no adverse effect even at this high 
concentration for the period of 44 h. This supports our prior results obtained via MTT assay on the 
safety of the monophosphonated CDs and is also compliant with the general safety of CDs as 
reported in the literature [119, 446, 451, 452]. For NPs over 10 nm where renal clearance is not 
viable, internal bio-digestion pathways should lead to their fragmentation [453]. The degradation 
of the prepared NPs was demonstrated by treating with human neutrophil enzyme 
myeloperoxidase (hMPO) and tracking using Raman spectroscopy over seven days. MPO is 
expressed in inflammatory cells to destroy the bacterial cell [454]. As can be observed in Figure 
5.16C, the intensity of the Raman peak decreased gradually over time suggesting the enzyme-
mediated degradation of NPs.  
The potential of the fluorescent monophosphonated-CDs for tissue imaging in vivo was 
explored using athymic nude mice. Strong fluorescence from CDs injected via tail vein could be 





Figure 5.16. Safety of monophosphonated CDs; (A) MTT cell viability assay of MG-63 osteoblast 
cells with persistently excellent cytocompatibility up to 2500 µg.ml-1; (B) The blood smear assay 
indicating no significant change in the blood cells morphology upon incubation with 
monophosphonated-CDs (2 mg.ml-1) vs. control: (i-iii) The bright field images of non- treated 
blood cells after 2, 24 and 48 h, respectively; (iv-vi) blood cells incubated with 
monophosphonated-CDs for 2, 24 and 48 h; (C) and (D) Enzymatic degradation of 





The mice (n=3) were injected with the NPs in the tibia and then were compared with the 
non-treated animal. As shown in Figure 5.17B vs Figure 5.17A, when excited at 430 nm and 
imaged at 600 nm, a prominent difference is observed in the PL emitted from tibia suggesting that 
the NPs can light up the tissue surrounding bone. 
Figure 5.17C is the fused fluorescence and CT image of the animal injected in tibia. For 
CT experiment, the animal was placed in a prone position and the signal in the tibia is originating 
from intramuscular injection of monophosphonated CDs. The NPs circulated for 30 minutes before 
imaging. The photon count was calculated for the control animal and the animal injected in the 
tibia (Figure 5.17D) where a statistically significant enhancement was detected for the treatment 
animal (p-value <0.05). The 3D reconstruction of the optical images alongside with the anatomical 
CT images are demonstrated in Movie S3. The high signal around tibia could be attributed to low 
circulation time. However, this time was sufficient to indicate the potential of the 
monophosphonated CDs for proper IVIS imaging. The animal study conducted here aimed to 
indicate the feasibility of tissue imaging and enough signal sensitivity with the monophosphonated 
CDs. These NPs were demonstrated to have potential to act as bone-seeking agent as demonstrated 
ex vivo and at the same time showed promise for generation of enough signal sensitivity at the 
tibia region after injection and circulation time of about 30 minutes. Full animal studies with bone 







Figure 5.17. In vivo fluorescence of monophosphonated-CDs in the tibia with distinct site- 
enhancement in the signal to background intensity. (A): Control non-treated mice and (B): Treated 
mice (𝜆𝑒𝑥=430 nm and 𝜆𝑒𝑚=600 nm); (C) The treated animal with the CT fused fluorescence 
image (𝜆𝑒𝑥=465 nm and 𝜆𝑒𝑚=700 nm). (D) The fluorescence radiance calculated with the same 
voxel in both animals where a significant enhancement was observed in student t-test (p-value < 






In conclusion, we have successfully synthesized the monophosphonated-CDs in a one-step 
carbonization process. As opposed to the previously reported bone-targeted probes, these NPs 
were shown to be biodegradable by human myeloperoxidase and had strong fluorescence for 
imaging. These NPs indicated affinity to HA as confirmed by HA binding assay while indicating 
remarkable florescence in an ex vivo bovine bone microcrack model. Importantly, our NPs retained 
their superior photoluminescence when injected in vivo and demonstrated the imaging feasibility 
of tibia. We demonstrated excellent homing properties by presenting multiple copies of 
monophosphonates at the nanoscale surface of CDs. This is the first report of a biodegradable self-
contained phosphonates tagged label-free fluorescence probes for optical imaging of bone 
microcracks. We envision to apply the monophosphonated-CDs for histopathological examination 
of the bone microdamage to provide a clear rendering of the troughs and walls of the microdamage. 
This information of the anatomy of the microdamage can enable the prediction of the bone failure 
considering the crack fracture mechanics. This can also be a predictor of the more serious 





CHAPTER 6: NANOPARTICLES FOR SYSTEMIC DISEASES 
6.1. Nanosalina: A tale of saline-loving algae from the lake’s agony to cancer therapy11 
6.1.1. Abstract 
The nanoparticles (NPs) that contain the therapeutic agent within themselves without 
further modifications can be coined as ‘self-therapeutic’ NPs. The development of these agents 
especially when derived from natural resources can lead to a paradigm shift in the field of cancer 
nanotechnology as they can immensely facilitate the complex chemistry procedures and the follow 
up biological complications. Herein, we demonstrate that inherently therapeutic NPs ‘integrating’ 
β-carotene can be synthesized from Dunaliella Salina microalgae in a single step without 
complicated chemistry. The facile synthesis involved microwave irradiation of aqueous 
suspension of algae which resulted in water dispersible NPs with hydrodynamic diameter of ~80 
nm. Subsequently, extensive physiochemical characterizations were performed to confirm the 
integrity of the particles. The pro-oxidant activities of the integrated β-carotene were triggered by 
photoexcitation under UV lamp (362 nm). It was demonstrated that after UV exposure, the C32 
human melanoma cells incubated with NPs experienced extensive cell death as opposed to non-
illuminated samples. Further cellular analysis revealed that the significant reactive oxygen species 
(ROS) and in particular singlet oxygen was responsible for the cells’ damage while the mode of 
cell death was dominated by apoptosis. Moreover, detailed endocytic inhibition studies specified 
that UV exposure affected NPs’ cellular uptake mechanism. These inherently therapeutic NPs can 
open new avenues for melanoma cancer treatment via ROS generation in vitro.                
                                                 
11 This part of the thesis is adapted from the following publication: 
Ostadhossein, F., Misra, S. K., Schwartz-Duval, A. S., Sharma, B. K., & Pan, D. (2017). Nanosalina: A Tale of Saline-




6.1.2. Introduction  
The hypersaline lake Urmia in the northwest of Iran has been reported to morph from green 
to bloody red, based on the images released by NASA that captured the changes from April-June 
2016.[455] The riddle of the ‘bloody pool’ doomed to death knell was attributed to the genus of 
microalgae called ‘Dunaliella Salina’ (D. Salina) [456, 457]. This  microalgae is known to 
accumulate massive carotenoids content especially β-carotene under the stress conditions such as 
high salinity, excessive irradiance, and nutrient deprivation [458]. Under these environmental 
stresses, the amount of reactive oxygen species (ROS) generated in the cell increase. In order to 
protect and quench high levels of ROS in the algae, the enzymatic and non-enzymatic pathways 
are activated and among them is the upregulation of carotenogenic gene [458].  
Carotenoids are terpenoid-based antioxidants with unique optical absorptive properties and 
benefit from preferential uptake by the cellular membrane due to their ability to be deeply fused 
with the lipid hydrophobic center [129, 459, 460]. β-carotene, in particular has been implicated to 
have effective protective antioxidant role in the free radical-mediated diseases such as cancer, 
cardiovascular disease, and macular degeneration [461-464]. Despite the highly documented 
antioxidant properties of β-carotene, the pro-oxidant property of this molecule is less emphasized 
[465, 466]. The intracellular free radical modulation has been observed in high concentration of 
β-carotene and in the presence of an external oxidative stress [465, 467, 468]. Several mechanisms 
have been proposed as to the ROS generation of β-carotene such as the induction of P450 isoforms, 
Fenton reaction modulation and auto- oxidation [459, 468-470].   
The utilization of the naturally occurring compounds as anticancer agents has garnered 
researchers’ interest specially when combined with nanotechnology approach [471, 472]. The 




where multiple therapeutic agents are combined together under the umbrella of ‘nanomedicine’ 
utilizing these small entities [473]. However, the introduction of additional functionalities requires 
complex chemistry, added cost, more convoluted characterizations in vitro and in vivo, and 
overcoming the unknown regulatory bottlenecks. This trade-off between additional functionality 
and complexity has led to extensive efforts to develop intrinsically therapeutic NPs (without 
further modification). Self-therapeutics NPs that preclude the use of additional cytotoxic agent 
obtained by green chemistry route have been coveted for long.  
The elevated amount of ROS is established in cancer cells, which is attributed to the altered 
biochemistry of the cells as a result of abnormal aerobic glycolysis aka. Warburg’s effect [474, 
475]. Moreover, cancer cells lack the full functionality of ROS-scavenging enzymes [476]. While 
reasonable amount of ROS is required to maintain the cellular activity, the excessive production 
of ROS can lead to cellular damage [477]. This vulnerability of cancer cells has been curbed to 
researchers’ benefit to develop strategies for the cancer treatment by ROS induction via exogenous 
chemicals while sparing the normal cells [478]. For instance, in photodynamic therapy, the 
photosensitizer agents would induce oxidative stress when activated by the light source of 
appropriate wavelength [479]. The inflammatory and immune response resulting from the 
generated ROS by the reaction would lead to tumor control [480-482]. These effects can be 
extended to 2D culture leading to cell growth regression.   
Herein, the synthesis of nanosalina particles has been accomplished via facile microwave 
irradiation using microalgae as the sole precursor. The use of algae as a natural source of NPs is 





Figure 6.1. (A) The schematic representation of the application of the nanosalina particles as 
inherently therapeutic anti-cancer agent. D. Salina is a rich source of β-carotene. As opposed to 
common theory, ample amounts of β-carotene indicate pro-oxidant properties. The NPs integrating 
β-carotene can generate ROS under UV exposure. The abnormal metabolism of the cancerous cells 
leads to excessive production of ROS. Additional ROS generation can result in cancer cell 
apoptosis. This enhanced ROS generation is produced by NPs when triggered with UV 
photoexcitation; (B) The steps required for the synthesis of the nanosalina particles. The dried 
microalgae are dispersed in water and then are irradiated with microwave for 45 min as shown in 
(C). Note that the microalgae are barely dispersible in water. (D) The nanosalina particles are 
prepared which integrate β-carotene. Upon UV photoexcitation, the green fluorescence of the NPs 
emerges.       
 
The resultant NPs were ~80 nm in hydrodynamic diameter with high aqueous dispersibility. 
Furthermore, these NPs were found to contain elements indispensable to maintain the nutrients’ 
balance for the algae such as Na, P, Si, and Fe. With additional high luminescent efficiency, these 
NPs were utilized for site-specific and UV-mediated therapy. Interestingly, the derived NPs 




photoexcitation at 362 nm without any exogenous drug use. This extraordinary property is 
hypothesized to originate from the ‘integrated’ β-carotene in the NPs leading to the burst of ROS 
and phototoxicity. Further biological assays pointed to the contributing role of ROS as the cell 
death-inducing mechanism. Specifically, the ample generation of singlet oxygen was detected over 
extended time on the cellular level after photoexcitation for ~30 min. The mode of cell death was 
found to be dominated by apoptosis as the preferred mode of growth regression and cancer cell 
therapy. Overall, these NPs are offered as novel cancer therapeutics for skin cancer nurtured by 
Mother Nature (Figure 6.1A).   
6.1.3. Experimental Section 
6.1.3.1. Physiochemical Characterizations  
The spray dried food grade Dunaliella salina microalgae was obtained from Illinois 
Sustainable Technology Center and was procured from buyalgae.com. A dispersion of 100 mg.ml-
1 of algae was made in water and was then subjected to microwave irradiation (Biotage® Initiator+ 
microwave synthesizer, Charlotte, NC, USA) at 150 ºC and 150 watts for 45 min. The temperature 
was chosen to be below the degradation temperature of β-carotene [485]. The as-synthesized NPs 
were passed through 0.45 and 0.22 µm syringe filters. Subsequently, extensive physiochemical 
characterizations were conducted. The morphological features of the samples were observed under 
the transmission electron microscopy (TEM) on a JEOL 2100 Cryo TEM machine (Tokyo, Japan) 
equipped with Gatan UltraScan 2k × 2k CCD camera. The holey carbon coated copper grid was 
utilized for TEM sample preparation. The hydrodynamic diameter and electrophoretic potential of 
the NPs were measured on a Malvern Zetasizer ZS90 instrument (Malvern Instruments Ltd, United 




Atomic force microscopy (AFM) was conducted for the sample deposited on a mica wafer 
secured on a stainless-steel disc in the tapping mode (Asylum Cypher (Asylum Research, Santa 
Barbara, CA)). The absorbance of the NPs in the UV and visible spectrum was recorded on a 
GENESYS 10 UV–vis spectrometer (Thermo Scientific, MA, USA) while the 2D fluorescence-
emission spectra of the samples were measured on a Horiba Aqualog Scanning Spectrofluorometer 
(Horiba scientific, Edison, NJ, USA). After each measurement, the first-order Rayleigh scattering 
was corrected and all spectra were normalized to 1 mg.l−1 quinine sulfate. X-ray photoluminescent 
spectrum (XPS) was obtained on a thick vacuum dried layer of the NPs applied on the glass surface 
using Physical Electronics PHI 5400 spectrometer with Al Kα (1486.6 eV) radiation. The spectrum 
was referenced to the adventitious C 1s feature at 284.8 eV. The chemical components of the NPs 
and raw algae were determined on an X-ray fluorescence (XRF) spectrometer/energy-dispersive 
X-ray (Shimadzu EDX 7000/8000 energy dispersive XRF spectrometer, Japan). Other elemental 
analysis included SEM/EDS using Hitachi (Schaumburg, Illinois) S-4700 SEM with Oxford 
Instruments (Abingdon, Oxford shire) ISIS EDS X-ray Microanalysis System and Centaurus BSE 
detector. The chemical characteristics of the NPs was inferred from 1H NMR analysis using a 500 
MHz machine (Varian VXR 500 (Varian, Inc., Palo Alto, CA)) equipped with a 5-mm Nalorac 
QUAD probe in deuterium oxide (D2O) (Cambridge Isotope Laboratories, Inc., MA, USA). The 
data was analyzed using MestRenova™ 8.1 software (Mestrelab Research SL; Santiago de 
Compostela, Spain).[486] Raw algae and β-carotene (Cayman chemical, Ann Arbor, Michigan, 
USA) were initially dissolved in small amount of DMSO and diluted in D2O. X-ray diffraction 
(XRD) patterns were collected on a Siemens-Bruker D5000 (Madison, WI, USA) using Cu-




1/min, and the step size of 0.02. The spectrum was smoothed using a 10-point Savitzky–Golay 
algorithm.  
6.1.3.2. Cell Viability Assessments 
C32 human melanoma cell lines obtained from American Type Culture Collection (ATCC, 
VA, USA) were cultured in Eagle's Minimum Essential Medium (EMEM) supplemented with 10% 
fetal bovine serum (FBS) and 1% pen-strep under 99% humidity and 5% CO2. The cells were 
passaged via trypsinaztion (0.1%) containing 0.02% ethylenediaminetetraacetic acid (EDTA) after 
being washed with Dulbecco’s phosphate-buffered saline (DPBS, pH 7.4). 10,000 cells in 200 µl 
were seeded in each well of a 96-well plate and were allowed to reach 80% confluence. The cells 
were incubated with NPs at concentration of 1.25 mg.ml-1 for 4 h and were subsequently irradiated 
with a UV lamp operating at 362 nm (Avantco W62, China, 60 Hz, 500 watts) for 30 min while 
maintaining the plate to source distance 10 cm. The cells without NPs were considered as control. 
A parallel experiment was conducted under similar conditions while no UV exposure was applied. 
After 44 h of incubation, the cells were imaged using bright field microscope. Next, 20 µl of MTT 
solution (5 mg.ml-1) was added to the growth medium, and then, the cells were incubated for an 
additional 4 h. The old media was replaced with 200 µl of DMSO to solubilize the formed 
formazan salt and the absorbance at 570 nm measured on multi-well plate reader (BioTek Synergy 
HT, USA) was correlated to the cell viability.  
6.1.3.3. Reactive Oxygen Species (ROS) Assays 
The treated and non-treated (with UV and/or NPs) C32 cells were investigated for the ROS 
generation using the Fluorometric Intracellular ROS Kit (Green Fluorescence, Catalog Number 
MAK143, Sigma- Aldrich, MO, USA). The cells (10,000 cells/well in 90 µl) grown for 24 h were 




were treated with the formulations (13.75 mg in 20 µl) for 4 h and irradiated with UV for 30 min. 
Finally, at the specified time points, the samples were analyzed under λex = 490/λem = 525 nm on 
a multi-well plate reader. 
The generation of the singlet oxygen was assessed utilizing the Singlet Oxygen Sensor 
Green Reagent (Molecular probes, S36002). The cells grown on the coverslips for 24 h, were 
treated with 1.5 µl of 5 mM reagent for 30 min. The cells were treated with the NPs (1.25 mg.ml-
1) for 1 h to allow internalization. Subsequently, UV treatment was conducted for 30 min. The 
cells were then thoroughly washed with DPBS and fresh media was supplemented. Further 
incubation for 2 h was conducted before the cells were stained and incubated with 2 µl of PI for 
30 min in dark. The cells were incubated with paraformaldehyde as previously mentioned followed 
by washing with DPBS. The imaging of the SOSG component was performed under the 514 nm 
excitation laser adopting the FITC channel for the imaging purposes.     
6.1.3.4. Apoptotic Assay 
To quantify and differentiate between the apoptotic and necrotic cells, the Annexin-V 
labeled FITC and PI double staining (ThermoFisher Scientific, Catalog number: V13242) have 
been implemented on the C32 cells in the absence or the presence of UV (30 min) with various 
formulations. DMSO (10% vol/vol)-treated cells were considered as positive control. The 
treatment lasted for 44 h. The staining has been carried out based on the manufacturer’s protocol. 
Briefly after harvesting the cells with trypsin, 5 μl of FITC labelled Annexin-V and 1 μL of the 
100 μgml-1 PI working solution were added to each 100 μl of cell suspension and incubated in dark 
for 15 min. Immediately afterwards, the cells were analyzed on a Guava® easyCyte Single Sample 




6.1.3.5. Study of the Nanoparticles’ Entry Pathway 
C32 cells grown for 24 h in 96 well plates were treated with various endocytic inhibitors 
(NaN3/DOG: 10/50 mM, Dyansore: 80 µM, CPM: 28 nM, nystatin: 180 nM) for 1 h. The old media 
was replaced with the NP suspensions (1.25 mg.ml-1) and the cells were incubated for 4 h before 
being irradiated with UV for 30 min. MTT assay was conducted as previously described to assess 
the cell viability after 48 h in the absence or presence of NPs and/or UV. The fold change was 
calculated with respect to the non-preinhibitor treated sample.  
Statistical Analysis: The tests were done in triplicate and the results were expressed as the 
mean±standard deviation. The data were analyzed on the GraphPad Prism 6.0 software using 
analysis of variance (ANOVA) Bonferroni correction for post hoc. The p<0.05 was considered 
significant and were marked with * for p<0.05 and **** for p<0.0001.   
6.1.4. Results and Discussion 
The nanosalina particles were synthesized utilizing microwave-based hydrothermal 
method.[487] The characterizations of the raw dried algae are shown in Figure 6.2 where the 
microstructure of the algae is shown in Figure 6.2A, B. A dispersion of dried D. Salina algae in 
water was irradiated with microwave for 45 min at 150 ºC (Figure 6.1B, C). The algae itself had 
limited dispersibility in water (Figure 6.1B) due to the presence of non-soluble carbohydrates, fat, 





Figure 6.2. The physico-chemical characterizations of the raw microalgae; (A) and (B) The TEM 
of the microalgae; (C) The XPS survey spectrum of the raw algae indicating C, O, Si, and Na 
peaks; (D) is the narrow scan of the C peak; (E) the narrow scan of Si 2p peak and its 
decomposition.  
 
The as-obtained NPs were passed through 0.45 and 0.22 µm filters to remove small percentage of 
large particles/aggregates and were used for further characterizations. The number-averaged 




images (Figure 6.3B) revealed the spherical morphology of the NPs without any distinct 
crystallographic features. The distribution of anhydrous diameter of NPs is shown in Figure 6.3A 
inset. X-ray diffraction (XRD) patterns (Figure 6.3D) further indicated that these NPs possessed 
shared diffraction patterns with carbon dots (CDs) with the broad diffraction peak happening at 2θ 
= 24° and a small shoulder peak at 44° that would correspond to (002) and (100) planes of graphitic 
carbon while the NPs are consisting of highly disordered carbon atoms in nature [488]. This is in 
contrast to the crystalline features found in the raw algae diffraction pattern (Figure S6.5). In 
addition, the anhydrous state morphology of the NPs was observed by atomic force microscopy 
and was determined to be spherical (Figure 6.3C). Zeta potential measurements of the NPs 
revealed that they were negatively charged with electrophoretic potential of -21±3 mV thus 
rendering them with colloidal stability (Figure S6.2).  
In addition, the optical properties of the prepared NPs are demonstrated in Figure 6.3E. 
The broad absorption band around 280 nm could signify the n–π* transition of the C=O bond and 
the π–π* transition of the conjugated C=C bond [383]. It is important to notice that the 
characteristic broad absorption peak of β-carotene at ca. 450 nm is absent in the UV-Vis patterns 
of the NPs implying that the β-carotene molecules are presumably ‘integrated’ within the NPs. 
However, the innate presence of the carotenoid was further corroborated through 1H NMR analysis 
(vide infra). In spectral plot, the photo luminescent (PL) emission spectrum of NPs upon excitation 
at 360 nm is shown (Figure 6.3E). The emission band appeared in 400-500 nm hence emitting in 
the green region. The digital camera images of the dispersed NPs under ambient white light and 
UV lamp (λexcitation=362 nm) indicated the strong green fluorescence of the NPs (Figure 6.3E inset). 




were highly fluorescent in the wide range of excitation wavelengths (260-400 nm) while showing 
excitation- dependent PL pattern as could be inferred from the shape of the fluorescent region. 
Moreover, to gain insight to the surface chemical composition of the algae and NPs, X-ray 
photoelectron spectra (XPS) were obtained as indicated in Figure 6.2C-E and Figure 6.4A-B as 
well as Figure S6.3 and S6.4. The survey spectrum (Figure 6.4A) demonstrated that the NPs were 
rich in C (61.0±0.3%) and O (37±0.3%) while they contained elements such as Na (0.4±0.1%), Si 
(0.6±0.2%) as detected by XPS. The presence of the elements other than C and O would make the 
composition of these NPs distinct from CD and/or graphene dot (GD) while partially sharing 
similar characters with the mentioned NPs.[489] The detected elements could be attributed to the 
natural mineral required for maintaining nutritional balance of algae since the raw algae itself had 
the similar elements available in them as observed in its XPS spectrum (Figure 6.2C) [490, 491]. 
It could be inferred from the decomposed C1S peaks (Figure 6.4B) that the aliphatic (C-C) bonds, 
carbonyl (C=O), ethereal (C-O), hydroxyl (C-OH) and ester (O=C(O)) would be present which 
conferred the NPs with water dispersibility. Further evidence of the availability of the elements in 
addition to C, H and O came from energy dispersive spectroscopy (EDS) as shown in Figure 6.4C. 
The peaks could be assigned to P, S, Cl, K and Cu as observed along with the formerly identified 
elements on the XPS spectrum. X-ray fluorescence (XRF) (Figure 6.4D) as a powerful elemental 
analysis tool also corroborated the trace amounts of minerals such as Fe, Na, Cu, and Si which can 






Figure 6.3. The physico-chemical characterizations of the NPs; (A) The hydrodynamic 
distribution of the NPs as measured by DLS. The hydrodynamic size was determined to be 76±10 
nm; The inset shows the anhydrous diameter distribution from TEM observation; (B) TEM images 
of the morphology of the NPs; (C) AFM height profile distribution of the NPs; (D) XRD pattern 
of NPs. A broad diffraction peak at 2θ=24º and a small shoulder peak at 44º were observed 
affirming to the amorphous nature of carbon; (E) The UV-Vis absorbance and photoluminescence 
spectra under excitation at 360 nm. The inset indicates the NPs under ambient white light and their 
green fluorescence under UV lamp (362 nm); (F) The 2D excitation-emission fluorescent 





1H NMR spectra of β-carotene and NPs are shown in Figure 6.4E. Besides, the comparison 
in the spectra between raw algae and β-carotene is made in Figure S6.6 while the comparison 
between raw algae and nanosalina particles are made in Figure S6.7. The peaks were assigned in 
β-carotene spectrum as could be seen in the Figure 6.4E a. It should be noted that the symmetry in 
the molecule has been considered and therefore, only the first set of numbers are shown on the 
spectrum. As could be seen in the spectrum of NPs (Figure 6.4Eb), the characteristic features of 
β-carotene have been retained even after undergoing microwave irradiation. In addition, other 
characteristic features emerged in the spectrum. Namely, the signals in 3-4 ppm could be due to 
protons in the vicinity of hydrophilic functional groups such as hydroxyl, carbonyl and ether [85]. 
The intact nature of β-carotene in the NPs and literature reports on therapeutic nature of β-carotene 
prompted us to seek its effect in an in vitro investigation. 
Light-sensitive drugs that absorbs ultraviolet (long wave - UVA) light are frequently used 
in the clinic together with ultraviolet light to treat skin conditions such as psoriasis and lymphomas. 
Methods such as PUVA and/ or PUVB therapy has emerged in the clinic for the treatment of severe 
skin diseases such as Psoriasis, dermatitis with little or no concern about skin cancer after short 
term exposure.[492] The viability of the C32 (human skin melanoma) cells was assessed based on 
the loss in the cell growth density and mitochondrial respiration via the MTT assay with/without 
UV irradiation. C32 cells were chosen since the depth of penetration of UV is limited in biological 
tissues and therefore skin is a good target for UV therapy. Initially, the nanosalina particles were 
tested in a range of concentrations where the decrease in the cell viability was evident in the UV 
treated vs. non-UV treated samples as shown in Figure S6.8. The concentration of the treatment 





Figure 6.4. (A) XPS survey spectrum of NPs indicating high content of O and C while containing 
elements such as Na and Si; (B) The decomposed XPS peak of C1S; (C) The EDS of NPs obtained 
from different areas of SEM images, except for Na and Si, other minerals e.g. K, P, and S essential 
for the maintenance of nutritional balance of D. Salina were detected; (D) XRF spectrum 
confirming the presence of various minerals; (E) 1H NMR of (a) NPs and (b) β-carotene. The 
solvents were a mixture of D2O and DMSO (non-deuterated) for β-carotene due to the solubility 
issues while it is only D2O for NPs. The peaks at 4.79 ppm is assigned to D2O while the peak at 
2.7 ppm is due to DMSO impurity in β-carotene spectrum. In (b) the peaks were assigned as 




The MTT results attested to the safety of the NPs for cells in absence of UV where nearly 
90% of the cells survived and is consistent with the prior observations to the cytocompatibility of 
the CDs [92, 489]. By contrast, upon UV irradiation, the cell viability markedly decreased and led 
to the mortality of ~80% of the cells suggesting the intrinsic therapeutic effects of the NPs activated 
by UV irradiation after 30 min of exposure (Figure 6.5E). The bright field images also showed the 
loss of cell growth density and induced cell shrinkage in the NP-treated samples under UV 
exposure (Figure 6.5D). In contrast, the NP treated samples in absence of UV exposure (Figure 
6.5C) did not show noticeable change in the morphology and preserved their spindle like shape, 
similar to the control cells (Figure 6.5A).  
 
Figure 6.5. The cytocompatibility investigation of human skin melanoma cells (C32) with NPs in 
the absence and the presence of UV. Bright field images of (A) and (B) C32 cells only in dark and 
UV, respectively. (C) and (D) cells incubated with 1.25 mg.ml-1 NPs without UV and with UV, 
respectively after 44 h. While there is not much difference between (A) and (C), the significant 
apoptotic features and cell shrinkage were observed in the UV treated sample. The scale bar 
corresponds to 40 μm; (E) MTT cell viability assay results (48 h) indicated significant loss of 
mitochondrial activity of C32 cells incubated with NPs when irradiated with UV. Student’s t-test 




After establishing the cancer cell growth regression benefits of the NPs as UV therapy 
agents, we investigated the potential mechanisms governing their efficacy. We hypothesized that 
ROS generation could be one of the plausible routes for the cell death. This hypothesis was further 
corroborated with the ROS induction assay where a significant time-dependent enhancement in 
the ROS level (up to 44 h after irradiation) was noticed in the UV treatment group compared with 
the non-UV irradiated cells (Figure 6.6A). Ample generation of singlet oxygen is one of the 
effective strategies to overcome the downsides of the conventional photodynamic agents [493]. 
The nanosalina particles may have potential as photosensitizer which requires high singlet oxygen 
quantum yield and plays the most prevalent role in the molecular processes initiated by 
photodynamic therapy [493-496]. Therefore, we investigated whether singlet oxygen generation 
could be ascribed as a mechanism involved in the cells’ death (Figure 6.6B and C).  
For the Singlet Oxygen Sensor Green (SOSG) detector, the fluorescent signal from the 
chromophore is quenched prior to the reaction with 1O2 due to intramolecular electron transfer. 
Upon the reaction of the 1O2 with the reporter, the electron transfer would be inhibited and 
endoperoxides would form by the reaction of 1O2 with the anthracene component of SOSG thus 
strong green fluorescence would emerge [497].  
The confocal images of the SOSG and the propidium iodide (PI) staining which identifies 
the dead cells are shown for the NP treatment (Figure 6.6C) and control cells (with UV exposure) 
(Figure 6.6B). It could be inferred from the images that the control cells indicated no significant 
green signal, nor have they experienced extensive cell death. However, for the UV irradiated cells, 
it was clear that the green signal could be co-localized with the red signal implying that the cells’ 





Figure 6.6. The ROS generation as the death-inducing mechanism of cells’ death. (A) is the ROS 
level as tested in C32 cells incubated with 1.25 mg.ml-1 NPs in dark and with UV. Significant burst 
of ROS was detected after UV treatment and was built up for the next 48 h. Two-way ANOVA 
test was conducted. Significant p-value<0.0001 is shown by ****; (B) and (C) SOSG of NPs 
incubated samples in dark and UV, respectively. Red is PI staining indicating the dead cells and 
green is singlet oxygen indicator. The co-localization of dead cells and green sensor is evident, 
suggesting that singlet oxygen generation is partly responsible for ROS accumulation. Scale bar 
corresponds to 75μm; (D) and (E) histograms of the distribution of red and green signal 
corresponding to (B) and (C), respectively. 
 
Nevertheless, the PI staining results revealed the loss of cell membrane integrity in the 
oxidatively stressed cells. Based on these findings, we hypothesize that the prevalent mechanism 




very short (approximately 10-320 ns) and therefore the diffusion is only expected to occur to the 
immediate biological entities, i.e. at only 10-55 nm in the cells, Therefore, the damage can be 
restricted intracellularly to a localized region [498].  On the other hand, we hypothesize that the 
other elements found in the system might not have contributed to the cytotoxic effects. The NPs 
seemed to be safe without UV activation while their cytotoxicity emerged after UV exposure.     
To quantify the apoptotic and necrotic cells, Annexin-V FITC/PI staining was utilized 
(Figure 6.7). At the early stages of apoptosis, phosphotidylserine (PS) would emerge in the outer 
leaflet of plasma membrane which could be detected by Annexin-V/FITC labeled protein. On the 
other hand, PI is known to intercalate DNA upon cell membrane damage and permeation. Here, 
DMSO (10% v/v) was used as a positive control, known as cause for inducing considerable 
apoptosis in human cancer cells [499]. The analysis revealed that the cells treated with NP in 
absence of UV exposure (Figure 6.7B) indicated negligible cell damage (4.9±1.9% cell apoptosis) 
and the results were in agreement with the control group (Figure 6.7A) with minimal apoptosis 
(6.6±1.6% cell apoptosis). In contrast, the cells treated with NPs under UV (Figure 6.7E) presented 
late stage apoptotic features (35.6±2.0% cell apoptosis) as the dominant death mode similar to 
DMSO treatment (Figure 6.7F).  
Finally, the effect of UV treatment on the NPs entry pathway was investigated by 
subjecting the cells to various endocytic pharmacological inhibitors (dynasore: inhibitor of 
dynamin-dependent endocytosis (80 µM), 2-deoxyglucose (DOG)/NaN3: energy mediated 
pathway inhibitor (10/50 mM), chlorpromazine (CPM): clathrin-mediated endocytosis inhibitor 
(28 nM), nystatin: caveolin/lipid raft mediated endocytosis endocytosis inhibitor (180 nM)[93, 






Figure 6.7. Annexin-V FITC/PI staining cell apoptosis assay as measured by flow cytometry in 
C32 cells; (A) cells alone, (B) treated with 1.25 mg.ml-1 NPs, (C) 10% DMSO, (D) cells+UV, (E) 
treated with 1.25 mg.ml-1 NPs+UV, (F) 10% DMSO+UV; (G) the total apoptotic cell percentage 
in the dark samples and (H) UV irradiated samples. The percent of apoptotic cells becomes 
significant with NPs treatment after UV photoexcitation vs. control. Student’s t-test was done for 




The cell viability was chosen as the criterion for comparison. Upon the inhibition of a 
particular pathway, it was predicted that the cell viability would increase due to the lowered level 
of cellular internalization. In general, the cellular internalization of the NPs is occurring via various 
pathways such as micropinocytosis, phagocytosis, passive diffusion, and pinocytosis and is highly 
dependent on the chemistry of the NPs [152, 502]. C32 cells were pretreated with the inhibitors 
for an hour and then were treated with the NPs and the remaining procedures were followed as 
described previously for the UV treated and dark samples. The cells with no treatment, cells 
pretreated with only inhibitors, and those treated with only NPs were adopted as the negative 
control. 
For the NP treated cells in absence of UV (Figure 6.8A), none of the investigated pathways 
was active and the difference between the negative control (NP treatment only) and the pre-
incubated samples with inhibitors was marginal. However, upon photoexcitation (Figure 6.8B) all 
of the investigated pathways were found to be contributing effectively to the NPs uptake by the 
cells. Of particular interest, was the cells treated with NaN3/DOG. NaN3 is a well-known ROS 
quencher. It is evident that upon ROS generation, some of the cytotoxic effects of the ROS would 
be diminished in the presence of NaN3 hence enhancing the cell viability. Our results are in good 
agreement with this explanation. Overall, this is the first report to study anti-cancer potential of a 





Figure 6.8. The investigation of the pathways responsible for the NPs uptake; C32 cells were 
preincubated with various pharmacological inhibitors for an hour and then were treated with 1.25 
mg.ml-1 NPs. The samples treated with NPs only was considered as negative control. Cell viability 
was investigated to understand the trend. (A) cells incubated with NPs in dark and (B) NP-treated 
cells with UV photoexcitation.  p-value<0.05 was considered significant.  
 
Our results demonstrated that NP can be derived using biological waste, which in turn 
retains some of the key functionalities that are present in the precursor materials that can 
potentially be used for the ROS generation for cancer therapy. Although out of the scope of this 
present study, the eventual clinical translation against melanoma cancer should be addressed by 
future experiments in vivo models.     
6.1.5. Conclusions 
In the current study, we synthesized NPs based on D. Salina which is a rich source of β-
carotene using the facile microwave irradiation. The structural properties of the NPs were 
characterized utilizing DLS, TEM, AFM, and XRD. In addition, the optical properties of NPs were 
investigated. It was demonstrated that the NPs would absorb strongly around 280 nm attributed to 




Moreover, the NPs had high fluorescence in a wide range of wavelengths. The 1H NMR 
spectroscopy confirmed that β-carotene remained intact even after MW synthesis. These NPs were 
found to induce extensive cells’ death in human skin melanoma cells when photoexcited in the UV 
range while this effect was absent otherwise. The hypothesized ROS-mediated death as a result of 
β-carotene was corroborated by the in vitro ROS assay and singlet oxygen sensor green combined 
with PI staining assay. Annexin-V FITC/PI assay revealed significant cell apoptosis in NP-treated 
samples triggered with UV. The altered mode of NP internalization was concluded from the 
inhibitor studies. Overall, these NPs would offer a self-contained inherent green solution to skin 
cancer and would open up new pathways in cancer therapy using self-therapeutic NPs from natural 






CHAPTER 7: CONCLUDING REMARKS 
 
In this document, I brought the strategies from the field of materials science and 
engineering and chemistry as the solution to the biomedical problems by using the well-defined, 
engineered nanoparticles of carbon dots and hafnium/ hafnium oxide. In the previous four chapters, 
I attempted to get this message across that by applying the knowledge of chemistry, one can 
address endless health-related problems whether it be bacterial biofilm, bone microdamage or 
cancer. The successful solution lies in establishing an understanding of the fundamental physical 
phenomena that govern emergent interesting properties in nanoparticles and curb their unique 
chemistries in our favor to resolve ever haunting challenges that compromise the human well-
being. 
To this end, I initially focused on elucidating the underlying properties observed in carbon 
dots and worked towards endowing them with the handedness in their structure which I showed 
can potentially be used to regulate many of the nanoparticle-cell interactions. Moreover, I indicated 
how by tuning the synthetic procedures, the carbon dot photoluminescence properties may be 
tuned so that they can be applied for multicolor imaging and potentially multiplexing on the 
multiscale in the upcoming researches. Not only, the carbon dots do possess amazing fluorescent 
properties, they also benefit from the characteristic spectroscopic features which make them 
‘visible’ in the hyperspectral dark field imaging. Through extensive studies, it was demonstrated 
that these platforms can aid in the drug release quantification by these carriers in the cells.      
 Having established a niche for the protentional of the nanoparticles simply by tuning their 
chemistry for imaging purposes, I focused on the specific areas for the application of the 
nanoparticles. I showed how the topical application of the nanoparticles based on carbon dots and 




the relevant animal models without upsetting the original oral microbiota diversity. Also, for the 
first time, I demonstrated the concept of the molecularly targeted nanoparticles for the sensitive 
X-ray imaging of the dental biofilm which has broad implications in the clinical applications to 
act as a visual aid in the dental clinics during the routine X-ray examination procedure. 
Another area where I indicated the nanoparticles’ utility was for the detection of the bone 
microdamages, again, in the typical imaging procedures carried out in the clinic. Combined with 
the advanced CT imaging technology, I showed that the confounding radiopacity of the bone which 
blurs our vision of the bone microdamages, can be overcome by using the targeted hafnium oxide 
nanoparticles. The spectral CT technology enabled the separation of the K-edge signal of Hf, bone 
and the soft tissue. On the other hand, a second probe based on the fluorescent targeted carbon 
dots to the bone microdamages were designed to obviate the need for the traditional fluorescent 
dyes which suffer from a multitude of issues. 
Finally, I used the inherently therapeutic carbon dots derived from a special type of algae 
to induce apoptosis in the cancerous cells by shining UV light. These nanoparticles can be used in 
skin related problems where UV therapy is a common approach. 
While reading this dissertation, one should consider that additional experiments in terms 
of the materials characterizations and in vivo such as acute toxicity, the effect of the nanoparticles 
on the downstream cell signaling and genetic alterations should be completed. In addition, most 
of the studies were confirmed in the preclinical animal models. For the ultimate in-human 
application resorting to bigger animal models such as swine or non- human primates is needed.  
The persistent problems in medicine require the development of new materials. Therefore, 




which have been engineered to induce bacterial damage only in the presence of a circularly 
polarized infrared laser. Another area is the specific delivery of ultrasmall Hf (instead of HfO2) to 
the blood-brain barrier by using natural nanoparticles of exosomes for the enhanced 
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APPENDIX A: SUPPORTING INFORMATION FOR CHAPTER 2 
 
 






Supplementary Figure 2.2. The XPS spectra and the corresponding narrow scan of the C, N and 




































Supplementary Figure 2.9. The dilution effect of the CD spectrum of D-Pro@CDots. No change 
in the chiral signal was detected excluding the possibly of chiral aggregation. 
 
Calculation of the density of modification of aminoacid per nanoparticle: 
The density of modification is defined as following: 
𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑚𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 =  
# 𝑜𝑓 𝑙𝑖𝑔𝑎𝑛𝑑𝑠
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑁𝑃𝑠
 
 
Based on the information regarding the concentration of the amino acid (10 mM) and nanoparticles 
as in 1 ml of sample 
Considering the nanoparticle diameter of ~13 nm. 
S = 6000/(d*ρ) 
where S = surface area; d = diameter and ρ = density. Density of CDots as 2.26 g/cm3 [CAS #: 
7440-44-0] 
S = 6000/ (13*2.26) = 6000/29.38 = 204 m2/g.wt of CDots per mL (considering the concentration 




Total CDots area per mL = 204 x 0.0001 m2 = 0.0204 m2 
No. of animo acid in 10 mM solution = 6.023 x 1021 / L = 6.023 x 1018 per mL 
Density of modification = (6.023 x 1024 )/ 0.0204 = 295.2 per m2 
No. of CDots in 1 mL suspension of (0.1 mg/mL) = 3.8 x 108 per mL  
modified Surface area per CDots = (0.0204 m2)/ (3.8 x 108) = 0.0053 x 10-8 m2 = 5.3 x 10-11 m2  
Thus, 
% surface area modified per particle = (5.3 x 10-11 m2)/ (2.04 x 10-2 m2) x 100 = 2.6 x 10-7  
No. of CDotsS in 1 mL suspension of (10 mg/mL): 
CDots volume = 4/3 πr3 = 4/3 x 3.14 x 6.53 = 1.33 x 3.14 x 274.6 = 1146.9 nm3 
CDots density = 0.0226 ug/um3  
wt per CDots = d x v = 0.0000226 ng/nm3 x 1146.9 nm3 = 0.026 ng 
No. of CDots in 1 mL suspension of (10 mg/mL) = 3.8 x 108 per mL 
 
As density of modification = 295.2 per m2  
Total surface area = 2.04 x 10-2 m2 












Supplementary Figure 2.10. Anhydrous state morphology of (A) (+)-CNTWZ and (B) (±)-





Supplementary Figure 2.11. (A) Acquired representative AFM image of (+)-CNTWZ and its (B) 






Supplementary Figure 2.12. Fluorescence emission spectra of CNT and CNTWZs at 0.1 mg/mL 
concentration. Nanoparticles (A) CNP; (B) ± CNTWZ; (C) +CNTWZ and (D) -CNTWZ were 





Supplementary Figure 2.13. Reconstructed 3D images from the Z-stack imaging in the confocal 
imaging (A, B) (-) CNTWZ, (C, D) (+) CNTWZ and (E, F) (±) CNTWZ treated MCF-7 cells. (A, 









Supplementary Figure 2.14. Cell cycle analysis performed on MCF-7 cells treated with (-)-
CNTWZ, (+)-CNTWZ and (±)-CNTWZs for 4h at a concentration of 100 µM respect to TB 
concentration present in CNTWZ followed by PI staining with 1 μg/mL (107 cells). Histogram 
represents comparative red fluorescent cell population unstained or stained with PI after 
treatment with (A) MCF-7 unstained, MCF-7 stained and (-)CNTWZ; (B) MCF-7 unstained, 
MCF-7 stained, CNP, (+)CNTWZ, (-)CNTWZ and (±)-CNTWZ; (C) MCF-7 unstained, 
MCF-7 stained and (+)CNTWZ; (D) MCF-7 unstained, MCF-7 stained and (±)CNTWZ; (E) 











PDI Anhydrous state 
size (nm) 
Zeta potential (mV) 
(+)-CNTWZ 95±15 0.7 40± 10 -15± 4 
(-)-CNTWZ 20±5 0.4 15 ± 2 -12 ± 3 
(±)-CNTWZ 120±15 0.6 70± 20 -14 ± 3 
 
Supplementary Table 2.2 Induced apoptotic cell population post 48h incubation of various 
CNTWZs at a concentration of 50 µM. Nifuroxazide (10 µM), a known apoptosis inducer, was 
used as positive control. 
Samples Live cells Apoptotic cells Necrotic cells 
Early apoptosis Late apoptosis 
Unstained cells 99.9 0.1 0 0 
Untreated 
stained cells 
97.2 2.6 0.1 0.1 
(+)-CNTWZ 95.9 3.9 0.1 0.1 
(±)-CNTWZ 94.8 4.7 0.2 0.3 
(-)-CNTWZ 86.2 12.4 0.3 1.0 
Nifuroxazide (50 
µM) 





Supplementary Table 2.3. Physico-chemical characteristics of aqueous suspensions of various 
 














Supplementary Figure 2.15. Zeta potential plots of various chiral carbon nanoparticle (CCNP) 







Supplementary Figure 2.16. Circular dichroism of (-)-sparteine and (+)-sparteine in water. 
 
 
Supplementary Figure 2.17. Circular dichroism spectra and adsorption ratio of L-/D-cysteine by 
(-)-SP/CNP and (+)-SP/CNP. Absorbance of L- and D- cysteine solution (circles and squares, 
respectively) by (-)-SP/CNP (A and C) and (+)-SP/CNP (B and D). Blank symbols correspond to 
signals from the solution of 2 mM concentration while filled symbols correspond to signals of the 
spectra after treatment with (-)-SP/CNP or (+)-SP/CNP. Chiral CNPs were prepared from (-)- or 









Supplementary Figure 2.18. Circular dichroism spectra and adsorption ratio of L- and D-cysteine 
solution (circles and squares, respectively) by (+)-SP/CNP prepared from (-)-sparteine:sugar = 
10:1. Blank symbols correspond to signals from the original amino acid solution of 2 mM 
concentration while filled symbols correspond to signals of the solution after treatment with (+)-
SP/CNP. Right: bar chart of the adsorption ratio for both the chiral CNPs. 
 
Supplementary Figure 2.19. Circular dichroism of (-) Sparteine only (A) and (+)-Sparteine only 
(B) upon its interaction with incremental addition of L-cysteine. Concentration of (-)-/(+)-SP is 3 






The selectivity could be due to the preferential chiral binding of L-cysteine or L-proline with the 
chiral surfaces of (-)-SP/CNP than that of (+)-SP/CNP. Similarly, D-cysteine and Dproline bind 
preferentially to (+)-SP/CNP. In order to probe this effect, we studied the effect on the CD spectra 
of (-)-sparteine upon incremental additions of L-Cysteine (Figure S2.20). We found that the peak 
at 215 nm for (-)-sparteine shifted to 208-209 nm after treatment with L-Cys (Fig S5A) whereas 
the peak of (+)-sparteine shifts from 211 nm to 212 nm, a very insignificant shift upon treatment 
with L-Cys demonstrating that L-cysteine has significantly higher chiral interaction with (-)-
sparteine than (+)-sparteine. 
 
Supplementary Figure 2.20. Circular dichroism spectra of (-)-sparteine and its interaction with 
CNPs with incremental addition of CNPs (4 mg/mL stock). The samples were incubated for 1 h 
before the CD spectrum was recorded. 
 
The interaction between the carbon nanoparticles and (-)-/(+)-sparteine is purely physical and 
electrostatic in nature, presumably arising from the tertiary amines of sparteine and surface 
abundant carboxylic acids groups in CNPs.7b,e,f In order to get more insight, we studied the CD 
of (-)-sparteine alone and incremental addition of CNPs to (-)-sparteine. We observed that the CD 




APPENDIX B: SUPPORTING INFORMATION FOR CHAPTER 3 
 
 
Supplementary Scheme 3.1. Synthesis of pro-bexarotene from Bexarotene (1) and 1-palmitoyl-
2-hydroxy-sn-glycero-3-phosphocholine (16:0 Lyso PC) (2) in presence of EDC/DMAP (catalytic 
amount) in CHCl3 for 24 h at RT. (yield: 56%). 
 
Supplementary Figure 3.1. Chemical characterization of pro-bexarotene before and after 
cleavage under low pH and lipase enzyme condition. Spectroscopic signatures of pro-bexarotene 
under (A) HS-MS spectrometry and mass fragments of pro-bexarotene after exposure to (B) pH 



















Supplementary Table 3.1. Summary of CNP composition, preparation and characterization. All 
the samples were prepared in H2O as solvent and the processing condition was 250 °C for 1h. 
 
 























CNP 1 - - - 77±03 0.5±0.1 50±10 -21±2 
Lipid-
CNP 
1 100 - - 36±02 0.4±0.1 15±02 -30±2 
Drug-CNP 1 100 10 - 33±03 0.3±0.1 20±05 -31±2 
Prodrug-
CNP 





Supplementary Figure 3.2. 1H NMR assignment of (A:Top) Bexarotene, (B:2nd Top) doxorubicin 















Supplementary Figure 3.3. Spectroscopic characterization of various CNP formulations. FT-IR 
signatures of (A) Lipid-CNP; (B) Drug-CNP; (C) Prodrug-CNP; (D) Lipid; (E) DOX; (F) 
Bexarotene; (G) CNP; (H) DOX, (I) Lipid (J)  Bexarotene and Raman spectroscopic features of 







Supplementary Figure 3.4. Bright field images of MCF-7 cells (A) untreated and treated with 
(B) NaN3/GOD (10/50 mM; for 1h) alone and additional Incubation with (C) CNP (1 mg/mL); 
(D) Lipid-CNP (1 mg/mL); (E) Drug-CNP (1 mg/mL); (F) Prodrug-CNP (1 mg/mL); (G) Lipid (2 
μg/mL); (H) DOX (2 μg/mL) and (I) bexarotene (2 μg/mL) atmaking a concentration of 5% (v/v) 
in growth medium for 48h. A non-synchronized population of cells (10 x 103) were plated in 96 








Supplementary Figure 3.5. Bright field images of MCF-7 cells (A) untreated and treated with 
(B) Sucrose (450 mM; for 1h) alone and additional Incubation with (C) CNP (1 mg/mL); (D) 
Lipid-CNP (1 mg/mL); (E) Drug-CNP (1 mg/mL); (F) Prodrug-CNP (1 mg/mL); (G) Lipid (2 
μg/mL); (H) DOX (2 μg/mL) and (I) bexarotene (2 μg/mL) atmaking a concentration of 5% (v/v) 
in growth medium for 48h.. A non-synchronized population of cells (10 x 103) were plated in 96 














Supplementary Figure 3.6. Bright field images of  MCF-7 cells (A) untreated and treated with 
(B) Nystatin (180 nM; for 1h) alone and additional Incubation with (C) CNP (1 mg/mL); (D) Lipid-
CNP (1 mg/mL); (E) Drug-CNP (1 mg/mL); (F) Prodrug-CNP (1 mg/mL); (G) Lipid (2 μg/mL); 
(H) DOX (2 μg/mL) and (I) bexarotene (2 μg/mL) at making a concentration of 5% (v/v) in growth 
medium for 48h.. Non-synchronized population of cells (10 x 103) were plated in 96 well plates 










Supplementary Figure 3.7. Bright field images of  MCF-7 cells (A) untreated and treated with 
(B) Dynasore (80 μM; for 1h) alone and additional Incubation with (C) CNP (1 mg/mL); (D) Lipid-
CNP (1 mg/mL); (E) Drug-CNP (1 mg/mL); (F) Prodrug-CNP (1 mg/mL); (G) Lipid (2 μg/mL); 
(H) DOX (2 μg/mL) and (I) bexarotene (2 μg/mL) at making a concentration of 5% (v/v) in growth 
medium for 48h.. Non-synchronized population of cells (10 x 103) were plated in 96 well plates 












Supplementary Table 3.2. Inhibitors and their treatment conditions for achieving endocytic 










Inhibits oxidative phosphorylation via inhibition of 






Inhibits Clathrin mediated endocytosis 28 nM 1h 
Sucrose 
Inhibits transport from very early endosomes to 
lysosomes 
450 mM  1h 
Nystatin Inhibits Caveolar endocytosis 180 nM 1h 
Dynasore 
Inhibits both clathrin- and caveolae mediated 
endocytosis 









Supplementary Figure 3.8. Hyperspectral microscopy for evaluation of spectral variation by 
Lipid-CNP in (A) aq. solution phase (B) 6x zoom; (C) visualization of particles in suspension and 
verification by fluorescence spectra (D) small, (E) medium and (F) larger CNP areas. (G) 
Hyperspectral imaging on Lipid-CNP inside cellular system revealing (H) spectral library plot, (I) 





Supplementary Figure 3.9. Drug release kinetics from Drug-CNP particles. Experiments were 








APPENDIX C: SUPPORTING INFORMATION FOR CHAPTER 4 
 
 
Supplementary Figure 4.1. The steps for the preparation of the Hf PS NPs; Inside the 
microemulsion hafnium ethoxide got converted to the nanoparticles of Hafnium oxide where the 
nanoparticles with anhydrous diameter less than 5 nm were formed. The metal alkoxide, Hf 
ethoxide (with the chemical formula Hf (OEt)4) was utilized as the precursor and was added to a 
mixture of IGEPAL® CO-520 (surfactant), cyclohexane (oil phase), and ethanol (co-surfactant) 
for conversion into HfO2 NPs via a base-catalyzed sol-gel reaction using NaOH as base. 
Separately, water was added in reaction mixture followed by Hf alkoxide. Water droplets confine 
the particle synthesis to nonreactor domains, creating favorable mild conditions for the reaction. 
Subsequently, the silane was condensed on the nanoparticles surface to impart colloidal stability 
and the positive charge. In the final step, the nanoparticles were precipitated out and the emulsifier 
was removed through multiple washing steps. The samples were dried overnight in the vacuum 








Supplementary Figure 4.2. Hf PS NPs (0.2 mg.ml-1) after being centrifuged at 100, 200, 500, 
1000, 2000, 3000 rpm for 2 min. 
 
 
Supplementary Figure 4.3. Hf PS NPs (2 mg.ml-1) after being centrifuged at 100, 200, 500, 1000, 
2000, 3000 rpm for 2 min. 







Supplementary Figure 4.4. Physicochemical characterizations of Hf PS NPs; (A, B) TEM images 
of the Hf PS NPs; (C) Histogram of the particle size distribution of the NPs obtained via 100 
random measurements of TEM micrographs. The average anhydrous diameter of the NPs was 
3.7±0.6 nm. The XPS peaks of Hf PS NPs and the corresponding peak decomposition for the 
narrow scan for (D) Si and (E) N. The silanol bond in A is observed and the amino groups of 






Supplementary Figure 4.5. The micro-CT 3D-renderings of the tooth phantom; (A) and (B) The 
arrows indicate the NPs. (C) the pixel intensity comparison before and after NP deposition in the 




Supplementary Figure 4.6. The change in the optical density of S.mutans exposed to 2, 1, 0.5, 







Supplementary Figure 4.7. The live/dead population ratios after 24 h; The results are obtained 
via fluorometric assay using a plate reader.  
 
Supplementary Figure 4.8. The dose dependent bactericidal properties measured by the optical 
density at 600 nm to determine the MIC50 at (A) 2 h and (B) 24 h. Hf PS NPs were applied to the 
bacteria grown to initial OD600=0.6 and were treated with nanoparticles in the range of 0.016 







Supplementary Figure 4.9. SEM micrographs of the treated vs non- treated bacteria; with (A-B) 
no treatment; Hf PS NP treatment, the arrows in (C-D) indicate swollen bacteria that were likely 
on the verge of bursting and death after for 2 h (2 mg.ml-1), and (E) Hf PS NP treatment for 24 h. 
The cellular features in (E-F) indicate morphological changes, the accumulation of cellular debris 
and the utter disruption of the cellular membrane. (F) demonstrate the feasibility of growing 
bacteria on the hydroxyapatite disc (representing the tooth surface) and the subsequent NP 
treatment. Morphological changes can be identified. The images were captured at various locations 






Supplementary Figure 4.10. TEM of bacteria after treatment with Hf PS NP; (A) cellular debris 





Supplementary Figure 4.11. TEM images of the internal structure of the bacteria; (A) untreated 










Supplementary Figure 4.12. Ninhydrin assay; (A) The calibration curve used for the 
determination of the primary amines in the ninhydrin assay. The linear trend was decided based 
on the Beer-Lambert’s law.  (B) the concentration of free amines was determined for the Hf PS 





Supplementary Figure 4.13. SEM micrographs of the bacteria treated with 0.2 mg.ml-1 for 20 













Supplementary Figure 4.15. Ex vivo antibacterial properties of Hf PS NPs; (A) A schematic 
representation of the stages of the ex vivo experiment. Biofilms were grown on human teeth for 48 
h. The teeth were then treated with various formulations for 20 min. The biofilms were scraped 
and spread on BHI agar plates: (B) control (no treatment) and treatment with (C) chlorhexidine 
and (D) Hf PS NPs. (E) Bacterial colony counts. In the statistical analysis, a p-value <0.05 was 
considered to be significantly different. (F) The sample preparation steps for the detection of 
bacteria with CT. Upon NP treatment, the bacteria tended to flocculate and settle down. (1) 
Untreated bacteria (2-4); bacteria treated with Hf PS NPs at 0.5, 1 and 1.5 mg.ml-1; (5) Hf PS NPs 
dispersed in water (0.5 mg.ml-1); (6) broth alone; and (7) bacteria treated with bacitracin (0.5 







Supplementary Figure 4.16. SEM of the biofilm grown on tooth; The biofilm grown for 48 h on 
the surface of the tooth and treated for 20 min with NPs. The samples were fixed and SEM imaging 
was done. The EDS confirmed the presence of Hf PS NPs. (A, B, C) are showing various 
magnification of the biofilm with increasing magnification of the same area. The arrow in B is 
indicating the cells damaged in the biofilm. The dotted area in C was scanned for EDS and the 






APPENDIX D: SUPPORTING INFORMATION FOR CHAPTER 5 
 
 
Supplementary Figure 5.1. left: PMMA calibration phantom with seven 200µL Eppendorf PCR 
inserts and five HA rod inserts. Right: Biological sample – micro damaged rat bone with Hf NTA 





















Supplementary Figure 5.4. 1H NMR spectroscopy of (A) α-Methoxy-ω-phosphate poly-ethylene 
glycol (PEG phosphate) (B) CDs (C) monophosphonated CDs. The peaks are assigned, and the 













Supplementary Figure 5.6. The comparison between the FTIR of the monophosphonated CDs 







Supplementary Figure 5.7. The IVIS fluorescence images of the (A) animal without treatment 











Supplementary Figure 6.1. The as-prepared nanoparticles after removing from microwave. The 














Supplementary Figure 6.3. XPS data of the raw algae (A) narrow scan of O1s and (B) narrow 


























Supplementary Figure 6.7. 1H NMR comparison between raw algae (bottom) and nanosalina 
particles. Note the similar features between the two spectra indicating the sustaining of the 

















Supplementary Figure 6.9. The bright field imaging comparison of UV treatment (B, D) and non 
UV treatment (A, C) in (A, B) Control C32 cells and (C, D) β-carotene cells. (E) MTT cell viability 
assay conducted at 2.5 mg.ml-1 of β-carotene under UV and non-UV irradiation. 
We have done the experiment in the C32 cells as shown in the Figure S6.9. The β-carotene had to 
be dispersed in DMSO due to the lack of solubility in aqueous media. We carried out the 
experiment at the 2.5 mg.ml-1. As could be seen here, β-carotene precipitated in the wells. 
However, the cell viability under UV is less than that of non-UV illuminated samples. Even 
though, the cell viability seems to be comparable with the UV irradiated algal NPs, the biggest 
hurdle with direct application of β-carotene is its solubility in the organic solvents due to its 
structural features which makes the application for biological purposes challenging. Moreover, 
this concentration should not be compared with the corresponding concentration of algal NPs 
because only a fraction of β-carotene would be present in the system. 
 
 
 
